{"id": "6b8bc3594012", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "dc994a3f6384", "text": "JSS = Junior Secondary School, JHS = Junior High School, SSS = Senior Secondary School, SHS = Senior High SchoolSurveyIn-depth interviewsFigures GhanaVariableN%N%%GenderFemale29351,3%1342%52,8%Male27848,7%1858%47,2%Age18–247012,3%13%24,7%*25-3412722,2%826%27,3%35–4411720,5%619%19,1%45–5410818,9%723%13,0%55–647613,3%619%7,3%65–74549,5%310%4,7%75 ≤193,3%00%3,8%Education**None569,8%310%28,5%Primary/JSS/JHS19133,5%826%34,1%Secondary/SHS/SSS17330,3%1032%27,3%Tertiary14926,1%1032%10,2%Unknown20,3%–––Area of livingRural area14024,5%826%49,1%Urban area43175,5%2374%50,9% *age group 15–19 was used, corrected to age range 18–19 and added to age group 20–24 **The figures from the educational attainment in Ghana and the four regions are from people 15 ≤ years old In this study, 14% of participants (n = 80) indicated they had never heard of the words “side effect”, “adverse drug reaction” or their local equivalents.", "entities": [], "input_ids": [2, 16883, 1036, 33, 22802, 4067, 5097, 16, 18093, 1036, 33, 22802, 2149, 5097, 16, 26571, 33, 14729, 4067, 5097, 16, 22705, 33, 14729, 2149, 10134, 28031, 10676, 1921, 17, 6070, 8038, 9344, 2352, 20685, 19313, 10844, 1022, 9, 56, 9, 9, 5125, 10140, 9578, 14806, 11436, 7912, 16, 23, 9, 12724, 1028, 9, 4764, 16, 28, 9, 4005, 28833, 6301, 16, 27, 9, 15659, 1025, 9, 4261, 16, 22, 9, 2632, 3928, 229, 20892, 6924, 1028, 16, 23, 9, 2590, 9, 2686, 16, 27, 9, 14, 2637, 17, 25676, 4282, 4460, 16, 22, 9, 6175, 1016, 9, 3225, 16, 23, 9, 3259, 229, 29904, 20347, 1008, 16, 25, 9, 5473, 1026, 9, 2282, 16, 21, 9, 3607, 229, 4584, 18175, 3928, 16, 29, 9, 4395, 1010, 9, 2590, 16, 20, 9, 4288, 229, 21402, 9171, 1010, 16, 23, 9, 5473, 1026, 9, 27, 16, 23, 9, 4459, 229, 5446, 10883, 16, 25, 9, 17966, 9, 24, 16, 27, 9, 4089, 373, 29056, 16, 23, 9, 2827, 9, 23, 16, 28, 9, 4767, 14, 14, 6046, 6369, 1026, 16, 28, 9, 17966, 9, 3158, 16, 25, 9, 3065, 19, 16883, 1036, 19, 18093, 12030, 12118, 6498, 16, 25, 9, 6175, 1016, 9, 3540, 16, 21, 9, 4067, 19, 22705, 19, 26571, 26654, 4294, 16, 23, 9, 9373, 1028, 9, 3225, 16, 23, 9, 10832, 22987, 4684, 16, 21, 9, 9373, 1028, 9, 2119, 16, 22, 9, 5435, 3520, 16, 23, 9, 229, 229, 229, 3403, 1927, 5818, 3176, 7317, 3403, 14482, 4561, 16, 25, 9, 6175, 1016, 9, 4343, 16, 21, 9, 7244, 3403, 7514, 23201, 16, 25, 9, 20528, 1006, 9, 2761, 16, 29, 9, 14, 2632, 2210, 2461, 229, 2282, 1982, 2251, 16, 7702, 1942, 2632, 3109, 2654, 229, 2282, 1930, 4057, 1942, 2632, 2210, 2036, 229, 2686, 14, 14, 1920, 5327, 2037, 1920, 8205, 17756, 1922, 20685, 1930, 1920, 3006, 3451, 2032, 2037, 4329, 2461, 373, 2739, 4156, 1922, 2052, 2161, 16, 2607, 9, 1927, 3003, 12, 56, 33, 3729, 13, 3391, 2611, 2430, 5211, 22938, 1927, 1920, 6906, 236, 4159, 2495, 237, 16, 236, 5246, 2838, 3227, 237, 2014, 2310, 3076, 17762, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "85737ddb20cb", "text": "Patients perceived such side effects as normal and reporting them held no relevance to them.", "entities": [], "input_ids": [2, 2132, 6523, 2427, 4159, 2564, 1966, 2791, 1930, 6605, 3581, 9865, 2239, 8043, 1942, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "3e0bbeefe10e", "text": "ConclusionThe key factors responsible for the inability of patients to report side effects from using ACT are lack of health education, attitude of some patients and the unpleasant behaviour of some health workers towards patients at the health facilities.", "entities": [], "input_ids": [2, 4180, 20536, 3834, 2790, 5061, 1958, 1920, 11752, 1927, 2132, 1942, 3809, 4159, 2564, 2037, 2193, 4033, 2032, 3630, 1927, 2436, 4767, 16, 14204, 1927, 2673, 2132, 1930, 1920, 25429, 6270, 1927, 2673, 2436, 7066, 5681, 2132, 2019, 1920, 2436, 8774, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "1e517fd4e359", "text": "The health professionals explained that some malaria patients only initiate treatment when the condition is severe and that this was responsible for some of the side effects and not necessarily the ACT.", "entities": [], "input_ids": [2, 1920, 2436, 9229, 6094, 1988, 2673, 7505, 2132, 2444, 11051, 2311, 2469, 1920, 2625, 1977, 4010, 1930, 1988, 2052, 1982, 5061, 1958, 2673, 1927, 1920, 4159, 2564, 1930, 2084, 9409, 1920, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 254, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 254, "end": 271, "label": "ADR", "text": "Swollen testicles"}, {"start": 311, "end": 334, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "c7f2fa273f3f", "text": "A 46-year old pharmacist shared his views this way on the issue:“Yes there is a procedure and what usually happens is that there is an institutional contact person that is the pharmacist, who is supposed to compile all the side effects people come to complain about.", "entities": [{"start": 1, "end": 24, "label": "PATIENT_DEMO", "text": "46-year old pharmacist"}], "input_ids": [2, 43, 4182, 17, 2476, 4156, 23400, 7115, 4167, 9792, 2052, 4222, 1990, 1920, 6972, 30, 236, 11633, 2276, 1977, 43, 4360, 1930, 4663, 5394, 20686, 1977, 1988, 2276, 1977, 1925, 6540, 5217, 5952, 1988, 1977, 1920, 23400, 16, 2746, 1977, 18310, 1942, 2059, 2383, 2136, 1920, 4159, 2564, 4329, 10449, 1942, 6581, 2005, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1bce2d9160c", "text": "Consequently, research studies that evaluated the performance of the new anti-malarials reported widespread severe side effects such as severe headache, body weakness, dizziness and vomiting [4, 5].", "entities": [{"start": 136, "end": 143, "label": "SEVERITY", "text": "severe"}, {"start": 143, "end": 151, "label": "ADR", "text": "headache"}, {"start": 153, "end": 166, "label": "ADR", "text": "body weakness"}, {"start": 168, "end": 177, "label": "ADR", "text": "dizziness"}, {"start": 182, "end": 190, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 7099, 16, 2659, 2351, 1988, 3747, 1920, 3604, 1927, 1920, 2814, 2246, 17, 29535, 1036, 2568, 9360, 4010, 4159, 2564, 2427, 1966, 4010, 12187, 16, 3362, 12175, 16, 24009, 1930, 13954, 37, 24, 16, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 3, 0, 3, 4, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f8a3f43705e2", "text": "Also, patients who experience side effects should be properly taken care of at the health facility during review visits.", "entities": [], "input_ids": [2, 2222, 16, 2132, 2746, 4848, 4159, 2564, 3066, 1998, 12846, 4208, 2859, 1927, 2019, 1920, 2436, 8598, 2409, 3043, 7870, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "590bfb302940", "text": "They added that poly-pharmacy was common within the health system and that drug interaction was more likely to cause some of the side effects that the patients complain about.", "entities": [], "input_ids": [2, 2611, 4057, 1988, 4286, 17, 14429, 1982, 3059, 2651, 1920, 2436, 2433, 1930, 1988, 2838, 2835, 1982, 2253, 3205, 1942, 3936, 2673, 1927, 1920, 4159, 2564, 1988, 1920, 2132, 6581, 2005, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a145da3c7c61", "text": "A 38-year old health worker had this to say on the issue:“Well, some patients vomit and there is dizziness as well, but it is the dizziness and the vomiting that I have heard a lot of people complained about.", "entities": [{"start": 2, "end": 28, "label": "PATIENT_DEMO", "text": "38-year old health worker"}, {"start": 77, "end": 84, "label": "ADR", "text": "vomit"}, {"start": 97, "end": 106, "label": "ADR", "text": "dizziness"}, {"start": 130, "end": 139, "label": "ADR", "text": "dizziness"}, {"start": 148, "end": 156, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 43, 3738, 17, 2476, 4156, 2436, 16187, 2430, 2052, 1942, 12471, 1990, 1920, 6972, 30, 236, 2486, 16, 2673, 2132, 13463, 1932, 1930, 2276, 1977, 24009, 1966, 2486, 16, 2308, 2176, 1977, 1920, 24009, 1930, 1920, 13954, 1988, 51, 2162, 22938, 43, 12026, 1927, 4329, 26199, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "979c1a5b0e93", "text": "Participants associated poor eating before taking their medications as the main cause of the side effects.", "entities": [], "input_ids": [2, 3003, 2458, 3930, 8979, 3119, 6303, 2310, 7719, 1966, 1920, 2730, 3936, 1927, 1920, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f5524806320b", "text": "And others will say that if I am strong enough to go to the facility why don’t I just go to the market and manage my business, so mostly that is the reason why they don’t come” (IDI: 29-year old health worker).Other patients said that previous reports of side effects yielded no benefits to them.", "entities": [{"start": 183, "end": 208, "label": "PATIENT_DEMO", "text": "29-year old health worker"}], "input_ids": [2, 1930, 4991, 2832, 12471, 1988, 2647, 51, 2150, 3206, 7867, 1942, 3611, 1942, 1920, 8598, 7348, 4330, 234, 62, 51, 6244, 3611, 1942, 1920, 10878, 1930, 12193, 3057, 16885, 16, 2577, 6969, 1988, 1977, 1920, 5070, 7348, 2611, 4330, 234, 62, 10449, 237, 12, 11407, 30, 3230, 17, 2476, 4156, 2436, 16187, 13, 18, 2303, 2132, 12029, 1988, 2555, 4710, 1927, 4159, 2564, 8193, 2239, 6382, 1942, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "d2f4bec877ba", "text": "Only a few patients reported receiving information on side effects of the ACT that was given but none reported being told to report back to the health facility if they experienced any side effects.", "entities": [], "input_ids": [2, 2444, 43, 3855, 2132, 2568, 5962, 2988, 1990, 4159, 2564, 1927, 1920, 4033, 1988, 1982, 3258, 2308, 6046, 2568, 3301, 18313, 1942, 3809, 3231, 1942, 1920, 2436, 8598, 2647, 2611, 6090, 2967, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "91ce1bfbe699", "text": "Purchasing medicines from unlicensed and itinerant sellers makes it difficult for patients to report ADRs because sometimes they are reluctant to mention or cannot trace where or whom they bought their medicines from as the interviews revealed.Table 3Identified obstacles experienced in ADR-reporting by Ghanaian patients and possible solutions to itObstaclePotential solutionsPoor dispensing practices of medicinesImprove the regulation of medicine dispensing practices.Urging pharmaceutical companies to produce smaller medicine boxesEducate HCWs on good dispensary practices of medicines in their education program and by in-service training.Substandard recognition of ADRs by patientsHCWs and primary schools should focus on educating (lower educated) patients on ADRs and how to recognize and assess ADRs.An easy tool can be developed to assist patients in the recognition and assessment of ADRs.Skipping the first line of healthcare in reporting ADRsThe authorities concerned need to make patients more aware of avenues to report and particularly urge patients to report ADRs to their first line of care which is the pharmacy attendants and then other HCWs.Pharmacists or attendants in turn need to improve their participation in ADR-reporting by improving their patient engagement with the hope of establishing a lasting trust-based relationship.Lacking awareness to report ADRs to HCWsBetter information provision practices from HCWs by including ADR reporting/patient education in the curriculum of healthcare disciplinesTargeted campaigns by the Ghana-FDA.Socio-economic differences between patients and HCWsPoint out alternative options for patient reporting of ADRs such as their first line of care (pharmacist) and/or the PRS.Lacking awareness of the PRS and willingness to use itCampaigns to make patients aware of the PRSCreating a patient-friendly version of the PRSThe second identified obstacle is substandard recognition of ADRs.", "entities": [], "input_ids": [2, 6336, 3274, 12864, 2037, 4774, 2927, 3355, 1919, 1930, 2176, 15120, 2031, 24908, 2045, 7645, 2176, 4571, 1958, 2132, 1942, 3809, 28863, 2882, 8929, 2611, 2032, 25287, 2031, 1942, 14515, 2014, 5156, 9950, 2597, 2014, 8566, 2611, 4078, 15130, 2310, 12864, 2037, 1966, 1920, 8038, 3404, 18, 2545, 29879, 5233, 11666, 20240, 6090, 1922, 17645, 17, 6605, 2007, 20685, 3122, 2132, 1930, 3216, 6551, 1942, 21384, 2083, 3857, 3283, 13067, 2514, 6551, 7056, 1924, 29857, 7300, 1927, 12864, 15230, 1931, 1961, 1920, 3640, 1927, 5380, 29857, 7300, 18, 11460, 1941, 11106, 15470, 1942, 5074, 5322, 5380, 12746, 1919, 29394, 2057, 4387, 8327, 1990, 4227, 13404, 2141, 7300, 1927, 12864, 1922, 2310, 4767, 3688, 1930, 2007, 1922, 17, 5948, 4096, 18, 4787, 3825, 8544, 5708, 1927, 28863, 2007, 2132, 7727, 8327, 1930, 3065, 10134, 3066, 3691, 1990, 4066, 2287, 12, 2826, 17696, 13, 2132, 1990, 28863, 1930, 2307, 1942, 9967, 1930, 2634, 28863, 18, 1925, 9040, 5229, 2112, 1998, 3530, 1942, 6589, 2132, 1922, 1920, 5708, 1930, 4076, 1927, 28863, 18, 26153, 1920, 2561, 2823, 1927, 5841, 1922, 6605, 28863, 20536, 18422, 13629, 2942, 1942, 5144, 2132, 2253, 11207, 1927, 24890, 1942, 3809, 1930, 4443, 11460, 1021, 2132, 1942, 3809, 28863, 1942, 2310, 2561, 2823, 1927, 2859, 2154, 1977, 1920, 14429, 10396, 2356, 1930, 2759, 2303, 4387, 8327, 18, 18019, 2014, 10396, 2356, 1922, 5165, 2942, 1942, 3326, 2310, 7204, 1922, 17645, 17, 6605, 2007, 7440, 2310, 2774, 9577, 1956, 1920, 12737, 1927, 11810, 43, 11671, 10626, 17, 2454, 3303, 18, 7046, 8755, 1942, 3809, 28863, 1942, 4387, 8327, 5873, 3519, 1915, 2988, 11148, 7300, 2037, 4387, 8327, 2007, 2710, 17645, 6605, 19, 2774, 4767, 1922, 1920, 15818, 1927, 5841, 20323, 3857, 1005, 6978, 1919, 20780, 2007, 1920, 20685, 17, 11394, 18, 7410, 17, 7029, 2886, 2192, 2132, 1930, 4387, 8327, 6881, 2397, 5012, 8416, 1958, 2774, 6605, 1927, 28863, 2427, 1966, 2310, 2561, 2823, 1927, 2859, 12, 23400, 13, 1930, 19, 2014, 1920, 20509, 18, 7046, 8755, 1927, 1920, 20509, 1930, 17092, 1942, 2485, 21761, 3456, 13744, 1036, 1942, 5144, 2132, 11207, 1927, 1920, 20509, 18662, 2287, 43, 2774, 17, 18494, 4671, 1927, 1920, 20509, 20536, 2812, 2899, 21123, 1977, 4787, 3825, 8544, 5708, 1927, 28863, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking artesunate-amodiaquine.“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 32-year old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 128, "label": "DRUG", "text": "artesunate-amodiaquine."}, {"start": 147, "end": 169, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 177, "end": 188, "label": "ADR", "text": "chest pains"}, {"start": 194, "end": 202, "label": "ADR", "text": "vomited"}, {"start": 210, "end": 236, "label": "PATIENT_DEMO", "text": "32-year old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 18, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f172a686d2bb", "text": "The most commonly reported side effects were general body weakness and dizziness.", "entities": [{"start": 45, "end": 67, "label": "ADR", "text": "general body weakness"}, {"start": 71, "end": 80, "label": "ADR", "text": "dizziness"}], "input_ids": [2, 1920, 2501, 5384, 2568, 4159, 2564, 1985, 3335, 3362, 12175, 1930, 24009, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 3, 0, -100], "source_type": "qualitative_interview"}
{"id": "5d7510510656", "text": "Majority of the patients who took artesunate-amodiaquine and artemether-lumefantrine, respectively, reported to have experienced side effects such as body weakness, dizziness, itching and abdominal pain [5–14].", "entities": [{"start": 34, "end": 57, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 60, "end": 84, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 150, "end": 163, "label": "ADR", "text": "body weakness"}, {"start": 165, "end": 174, "label": "ADR", "text": "dizziness"}, {"start": 176, "end": 183, "label": "ADR", "text": "itching"}, {"start": 188, "end": 202, "label": "ADR", "text": "abdominal pain"}], "input_ids": [2, 4827, 1927, 1920, 2132, 2746, 8659, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 1930, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 16, 2763, 16, 2568, 1942, 2162, 6090, 4159, 2564, 2427, 1966, 3362, 12175, 16, 24009, 16, 20687, 1941, 1930, 6900, 3594, 37, 25, 229, 2607, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "37cb945d14f6", "text": "Patients were of the opinion that there should be a policy whereby people who took ACT and got side effects should not be made to join long queues at the hospital during review visits.“The nurses should have patience when dealing with people at the health facility.", "entities": [], "input_ids": [2, 2132, 1985, 1927, 1920, 13360, 1988, 2276, 3066, 1998, 43, 7299, 12507, 4329, 2746, 8659, 4033, 1930, 14643, 4159, 2564, 3066, 2084, 1998, 3915, 1942, 23604, 2815, 10730, 2291, 2019, 1920, 3461, 2409, 3043, 7870, 18, 236, 1920, 8203, 3066, 2162, 2091, 2055, 2469, 17463, 1956, 4329, 2019, 1920, 2436, 8598, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6518fc1325ac", "text": "We got this experience from our father who died of malaria” (IDI: 32-year old female patient).Similar views were shared by health professionals and chemical shop owners on the side effects patients with malaria experience from using ACT.", "entities": [{"start": 66, "end": 93, "label": "PATIENT_DEMO", "text": "32-year old female patient)"}], "input_ids": [2, 2038, 14643, 2052, 4848, 2037, 2342, 14854, 2746, 8545, 1927, 7505, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 4232, 2774, 13, 18, 2551, 9792, 1985, 7115, 2007, 2436, 9229, 1930, 4399, 25160, 15373, 1990, 1920, 4159, 2564, 2132, 1956, 7505, 4848, 2037, 2193, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "719820e3cdff", "text": "They were particularly concerned about overdosing of medications, including ACT, by some patients as a contributor to these side effects.“The other reason is that they think that when they take overdose it will help to cure the illness fast and this makes them get the side effect.", "entities": [], "input_ids": [2, 2611, 1985, 4443, 13629, 3001, 17612, 11934, 1927, 7719, 16, 2710, 4033, 16, 2007, 2673, 2132, 1966, 43, 17679, 1942, 2144, 4159, 2564, 18, 236, 1920, 2303, 5070, 1977, 1988, 2611, 8727, 1988, 2469, 2611, 6132, 21090, 2176, 2832, 4087, 1942, 12338, 1920, 6455, 5867, 1930, 2052, 7645, 3581, 7691, 1920, 4159, 2495, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4908fb42d3ae", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 96, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 187, "label": "ADR", "text": "poor vision"}, {"start": 212, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 248, "label": "ADR", "text": "difficulty to hear"}, {"start": 265, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5edd1e1ba1d0", "text": "The health workers reported non-adherence to the dosing regimen as a significant contributor to side effects.", "entities": [], "input_ids": [2, 1920, 2436, 7066, 2568, 2447, 17, 7015, 1942, 1920, 10654, 8607, 1966, 43, 2228, 17679, 1942, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6a858f082579", "text": "Body weakness and dizziness are the most frequent side effects many of the patients reported.", "entities": [{"start": 0, "end": 13, "label": "ADR", "text": "Body weakness"}, {"start": 18, "end": 27, "label": "ADR", "text": "dizziness"}], "input_ids": [2, 3362, 12175, 1930, 24009, 2032, 1920, 2501, 6439, 4159, 2564, 3086, 1927, 1920, 2132, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f9bce99c9651", "text": "The participants reported that this was common with patients who suffered side effects due to non-adherence to the dosing regimen because they were likely to be verbally abused by the health workers.", "entities": [], "input_ids": [2, 1920, 3003, 2568, 1988, 2052, 1982, 3059, 1956, 2132, 2746, 13949, 4159, 2564, 2810, 1942, 2447, 17, 7015, 1942, 1920, 10654, 8607, 2882, 2611, 1985, 3205, 1942, 1998, 10011, 1954, 7764, 1007, 2007, 1920, 2436, 7066, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "76cd3a824efd", "text": "Opinions from patients who use artesunate-amodiaquine in this study suggested that the components are still high and that could be the reason why they are still experiencing these side effects.", "entities": [{"start": 31, "end": 53, "label": "DRUG", "text": "artesunate-amodiaquine"}], "input_ids": [2, 17689, 2037, 2132, 2746, 2485, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 1922, 2052, 2161, 3978, 1988, 1920, 4178, 2032, 3974, 2149, 1930, 1988, 2578, 1998, 1920, 5070, 7348, 2611, 2032, 3974, 12511, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "fd3d11df49fd", "text": "So we have to monitor the person and make sure that he/she takes the drug correctly and if the same side effects are presented then you have to change treatment for the person and see” (IDI: 46-year old pharmacist).", "entities": [{"start": 191, "end": 213, "label": "PATIENT_DEMO", "text": "46-year old pharmacist"}], "input_ids": [2, 2577, 2038, 2162, 1942, 8434, 1920, 5952, 1930, 5144, 16320, 1988, 2234, 19, 4693, 9620, 1920, 2838, 10329, 1930, 2647, 1920, 2841, 4159, 2564, 2032, 3549, 2759, 6253, 2162, 1942, 3185, 2311, 1958, 1920, 5952, 1930, 3365, 237, 12, 11407, 30, 4182, 17, 2476, 4156, 23400, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "9e21d54664cc", "text": "Patients with mild side effects were able to contain them at home and severe cases reported to health facilities.", "entities": [{"start": 13, "end": 18, "label": "SEVERITY", "text": "mild"}, {"start": 69, "end": 77, "label": "SEVERITY", "text": "severe"}], "input_ids": [2, 2132, 1956, 5809, 4159, 2564, 1985, 4236, 1942, 5531, 3581, 2019, 4502, 1930, 4010, 2919, 2568, 1942, 2436, 8774, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5f5cf273de2a", "text": "It is possible that these differences in views on the side effects on the use of ACT could be as a result of differences in individual human system.Patients are supposed to eat very well before using these medications.", "entities": [], "input_ids": [2, 2176, 1977, 3216, 1988, 2144, 2886, 1922, 9792, 1990, 1920, 4159, 2564, 1990, 1920, 2485, 1927, 4033, 2578, 1998, 1966, 43, 3211, 1927, 2886, 1922, 2725, 2616, 2433, 18, 2132, 2032, 18310, 1942, 13619, 3345, 2486, 3119, 2193, 2144, 7719, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c6202105654a", "text": "Older participants were significantly more likely to be familiar with the words “side effect”, “ADR” or their local translation (p = 0.004) compared to younger participants.", "entities": [], "input_ids": [2, 4706, 3003, 1985, 2567, 2253, 3205, 1942, 1998, 10859, 1956, 1920, 6906, 236, 4159, 2495, 237, 16, 236, 17645, 237, 2014, 2310, 3076, 6410, 12, 58, 33, 20, 18, 11373, 13, 2452, 1942, 7237, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "1b83bb52b148", "text": "These side effects have not been reported in this study.", "entities": [], "input_ids": [2, 2144, 4159, 2564, 2162, 2084, 2252, 2568, 1922, 2052, 2161, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "92245425f03a", "text": "For example, one participant described an ADR as: “If you should take the drug and should become plenty, it gives you a side effect.” [Participant 7: male, finished primary school].", "entities": [{"start": 149, "end": 154, "label": "PATIENT_DEMO", "text": "male"}, {"start": 156, "end": 179, "label": "PATIENT_DEMO", "text": "finished primary school"}], "input_ids": [2, 1958, 3534, 16, 2340, 6323, 2910, 1925, 17645, 1966, 30, 236, 2647, 6253, 3066, 6132, 1920, 2838, 1930, 3066, 5433, 6483, 4905, 1012, 16, 2176, 10006, 6253, 43, 4159, 2495, 18, 237, 37, 6323, 27, 30, 4005, 16, 23507, 3065, 5097, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 0, 7, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1698bc5c842", "text": "Despite the fact that some level of health education has been given to patients by health workers on the use of ACT and how to prevent malaria, there is a need for health workers to specifically educate patients on the side effects of ACT.It is, therefore, recommended that intensive and continued education should be incorporated into the routine health care activities.", "entities": [], "input_ids": [2, 4281, 1920, 2371, 1988, 2673, 2237, 1927, 2436, 4767, 2258, 2252, 3258, 1942, 2132, 2007, 2436, 7066, 1990, 1920, 2485, 1927, 4033, 1930, 2307, 1942, 4625, 7505, 16, 2276, 1977, 43, 2942, 1958, 2436, 7066, 1942, 4475, 4066, 2010, 2132, 1990, 1920, 4159, 2564, 1927, 4033, 18, 2176, 1977, 16, 2955, 16, 6198, 1988, 8100, 1930, 7583, 4767, 3066, 1998, 8800, 2460, 1920, 7341, 2436, 2859, 4209, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6cc7bd9848be", "text": "Instead of them to tell you that when you take the drug and get side effects, you should come back to complain they don’t do that.", "entities": [], "input_ids": [2, 5974, 1927, 3581, 1942, 17812, 6253, 1988, 2469, 6253, 6132, 1920, 2838, 1930, 7691, 4159, 2564, 16, 6253, 3066, 10449, 3231, 1942, 6581, 2005, 2611, 4330, 234, 62, 2608, 1988, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "10cf568d694e", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears”(IDI: 38-year old health worker).The health workers explained that some malaria patients only initiate treatment when the condition is severe and that this was responsible for some of the side effects and not necessarily ACT.", "entities": [{"start": 23, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 83, "end": 102, "label": "ADR", "text": "noise in their ears"}, {"start": 108, "end": 134, "label": "PATIENT_DEMO", "text": "38-year old health worker"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 30, 3738, 17, 2476, 4156, 2436, 16187, 13, 18, 1920, 2436, 7066, 6094, 1988, 2673, 7505, 2132, 2444, 11051, 2311, 2469, 1920, 2625, 1977, 4010, 1930, 1988, 2052, 1982, 5061, 1958, 2673, 1927, 1920, 4159, 2564, 1930, 2084, 9409, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4e795e092314", "text": "DiscussionThe study presents reported side effects as are experienced from using ACT to treat uncomplicated malaria using qualitative approach.", "entities": [], "input_ids": [2, 7248, 20536, 2161, 8178, 2568, 4159, 2564, 1966, 2032, 6090, 2037, 2193, 4033, 1942, 2297, 22050, 7505, 2193, 7678, 2998, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "8c7989eb92a9", "text": "According to the study participants, patients’ inability to eat food before using the drugs made them to experience these side effects.", "entities": [], "input_ids": [2, 3147, 1942, 1920, 2161, 3003, 16, 2132, 234, 11752, 1942, 13619, 3959, 3119, 2193, 1920, 4195, 3915, 3581, 1942, 4848, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4835553e0798", "text": "Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [], "input_ids": [2, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f2fc36d10989", "text": "Artemether-lumefantrine and dihydroartemisinin-piperaquine were subsequently added as first-line anti-malarial treatment for uncomplicated malaria to cater for those who could not tolerate the artesunate-amodiaqiune [7].These different artemisinin-based combinations have been used to treat uncomplicated malaria in Ghana for about a decade now.", "entities": [{"start": 0, "end": 23, "label": "DRUG", "text": "Artemether-lumefantrine"}, {"start": 27, "end": 58, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}, {"start": 193, "end": 216, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1930, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1985, 5326, 4057, 1966, 2561, 17, 2823, 2246, 17, 29535, 2311, 1958, 22050, 7505, 1942, 3115, 1915, 1958, 2690, 2746, 2578, 2084, 21407, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 19640, 17014, 37, 27, 39, 18, 2144, 2413, 27730, 17, 2454, 7763, 2162, 2252, 2251, 1942, 2297, 22050, 7505, 1922, 20685, 1958, 3001, 43, 10468, 5195, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 2, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "526199857826", "text": "Some patients shared their experiences in the excerpts below.“I was given artesunate-amodiaquine and when I started taking the drug I could not do anything because my whole body was weak” (IDI: 29-year old male patient).The other side effects reported were vomiting, chest pains, itching, loss of appetite, poor vision and shivering.", "entities": [{"start": 74, "end": 97, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 164, "end": 186, "label": "ADR", "text": "my whole body was weak"}, {"start": 193, "end": 218, "label": "PATIENT_DEMO", "text": "29-year old male patient"}, {"start": 257, "end": 265, "label": "ADR", "text": "vomiting"}, {"start": 267, "end": 278, "label": "ADR", "text": "chest pains"}, {"start": 280, "end": 287, "label": "ADR", "text": "itching"}, {"start": 289, "end": 305, "label": "ADR", "text": "loss of appetite"}, {"start": 306, "end": 318, "label": "ADR", "text": "poor vision"}, {"start": 323, "end": 332, "label": "ADR", "text": "shivering"}], "input_ids": [2, 2673, 2132, 7115, 2310, 7651, 1922, 1920, 5585, 11119, 1973, 4535, 18, 236, 51, 1982, 3258, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 1930, 2469, 51, 8074, 6303, 1920, 2838, 51, 2578, 2084, 2608, 22491, 2882, 3057, 4292, 3362, 1982, 5015, 237, 12, 11407, 30, 3230, 17, 2476, 4156, 4005, 2774, 13, 18, 1920, 2303, 4159, 2564, 2568, 1985, 13954, 16, 8475, 3594, 1036, 16, 20687, 1941, 16, 3257, 1927, 17990, 16, 3930, 9266, 1930, 20837, 2004, 1941, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 4, 4, 0, 3, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "adc8f7ef8559", "text": "The health professionals were selected to share their experiences on the side effects of ACT and the factors affecting side effects reporting.Data collectionThe in-depth interviews were conducted by trained university graduates with experience in qualitative research technique.", "entities": [], "input_ids": [2, 1920, 2436, 9229, 1985, 3790, 1942, 7948, 2310, 7651, 1990, 1920, 4159, 2564, 1927, 4033, 1930, 1920, 2790, 7359, 4159, 2564, 6605, 18, 2230, 4957, 20536, 1922, 17, 6070, 8038, 1985, 3609, 2007, 7800, 3926, 25378, 1956, 4848, 1922, 7678, 2659, 4778, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a5656106f8c0", "text": "Earlier study reported that because of lack of knowledge, seventy-five percent (75) % of those who experienced side effects did not report to health workers [4].Based on the views shared by participants, health workers are not educating patients on the possible side effects they are likely to experience and the need to report them.", "entities": [], "input_ids": [2, 5556, 2161, 2568, 1988, 2882, 1927, 3630, 1927, 4163, 16, 16270, 17, 3628, 3564, 12, 4089, 13, 9, 1927, 2690, 2746, 6090, 4159, 2564, 2811, 2084, 3809, 1942, 2436, 7066, 37, 24, 39, 18, 2454, 1990, 1920, 9792, 7115, 2007, 3003, 16, 2436, 7066, 2032, 2084, 4066, 2287, 2132, 1990, 1920, 3216, 4159, 2564, 2611, 2032, 3205, 1942, 4848, 1930, 1920, 2942, 1942, 3809, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4cc93eff6a83", "text": "Although most of the causes of the side effects were drug-related, some were due to the introduction of generics that were poorly formulated and poor compliance to drug regimens [4].Ghana changed her first-line anti-malarial drug policy in 2004, from chloroquine to the use of artesunate-amodiaquine as the first-line drug for the treatment of uncomplicated malaria [7].", "entities": [{"start": 251, "end": 262, "label": "DRUG", "text": "chloroquine"}, {"start": 277, "end": 299, "label": "DRUG", "text": "artesunate-amodiaquine"}], "input_ids": [2, 2876, 2501, 1927, 1920, 5092, 1927, 1920, 4159, 2564, 1985, 2838, 17, 2712, 16, 2673, 1985, 2810, 1942, 1920, 6935, 1927, 13459, 1036, 1988, 1985, 7865, 16174, 1930, 3930, 9135, 1942, 2838, 9922, 37, 24, 39, 18, 20685, 7003, 3656, 2561, 17, 2823, 2246, 17, 29535, 2838, 7299, 1922, 4247, 16, 2037, 20813, 1942, 1920, 2485, 1927, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 1966, 1920, 2561, 17, 2823, 2838, 1958, 1920, 2311, 1927, 22050, 7505, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "87aeb0631c5d", "text": "Others however thought that the components of artesunate-amodiaqiune were too high for them and, therefore, the side effects.", "entities": [{"start": 45, "end": 68, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4991, 2406, 6212, 1988, 1920, 4178, 1927, 20897, 20490, 5791, 1021, 17, 2150, 13968, 19640, 17014, 1985, 7405, 2149, 1958, 3581, 1930, 16, 2955, 16, 1920, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "954aa74eadbf", "text": "The temporal assessment of an ADR is illustrated by a quote: “The way I was before I visited the hospital, it has become over (after taking the medicine).” [Participant 11: female, no education].Only one participant assessed an ADR with the help of a family member.", "entities": [{"start": 173, "end": 179, "label": "PATIENT_DEMO", "text": "female"}, {"start": 180, "end": 193, "label": "PATIENT_DEMO", "text": "no education"}], "input_ids": [2, 1920, 5338, 4076, 1927, 1925, 17645, 1977, 9125, 2007, 43, 2571, 7229, 30, 236, 1920, 4222, 51, 1982, 3119, 51, 17365, 1920, 3461, 16, 2176, 2258, 5433, 2338, 12, 2256, 6303, 1920, 5380, 13, 18, 237, 37, 6323, 2513, 30, 4232, 16, 2239, 4767, 39, 18, 2444, 2340, 6323, 3683, 1925, 17645, 1956, 1920, 4087, 1927, 43, 3416, 7210, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "e1bf040441bb", "text": "Other participants mentioned every effect after taking a medicine (n = 4), an unexpected effect after taking a medicine (n = 3), the effect after taking an overdose of a medicine (n = 2) or the medicine is not working (n = 1) as definitions of an ADR.", "entities": [], "input_ids": [2, 2303, 3003, 6996, 4808, 2495, 2256, 6303, 43, 5380, 12, 56, 33, 24, 13, 16, 1925, 9892, 2495, 2256, 6303, 43, 5380, 12, 56, 33, 23, 13, 16, 1920, 2495, 2256, 6303, 1925, 21090, 1927, 43, 5380, 12, 56, 33, 22, 13, 2014, 1920, 5380, 1977, 2084, 5905, 12, 56, 33, 21, 13, 1966, 11952, 1927, 1925, 17645, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "b0deef8077ae", "text": "Two participants indicated they did not know the medicine that caused the ADR, because they took multiple drugs: “If I was taking one particular medicine, I would say ‘okay when I take this medicine, this is the side effect’.", "entities": [], "input_ids": [2, 2288, 3003, 3391, 2611, 2811, 2084, 3758, 1920, 5380, 1988, 4189, 1920, 17645, 16, 2882, 2611, 8659, 3137, 4195, 30, 236, 2647, 51, 1982, 6303, 2340, 3278, 5380, 16, 51, 2962, 12471, 233, 12167, 2050, 2469, 51, 6132, 2052, 5380, 16, 2052, 1977, 1920, 4159, 2495, 234, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2e093b8ba60b", "text": "Now that they said it is as a result of the drug and nothing else why then would you waste your time going if you take the drug again and get these side effects.", "entities": [], "input_ids": [2, 5195, 1988, 2611, 12029, 2176, 1977, 1966, 43, 3211, 1927, 1920, 2838, 1930, 20076, 19467, 7348, 2759, 2962, 6253, 10437, 10186, 2367, 12250, 2647, 6253, 6132, 1920, 2838, 3116, 1930, 7691, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "b78cb8a22a5a", "text": "Patients preferred to endure such side effects at home rather than report them to the health facility with the reason that every drug has a side effect and therefore it was normal to experience them.“The reason is that I know the way it works and that made me not to go back and I was waiting to see what would happen after the third day….So because I know how the drug works is the reason why I did not go back to tell them” (IDI: 30-year old female patient).Participants also identified long queues at the OPD that led to long waiting-time before receiving care as a critical factor that affect the reporting of adverse events.", "entities": [{"start": 432, "end": 458, "label": "PATIENT_DEMO", "text": "30-year old female patient"}], "input_ids": [2, 2132, 8579, 1942, 2482, 2027, 2427, 4159, 2564, 2019, 4502, 4356, 2254, 3809, 3581, 1942, 1920, 2436, 8598, 1956, 1920, 5070, 1988, 4808, 2838, 2258, 43, 4159, 2495, 1930, 2955, 2176, 1982, 2791, 1942, 4848, 3581, 18, 236, 1920, 5070, 1977, 1988, 51, 3758, 1920, 4222, 2176, 10997, 1930, 1988, 3915, 2142, 2084, 1942, 3611, 3231, 1930, 51, 1982, 15215, 1942, 3365, 4663, 2962, 20492, 2256, 1920, 4563, 3007, 244, 18, 2577, 2882, 51, 3758, 2307, 1920, 2838, 10997, 1977, 1920, 5070, 7348, 51, 2811, 2084, 3611, 3231, 1942, 17812, 3581, 237, 12, 11407, 30, 2627, 17, 2476, 4156, 4232, 2774, 13, 18, 3003, 2222, 2899, 2815, 10730, 2291, 2019, 1920, 2494, 1007, 1988, 4866, 1942, 2815, 15215, 17, 2367, 3119, 5962, 2859, 1966, 43, 4140, 2991, 1988, 4081, 1920, 6605, 1927, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c4ca791e4fc6", "text": "Of 439 participants that received medicines from the dispensary, 6% received information about possible side effects of medicines from their HCW.Table 2Persons or institutions to whom the participants reported or would report an adverse drug reaction (ADR).", "entities": [], "input_ids": [2, 1927, 3941, 1026, 3003, 1988, 4004, 12864, 2037, 1920, 13404, 2141, 16, 26, 9, 4004, 2988, 3001, 3216, 4159, 2564, 1927, 12864, 2037, 2310, 4387, 1018, 18, 2545, 21981, 12269, 1036, 2014, 10977, 1942, 8566, 1920, 3003, 2568, 2014, 2962, 3809, 1925, 5246, 2838, 3227, 12, 17645, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "1ca1af282bf4", "text": "The health professionals were selected to share their experiences on the side effects of ACT and the factors affecting side effects reporting.", "entities": [], "input_ids": [2, 1920, 2436, 9229, 1985, 3790, 1942, 7948, 2310, 7651, 1990, 1920, 4159, 2564, 1927, 4033, 1930, 1920, 2790, 7359, 4159, 2564, 6605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "3bfce90f3beb", "text": "This will encourage patients who experience side effects to report them.", "entities": [], "input_ids": [2, 2052, 2832, 14549, 2132, 2746, 4848, 4159, 2564, 1942, 3809, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2df3dddb42fd", "text": "This is the one other reason why such people who get these side effects do not report”(IDI: 26-year old female patient).", "entities": [{"start": 92, "end": 118, "label": "PATIENT_DEMO", "text": "26-year old female patient"}], "input_ids": [2, 2052, 1977, 1920, 2340, 2303, 5070, 7348, 2427, 4329, 2746, 7691, 2144, 4159, 2564, 2608, 2084, 3809, 237, 12, 11407, 30, 3179, 17, 2476, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "0b8a120dbaa0", "text": "ADR = adverse drug reaction, HCW = health care workerThe way patients discover ADRs (Discovery) and reasons why they act when experiencing an ADR (Action) were two themes within the conceptual framework based on earlier studies [17, 18, 21, 23].", "entities": [], "input_ids": [2, 17645, 33, 5246, 2838, 3227, 16, 4387, 1018, 33, 2436, 2859, 16187, 20536, 4222, 2132, 5079, 28863, 12, 7139, 13, 1930, 6662, 7348, 2611, 4033, 2469, 12511, 1925, 17645, 12, 4615, 13, 1985, 2288, 12181, 2651, 1920, 9829, 6465, 2454, 1990, 5556, 2351, 37, 2752, 16, 2654, 16, 2900, 16, 3020, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "7e7ec92d38f3", "text": "ResultsExperience of side-effects of ACTThe findings revealed that participants who took artesunate-amodiaqiune to treat malaria reported most side effects.", "entities": [{"start": 89, "end": 111, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 2274, 15583, 18842, 2055, 1927, 4159, 17, 2564, 1927, 4033, 20536, 3056, 3404, 1988, 3003, 2746, 8659, 20897, 20490, 5791, 1021, 17, 2150, 13968, 19640, 17014, 1942, 2297, 7505, 2568, 2501, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "0082195ab134", "text": "The problem is that when they take the drugs wrongly and get problems (side effects) at home, they are afraid to go and tell the doctor because they do not know what the doctor would say and sometime, they could be insulted by these health workers.", "entities": [], "input_ids": [2, 1920, 4915, 1977, 1988, 2469, 2611, 6132, 1920, 4195, 18065, 1954, 1930, 7691, 4951, 12, 4159, 2564, 13, 2019, 4502, 16, 2611, 2032, 2221, 5524, 1960, 1942, 3611, 1930, 17812, 1920, 11622, 2882, 2611, 2608, 2084, 3758, 4663, 1920, 11622, 2962, 12471, 1930, 2673, 6995, 16, 2611, 2578, 1998, 20110, 1919, 2007, 2144, 2436, 7066, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "94d48abf79be", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 97, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 188, "label": "ADR", "text": "poor vision"}, {"start": 213, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 247, "label": "ADR", "text": "difficulty to hear"}, {"start": 266, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, -100], "source_type": "qualitative_interview"}
{"id": "be6830eb7dbe", "text": "So we have to monitor the person and make sure that he/she takes the drug correctly and if the same side effects are presented then you have to change treatment for the person and see” (IDI: 46-year old pharmacist).Factors affecting adverse events reportingProvider and patient-related factors were the two broad factors identified to be responsible for the low reports of adverse drug reactions in the study area.Provider-related factorsThe providers reported that, doctors, pharmacists and dispensary technicians who are required to educate patients on adverse drug events are few and the pressure of work leaves them no time to discharge such duties.", "entities": [{"start": 190, "end": 213, "label": "PATIENT_DEMO", "text": "46-year old pharmacist"}], "input_ids": [2, 2577, 2038, 2162, 1942, 8434, 1920, 5952, 1930, 5144, 16320, 1988, 2234, 19, 4693, 9620, 1920, 2838, 10329, 1930, 2647, 1920, 2841, 4159, 2564, 2032, 3549, 2759, 6253, 2162, 1942, 3185, 2311, 1958, 1920, 5952, 1930, 3365, 237, 12, 11407, 30, 4182, 17, 2476, 4156, 23400, 13, 18, 2790, 7359, 5246, 3916, 6605, 2216, 2165, 2179, 1930, 2774, 17, 2712, 2790, 1985, 1920, 2288, 4949, 2790, 2899, 1942, 1998, 5061, 1958, 1920, 2330, 4710, 1927, 5246, 2838, 5298, 1922, 1920, 2161, 3403, 18, 10989, 17, 2712, 2790, 20536, 8044, 2568, 1988, 16, 11849, 16, 18019, 1930, 13404, 2141, 28873, 2746, 2032, 3414, 1942, 4066, 2010, 2132, 1990, 5246, 2838, 3916, 2032, 3855, 1930, 1920, 3772, 1927, 2778, 7484, 3581, 2239, 2367, 1942, 7695, 2427, 10793, 2062, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-32 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 164, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 165, "end": 181, "label": "ADR", "text": "Loss of appetite"}, {"start": 188, "end": 196, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 206, "end": 228, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 237, "end": 241, "label": "ADR", "text": "weak"}, {"start": 246, "end": 269, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "808ff96d0d13", "text": "These facilities reported using feedback from the FDA, to observe patients who suffered particular side effects during subsequent treatments, Most of the community health compounds had never documented any side effect and they did not have the appropriate forms to capture adverse events.", "entities": [], "input_ids": [2, 2144, 8774, 2568, 2193, 6491, 2037, 1920, 11394, 16, 1942, 7974, 2132, 2746, 13949, 3278, 4159, 2564, 2409, 4521, 4930, 16, 2501, 1927, 1920, 4413, 2436, 4300, 2430, 5211, 6974, 2967, 4159, 2495, 1930, 2611, 2811, 2084, 2162, 1920, 4703, 4952, 1942, 7573, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f308a9a04cb3", "text": "N = 491 Yes45 (9,2%)p = 0.162p = 0.238T = 0.159p = < 0.001*T = < 0.001*p = 0.047*No446 (90,8%)Information about ADRs provided by pharmacists N = 439 Yes25 (5,7%)No414 (94,3%) *indicates statistical significance Participants with higher education were significantly more likely to be familiar with the words “side effect”, “ADR” or their local translation (p < 0.001).", "entities": [], "input_ids": [2, 56, 33, 4343, 1009, 11633, 6803, 12, 29, 16, 22, 9, 13, 58, 33, 20, 18, 15333, 1034, 33, 20, 18, 19474, 1031, 33, 20, 18, 14486, 1034, 33, 32, 20, 18, 3472, 14, 62, 33, 32, 20, 18, 3472, 14, 58, 33, 20, 18, 24901, 14, 2239, 6609, 1016, 12, 3865, 16, 28, 9, 13, 2988, 3001, 28863, 3675, 2007, 18019, 56, 33, 3941, 1026, 11633, 4198, 12, 25, 16, 27, 9, 13, 2239, 8099, 1006, 12, 5650, 16, 23, 9, 13, 14, 4538, 3850, 4550, 3003, 1956, 2580, 4767, 1985, 2567, 2253, 3205, 1942, 1998, 10859, 1956, 1920, 6906, 236, 4159, 2495, 237, 16, 236, 17645, 237, 2014, 2310, 3076, 6410, 12, 58, 32, 20, 18, 3472, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "97d2bdd4d7af", "text": "It is demonstrated that poor noncompliance to guidelines to the use of medications accounted for drug side effects [15].", "entities": [], "input_ids": [2, 2176, 1977, 3161, 1988, 3930, 22849, 2030, 8195, 1942, 5522, 1942, 1920, 2485, 1927, 7719, 9448, 1958, 2838, 4159, 2564, 37, 2461, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f29b4b315333", "text": "Experience of side-effects of ACTThe findings revealed that participants who took artesunate-amodiaqiune to treat malaria reported most side effects.", "entities": [{"start": 82, "end": 105, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4848, 1927, 4159, 17, 2564, 1927, 4033, 20536, 3056, 3404, 1988, 3003, 2746, 8659, 20897, 20490, 5791, 1021, 17, 2150, 13968, 19640, 17014, 1942, 2297, 7505, 2568, 2501, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "9c15791b5ed2", "text": "They were particularly concerned about overdosing by some patients.In Ghana, the policy is that all patients are supposed to be well informed by prescribers and pharmacists on the possible side effect they are likely to experience from the use of ACT and the need for them to report.", "entities": [], "input_ids": [2, 2611, 1985, 4443, 13629, 3001, 17612, 11934, 2007, 2673, 2132, 18, 1922, 20685, 16, 1920, 7299, 1977, 1988, 2136, 2132, 2032, 18310, 1942, 1998, 2486, 6210, 2007, 30333, 5675, 1930, 18019, 1990, 1920, 3216, 4159, 2495, 2611, 2032, 3205, 1942, 4848, 2037, 1920, 2485, 1927, 4033, 1930, 1920, 2942, 1958, 3581, 1942, 3809, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 38-year old female patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 41-year old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 447, "label": "PATIENT_DEMO", "text": "38-year old female patient"}, {"start": 923, "end": 948, "label": "PATIENT_DEMO", "text": "41-year old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3738, 17, 2476, 4156, 4232, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 4353, 17, 2476, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "9d6e1608c526", "text": "It is possible that swollen testes may not be as a result of the use of ACT as reported by participants.", "entities": [{"start": 20, "end": 34, "label": "ADR", "text": "swollen testes"}], "input_ids": [2, 2176, 1977, 3216, 1988, 23561, 16880, 2278, 2084, 1998, 1966, 43, 3211, 1927, 1920, 2485, 1927, 4033, 1966, 2568, 2007, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c87cbf60893a", "text": "Exposed HCWs/HCSs on 3TC/AZT for 28 days reported nausea (63 %), weakness (37 %), fatigue (28 %) and dizziness (27 %) as the four most reported adverse events.", "entities": [{"start": 7, "end": 17, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 20, "end": 24, "label": "DRUG", "text": "3TC"}, {"start": 25, "end": 28, "label": "DRUG", "text": "AZT"}, {"start": 50, "end": 56, "label": "ADR", "text": "nausea"}, {"start": 65, "end": 74, "label": "ADR", "text": "weakness"}, {"start": 82, "end": 89, "label": "ADR", "text": "fatigue"}, {"start": 101, "end": 110, "label": "ADR", "text": "dizziness"}], "input_ids": [2, 4616, 4387, 8327, 19, 19760, 1036, 1990, 25464, 1030, 19, 28301, 1958, 3158, 3000, 2568, 13759, 12, 4968, 9, 13, 16, 12175, 12, 3191, 9, 13, 16, 8656, 12, 3158, 9, 13, 1930, 24009, 12, 3225, 9, 13, 1966, 1920, 3006, 2501, 2568, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 8, 8, 8, 8, 8, 0, 2, 2, 0, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "da69e995560c", "text": "The difference in occurrence of adverse reactions by gender was statistically significant only for anaemia.", "entities": [{"start": 99, "end": 106, "label": "ADR", "text": "anaemia"}], "input_ids": [2, 1920, 3175, 1922, 6564, 1927, 5246, 5298, 2007, 5125, 1982, 4388, 2228, 2444, 1958, 19682, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "cohort_study"}
{"id": "5673dd503067", "text": "Some of the commonly reported adverse drug reactions include injection site pain, redness, tiredness, or body ache [5, 6, 15, 16].Although most of the AEFIs reported to be associated with the COVID-19 vaccines are generally mild to moderate, there have been reports of some very rare and serious reactions including deaths associated with the use of the vaccines.", "entities": [{"start": 61, "end": 80, "label": "ADR", "text": "injection site pain"}, {"start": 82, "end": 89, "label": "ADR", "text": "redness"}, {"start": 91, "end": 100, "label": "ADR", "text": "tiredness"}, {"start": 105, "end": 114, "label": "ADR", "text": "body ache"}, {"start": 288, "end": 296, "label": "SEVERITY", "text": "serious"}, {"start": 316, "end": 322, "label": "ADR", "text": "deaths"}], "input_ids": [2, 2673, 1927, 1920, 5384, 2568, 5246, 2838, 5298, 3951, 4107, 3200, 3594, 16, 2312, 2971, 16, 16661, 1919, 2971, 16, 2014, 3362, 18564, 37, 25, 16, 26, 16, 2461, 16, 2641, 39, 18, 2876, 2501, 1927, 1920, 10194, 19894, 1036, 2568, 1942, 1998, 2458, 1956, 1920, 6083, 1960, 17, 2282, 9375, 2032, 4933, 5809, 1942, 5086, 16, 2276, 2162, 2252, 4710, 1927, 2673, 3345, 5844, 1930, 7433, 5298, 2710, 7601, 2458, 1956, 1920, 2485, 1927, 1920, 9375, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "7343bdc1bdcd", "text": "The results cannot therefore be extrapolated to verify or refute known HAART induced toxicities like hepatitis or zidovudine-induced anaemia [32] which occur during the initial months of therapy in HIV-positive patients.", "entities": [{"start": 101, "end": 110, "label": "ADR", "text": "hepatitis"}, {"start": 114, "end": 124, "label": "DRUG", "text": "zidovudine"}, {"start": 133, "end": 140, "label": "ADR", "text": "anaemia"}, {"start": 198, "end": 219, "label": "PATIENT_DEMO", "text": "HIV-positive patients"}], "input_ids": [2, 1920, 2274, 5156, 2955, 1998, 23221, 1942, 10491, 2014, 4082, 2696, 3171, 18711, 2719, 15251, 3189, 7977, 2014, 28666, 22389, 1020, 20597, 17, 2719, 19682, 37, 3323, 39, 2154, 4704, 2409, 1920, 3754, 3221, 1927, 3181, 1922, 3525, 17, 2843, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 2, 2, 2, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, -100], "source_type": "cohort_study"}
{"id": "c4eb4d48561e", "text": "Both cases were also associated with severe diarrhoea and vomiting and the subjects were rehydrated, stabilized and discharged, with appropriate counselling to continue and complete the course of 28 days since their risk assessment were rated high.", "entities": [{"start": 36, "end": 43, "label": "SEVERITY", "text": "severe"}, {"start": 44, "end": 53, "label": "ADR", "text": "diarrhoea"}, {"start": 58, "end": 66, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 2321, 2919, 1985, 2222, 2458, 1956, 4010, 20998, 1930, 13954, 1930, 1920, 3297, 1985, 26583, 16, 12017, 1930, 14062, 16, 1956, 4703, 19765, 1942, 9085, 1930, 4080, 1920, 4914, 1927, 3158, 3000, 3328, 2310, 2565, 4076, 1985, 10036, 2149, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 6, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "2af8f725a4f1", "text": "Concomitant drugs started the same day as the suspected drugs were zinc, enoxaparin injection, vitamin C and ceftriaxone.", "entities": [{"start": 67, "end": 71, "label": "DRUG", "text": "zinc"}, {"start": 73, "end": 84, "label": "DRUG", "text": "enoxaparin"}, {"start": 95, "end": 104, "label": "DRUG", "text": "vitamin C"}, {"start": 109, "end": 120, "label": "DRUG", "text": "ceftriaxone"}], "input_ids": [2, 8537, 4195, 8074, 1920, 2841, 3007, 1966, 1920, 9407, 4195, 1985, 7997, 16, 2066, 2325, 29398, 5572, 4107, 16, 6111, 45, 1930, 28248, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 0, 1, 2, 0, 1, 0, -100], "source_type": "cohort_study"}
{"id": "4d1bfd41680a", "text": "However, for the Sputnik V and the J&J vaccines, more males reported a higher incidence of AEFIs.", "entities": [{"start": 17, "end": 26, "label": "DRUG", "text": "Sputnik V"}, {"start": 35, "end": 38, "label": "DRUG", "text": "J&J"}], "input_ids": [2, 2406, 16, 1958, 1920, 13113, 23705, 64, 1930, 1920, 52, 10, 52, 9375, 16, 2253, 5129, 2568, 43, 2580, 4332, 1927, 10194, 19894, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 1, 2, 2, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1f36ef0390d9", "text": "Informing the public about the safety of the vaccines as well as the potential side effects, may increase public trust and acceptance decreasing vaccine hesitancy in current and future vaccination programmes.", "entities": [], "input_ids": [2, 28778, 1920, 4462, 3001, 1920, 5407, 1927, 1920, 9375, 1966, 2486, 1966, 1920, 2889, 4159, 2564, 16, 2278, 2760, 4462, 10626, 1930, 12513, 7742, 5955, 10688, 16503, 13796, 1922, 3214, 1930, 4115, 7507, 13638, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "cfd45aa82736", "text": "As with all the other adverse drug reactions studied in our data, anaemia was more frequent in females.", "entities": [{"start": 66, "end": 73, "label": "ADR", "text": "anaemia"}], "input_ids": [2, 1966, 1956, 2136, 1920, 2303, 5246, 2838, 5298, 3942, 1922, 2342, 2230, 16, 19682, 1982, 2253, 6439, 1922, 5027, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "86766302174d", "text": "This was likely as a result of zidovudine being the first line first choice NRTI.The study found that HIV-infected females were at a significantly higher risk of experiencing an ADR than males.", "entities": [{"start": 31, "end": 41, "label": "DRUG", "text": "zidovudine"}, {"start": 102, "end": 122, "label": "PATIENT_DEMO", "text": "HIV-infected females"}], "input_ids": [2, 2052, 1982, 3205, 1966, 43, 3211, 1927, 28666, 22389, 1020, 20597, 3301, 1920, 2561, 2823, 2561, 6259, 5214, 1914, 18, 1920, 2161, 2435, 1988, 3525, 17, 4014, 5027, 1985, 2019, 43, 2567, 2580, 2565, 1927, 12511, 1925, 17645, 2254, 5129, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "465af829d611", "text": "Other cohorts had high levels of rash, 17.83% in a cohort in Ethiopia [16] and 15.2% in a cohort in India using mainly nevirapine like Ghana [15].In addition, our study found a very low rate of hepatotoxicity compared with other studies in developing countries such as Thailand [14].", "entities": [{"start": 33, "end": 37, "label": "ADR", "text": "rash"}, {"start": 119, "end": 129, "label": "DRUG", "text": "nevirapine"}, {"start": 194, "end": 208, "label": "ADR", "text": "hepatotoxicity"}], "input_ids": [2, 2303, 8509, 2430, 2149, 2428, 1927, 18469, 16, 2752, 18, 5893, 9, 1922, 43, 4382, 1922, 18847, 37, 2641, 39, 1930, 2461, 18, 22, 9, 1922, 43, 4382, 1922, 9288, 2193, 4994, 27360, 11979, 12184, 3189, 20685, 37, 2461, 39, 18, 1922, 2459, 16, 2342, 2161, 2435, 43, 3345, 2330, 2769, 1927, 24126, 2452, 1956, 2303, 2351, 1922, 5130, 5085, 2427, 1966, 17445, 37, 2607, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ae217620f10f", "text": "A case control study among HCWs showed that post-exposure use of zidovudine after percutaneous exposure to HIV infected blood was associated with a reduction of the risk of HIV infection by about 81 % [3, 4].In HIV-infected patients, combination regimens have proven to be superior to monotherapy regimens in reducing viral load [5, 6].", "entities": [{"start": 26, "end": 32, "label": "PATIENT_DEMO", "text": "HCWs"}, {"start": 65, "end": 75, "label": "DRUG", "text": "zidovudine"}, {"start": 211, "end": 232, "label": "PATIENT_DEMO", "text": "HIV-infected patients"}], "input_ids": [2, 43, 3087, 2285, 2161, 2706, 4387, 8327, 2594, 1988, 2753, 17, 3395, 2485, 1927, 28666, 22389, 1020, 20597, 2256, 12826, 3395, 1942, 3525, 4014, 2877, 1982, 2458, 1956, 43, 3378, 1927, 1920, 2565, 1927, 3525, 2909, 2007, 3001, 6206, 9, 37, 23, 16, 24, 39, 18, 1922, 3525, 17, 4014, 2132, 16, 3921, 9922, 2162, 9253, 1942, 1998, 6566, 1942, 13767, 9922, 1922, 5526, 4324, 4019, 37, 25, 16, 26, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 8, 8, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6e85a6a33cae", "text": "ConclusionADR reporting from Treatment Centres was low with top three ADRs being diarrhoea, dizziness and pruritus.", "entities": [{"start": 81, "end": 90, "label": "ADR", "text": "diarrhoea"}, {"start": 92, "end": 101, "label": "ADR", "text": "dizziness"}, {"start": 106, "end": 114, "label": "ADR", "text": "pruritus"}], "input_ids": [2, 4180, 2015, 1005, 6605, 2037, 2311, 13152, 1982, 2330, 1956, 3700, 2559, 28863, 3301, 20998, 16, 24009, 1930, 27496, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, -100], "source_type": "cohort_study"}
{"id": "27c261f6a394", "text": "As of 30th June 2022, the total number of COVID-19 vaccine doses administered in Ghana (AstraZeneca, Moderna, Pfizer, Johnson and Johnson and Sputnik V) was 17,409,005 [26].", "entities": [{"start": 88, "end": 99, "label": "DRUG", "text": "AstraZeneca"}, {"start": 101, "end": 108, "label": "DRUG", "text": "Moderna"}, {"start": 110, "end": 116, "label": "DRUG", "text": "Pfizer"}, {"start": 118, "end": 137, "label": "DRUG", "text": "Johnson and Johnson"}, {"start": 142, "end": 151, "label": "DRUG", "text": "Sputnik V"}], "input_ids": [2, 1966, 1927, 2627, 1963, 10343, 17401, 1028, 16, 1920, 2698, 2529, 1927, 6083, 1960, 17, 2282, 5955, 5312, 5254, 1922, 20685, 12, 20329, 27168, 19384, 16, 10174, 1019, 16, 21932, 16, 13890, 1930, 13890, 1930, 13113, 23705, 64, 13, 1982, 2752, 16, 28536, 16, 9163, 37, 3179, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 1, 0, 1, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "a66f77fade17", "text": "The commonest ADRs were anaemia and diarrhoea.", "entities": [{"start": 24, "end": 31, "label": "ADR", "text": "anaemia"}, {"start": 36, "end": 45, "label": "ADR", "text": "diarrhoea"}], "input_ids": [2, 1920, 29200, 28863, 1985, 19682, 1930, 20998, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 0, 3, 0, -100], "source_type": "cohort_study"}
{"id": "ddb4adcb94b0", "text": "Adverse drug reactionsThe most common adverse reaction in our patients was anaemia, comprising almost half of the total number of episodes (45.6%), with diarrhoea taking a close second place (Table 2).", "entities": [{"start": 75, "end": 82, "label": "ADR", "text": "anaemia"}, {"start": 153, "end": 162, "label": "ADR", "text": "diarrhoea"}], "input_ids": [2, 5246, 2838, 5298, 20536, 2501, 3059, 5246, 3227, 1922, 2342, 2132, 1982, 19682, 16, 10351, 5365, 4768, 1927, 1920, 2698, 2529, 1927, 9232, 12, 3607, 18, 26, 9, 13, 16, 1956, 20998, 6303, 43, 5428, 2812, 4368, 12, 2545, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "b1e49d8f9030", "text": "For the Moderna vaccine, there was 1 case of gastroenteritis and 1 case of Stevens-Johnson syndrome.", "entities": [{"start": 8, "end": 16, "label": "DRUG", "text": "Moderna"}, {"start": 44, "end": 60, "label": "ADR", "text": "gastroenteritis"}, {"start": 75, "end": 99, "label": "ADR", "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 1958, 1920, 10174, 1019, 5955, 16, 2276, 1982, 21, 3087, 1927, 28189, 1930, 21, 3087, 1927, 26913, 2099, 17, 13890, 4741, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "cohort_study"}
{"id": "a0eb0bc9bc29", "text": "Female sex and high CD4 counts > 250mm3 were predictors of ADRs whereas females were significantly more likely to develop anaemia than males.", "entities": [{"start": 71, "end": 79, "label": "PATIENT_DEMO", "text": "females"}, {"start": 122, "end": 129, "label": "ADR", "text": "anaemia"}, {"start": 135, "end": 140, "label": "PATIENT_DEMO", "text": "males"}], "input_ids": [2, 4232, 3486, 1930, 2149, 4095, 6965, 34, 6330, 7445, 1010, 1985, 7450, 1927, 28863, 3417, 5027, 1985, 2567, 2253, 3205, 1942, 2392, 19682, 2254, 5129, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 0, 0, 0, 0, 0, 0, 3, 0, 7, 0, -100], "source_type": "cohort_study"}
{"id": "d0040c926d68", "text": "Anaemia was observed as an ADR in cohorts on ART, whether or not they took zidovudine (ZDV) [10].In an effort to scale up HAART to those who needed it most, the WHO in 2003 launched the “3 by 5” initiative with an objective of placing 3 million persons living with HIV on HAART by 2005 [11].", "entities": [{"start": 0, "end": 7, "label": "ADR", "text": "Anaemia"}, {"start": 75, "end": 85, "label": "DRUG", "text": "zidovudine"}, {"start": 87, "end": 90, "label": "DRUG", "text": "ZDV"}], "input_ids": [2, 19682, 1982, 2528, 1966, 1925, 17645, 1922, 8509, 1990, 6903, 16, 3053, 2014, 2084, 2611, 8659, 28666, 22389, 1020, 20597, 12, 68, 17332, 13, 37, 2119, 39, 18, 1922, 1925, 8430, 1942, 3536, 2353, 18711, 1942, 2690, 2746, 4500, 2176, 2501, 16, 1920, 2746, 1922, 4450, 24850, 1920, 236, 23, 2007, 25, 237, 13690, 1956, 1925, 4470, 1927, 16278, 23, 7068, 7618, 5818, 1956, 3525, 1990, 18711, 2007, 4083, 37, 2513, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "2b60ee29a5d2", "text": "This may be explained by the routine use of lead-in dosage of Nevirapine of 200 mg once daily, followed by gradual escalation to the full 200 mg twice daily after 2 weeks.", "entities": [{"start": 62, "end": 72, "label": "DRUG", "text": "Nevirapine"}], "input_ids": [2, 2052, 2278, 1998, 6094, 2007, 1920, 7341, 2485, 1927, 2949, 17, 1922, 9998, 1927, 27360, 11979, 12184, 1927, 2191, 2786, 5361, 4692, 16, 3489, 2007, 13802, 20720, 1942, 1920, 4125, 2191, 2786, 6470, 4692, 2256, 22, 3625, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "dd2a5ceaf932", "text": "In addition, persons fully vaccinated (received 2 doses of AstraZeneca, Pfizer, Moderna and Sputnik V or received one dose of J&J) were 7,510,586 which was 32.9% of the targeted 22.9 million (23.7% of the total Ghanaian population).", "entities": [{"start": 59, "end": 70, "label": "DRUG", "text": "AstraZeneca"}, {"start": 71, "end": 78, "label": "DRUG", "text": "Pfizer"}, {"start": 80, "end": 87, "label": "DRUG", "text": "Moderna"}, {"start": 92, "end": 101, "label": "DRUG", "text": "Sputnik V"}, {"start": 125, "end": 129, "label": "DRUG", "text": "J&J"}], "input_ids": [2, 1922, 2459, 16, 7618, 5437, 13122, 12, 4004, 22, 5312, 1927, 20329, 27168, 19384, 16, 21932, 16, 10174, 1019, 1930, 13113, 23705, 64, 2014, 4004, 2340, 3253, 1927, 52, 10, 52, 13, 1985, 27, 16, 20089, 16, 4804, 1016, 2154, 1982, 3323, 18, 29, 9, 1927, 1920, 5154, 2950, 18, 29, 7068, 12, 3020, 18, 27, 9, 1927, 1920, 2698, 20685, 3122, 2973, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 2, 0, 1, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "dcb50400045c", "text": "These vaccines were AstraZeneca, Moderna, Pfizer-BioNTech, Johnson and Johnson (J&J) and Sputnik V [24, 25].", "entities": [{"start": 20, "end": 31, "label": "DRUG", "text": "AstraZeneca"}, {"start": 33, "end": 40, "label": "DRUG", "text": "Moderna"}, {"start": 42, "end": 57, "label": "DRUG", "text": "Pfizer-BioNTech"}, {"start": 59, "end": 85, "label": "DRUG", "text": "Johnson and Johnson (J&J)"}, {"start": 89, "end": 98, "label": "DRUG", "text": "Sputnik V"}], "input_ids": [2, 2144, 9375, 1985, 20329, 27168, 19384, 16, 10174, 1019, 16, 21932, 17, 3718, 4905, 2305, 16, 13890, 1930, 13890, 12, 52, 10, 52, 13, 1930, 13113, 23705, 64, 37, 2686, 16, 2637, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 1, 2, 2, 2, 2, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "7da9359ba9ad", "text": "There was no significant difference (p = 0.817) in the reporting of adverse events between exposed HCWs/HCSs administered 3TC/AZT for 28 days and exposed HCWs/HCSs administered 3TC/AZT/LPV-RTV for 28 days in the multivariate analysis.Table 2Factors associated with reported adverse events in 228 exposed HCWs/HCSs on HIV post-exposure prophylaxisCharacteristicAdverse events status1 Crude hazard ratio [95 % CI] p-valueAdjusted hazard ratio [95 % CI] p-valuePresentAbsentDrug regimen3TC/AZT −28 days6871.001.003TC/AZT-3 days28730.31 [0.20–0.48]<0.0010.30 [0.18–0.48]<0.0013TC/AZT/LPV-RTV-28 days5021.06 [0.74–1.53]0.7521.06 [0.65–1.72]0.817Gender-Female81501.00Male65321.08 [0.78–1.50]0.629Type of exposure-Percutaneous131801.00Mucocutaneous1521.42 [0.83–2.43]0.197Age category (yrs)-18–30101601.0031–4032181.02 [0.69–1.52]0.92141–50821.28 [0.62–2.62]0.508>51521.14 [0.46–2.80]0.777Risk assessmentLow51631.001.00Medium40161.60 [1.06–2.42]0.0270.95 [0.61–1.49]0.885High5532.12 [1.45–3.10]<0.0010.97 [0.57–1.66]0.922Profession-Nurses51311.00HCS14100.94 [0.52–1.69]0.832Laboratory Staff1511.51 [0.85–2.68]0.162Medical Doctors46310.96 [0.65–1.43]0.843Ward Attendants2091.11 [0.66–1.86]0.695 1N = 228, exposed HCWs/HCSs lost to follow (n = 36) and exposed HCWs/HCSs who truncated their schedule due to source patient testing HIV negative (n = 16) were excluded; 3TC = lamivudine; AZT = zidovudine; LPV-RTV = lopinavir-ritonavir; CI = confidence interval", "entities": [{"start": 99, "end": 109, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 122, "end": 125, "label": "DRUG", "text": "3TC"}, {"start": 126, "end": 129, "label": "DRUG", "text": "AZT"}, {"start": 154, "end": 164, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 176, "end": 180, "label": "DRUG", "text": "3TC"}, {"start": 181, "end": 184, "label": "DRUG", "text": "AZT"}, {"start": 185, "end": 192, "label": "DRUG", "text": "LPV-RTV"}, {"start": 303, "end": 313, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 483, "end": 486, "label": "DRUG", "text": "3TC"}, {"start": 487, "end": 491, "label": "DRUG", "text": "AZT"}, {"start": 510, "end": 513, "label": "DRUG", "text": "3TC"}, {"start": 514, "end": 517, "label": "DRUG", "text": "AZT"}, {"start": 572, "end": 575, "label": "DRUG", "text": "3TC"}, {"start": 576, "end": 579, "label": "DRUG", "text": "AZT"}, {"start": 580, "end": 587, "label": "DRUG", "text": "LPV-RTV"}, {"start": 647, "end": 653, "label": "PATIENT_DEMO", "text": "Female"}, {"start": 661, "end": 665, "label": "PATIENT_DEMO", "text": "Male"}, {"start": 1205, "end": 1216, "label": "PATIENT_DEMO", "text": "HCWs/HCSs l"}, {"start": 1251, "end": 1260, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 1357, "end": 1360, "label": "DRUG", "text": "3TC"}, {"start": 1363, "end": 1373, "label": "DRUG", "text": "lamivudine"}, {"start": 1375, "end": 1378, "label": "DRUG", "text": "AZT"}, {"start": 1381, "end": 1391, "label": "DRUG", "text": "zidovudine"}, {"start": 1392, "end": 1400, "label": "DRUG", "text": "LPV-RTV"}, {"start": 1403, "end": 1412, "label": "DRUG", "text": "lopinavir"}, {"start": 1413, "end": 1422, "label": "DRUG", "text": "ritonavir"}], "input_ids": [2, 2276, 1982, 2239, 2228, 3175, 12, 58, 33, 20, 18, 6206, 1027, 13, 1922, 1920, 6605, 1927, 5246, 3916, 2192, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 1958, 3158, 3000, 1930, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 1922, 1920, 6884, 2333, 18, 2545, 13775, 19002, 2458, 1956, 2568, 5246, 3916, 1922, 19650, 4616, 4387, 8327, 19, 19760, 1036, 1990, 3525, 2753, 17, 3395, 12725, 25588, 5524, 2341, 18842, 2156, 6102, 17332, 2045, 1021, 3916, 3642, 1009, 10289, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 15833, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 2724, 10653, 2083, 1939, 20556, 8607, 1010, 6916, 19, 28301, 13342, 1025, 3000, 6735, 9948, 18, 3472, 18, 10438, 6916, 19, 28301, 17, 23, 3000, 30416, 4294, 18, 3470, 37, 20, 18, 2036, 229, 20, 18, 3427, 39, 32, 20, 18, 3472, 1008, 18, 2627, 37, 20, 18, 2654, 229, 20, 18, 3427, 39, 32, 20, 18, 3472, 1010, 6916, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 17, 3158, 3000, 3382, 4716, 18, 6604, 37, 20, 18, 5446, 229, 21, 18, 4522, 39, 20, 18, 4089, 4716, 18, 6604, 37, 20, 18, 4459, 229, 21, 18, 4395, 39, 20, 18, 6206, 1027, 21429, 1915, 17, 4232, 11425, 3382, 1009, 18, 2827, 9578, 1021, 5964, 6763, 1009, 18, 6709, 37, 20, 18, 5440, 229, 21, 18, 2761, 39, 20, 18, 5374, 1026, 13686, 1927, 3395, 17, 12826, 22977, 4476, 1009, 18, 2827, 23010, 4879, 18021, 3285, 1021, 2080, 22249, 1009, 18, 3858, 37, 20, 18, 5893, 229, 22, 18, 3941, 39, 20, 18, 5876, 2170, 6891, 12, 25397, 13, 17, 2654, 229, 21663, 6924, 5127, 1009, 18, 10438, 1009, 229, 28136, 4716, 11425, 18, 5725, 37, 20, 18, 5349, 229, 21, 18, 4764, 39, 20, 18, 6224, 27311, 229, 2761, 11715, 1009, 18, 3158, 37, 20, 18, 5374, 229, 22, 18, 5374, 39, 20, 18, 2761, 1025, 34, 25585, 4716, 18, 2607, 37, 20, 18, 4182, 229, 22, 18, 3729, 39, 20, 18, 5517, 1027, 13950, 1040, 4076, 16496, 7912, 7576, 1009, 18, 3472, 18, 2827, 5476, 1989, 4241, 26792, 18, 3276, 37, 21, 18, 6604, 229, 22, 18, 3858, 39, 20, 18, 19310, 1008, 18, 3002, 37, 20, 18, 5473, 229, 21, 18, 4343, 39, 20, 18, 5744, 1015, 23216, 7054, 6763, 18, 2369, 37, 21, 18, 3607, 229, 23, 18, 2119, 39, 32, 20, 18, 3472, 1008, 18, 5749, 37, 20, 18, 4786, 229, 21, 18, 4970, 39, 20, 18, 6224, 17999, 28716, 2881, 17, 8203, 7912, 6800, 1009, 18, 2827, 7727, 12030, 8099, 2283, 18, 5650, 37, 20, 18, 4764, 229, 21, 18, 5349, 39, 20, 18, 5893, 1028, 11792, 8846, 27708, 6651, 23375, 1009, 18, 4892, 37, 20, 18, 5140, 229, 22, 18, 5117, 39, 20, 18, 15333, 5476, 5657, 11849, 7772, 6800, 1008, 18, 4746, 37, 20, 18, 4459, 229, 21, 18, 3941, 39, 20, 18, 5686, 1010, 3118, 10396, 2356, 26434, 1009, 18, 2513, 37, 20, 18, 4970, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 2, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "39581cd9a54d", "text": "For instance, the most commonly reported ADRs, namely; diarrhoea (14), dizziness (7), dyspnoea (5) and headache have been reported as symptoms of COVID-19. 32,33Cardiac related ADRs accounted for 11(10.9%) of all ADRs with hydroxychloroquine alone, hydroxychloroquine in combination with azithromycin and chloroquine alone accounting for 5 (45.5%), 3 (27.3%) and 1(9.0%) respectively.", "entities": [{"start": 55, "end": 64, "label": "ADR", "text": "diarrhoea"}, {"start": 71, "end": 80, "label": "ADR", "text": "dizziness"}, {"start": 86, "end": 94, "label": "ADR", "text": "dyspnoea"}, {"start": 103, "end": 111, "label": "ADR", "text": "headache"}, {"start": 223, "end": 241, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 249, "end": 267, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 305, "end": 316, "label": "DRUG", "text": "chloroquine"}], "input_ids": [2, 1958, 7303, 16, 1920, 2501, 5384, 2568, 28863, 16, 8129, 31, 20998, 12, 2607, 13, 16, 24009, 12, 27, 13, 16, 14633, 26447, 12, 25, 13, 1930, 12187, 2162, 2252, 2568, 1966, 3601, 1927, 6083, 1960, 17, 2282, 18, 3323, 16, 3401, 15339, 7408, 1948, 2712, 28863, 9448, 1958, 2513, 12, 2119, 18, 29, 9, 13, 1927, 2136, 28863, 1956, 8275, 11600, 1037, 15520, 4298, 16, 8275, 11600, 1037, 15520, 1922, 3921, 1956, 28350, 1930, 20813, 4298, 10919, 1958, 25, 12, 3607, 18, 25, 9, 13, 16, 23, 12, 3225, 18, 23, 9, 13, 1930, 21, 12, 29, 18, 20, 9, 13, 2763, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 3, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "e679569db233", "text": "Furthermore, informing the public about potential side effects to expect after COVID-19 vaccinations, may increase public trust and acceptance (decrease vaccine hesitancy) in current and future vaccination programmes.This manuscript presents a comprehensive review of spontaneous reporting data on adverse events following COVID-19 vaccination in Ghana and reports of the FDA’s Joint COVID-19 Vaccine Safety Review.", "entities": [], "input_ids": [2, 3677, 16, 28778, 1920, 4462, 3001, 2889, 4159, 2564, 1942, 6324, 2256, 6083, 1960, 17, 2282, 27903, 16, 2278, 2760, 4462, 10626, 1930, 12513, 12, 3714, 5955, 10688, 16503, 13796, 13, 1922, 3214, 1930, 4115, 7507, 13638, 18, 2052, 4319, 8178, 43, 6911, 3043, 1927, 6242, 6605, 2230, 1990, 5246, 3916, 2894, 6083, 1960, 17, 2282, 7507, 1922, 20685, 1930, 4710, 1927, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "56312b0a6274", "text": "The profile of most ADRs reported was consistent with the summary of product characteristics with a few exceptions, such as, tremor for doxycycline; scrotal pain, dyspnoea, gait disturbances and dysgeusia for chloroquine; and dry throat, hyperhidrosis, restlessness and increased frequency of micturition for hydroxychloroquine being new as per summary of product characteristics.A study with a larger sample size with well-defined denominator is paramount in determining the relative risk of medications in SARS-CoV-2 positive patients and incidence rate of newly reported ADRs.", "entities": [{"start": 125, "end": 131, "label": "ADR", "text": "tremor"}, {"start": 136, "end": 147, "label": "DRUG", "text": "doxycycline"}, {"start": 149, "end": 161, "label": "ADR", "text": "scrotal pain"}, {"start": 163, "end": 171, "label": "ADR", "text": "dyspnoea"}, {"start": 173, "end": 191, "label": "ADR", "text": "gait disturbances"}, {"start": 195, "end": 204, "label": "ADR", "text": "dysgeusia"}, {"start": 209, "end": 220, "label": "DRUG", "text": "chloroquine"}, {"start": 226, "end": 236, "label": "ADR", "text": "dry throat"}, {"start": 238, "end": 251, "label": "ADR", "text": "hyperhidrosis"}, {"start": 253, "end": 265, "label": "ADR", "text": "restlessness"}, {"start": 270, "end": 304, "label": "ADR", "text": "increased frequency of micturition"}, {"start": 309, "end": 327, "label": "DRUG", "text": "hydroxychloroquine"}], "input_ids": [2, 1920, 5174, 1927, 2501, 28863, 2568, 1982, 3499, 1956, 1920, 6099, 1927, 4863, 3779, 1956, 43, 3855, 18482, 16, 2427, 1966, 16, 18388, 1958, 16647, 31, 7572, 10868, 3594, 16, 14633, 26447, 16, 11031, 12654, 1930, 3890, 2106, 24327, 1019, 1958, 20813, 31, 1930, 7143, 23555, 16, 4194, 7969, 3883, 2475, 16, 6172, 26481, 1930, 2502, 3528, 1927, 2206, 1031, 25682, 1958, 8275, 11600, 1037, 15520, 3301, 2814, 1966, 2079, 6099, 1927, 4863, 3779, 18, 43, 2161, 1956, 43, 4327, 2983, 3081, 1956, 2486, 17, 3608, 26475, 1977, 25316, 1922, 7426, 1920, 3338, 2565, 1927, 7719, 1922, 20466, 17, 6083, 17, 22, 2843, 2132, 1930, 4332, 2769, 1927, 7471, 2568, 28863, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 0, 3, 4, 4, 4, 0, 1, 0, 0, 3, 4, 0, 3, 4, 4, 4, 0, 3, 4, 0, 3, 4, 4, 4, 4, 4, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "14f8af05c715", "text": "In a cohort predominantly on d4T, Wabe et al still had 17.39% of all adverse effects attributable to anaemia in Ethiopia [16].Diarrhoea was a common side effect of treatment in our patients.", "entities": [{"start": 28, "end": 32, "label": "DRUG", "text": "d4T"}, {"start": 101, "end": 108, "label": "ADR", "text": "anaemia"}, {"start": 126, "end": 135, "label": "ADR", "text": "Diarrhoea"}], "input_ids": [2, 1922, 43, 4382, 7700, 1990, 16603, 1031, 16, 4114, 5873, 2140, 1969, 3974, 2430, 2752, 18, 3886, 9, 1927, 2136, 5246, 2564, 11081, 1942, 19682, 1922, 18847, 37, 2641, 39, 18, 20998, 1982, 43, 3059, 4159, 2495, 1927, 2311, 1922, 2342, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "cbe00ece0779", "text": "The reactions stopped when the suspected medication was discontinued.Causality Assessment of ADRsCausality assessment was done for 98 out of the 101 ADRs received with 7(7.1%) and 70(70.1%) classified as certain and possible respectively.Table 2 shows the detail of the causality assessment terminology assigned to the ADRs.Table 2Causality scores assigned to the ADRsWHO-UMC TerminologyNumber of ADRs*Proportion (%)Certain77.1Possible/Likely7071.4Probable1010.2Unlikely1010.2Conditional/Unclassified00.0Unassessable/Unclassifiable11.0*Causality assessment was done for all ADRs except PTs classified as medication errors and circumstance or information capable of leading to a medication error.", "entities": [], "input_ids": [2, 1920, 5298, 12032, 2469, 1920, 9407, 6093, 1982, 16087, 18, 19140, 4076, 1927, 28863, 3375, 7545, 1999, 4076, 1982, 5404, 1958, 5613, 2397, 1927, 1920, 9447, 28863, 4004, 1956, 27, 12, 27, 18, 21, 9, 13, 1930, 3895, 12, 3895, 18, 21, 9, 13, 5947, 1966, 4908, 1930, 3216, 2763, 18, 2545, 22, 3661, 1920, 3966, 1927, 1920, 19140, 4076, 20179, 6304, 1942, 1920, 28863, 18, 2545, 6921, 26973, 5951, 3888, 6304, 1942, 1920, 28863, 5975, 1037, 17, 8736, 1030, 20179, 1022, 22660, 1927, 28863, 14, 4242, 12, 9, 13, 4908, 7658, 18, 21727, 3117, 2563, 19, 3205, 4618, 9948, 18, 24, 2216, 7972, 7272, 13100, 1008, 18, 22, 1983, 12191, 20133, 13294, 6924, 1008, 18, 6921, 14721, 1923, 19, 29562, 2828, 2283, 18, 20, 17864, 5590, 1979, 2115, 19, 29562, 18860, 3242, 18, 20, 14, 19140, 4076, 1982, 5404, 1958, 2136, 28863, 5574, 8618, 5947, 1966, 6093, 6109, 1930, 11609, 2152, 2014, 2988, 7131, 1927, 4523, 1942, 43, 6093, 4622, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "234306811c4b", "text": "Seven of these events occurred after the first dose except for Stevens-Johnson syndrome for which the dose number was not stated.Outcome of AEFIs among those who reported AEFIsAmong the 4,295 persons who experienced AEFIs, 54.1% were still recovering, 42.1% recovered, 3.3% was not indicated and 0.4% were documented as deaths (Fig 4).10.1371/journal.pgph.0003770.g004Fig 4Outcome of AEFIs among the vaccine recipients in Ghana.Table 6 below shows the distribution of the outcomes of AEFIs across the reported characteristics.", "entities": [{"start": 63, "end": 87, "label": "ADR", "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 5260, 1927, 2144, 3916, 4807, 2256, 1920, 2561, 3253, 5574, 1958, 26913, 2099, 17, 13890, 4741, 1958, 2154, 1920, 3253, 2529, 1982, 2084, 9662, 18, 3924, 1927, 10194, 19894, 1036, 2706, 2690, 2746, 2568, 10194, 19894, 5735, 3947, 1029, 1920, 24, 16, 21102, 7618, 2746, 6090, 10194, 19894, 1036, 16, 4584, 18, 21, 9, 1985, 3974, 27283, 16, 3858, 18, 21, 9, 8294, 16, 23, 18, 23, 9, 1982, 2084, 3391, 1930, 20, 18, 24, 9, 1985, 6974, 1966, 7601, 12, 2095, 24, 13, 18, 2119, 18, 28687, 19, 5776, 18, 22534, 1023, 18, 25209, 7658, 1008, 18, 17287, 14743, 9344, 24, 2382, 18864, 1927, 10194, 19894, 1036, 2706, 1920, 5955, 9336, 1922, 20685, 18, 2545, 26, 4535, 3661, 1920, 3282, 1927, 1920, 3685, 1927, 10194, 19894, 1036, 3436, 1920, 2568, 3779, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6b8d763b650b", "text": "In contrast to the high incidence of AEFIs from the Sputnik V vaccine in Ghana, Hasan et al., [36] reported a rather low incidence of AEFIs following the administration of the vaccine in Pakistan.", "entities": [{"start": 52, "end": 61, "label": "DRUG", "text": "Sputnik V"}, {"start": 73, "end": 78, "label": "PATIENT_DEMO", "text": "Ghana"}, {"start": 187, "end": 195, "label": "PATIENT_DEMO", "text": "Pakistan"}], "input_ids": [2, 1922, 3320, 1942, 1920, 2149, 4332, 1927, 10194, 19894, 1036, 2037, 1920, 13113, 23705, 64, 5955, 1922, 20685, 16, 2258, 1928, 2140, 1969, 18, 16, 37, 3480, 39, 2568, 43, 4356, 2330, 4332, 1927, 10194, 19894, 1036, 2894, 1920, 4183, 1927, 1920, 5955, 1922, 21493, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, -100], "source_type": "cohort_study"}
{"id": "0f87259812ca", "text": "The remaining two cases were gastroenteritis and Stevens-Johnson syndrome for the Moderna vaccine.", "entities": [{"start": 29, "end": 44, "label": "ADR", "text": "gastroenteritis"}, {"start": 49, "end": 73, "label": "ADR", "text": "Stevens-Johnson syndrome"}, {"start": 81, "end": 89, "label": "DRUG", "text": "Moderna"}], "input_ids": [2, 1920, 5719, 2288, 2919, 1985, 28189, 1930, 26913, 2099, 17, 13890, 4741, 1958, 1920, 10174, 1019, 5955, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, 0, 2, 2, 0, 0, -100], "source_type": "cohort_study"}
{"id": "f73919382cc7", "text": "Conversely, having a low CD4 count of less than 250 mm3 was actually protective - the odds of an adverse reaction in a patient with a CD4 count of less than 250 cells/ mm3 was about 40% less compared to a patient with a CD4 count of 250 cells/ mm3 or more, both before (p = 0.02) and after (p = 0.01, CI: 0.37-0.88) adjustment for demographic and other clinical variables.", "entities": [], "input_ids": [2, 8990, 16, 4537, 43, 2330, 4095, 6500, 1927, 2941, 2254, 6330, 14226, 1982, 9014, 6337, 17, 1920, 6408, 1927, 1925, 5246, 3227, 1922, 43, 2774, 1956, 43, 4095, 6500, 1927, 2941, 2254, 6330, 2094, 19, 14226, 1982, 3001, 3040, 9, 2941, 2452, 1942, 43, 2774, 1956, 43, 4095, 6500, 1927, 6330, 2094, 19, 14226, 2014, 2253, 16, 2321, 3119, 12, 58, 33, 20, 18, 5725, 13, 1930, 2256, 12, 58, 33, 20, 18, 3287, 16, 3371, 30, 20, 18, 3191, 17, 20, 18, 5744, 13, 7970, 1958, 6611, 1930, 2303, 2535, 3832, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ce453d178b65", "text": "Materials and methodsStudy designThis was an analytic cross-sectional study involving secondary data analyses of COVID-19 vaccine-related AEFI reports in the safety database of the Ghana FDA, followed by analysis of causality assessment reports on all serious AEFIs.", "entities": [], "input_ids": [2, 4751, 1930, 2860, 2156, 2009, 1012, 3036, 22523, 1036, 1982, 1925, 14697, 3567, 17, 7360, 2161, 5884, 4067, 2230, 3247, 1927, 6083, 1960, 17, 2282, 5955, 17, 2712, 10194, 19894, 4710, 1922, 1920, 5407, 5039, 1927, 1920, 20685, 11394, 16, 3489, 2007, 2333, 1927, 19140, 4076, 4710, 1990, 2136, 7433, 10194, 19894, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1fd35d41712c", "text": "Nausea, weakness, malaise and dizziness (17 %, 10 %, 6 % and 6 %, respectively) were the four most-commonly reported adverse events in exposed HCWs/HCSs administered 3TC/AZT for 3 days.", "entities": [{"start": 0, "end": 6, "label": "ADR", "text": "Nausea"}, {"start": 7, "end": 16, "label": "ADR", "text": "weakness"}, {"start": 18, "end": 25, "label": "ADR", "text": "malaise"}, {"start": 30, "end": 39, "label": "ADR", "text": "dizziness"}, {"start": 143, "end": 152, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 166, "end": 169, "label": "DRUG", "text": "3TC"}, {"start": 170, "end": 173, "label": "DRUG", "text": "AZT"}], "input_ids": [2, 13759, 16, 12175, 16, 3054, 5504, 4127, 1930, 24009, 12, 2752, 9, 16, 2119, 9, 16, 26, 9, 1930, 26, 9, 16, 2763, 13, 1985, 1920, 3006, 2501, 17, 5384, 2568, 5246, 3916, 1922, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 1958, 23, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 4, 0, 3, 4, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "3a0c13140b15", "text": "Serious AEFIs reported was 1.0% (CI: 0.7–1.3%) among those who received AstraZeneca, 11.1% (CI: 5.4–21.5%) among those who received J&J vaccine, 6.6% (CI: 2.5–16.2%) among those who received Moderna, 17.5% (CI: 9.7–29.6%) among those who received Pfizer.", "entities": [{"start": 72, "end": 83, "label": "DRUG", "text": "AstraZeneca"}, {"start": 132, "end": 135, "label": "DRUG", "text": "J&J"}, {"start": 191, "end": 198, "label": "DRUG", "text": "Moderna"}, {"start": 247, "end": 254, "label": "DRUG", "text": "Pfizer."}], "input_ids": [2, 7433, 10194, 19894, 1036, 2568, 1982, 21, 18, 20, 9, 12, 3371, 30, 20, 18, 27, 229, 21, 18, 23, 9, 13, 2706, 2690, 2746, 4004, 20329, 27168, 19384, 16, 2513, 18, 21, 9, 12, 3371, 30, 25, 18, 24, 229, 2900, 18, 25, 9, 13, 2706, 2690, 2746, 4004, 52, 10, 52, 5955, 16, 26, 18, 26, 9, 12, 3371, 30, 22, 18, 25, 229, 2641, 18, 22, 9, 13, 2706, 2690, 2746, 4004, 10174, 1019, 16, 2752, 18, 25, 9, 12, 3371, 30, 29, 18, 27, 229, 3230, 18, 26, 9, 13, 2706, 2690, 2746, 4004, 21932, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, -100], "source_type": "cohort_study"}
{"id": "e634a2fa91a6", "text": "The Committee in its assessment, employed the procedure outlined in the World Health Organization (WHO) User Manual for the Revised WHO Classification on Causality Assessment of An Adverse Event Following Immunization (AEFI) [33].", "entities": [], "input_ids": [2, 1920, 6182, 1922, 2496, 4076, 16, 5789, 1920, 4360, 12312, 1922, 1920, 4867, 2436, 5901, 12, 2746, 13, 8124, 8507, 1958, 1920, 10041, 2746, 5492, 1990, 19140, 4076, 1927, 1925, 5246, 4817, 2894, 10139, 12, 10194, 19894, 13, 37, 3401, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "898689065b09", "text": "The Committee in its assessment, employed the procedure outlined in the World Health Organization (WHO) User Manual for the Revised WHO Classification on Causality Assessment of An Adverse Event Following Immunization (AEFI) [33].Study populationThe study involved COVID-19 vaccine AEFI data which were obtained through spontaneous reporting by individuals aged 18 years or older in Ghana who had received at least one dose of any of the five vaccines deployed in the nationwide mass vaccination campaign from 2nd March 2021 to 30th June 2022.", "entities": [{"start": 357, "end": 380, "label": "PATIENT_DEMO", "text": "aged 18 years or older"}], "input_ids": [2, 1920, 6182, 1922, 2496, 4076, 16, 5789, 1920, 4360, 12312, 1922, 1920, 4867, 2436, 5901, 12, 2746, 13, 8124, 8507, 1958, 1920, 10041, 2746, 5492, 1990, 19140, 4076, 1927, 1925, 5246, 4817, 2894, 10139, 12, 10194, 19894, 13, 37, 3401, 39, 18, 2161, 2973, 20536, 2161, 3286, 6083, 1960, 17, 2282, 5955, 10194, 19894, 2230, 2154, 1985, 2926, 2596, 6242, 6605, 2007, 3445, 5177, 2654, 2739, 2014, 4706, 1922, 20685, 2746, 2430, 4004, 2019, 3464, 2340, 3253, 1927, 2967, 1927, 1920, 3628, 9375, 20224, 1922, 1920, 19006, 3411, 7507, 13986, 2037, 14886, 10225, 17401, 1009, 1942, 2627, 1963, 10343, 17401, 1028, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "55ee68f62b18", "text": "Multiple symptoms were reported among more than half of those who took AstraZeneca (76.6%), J&J (65.1%), Moderna (67.2%) and Pfizer (54.4%).", "entities": [{"start": 71, "end": 82, "label": "DRUG", "text": "AstraZeneca"}, {"start": 105, "end": 113, "label": "DRUG", "text": "Moderna"}, {"start": 125, "end": 131, "label": "DRUG", "text": "Pfizer"}], "input_ids": [2, 3137, 3601, 1985, 2568, 2706, 2253, 2254, 4768, 1927, 2690, 2746, 8659, 20329, 27168, 19384, 12, 5439, 18, 26, 9, 13, 16, 52, 10, 52, 12, 4459, 18, 21, 9, 13, 16, 10174, 1019, 12, 4838, 18, 22, 9, 13, 1930, 21932, 12, 4584, 18, 24, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "c1a45c988333", "text": "It has been shown that knowledge and proper communication of expected side effects of ARVs in patients leads to increased rate of adherence to the treatment [30].", "entities": [], "input_ids": [2, 2176, 2258, 2252, 2522, 1988, 4163, 1930, 3405, 6396, 1927, 4100, 4159, 2564, 1927, 21502, 1036, 1922, 2132, 5029, 1942, 2502, 2769, 1927, 7015, 1942, 1920, 2311, 37, 2627, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "653d96014611", "text": "Causality Assessment of ADRsCausality assessment was done for 98 out of the 101 ADRs received with 7(7.1%) and 70(70.1%) classified as certain and possible respectively.Table 2 shows the detail of the causality assessment terminology assigned to the ADRs.Table 2Causality scores assigned to the ADRsWHO-UMC TerminologyNumber of ADRs*Proportion (%)Certain77.1Possible/Likely7071.4Probable1010.2Unlikely1010.2Conditional/Unclassified00.0Unassessable/Unclassifiable11.0*Causality assessment was done for all ADRs except PTs classified as medication errors and circumstance or information capable of leading to a medication error.", "entities": [], "input_ids": [2, 19140, 4076, 1927, 28863, 3375, 7545, 1999, 4076, 1982, 5404, 1958, 5613, 2397, 1927, 1920, 9447, 28863, 4004, 1956, 27, 12, 27, 18, 21, 9, 13, 1930, 3895, 12, 3895, 18, 21, 9, 13, 5947, 1966, 4908, 1930, 3216, 2763, 18, 2545, 22, 3661, 1920, 3966, 1927, 1920, 19140, 4076, 20179, 6304, 1942, 1920, 28863, 18, 2545, 6921, 26973, 5951, 3888, 6304, 1942, 1920, 28863, 5975, 1037, 17, 8736, 1030, 20179, 1022, 22660, 1927, 28863, 14, 4242, 12, 9, 13, 4908, 7658, 18, 21727, 3117, 2563, 19, 3205, 4618, 9948, 18, 24, 2216, 7972, 7272, 13100, 1008, 18, 22, 1983, 12191, 20133, 13294, 6924, 1008, 18, 6921, 14721, 1923, 19, 29562, 2828, 2283, 18, 20, 17864, 5590, 1979, 2115, 19, 29562, 18860, 3242, 18, 20, 14, 19140, 4076, 1982, 5404, 1958, 2136, 28863, 5574, 8618, 5947, 1966, 6093, 6109, 1930, 11609, 2152, 2014, 2988, 7131, 1927, 4523, 1942, 43, 6093, 4622, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "9b3d3aa570b4", "text": "It was however thought that the diarrhea could have been due to opportunistic infections like abdominal tuberculosis, parasitic or helminthic infections and not a drug side effect especially since diarrhea was a presenting symptom in many new patients.", "entities": [], "input_ids": [2, 2176, 1982, 2406, 6212, 1988, 1920, 11904, 2578, 2162, 2252, 2810, 1942, 19169, 5024, 3189, 6900, 8449, 16, 16445, 2014, 21573, 1935, 5024, 1930, 2084, 43, 2838, 4159, 2495, 4369, 3328, 11904, 1982, 43, 8326, 3226, 1922, 3086, 2814, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "5504687ac7ca", "text": "The first was an exposed female HCW of 26 years administered 3TC/AZT/LPV-RTV for 28 days who reported of dizziness, excessive flatulence, headache, nausea, vomiting, restlessness and dark pigmentation of finger & toe nails (which later came off) and was hospitalised for three days.", "entities": [{"start": 24, "end": 35, "label": "PATIENT_DEMO", "text": "female HCW"}, {"start": 60, "end": 64, "label": "DRUG", "text": "3TC"}, {"start": 65, "end": 68, "label": "DRUG", "text": "AZT"}, {"start": 69, "end": 77, "label": "DRUG", "text": "LPV-RTV"}, {"start": 105, "end": 114, "label": "ADR", "text": "dizziness"}, {"start": 116, "end": 136, "label": "ADR", "text": "excessive flatulence"}, {"start": 138, "end": 146, "label": "ADR", "text": "headache"}, {"start": 148, "end": 154, "label": "ADR", "text": "nausea"}, {"start": 156, "end": 164, "label": "ADR", "text": "vomiting"}, {"start": 166, "end": 178, "label": "ADR", "text": "restlessness"}, {"start": 182, "end": 223, "label": "ADR", "text": "dark pigmentation of finger & toe nails"}], "input_ids": [2, 1920, 2561, 1982, 1925, 4616, 4232, 4387, 1018, 1927, 3179, 2739, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 2746, 2568, 1927, 24009, 16, 9122, 9778, 25916, 16, 12187, 16, 13759, 16, 13954, 16, 6172, 26481, 1930, 6190, 20542, 1927, 8497, 10, 22820, 20695, 1036, 12, 2154, 3690, 12411, 4013, 13, 1930, 1982, 3461, 3495, 1958, 2559, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 8, 8, 8, 0, 0, 0, 0, 2, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 3, 0, 3, 0, 3, 0, 3, 4, 0, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "55f8989bb01d", "text": "This higher incidence among females was observed across AstraZeneca, Moderna and Pfizer which is consistent with reports from previous studies [30, 40–42].", "entities": [{"start": 56, "end": 67, "label": "DRUG", "text": "AstraZeneca"}, {"start": 69, "end": 76, "label": "DRUG", "text": "Moderna"}, {"start": 81, "end": 87, "label": "DRUG", "text": "Pfizer"}], "input_ids": [2, 2052, 2580, 4332, 2706, 5027, 1982, 2528, 3436, 20329, 27168, 19384, 16, 10174, 1019, 1930, 21932, 2154, 1977, 3499, 1956, 4710, 2037, 2555, 2351, 37, 2627, 16, 3040, 229, 3858, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1f2dcfc90bb4", "text": "Nucleoside reverse transcriptase inhibitors can cause mitochondrial toxicity and anaemia; non-nucleoside transcriptase inhibitors are associated with rash and central nervous system disturbance; protease inhibitors cause gastrointestinal effects and metabolic problems including hyperlipidaemia, lipodystrophy, and insulin resistance.", "entities": [{"start": 53, "end": 76, "label": "ADR", "text": "mitochondrial toxicity"}, {"start": 81, "end": 88, "label": "ADR", "text": "anaemia"}, {"start": 150, "end": 154, "label": "ADR", "text": "rash"}, {"start": 158, "end": 193, "label": "ADR", "text": "central nervous system disturbance"}, {"start": 221, "end": 245, "label": "ADR", "text": "gastrointestinal effects"}, {"start": 279, "end": 294, "label": "ADR", "text": "hyperlipidaemia"}, {"start": 296, "end": 309, "label": "ADR", "text": "lipodystrophy"}, {"start": 314, "end": 333, "label": "ADR", "text": "insulin resistance"}], "input_ids": [2, 18015, 5267, 13335, 4472, 2112, 3936, 4596, 5532, 1930, 19682, 31, 2447, 17, 18015, 13335, 4472, 2032, 2458, 1956, 18469, 1930, 4101, 7580, 2433, 12732, 31, 7154, 4472, 3936, 8375, 2564, 1930, 4487, 4951, 2710, 4194, 8257, 10828, 6026, 16, 3178, 26812, 1997, 2688, 1012, 16, 1930, 4122, 3554, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 4, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 3, 4, 4, 4, 4, 0, 0, 4, 4, 0, -100], "source_type": "cohort_study"}
{"id": "3e6ae6478421", "text": "All adverse events solicited post-treatment were new events that could conceivably be associated with PEP though no formal case-causality assessment was carried out on the individual reports.Adherence was determined by the completion of prophylaxis schedule assessed during the follow-up period by the use of a questionnaire.", "entities": [], "input_ids": [2, 2136, 5246, 3916, 2638, 19753, 1919, 2753, 17, 2311, 1985, 2814, 3916, 1988, 2578, 17945, 3458, 1998, 2458, 1956, 9110, 4170, 2239, 7007, 3087, 17, 19140, 4076, 1982, 4371, 2397, 1990, 1920, 2725, 4710, 18, 7015, 1982, 3180, 2007, 1920, 9297, 1927, 12725, 11660, 3683, 2409, 1920, 2396, 17, 2353, 3047, 2007, 1920, 2485, 1927, 43, 5564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "f3bff5f755a3", "text": "In addition to the active follow-up, exposed HCWs/HCSs were asked to report events of medical concern (literally “anything that worries you”) at any time during the follow-up period, noting especially the following signs; fever, rash, lymphadenopathy, dark-coloured urine, sore throat and bruising or bleeding from any part of the body.", "entities": [{"start": 45, "end": 54, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 222, "end": 227, "label": "ADR", "text": "fever"}, {"start": 228, "end": 233, "label": "ADR", "text": "rash"}, {"start": 234, "end": 250, "label": "ADR", "text": "lymphadenopathy"}, {"start": 252, "end": 271, "label": "ADR", "text": "dark-coloured urine"}, {"start": 272, "end": 285, "label": "ADR", "text": "sore throat"}, {"start": 289, "end": 310, "label": "ADR", "text": "bruising or bleeding"}], "input_ids": [2, 1922, 2459, 1942, 1920, 3500, 2396, 17, 2353, 16, 4616, 4387, 8327, 19, 19760, 1036, 1985, 6660, 1942, 3809, 3916, 1927, 3423, 8353, 12, 4154, 2169, 236, 22491, 1988, 4315, 25921, 6253, 237, 13, 2019, 2967, 2367, 2409, 1920, 2396, 17, 2353, 3047, 16, 16415, 4369, 1920, 2894, 6879, 31, 9087, 16, 18469, 16, 25948, 16, 6190, 17, 24960, 6960, 16, 6548, 1021, 23555, 1930, 28171, 4007, 2014, 7633, 2037, 2967, 3131, 1927, 1920, 3362, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 4, 0, 3, 4, 4, 4, 0, 4, 4, 4, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1bafa1fd003b", "text": "Hydroxychloroquine and azithromycin were withdrawn on the second and third days respectively with the patient treated with antacids (a suspension of alginic acid, aluminium hydroxide and magnesium trisilicate and esomeprazole).All other medications were continued until the fifth day (22nd April 2020).", "entities": [{"start": 0, "end": 18, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 22, "end": 36, "label": "DRUG", "text": "azithromycin"}, {"start": 149, "end": 161, "label": "DRUG", "text": "alginic acid"}, {"start": 163, "end": 182, "label": "DRUG", "text": "aluminium hydroxide"}, {"start": 187, "end": 209, "label": "DRUG", "text": "magnesium trisilicate"}, {"start": 213, "end": 226, "label": "DRUG", "text": "esomeprazole)"}], "input_ids": [2, 8275, 11600, 1037, 15520, 1930, 28350, 1985, 19540, 1990, 1920, 2812, 1930, 4563, 3000, 2763, 1956, 1920, 2774, 2868, 1956, 4942, 29272, 1036, 12, 43, 8971, 1927, 4326, 26386, 2687, 16, 30094, 19595, 1930, 13148, 6349, 10029, 2010, 1930, 2376, 2225, 26252, 13, 18, 2136, 2303, 7719, 1985, 7583, 4801, 1920, 12052, 3007, 12, 2950, 10249, 11071, 22656, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 1, 2, 2, 2, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "743ed0607a0f", "text": "The other AEFIs had been reported through active surveillance but were excluded from the analyses as this was not the study’s focus.A total of 3,590 of the AEFI reports received through the spontaneous system (83.6%) were from AstraZeneca, with 524 (12.2%) recorded from Sputnik V, 63 (1.5%) from Johnson and Johnson, 61 from (1.4%) Moderna vaccine and 57 (1.3%) from Pfizer.", "entities": [{"start": 227, "end": 238, "label": "DRUG", "text": "AstraZeneca"}, {"start": 271, "end": 280, "label": "DRUG", "text": "Sputnik V"}, {"start": 297, "end": 316, "label": "DRUG", "text": "Johnson and Johnson"}, {"start": 333, "end": 340, "label": "DRUG", "text": "Moderna"}, {"start": 368, "end": 374, "label": "DRUG", "text": "Pfizer"}], "input_ids": [2, 1920, 2303, 10194, 19894, 1036, 2430, 2252, 2568, 2596, 3500, 7889, 2308, 1985, 5450, 2037, 1920, 3247, 1966, 2052, 1982, 2084, 1920, 2161, 234, 61, 3691, 18, 43, 2698, 1927, 23, 16, 24886, 1927, 1920, 10194, 19894, 4710, 4004, 2596, 1920, 6242, 2433, 12, 5893, 18, 26, 9, 13, 1985, 2037, 20329, 27168, 19384, 16, 1956, 4764, 1006, 12, 2369, 18, 22, 9, 13, 4562, 2037, 13113, 23705, 64, 16, 4968, 12, 21, 18, 25, 9, 13, 2037, 13890, 1930, 13890, 16, 5473, 2037, 12, 21, 18, 24, 9, 13, 10174, 1019, 5955, 1930, 4786, 12, 21, 18, 23, 9, 13, 2037, 21932, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "cohort_study"}
{"id": "0a32c26b0781", "text": "On the same day, the patient was given hydroxychloroquine, azithromycin, vitamin C, ceftriaxone, methylprednisolone, salbutamol nebuliser, adrenaline, zinc and enoxaparin.", "entities": [{"start": 39, "end": 57, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 59, "end": 71, "label": "DRUG", "text": "azithromycin"}, {"start": 73, "end": 82, "label": "DRUG", "text": "vitamin C"}, {"start": 84, "end": 95, "label": "DRUG", "text": "ceftriaxone"}, {"start": 96, "end": 115, "label": "DRUG", "text": "methylprednisolone"}, {"start": 117, "end": 127, "label": "DRUG", "text": "salbutamol"}, {"start": 139, "end": 149, "label": "DRUG", "text": "adrenaline"}, {"start": 151, "end": 156, "label": "DRUG", "text": "zinc"}, {"start": 160, "end": 171, "label": "DRUG", "text": "enoxaparin."}], "input_ids": [2, 1990, 1920, 2841, 3007, 16, 1920, 2774, 1982, 3258, 8275, 11600, 1037, 15520, 16, 28350, 16, 6111, 45, 16, 28248, 16, 30087, 16, 3370, 16119, 20624, 25458, 19649, 16, 10651, 2053, 16, 7997, 1930, 2066, 2325, 29398, 5572, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 1, 2, 0, 1, 0, 2, 0, 1, 2, 2, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, -100], "source_type": "cohort_study"}
{"id": "5e4784847895", "text": "The members of TAC-SM review each ADR taking into consideration the temporal relationship between the drug administration and onset of reaction, individual patient factors including comorbid conditions and concomitant medicines as well as the pharmacological properties of the suspected drug(s).Expectedness of each adverse drug reaction was assessed using the Summary of Product Characteristics (SmPCs).", "entities": [], "input_ids": [2, 1920, 4678, 1927, 9214, 17, 2426, 3043, 2362, 17645, 6303, 2460, 8707, 1920, 5338, 3303, 2192, 1920, 2838, 4183, 1930, 4727, 1927, 3227, 16, 2725, 2774, 2790, 2710, 9006, 2961, 1930, 8537, 12864, 1966, 2486, 1966, 1920, 7683, 3879, 1927, 1920, 9407, 2838, 12, 61, 13, 18, 4100, 2971, 1927, 2362, 5246, 2838, 3227, 1982, 3683, 2193, 1920, 6099, 1927, 4863, 3779, 12, 2426, 7693, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "200db24f29e6", "text": "This observation is consistent with reports from early phase trials and real-life administration studies on the AstraZeneca vaccine [44–46].", "entities": [{"start": 112, "end": 123, "label": "DRUG", "text": "AstraZeneca"}], "input_ids": [2, 2052, 5275, 1977, 3499, 1956, 4710, 2037, 3120, 3193, 3848, 1930, 4105, 17, 3308, 4183, 2351, 1990, 1920, 20329, 27168, 19384, 5955, 37, 4044, 229, 4182, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "68806e0523be", "text": "Exposed HCWs/HCSs were administered either lamivudine/zidovudine (3TC/AZT) (dual therapy) for 3 or 28 days (depending on the outcome of the risk assessment made) or lamivudine/zidovudine/lopinavir-ritonavir (3TC/AZT/LPV-RTV) (triple therapy) for 28 days.", "entities": [{"start": 7, "end": 17, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 43, "end": 53, "label": "DRUG", "text": "lamivudine"}, {"start": 54, "end": 64, "label": "DRUG", "text": "zidovudine"}, {"start": 66, "end": 69, "label": "DRUG", "text": "3TC"}, {"start": 70, "end": 73, "label": "DRUG", "text": "AZT"}, {"start": 165, "end": 175, "label": "DRUG", "text": "lamivudine"}, {"start": 176, "end": 186, "label": "DRUG", "text": "zidovudine"}, {"start": 187, "end": 196, "label": "DRUG", "text": "lopinavir"}, {"start": 197, "end": 206, "label": "DRUG", "text": "ritonavir"}, {"start": 208, "end": 211, "label": "DRUG", "text": "3TC"}, {"start": 212, "end": 215, "label": "DRUG", "text": "AZT"}, {"start": 216, "end": 223, "label": "DRUG", "text": "LPV-RTV"}], "input_ids": [2, 4616, 4387, 8327, 19, 19760, 1036, 1985, 5254, 3108, 30208, 19, 28666, 22389, 1020, 20597, 12, 25464, 1030, 19, 28301, 13, 12, 7064, 3181, 13, 1958, 23, 2014, 3158, 3000, 12, 6362, 1990, 1920, 3924, 1927, 1920, 2565, 4076, 3915, 13, 2014, 30208, 19, 28666, 22389, 1020, 20597, 19, 3004, 9512, 11046, 17, 24019, 12502, 3026, 12, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 13, 12, 10073, 3181, 13, 1958, 3158, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 8, 8, 8, 8, 8, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "d3cbfc4a4237", "text": "In addition, reports of thrombosis with thrombocytopenia syndrome (TTS) have also been recorded [19, 20].", "entities": [{"start": 40, "end": 65, "label": "ADR", "text": "thrombocytopenia syndrome"}, {"start": 67, "end": 70, "label": "ADR", "text": "TTS"}], "input_ids": [2, 1922, 2459, 16, 4710, 1927, 11354, 1956, 17100, 4741, 12, 29958, 13, 2162, 2222, 2252, 4562, 37, 2282, 16, 2036, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "b6d9d3177172", "text": "In contrast to the unexpected finding of anaemia in less than a tenth of patients in an Indian study (5.4%) [15], almost half of our patients had clinically significant anaemia.", "entities": [{"start": 41, "end": 48, "label": "ADR", "text": "anaemia"}, {"start": 169, "end": 176, "label": "ADR", "text": "anaemia"}], "input_ids": [2, 1922, 3320, 1942, 1920, 9892, 2849, 1927, 19682, 1922, 2941, 2254, 43, 29671, 1927, 2132, 1922, 1925, 10733, 2161, 12, 25, 18, 24, 9, 13, 37, 2461, 39, 16, 5365, 4768, 1927, 2342, 2132, 2430, 5908, 2228, 19682, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "cohort_study"}
{"id": "2134a7fd140d", "text": "Causality assessment of serious AEFIsA total of 57 AEFIs were classified as serious per the WHO’s definition of ‘serious AEFI’.", "entities": [], "input_ids": [2, 19140, 4076, 1927, 7433, 10194, 19894, 5735, 2698, 1927, 4786, 10194, 19894, 1036, 1985, 5947, 1966, 7433, 2079, 1920, 2746, 234, 61, 6600, 1927, 233, 7433, 10194, 19894, 234, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "fdd13791aa86", "text": "The patient had abdominal pain, headache, sinus tachycardia, dyspnoea, nausea and vomiting, which started on the day these drugs were given.", "entities": [{"start": 16, "end": 30, "label": "ADR", "text": "abdominal pain"}, {"start": 32, "end": 40, "label": "ADR", "text": "headache"}, {"start": 41, "end": 59, "label": "ADR", "text": "sinus tachycardia"}, {"start": 61, "end": 69, "label": "ADR", "text": "dyspnoea"}, {"start": 71, "end": 77, "label": "ADR", "text": "nausea"}, {"start": 82, "end": 90, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 1920, 2774, 2430, 6900, 3594, 16, 12187, 16, 9414, 17397, 16, 14633, 26447, 16, 13759, 1930, 13954, 16, 2154, 8074, 1990, 1920, 3007, 2144, 4195, 1985, 3258, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 4, 0, 3, 0, 4, 4, 0, 3, 4, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "2c269f132228", "text": "Stavudine (d4T) was kept as alternative to Zidovudine.By June 2007, the HIV Treatment Centre (Fevers Unit) of the hospital had almost 6500 patients on register and 2,042 patients on HAART.", "entities": [{"start": 0, "end": 9, "label": "DRUG", "text": "Stavudine"}, {"start": 11, "end": 14, "label": "DRUG", "text": "d4T"}, {"start": 43, "end": 53, "label": "DRUG", "text": "Zidovudine"}], "input_ids": [2, 23891, 1020, 20597, 12, 16603, 1031, 13, 1982, 8356, 1966, 5012, 1942, 28666, 22389, 1020, 20597, 18, 2007, 10343, 3826, 16, 1920, 3525, 2311, 8141, 12, 9087, 1036, 5344, 13, 1927, 1920, 3461, 2430, 5365, 18529, 1008, 2132, 1990, 13801, 1930, 22, 16, 25413, 2132, 1990, 18711, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1354f015b0d1", "text": "A total of 293 (6.8%) reported having an existing medical condition; hypertension (49.5%), diabetes (12.6%), stomach ulcer (11.6%) and asthma (10.6%) were the most common.", "entities": [{"start": 69, "end": 81, "label": "ADR", "text": "hypertension"}, {"start": 91, "end": 100, "label": "ADR", "text": "diabetes"}, {"start": 109, "end": 122, "label": "ADR", "text": "stomach ulcer"}, {"start": 134, "end": 141, "label": "ADR", "text": "asthma"}], "input_ids": [2, 43, 2698, 1927, 9728, 12, 26, 18, 28, 9, 13, 2568, 4537, 1925, 6124, 3423, 2625, 31, 5579, 12, 4343, 18, 25, 9, 13, 16, 4032, 12, 2369, 18, 26, 9, 13, 16, 11399, 10096, 12, 2513, 18, 26, 9, 13, 1930, 6678, 12, 2119, 18, 26, 9, 13, 1985, 1920, 2501, 3059, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "9b8cdd01db06", "text": "Nausea was the most commonly reported adverse events in all three regimens.", "entities": [{"start": 0, "end": 6, "label": "ADR", "text": "Nausea"}], "input_ids": [2, 13759, 1982, 1920, 2501, 5384, 2568, 5246, 3916, 1922, 2136, 2559, 9922, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "50b63a1866a9", "text": "Having a relatively high CD4 count 250 cells/mm3 or more was significantly associated with the occurrence of an adverse drug reaction.", "entities": [], "input_ids": [2, 4537, 43, 4322, 2149, 4095, 6500, 6330, 2094, 19, 14226, 2014, 2253, 1982, 2567, 2458, 1956, 1920, 6564, 1927, 1925, 5246, 2838, 3227, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "df215857312c", "text": "The third case involved an exposed female HCW of 42 years who was administered 3TC/AZT for 28 days and reported of fatigue, headache and weakness which according to her resulted in a “near death” experience.", "entities": [{"start": 35, "end": 58, "label": "PATIENT_DEMO", "text": "female HCW of 42 years"}, {"start": 78, "end": 82, "label": "DRUG", "text": "3TC"}, {"start": 83, "end": 86, "label": "DRUG", "text": "AZT"}, {"start": 115, "end": 122, "label": "ADR", "text": "fatigue"}, {"start": 124, "end": 132, "label": "ADR", "text": "headache"}, {"start": 137, "end": 145, "label": "ADR", "text": "weakness"}, {"start": 183, "end": 195, "label": "ADR", "text": "“near death”"}], "input_ids": [2, 1920, 4563, 3087, 3286, 1925, 4616, 4232, 4387, 1018, 1927, 3858, 2739, 2746, 1982, 5254, 25464, 1030, 19, 28301, 1958, 3158, 3000, 1930, 2568, 1927, 8656, 16, 12187, 1930, 12175, 2154, 3147, 1942, 3656, 4306, 1922, 43, 236, 4931, 3539, 237, 4848, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, -100], "source_type": "cohort_study"}
{"id": "8ada398f7ecd", "text": "Luma and colleagues, studying patients in Cameroun found an adverse drug reaction (ADR) prevalence of 19.5% of which 21.2% were due to peripheral neuropathy.", "entities": [{"start": 135, "end": 156, "label": "ADR", "text": "peripheral neuropathy"}], "input_ids": [2, 5491, 1019, 1930, 7858, 16, 9689, 2132, 1922, 29036, 1983, 2435, 1925, 5246, 2838, 3227, 12, 17645, 13, 4077, 1927, 2282, 18, 25, 9, 1927, 2154, 2900, 18, 22, 9, 1985, 2810, 1942, 5009, 13177, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "cohort_study"}
{"id": "2a79733aef89", "text": "The highest cumulative incidence of 2,914 per 100,000 persons vaccinated was observed among Sputnik V vaccine recipients, while recipients of the Pfizer vaccine reported the least cumulative incidence of 1.5 per 100,000 (Table 3).10.1371/journal.pgph.0003770.t003Table 3Cumulative incidence of AEFIs from the spontaneous reports.VaccineTotal number of Doses GivenNumber of Spontaneous AEFI ReportsIncidence per 100,000 personsAstraZeneca10,096,9253,59035.55537948Moderna1,065,357615.725780184Pfizer3,910,669571.457551125Sputnik17,9825242,914.025136Janssen2,318,072632.717775807Total17,409,0054,29524.67114002Number of AEFIs experienced after receiving COVID-19 vaccine doseTable 4 shows the number of AEFIs experienced by the various observed characteristics.", "entities": [{"start": 92, "end": 101, "label": "DRUG", "text": "Sputnik V"}, {"start": 146, "end": 152, "label": "DRUG", "text": "Pfizer"}, {"start": 426, "end": 437, "label": "DRUG", "text": "AstraZeneca"}, {"start": 463, "end": 470, "label": "DRUG", "text": "Moderna"}, {"start": 492, "end": 497, "label": "DRUG", "text": "Pfize"}, {"start": 520, "end": 527, "label": "DRUG", "text": "Sputnik"}], "input_ids": [2, 1920, 4554, 8274, 4332, 1927, 22, 16, 6550, 1006, 2079, 2813, 16, 3240, 7618, 13122, 1982, 2528, 2706, 13113, 23705, 64, 5955, 9336, 16, 2679, 9336, 1927, 1920, 21932, 5955, 2568, 1920, 3464, 8274, 4332, 1927, 21, 18, 25, 2079, 2813, 16, 3240, 12, 2545, 23, 13, 18, 2119, 18, 28687, 19, 5776, 18, 22534, 1023, 18, 25209, 7658, 1008, 18, 14575, 1010, 11577, 7550, 1989, 7797, 4332, 1927, 10194, 19894, 1036, 2037, 1920, 6242, 4710, 18, 5955, 4575, 2381, 2529, 1927, 5312, 3258, 1022, 22660, 1927, 6242, 10194, 19894, 4710, 4006, 2655, 2079, 2813, 16, 3240, 7618, 23593, 27168, 19384, 2930, 16, 7102, 1016, 16, 6224, 3786, 16, 24886, 5798, 18, 24098, 5494, 11226, 1025, 7993, 1915, 2175, 1009, 16, 6604, 1015, 16, 26099, 9171, 1015, 18, 4395, 5071, 4476, 21794, 1034, 19894, 14151, 1010, 16, 6550, 1008, 16, 4970, 8803, 9948, 18, 30321, 7054, 28135, 1015, 3508, 1984, 23705, 3952, 16, 5613, 4198, 29234, 16, 6550, 1006, 18, 15008, 22744, 23236, 5590, 1917, 1028, 16, 24543, 16, 6627, 4684, 6763, 18, 5858, 7658, 8245, 4476, 1027, 4575, 2381, 3952, 16, 28536, 16, 9163, 1006, 16, 21102, 4561, 18, 4838, 19843, 22536, 1022, 22660, 1927, 10194, 19894, 1036, 6090, 2256, 5962, 6083, 1960, 17, 2282, 5955, 3253, 11577, 24, 3661, 1920, 2529, 1927, 10194, 19894, 1036, 6090, 2007, 1920, 3425, 2528, 3779, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "d5e037d75f74", "text": "The recommendations for vaccinating these special populations against COVID‐19 will continue to evolve as research advances [51].From the Adjusted Logistic Regression model of factors associated with the seriousness of AEFIs among people who reported COVID-19 vaccine-related AEFIs, relative to those 50 years and above, the odds of serious AEFI was 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019).It is, however, worth noting that of the 57 serious AEFIs, the causality assessment by the FDA’s Joint COVID-19 Vaccine Safety Review Committee indicated that only 8 (14%) were vaccine product-related reactions providing further assurance of the safety of the vaccines in Ghana.The eight serious AEFIs which resulted in hospitalization were assessed by the FDA’s Joint COVID-19 Vaccine Safety Review Committee using the WHO Guidelines on Causality Assessment of AEFIs as having a Consistent causal association to immunization (A1: Vaccine product-related) [33].", "entities": [{"start": 301, "end": 319, "label": "PATIENT_DEMO", "text": "50 years and above"}, {"start": 371, "end": 385, "label": "PATIENT_DEMO", "text": "aged <30 years"}, {"start": 472, "end": 485, "label": "SEVERITY", "text": "serious AEFIs"}], "input_ids": [2, 1920, 7578, 1958, 4117, 9691, 2144, 5180, 4098, 3316, 6083, 1960, 226, 2282, 2832, 9085, 1942, 17175, 1966, 2659, 9382, 37, 4892, 39, 18, 2037, 1920, 4967, 6933, 4165, 2322, 1927, 2790, 2458, 1956, 1920, 7433, 2971, 1927, 10194, 19894, 1036, 2706, 4329, 2746, 2568, 6083, 1960, 17, 2282, 5955, 17, 2712, 10194, 19894, 1036, 16, 3338, 1942, 2690, 2761, 2739, 1930, 3538, 16, 1920, 6408, 1927, 7433, 10194, 19894, 1982, 3276, 9, 2941, 2706, 2690, 5177, 32, 2627, 2739, 12, 14973, 33, 20, 18, 3040, 16, 3371, 30, 37, 20, 18, 2282, 16, 20, 18, 5713, 39, 16, 58, 33, 20, 18, 19074, 13, 18, 2176, 1977, 16, 2406, 16, 10267, 16415, 1988, 1927, 1920, 4786, 7433, 10194, 19894, 1036, 16, 1920, 19140, 4076, 2007, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 3391, 1988, 2444, 28, 12, 2607, 9, 13, 1985, 5955, 4863, 17, 2712, 5298, 5453, 2520, 21625, 1927, 1920, 5407, 1927, 1920, 9375, 1922, 20685, 18, 1920, 5066, 7433, 10194, 19894, 1036, 2154, 4306, 1922, 9679, 1985, 3683, 2007, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 2193, 1920, 2746, 5522, 1990, 19140, 4076, 1927, 10194, 19894, 1036, 1966, 4537, 43, 3499, 9263, 3279, 1942, 10139, 12, 8080, 30, 5955, 4863, 17, 2712, 13, 37, 3401, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 6, 6, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "92e010a01c12", "text": "There were a total of five reports of rashes-two reports each in exposed HCWs/HCSs administered 3TC/AZT for 3 days and 28 days and one report in an exposed HCW administered 3TC/AZT/LPV-RTV for 28 days (Table 3).Table 3Preferred term within system organ classification of reported adverse events of 228 exposed HCWs/HCSs on HIV post-exposure prophylaxisNumber of adverse events reported by preferred term within system organ classification (n, %1)Total3TC/AZT-3 days3TC/AZT-28 days33TC/AZT/LPV-RTV-28 days N = 228 N = 101 N = 75 N = 52n, %1, 2 n, %1, 2 n, %1, 2 Gastrointestinal (n = 122, 53.5)Nausea101 (44.3)17 (16.8)47 (62.7)37 (71.2)Diarrhoea38 (16.7)3 (3.0)1 (1.3)34 (65.4)Vomiting24 (10.5)1 (1.0)5 (6.7)18 (34.6)Loss of appetite14 (6.1)3 (3.0)6 (8.0)5 (9.6)Abdominal pains14 (6.1)2 (2.0)5 (6.7)7 (13.5)Anorexia5 (2.2)-2 (2.7)3 (5.8)Dehydration1 (0.4)-1 (1.3)-Bitter mouth1 (0.4)1 (1.0)--Constipation1 (0.4)-1 (1.3)-Excessive flatulence1 (0.4)--1 (1.9)Abdominal discomfort1 (0.4)-1 (1.3)-Hyper-salivation1 (0.4)--1 (1.9)Sore throat1 (0.4)--1 (1.9)Excessive spitting1 (0.4)-1 (1.3)-Hunger pain1 (0.4)-1 (1.3)-Systematic signs & symptoms (n = 106, 46.5)Weakness54 (23.7)10 (9.9)28 (37.3)16 (30.8)Malaise37 (16.2)6 (5.9)17 (22.7)14 (26.9)Dizziness30 (13.2)6 (5.9)20 (26.7)4 (7.7)Fatigue28 (12.3)2 (2.0)21 (28.0)5 (9.6)Feverish5 (2.2)-2 (2.7)3 (5.8)General body pains2 (0.9)-2 (2.7)-Neurological system (n = 42, 18.4)Headache27 (11.8)3 (3.0)19 (25.3)5 (9.6)Restlessness8 (3.5)2 (2.0)4 (5.3)2 (3.8)Insomnia7 (3.1)1 (1.0)4 (5.3)2 (3.8)Drowsiness5 (2.2)1 (1.0)1 (1.3)3 (5.8)Depression1 (0.4)-1 (1.3)-Skin (n = 9, 3.9)Rashes5 (2.2)2 (2.0)2 (2.7)1 (1.9)Itching2 (0.9)2 (2.0)--Alopecia1 (0.4)-1 (1.3)-Dark pigmentation of finger & toe nails1 (0.4)--1 (1.9)Central/peripheral nervous system (n = 4, 1.8)Eye pain1 (0.4)-1 (1.3)-Leg pains1 (0.4)-1 (1.3)-Neck pains1 (0.4)--1 (1.9)Pain in feet1 (0.4)--1 (1.9)Red eye1 (0.4)--1 (1.9)Hepatitis (n = 2, 0.9)Yellow eyes1 (0.4)-1 (1.3)-Jaundice1 (0.4)--1 (1.9)Cardiac (n = 1, 0.4)Tightness in chest1 (0.4)-1 (1.3)-Reproductive/gynaecological (n = 1, 0.4)Spontaneous abortion1 (0.4)--1 (1.9)Bleeding1 (0.4)--1 (1.9) 1Percentages may add up to >100 2% are percentages within each drug column; 3TC = lamivudine; AZT = zidovudine; LPV-RTV = lopinavir-ritonavirThere were three spontaneous reports of adverse events which ended up in hospitalisation but all recovered.", "entities": [{"start": 72, "end": 82, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 96, "end": 99, "label": "DRUG", "text": "3TC"}, {"start": 100, "end": 103, "label": "DRUG", "text": "AZT"}, {"start": 156, "end": 159, "label": "PATIENT_DEMO", "text": "HCW"}, {"start": 173, "end": 176, "label": "DRUG", "text": "3TC"}, {"start": 177, "end": 180, "label": "DRUG", "text": "AZT"}, {"start": 181, "end": 189, "label": "DRUG", "text": "LPV-RTV"}, {"start": 451, "end": 454, "label": "DRUG", "text": "3TC"}, {"start": 455, "end": 458, "label": "DRUG", "text": "AZT"}, {"start": 465, "end": 468, "label": "DRUG", "text": "3TC"}, {"start": 469, "end": 472, "label": "DRUG", "text": "AZT"}, {"start": 481, "end": 484, "label": "DRUG", "text": "3TC"}, {"start": 485, "end": 488, "label": "DRUG", "text": "AZT"}, {"start": 489, "end": 496, "label": "DRUG", "text": "LPV-RTV"}, {"start": 561, "end": 577, "label": "ADR", "text": "Gastrointestinal"}, {"start": 593, "end": 599, "label": "ADR", "text": "Nausea"}, {"start": 636, "end": 645, "label": "ADR", "text": "Diarrhoea"}, {"start": 677, "end": 685, "label": "ADR", "text": "Vomiting"}, {"start": 717, "end": 733, "label": "ADR", "text": "Loss of appetite"}, {"start": 762, "end": 777, "label": "ADR", "text": "Abdominal pains"}, {"start": 807, "end": 815, "label": "ADR", "text": "Anorexia"}, {"start": 837, "end": 848, "label": "ADR", "text": "Dehydration"}, {"start": 864, "end": 876, "label": "ADR", "text": "Bitter mouth"}, {"start": 892, "end": 904, "label": "ADR", "text": "Constipation"}, {"start": 920, "end": 940, "label": "ADR", "text": "Excessive flatulence"}, {"start": 956, "end": 976, "label": "ADR", "text": "Abdominal discomfort"}, {"start": 992, "end": 1008, "label": "ADR", "text": "Hyper-salivation"}, {"start": 1024, "end": 1035, "label": "ADR", "text": "Sore throat"}, {"start": 1051, "end": 1069, "label": "ADR", "text": "Excessive spitting"}, {"start": 1085, "end": 1096, "label": "ADR", "text": "Hunger pain"}, {"start": 1155, "end": 1163, "label": "ADR", "text": "Weakness"}, {"start": 1239, "end": 1248, "label": "ADR", "text": "Dizziness"}, {"start": 1280, "end": 1287, "label": "ADR", "text": "Fatigue"}, {"start": 1319, "end": 1327, "label": "ADR", "text": "Feverish"}, {"start": 1349, "end": 1367, "label": "ADR", "text": "General body pains"}, {"start": 1417, "end": 1425, "label": "ADR", "text": "Headache"}, {"start": 1457, "end": 1469, "label": "ADR", "text": "Restlessness"}, {"start": 1497, "end": 1505, "label": "ADR", "text": "Insomnia"}, {"start": 1533, "end": 1543, "label": "ADR", "text": "Drowsiness"}, {"start": 1571, "end": 1581, "label": "ADR", "text": "Depression"}, {"start": 1597, "end": 1601, "label": "ADR", "text": "Skin"}, {"start": 1614, "end": 1620, "label": "ADR", "text": "Rashes"}, {"start": 1648, "end": 1655, "label": "ADR", "text": "Itching"}, {"start": 1671, "end": 1679, "label": "ADR", "text": "Alopecia"}, {"start": 1694, "end": 1734, "label": "ADR", "text": "-Dark pigmentation of finger & toe nails"}, {"start": 1796, "end": 1804, "label": "ADR", "text": "Eye pain"}, {"start": 1820, "end": 1829, "label": "ADR", "text": "Leg pains"}, {"start": 1845, "end": 1855, "label": "ADR", "text": "Neck pains"}, {"start": 1871, "end": 1883, "label": "ADR", "text": "Pain in feet"}, {"start": 1899, "end": 1905, "label": "ADR", "text": "Red ey"}, {"start": 1922, "end": 1931, "label": "ADR", "text": "Hepatitis"}, {"start": 1944, "end": 1955, "label": "ADR", "text": "Yellow eyes"}, {"start": 1971, "end": 1979, "label": "ADR", "text": "Jaundice"}, {"start": 2015, "end": 2033, "label": "ADR", "text": "Tightness in chest"}, {"start": 2089, "end": 2109, "label": "ADR", "text": "Spontaneous abortion"}, {"start": 2226, "end": 2229, "label": "DRUG", "text": "3TC"}, {"start": 2232, "end": 2242, "label": "DRUG", "text": "lamivudine"}, {"start": 2244, "end": 2247, "label": "DRUG", "text": "AZT"}, {"start": 2250, "end": 2260, "label": "DRUG", "text": "zidovudine"}, {"start": 2262, "end": 2269, "label": "DRUG", "text": "LPV-RTV"}, {"start": 2272, "end": 2281, "label": "DRUG", "text": "lopinavir"}], "input_ids": [2, 2276, 1985, 43, 2698, 1927, 3628, 4710, 1927, 18469, 1918, 17, 2288, 4710, 2362, 1922, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 1958, 23, 3000, 1930, 3158, 3000, 1930, 2340, 3809, 1922, 1925, 4616, 4387, 1018, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 12, 2545, 23, 13, 18, 2545, 11469, 24864, 5385, 1919, 2576, 2651, 2433, 3090, 5492, 1927, 2568, 5246, 3916, 1927, 19650, 4616, 4387, 8327, 19, 19760, 1036, 1990, 3525, 2753, 17, 3395, 12725, 1022, 22660, 1927, 5246, 3916, 2568, 2007, 8579, 2576, 2651, 2433, 3090, 5492, 12, 56, 16, 9, 21, 13, 2698, 1010, 6916, 19, 28301, 17, 23, 3000, 1010, 6916, 19, 28301, 17, 3158, 3000, 6498, 6916, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 17, 3158, 3000, 56, 33, 19650, 56, 33, 9447, 56, 33, 4089, 56, 33, 4764, 1022, 16, 9, 21, 16, 22, 56, 16, 9, 21, 16, 22, 56, 16, 9, 21, 16, 22, 8375, 12, 56, 33, 11191, 16, 4522, 18, 25, 13, 13759, 13100, 12, 4044, 18, 23, 13, 2752, 12, 2641, 18, 28, 13, 4261, 12, 5374, 18, 27, 13, 3191, 12, 5858, 18, 22, 13, 20998, 4745, 12, 2641, 18, 27, 13, 23, 12, 23, 18, 20, 13, 21, 12, 21, 18, 23, 13, 3540, 12, 4459, 18, 24, 13, 13954, 4561, 12, 2119, 18, 25, 13, 21, 12, 21, 18, 20, 13, 25, 12, 26, 18, 27, 13, 2654, 12, 3540, 18, 26, 13, 3257, 1927, 17990, 3745, 12, 26, 18, 21, 13, 23, 12, 23, 18, 20, 13, 26, 12, 28, 18, 20, 13, 25, 12, 29, 18, 26, 13, 6900, 3594, 12030, 1006, 12, 26, 18, 21, 13, 22, 12, 22, 18, 20, 13, 25, 12, 26, 18, 27, 13, 27, 12, 2590, 18, 25, 13, 21810, 1015, 12, 22, 18, 22, 13, 17, 22, 12, 22, 18, 27, 13, 23, 12, 25, 18, 28, 13, 16585, 1009, 12, 20, 18, 24, 13, 17, 21, 12, 21, 18, 23, 13, 17, 28753, 11701, 1009, 12, 20, 18, 24, 13, 21, 12, 21, 18, 20, 13, 17, 17, 19618, 1009, 12, 20, 18, 24, 13, 17, 21, 12, 21, 18, 23, 13, 17, 9122, 9778, 25916, 1009, 12, 20, 18, 24, 13, 17, 17, 21, 12, 21, 18, 29, 13, 6900, 15335, 1009, 12, 20, 18, 24, 13, 17, 21, 12, 21, 18, 23, 13, 17, 4194, 17, 12999, 1929, 1009, 12, 20, 18, 24, 13, 17, 17, 21, 12, 21, 18, 29, 13, 6548, 1021, 23555, 1009, 12, 20, 18, 24, 13, 17, 17, 21, 12, 21, 18, 29, 13, 9122, 15776, 3519, 1941, 1009, 12, 20, 18, 24, 13, 17, 21, 12, 21, 18, 23, 13, 17, 26452, 3594, 1009, 12, 20, 18, 24, 13, 17, 21, 12, 21, 18, 23, 13, 17, 5614, 6879, 10, 3601, 12, 56, 33, 7758, 16, 4182, 18, 25, 13, 12175, 5651, 12, 3020, 18, 27, 13, 2119, 12, 29, 18, 29, 13, 3158, 12, 3191, 18, 23, 13, 2641, 12, 2627, 18, 28, 13, 3054, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "526e483827fc", "text": "The adenovirus viral vector-based vaccines like Johnson and Johnson and Covishield (AstraZeneca) have also been linked to TTS and pulmonary embolism [21–23].In Ghana, five vaccines were given Emergency Use Authorization (EUA) as of 20th December 2021 by the National Regulatory Agency, the Food and Drugs Authority (FDA) for deployment in the mass vaccination programme following the COVID-19 outbreak.", "entities": [{"start": 48, "end": 67, "label": "DRUG", "text": "Johnson and Johnson"}, {"start": 72, "end": 82, "label": "DRUG", "text": "Covishield"}, {"start": 84, "end": 95, "label": "DRUG", "text": "AstraZeneca"}, {"start": 122, "end": 125, "label": "ADR", "text": "TTS"}, {"start": 130, "end": 149, "label": "ADR", "text": "pulmonary embolism"}], "input_ids": [2, 1920, 13354, 4324, 4580, 17, 2454, 9375, 3189, 13890, 1930, 13890, 1930, 6083, 26458, 2884, 12, 20329, 27168, 19384, 13, 2162, 2222, 2252, 4624, 1942, 29958, 1930, 5352, 19287, 37, 2900, 229, 3020, 39, 18, 1922, 20685, 16, 3628, 9375, 1985, 3258, 7877, 2485, 6799, 2466, 12, 4791, 1019, 13, 1966, 1927, 25673, 9474, 17401, 1009, 2007, 1920, 3852, 4948, 11920, 16, 1920, 3959, 1930, 4195, 18791, 12, 11394, 13, 1958, 18898, 1922, 1920, 3411, 7507, 9481, 2894, 1920, 6083, 1960, 17, 2282, 9571, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "a2abc901798a", "text": "Curkendall compared a ZDV cohort to a non ZDV cohort and observed a 3 fold increase in the incidence of anaemia in the ZDV group after 6 months of follow up and a little over 2 fold over 24 months of follow up[10].Further, female patients in our data were significantly more likely than males to experience anaemia.", "entities": [{"start": 22, "end": 25, "label": "DRUG", "text": "ZDV"}, {"start": 41, "end": 45, "label": "DRUG", "text": "ZDV"}, {"start": 104, "end": 111, "label": "ADR", "text": "anaemia"}, {"start": 119, "end": 122, "label": "DRUG", "text": "ZDV"}, {"start": 223, "end": 238, "label": "PATIENT_DEMO", "text": "female patients"}, {"start": 307, "end": 314, "label": "ADR", "text": "anaemia"}], "input_ids": [2, 3580, 11341, 3825, 11560, 2452, 43, 68, 17332, 4382, 1942, 43, 2447, 68, 17332, 4382, 1930, 2528, 43, 23, 3728, 2760, 1922, 1920, 4332, 1927, 19682, 1922, 1920, 68, 17332, 2210, 2256, 26, 3221, 1927, 2396, 2353, 1930, 43, 5082, 2338, 22, 3728, 2338, 2686, 3221, 1927, 2396, 2353, 37, 2119, 39, 18, 2520, 16, 4232, 2132, 1922, 2342, 2230, 1985, 2567, 2253, 3205, 2254, 5129, 1942, 4848, 19682, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "cohort_study"}
{"id": "9260e8ba3b51", "text": "HCWs/HCSs with exposures assessed as high risk were administered either lamivudine/zidovudine/lopinavir-ritonavir (3TC/AZT/LPV-RTV) (triple therapy) for 28 days or lamivudine/zidovudine (3TC/AZT) (dual therapy) for 28 days.", "entities": [{"start": 0, "end": 9, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 72, "end": 82, "label": "DRUG", "text": "lamivudine"}, {"start": 83, "end": 93, "label": "DRUG", "text": "zidovudine"}, {"start": 94, "end": 103, "label": "DRUG", "text": "lopinavir"}, {"start": 104, "end": 113, "label": "DRUG", "text": "ritonavir"}, {"start": 115, "end": 118, "label": "DRUG", "text": "3TC"}, {"start": 119, "end": 122, "label": "DRUG", "text": "AZT"}, {"start": 123, "end": 130, "label": "DRUG", "text": "LPV-RTV"}, {"start": 164, "end": 174, "label": "DRUG", "text": "lamivudine"}, {"start": 175, "end": 185, "label": "DRUG", "text": "zidovudine"}, {"start": 187, "end": 190, "label": "DRUG", "text": "3TC"}, {"start": 191, "end": 195, "label": "DRUG", "text": "AZT)"}], "input_ids": [2, 4387, 8327, 19, 19760, 1036, 1956, 10043, 3683, 1966, 2149, 2565, 1985, 5254, 3108, 30208, 19, 28666, 22389, 1020, 20597, 19, 3004, 9512, 11046, 17, 24019, 12502, 3026, 12, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 13, 12, 10073, 3181, 13, 1958, 3158, 3000, 2014, 30208, 19, 28666, 22389, 1020, 20597, 12, 25464, 1030, 19, 28301, 13, 12, 7064, 3181, 13, 1958, 3158, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "de155bccf56b", "text": "As indicated under the results section, of the eight cases, five and one were diagnosed as febrile illness and cerebrovascular accident respectively with the AstraZeneca vaccine.", "entities": [{"start": 91, "end": 106, "label": "ADR", "text": "febrile illness"}, {"start": 111, "end": 135, "label": "ADR", "text": "cerebrovascular accident"}, {"start": 158, "end": 169, "label": "DRUG", "text": "AstraZeneca"}], "input_ids": [2, 1966, 3391, 2441, 1920, 2274, 3314, 16, 1927, 1920, 5066, 2919, 16, 3628, 1930, 2340, 1985, 5377, 1966, 18850, 6455, 1930, 16221, 17713, 2763, 1956, 1920, 20329, 27168, 19384, 5955, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 0, 0, 0, 1, 2, 2, 0, 0, -100], "source_type": "cohort_study"}
{"id": "0e2e716eba8b", "text": "The prevalence of particular side effects in resource-poor settings is therefore often linked with the drugs comprising the first-line regimen in that setting as was shown in this study.Most adverse effects can be determined by appropriate clinical examination for specific symptoms and signs, including fatigue with conjunctival pallor (due to Zidovudine-related anaemia); neuropsychiatric problems (due to Efavirenz toxicity); peripheral wasting (due to Stavudine-related lipodystrophy); [14] and rash (due to Nevirapine, Efavirenz or Abacavir).", "entities": [{"start": 304, "end": 311, "label": "ADR", "text": "fatigue"}, {"start": 317, "end": 337, "label": "ADR", "text": "conjunctival pallor"}, {"start": 345, "end": 355, "label": "DRUG", "text": "Zidovudine"}, {"start": 364, "end": 371, "label": "ADR", "text": "anaemia"}, {"start": 373, "end": 399, "label": "ADR", "text": "neuropsychiatric problems"}, {"start": 408, "end": 417, "label": "DRUG", "text": "Efavirenz"}, {"start": 428, "end": 447, "label": "ADR", "text": "peripheral wasting"}, {"start": 456, "end": 465, "label": "DRUG", "text": "Stavudine"}, {"start": 474, "end": 487, "label": "DRUG", "text": "lipodystrophy"}, {"start": 499, "end": 503, "label": "ADR", "text": "rash"}, {"start": 512, "end": 522, "label": "DRUG", "text": "Nevirapine"}, {"start": 524, "end": 533, "label": "DRUG", "text": "Efavirenz"}, {"start": 537, "end": 545, "label": "DRUG", "text": "Abacavir"}], "input_ids": [2, 1920, 4077, 1927, 3278, 4159, 2564, 1922, 7965, 17, 3930, 6457, 1977, 2955, 3868, 4624, 1956, 1920, 4195, 10351, 1920, 2561, 17, 2823, 8607, 1922, 1988, 4308, 1966, 1982, 2522, 1922, 2052, 2161, 18, 2501, 5246, 2564, 2112, 1998, 3180, 2007, 4703, 2535, 4981, 1958, 2487, 3601, 1930, 6879, 16, 2710, 8656, 1956, 23702, 9396, 1924, 12, 2810, 1942, 28666, 22389, 1020, 20597, 17, 2712, 19682, 13, 31, 19305, 4951, 12, 2810, 1942, 8485, 11046, 4389, 5532, 13, 31, 5009, 23217, 12, 2810, 1942, 23891, 1020, 20597, 17, 2712, 3178, 26812, 1997, 2688, 1012, 13, 31, 37, 2607, 39, 1930, 18469, 12, 2810, 1942, 27360, 11979, 12184, 16, 8485, 11046, 4389, 2014, 13195, 3375, 3026, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 0, 0, 1, 2, 2, 2, 0, 0, 3, 0, 0, 4, 4, 0, 0, 0, 1, 2, 2, 0, 0, 0, 4, 4, 0, 0, 0, 1, 2, 2, 0, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 0, 0, -100], "source_type": "cohort_study"}
{"id": "e68b75d4679f", "text": "Gastrointestinal disorders, nervous system disorders and general disorders and administration site conditions were the three most frequently reported SOCs.Table 1Description of ADRs and type of drugsADR (Classified as SOC and PT)No. of ADRs (%)Suspected Drugs (Number of ADRs)Gastrointestinal disorders23 (22.8)Hydroxychloroquine (6), Aminophylline/Magnesium sulphate (3), Hydroxychloroquine/ Azithromycin (3), Chloroquine (4), Azithromycin (1), Vitamin C (1), Lopinavir/Ritonavir (1), Azithromycin (2), Metformin/Vildagliptin (1)Diarrhoea13Abdominal pain1Abdominal pain upper2Nausea2Abdominal discomfort2Vomiting1Oropharyngeal pain1Nervous system disorders17 (16.8)Hydroxychloroquine (7), Chloroquine (5), Azithromycin (2), Doxycycline (1), Hydroxychloroquine/Azithromycin (2), Aminophylline/Magnesium sulphate (1)Dizziness7Headache5Tremor3Restlessness1Dysgeusia1General disorders and administration site conditions14 (13.9)Hydroxychloroquine (7), Chloroquine (5), Meropenem (1), Zinc (1)Asthenia4Treatment failure3Pyrexia2Lethargy1Hyperhidrosis1Weak joint1Gait disturbances1Fatigue1Cardiac disorders11 (10.9)Hydroxychloroquine (5), Hydroxychloroquine/Azithromycin (3), Chloroquine (1), Aminophylline/Magnesium sulphate (1), Azithromycin (1)Palpitations5Sinus tachycardia2Supraventricular tachycardia1Chest pain1Chest discomfort1Electrocardiogram QT prolonged1ADR (Classified as SOC and PT)Number of CasesSuspected Drugs (Number of cases)Psychiatric disorders9 (8.9)Hydroxychloroquine (6), Chloroquine (2), Hydroxychloroquine/Azithromycin (1)Insomnia4Hallucinations2Somnolence1Mood swings1Slurred speech1Skin and subcutaneous tissue disorders9 (8.9)Hydroxychloroquine (2), Chloroquine (2), Ciprofloxacin (2), Azithromycin (1), Tramadol/Paracetamol (1), Amoxicillin / Clavulanic acid (1)Pruritus6Rash2Urticaria1Respiratory, thoracic and mediastinal disorders7 (6.9)Hydroxychloroquine/Azithromycin (3), Hydroxychloroquine (1), Chloroquine (1), Azithromycin (1), Aminophylline/Magnesium sulphate (1)Dyspnoea5Dry throat1Cough1Eye disorders3 (3.0)Hydroxychloroquine (2), Chloroquine (1)Vision blurred2Eye pain1Injury, poisoning and procedural complications4 (4.0)Chloroquine (1), Azithromycin (1), Amiodarone (1), Esomeprazole (1)Circumstance or information capable of leading to medication error1Medication error3Renal and urinary disorders2 (2.0)Hydroxychloroquine/Azithromycin (1), Chloroquine (1)Chromaturia2Reproductive system and breast disorders1 (1.0)Hydroxychloroquine (2)Scrotal pain1Metabolism and nutrition disorders1 (1.0)Chloroquine (1)Micturition frequency increased1The first three commonly reported ADRs by PT were diarrhoea (14), dizziness (7) and pruritus.", "entities": [{"start": 311, "end": 329, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 335, "end": 367, "label": "DRUG", "text": "Aminophylline/Magnesium sulphate"}, {"start": 373, "end": 391, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 393, "end": 405, "label": "DRUG", "text": "Azithromycin"}, {"start": 411, "end": 422, "label": "DRUG", "text": "Chloroquine"}, {"start": 428, "end": 441, "label": "DRUG", "text": "Azithromycin"}, {"start": 445, "end": 456, "label": "DRUG", "text": "Vitamin C"}, {"start": 461, "end": 470, "label": "DRUG", "text": "Lopinavir"}, {"start": 471, "end": 480, "label": "DRUG", "text": "Ritonavir"}, {"start": 504, "end": 513, "label": "DRUG", "text": "Metformin"}, {"start": 530, "end": 539, "label": "ADR", "text": "Diarrhoea"}, {"start": 541, "end": 555, "label": "ADR", "text": "Abdominal pain"}, {"start": 556, "end": 570, "label": "ADR", "text": "Abdominal pain"}, {"start": 577, "end": 583, "label": "ADR", "text": "Nausea"}, {"start": 584, "end": 604, "label": "ADR", "text": "Abdominal discomfort"}, {"start": 605, "end": 613, "label": "ADR", "text": "Vomiting"}, {"start": 614, "end": 632, "label": "ADR", "text": "Oropharyngeal pain"}, {"start": 633, "end": 657, "label": "ADR", "text": "Nervous system disorders"}, {"start": 666, "end": 684, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 690, "end": 701, "label": "DRUG", "text": "Chloroquine"}, {"start": 707, "end": 719, "label": "DRUG", "text": "Azithromycin"}, {"start": 725, "end": 736, "label": "DRUG", "text": "Doxycycline"}, {"start": 742, "end": 760, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 761, "end": 773, "label": "DRUG", "text": "Azithromycin"}, {"start": 779, "end": 811, "label": "DRUG", "text": "Aminophylline/Magnesium sulphate"}, {"start": 814, "end": 824, "label": "ADR", "text": ")Dizziness"}, {"start": 825, "end": 833, "label": "ADR", "text": "Headache"}, {"start": 834, "end": 840, "label": "ADR", "text": "Tremor"}, {"start": 841, "end": 853, "label": "ADR", "text": "Restlessness"}, {"start": 854, "end": 863, "label": "ADR", "text": "Dysgeusia"}, {"start": 864, "end": 881, "label": "ADR", "text": "General disorders"}, {"start": 885, "end": 916, "label": "ADR", "text": "administration site conditions"}, {"start": 925, "end": 943, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 949, "end": 960, "label": "DRUG", "text": "Chloroquine"}, {"start": 965, "end": 975, "label": "DRUG", "text": "Meropenem"}, {"start": 980, "end": 985, "label": "DRUG", "text": "Zinc"}, {"start": 1033, "end": 1046, "label": "ADR", "text": "Hyperhidrosis"}, {"start": 1047, "end": 1057, "label": "ADR", "text": "Weak joint"}, {"start": 1058, "end": 1075, "label": "ADR", "text": "Gait disturbances"}, {"start": 1076, "end": 1083, "label": "ADR", "text": "Fatigue"}, {"start": 1084, "end": 1101, "label": "ADR", "text": "Cardiac disorders"}, {"start": 1110, "end": 1128, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1134, "end": 1152, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1153, "end": 1165, "label": "DRUG", "text": "Azithromycin"}, {"start": 1171, "end": 1182, "label": "DRUG", "text": "Chloroquine"}, {"start": 1188, "end": 1221, "label": "DRUG", "text": "Aminophylline/Magnesium sulphate"}, {"start": 1225, "end": 1238, "label": "DRUG", "text": "Azithromycin"}, {"start": 1302, "end": 1312, "label": "ADR", "text": "Chest pain"}, {"start": 1313, "end": 1329, "label": "ADR", "text": "Chest discomfort"}, {"start": 1439, "end": 1460, "label": "ADR", "text": "Psychiatric disorders"}, {"start": 1467, "end": 1485, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1491, "end": 1502, "label": "DRUG", "text": "Chloroquine"}, {"start": 1508, "end": 1526, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1543, "end": 1551, "label": "ADR", "text": "Insomnia"}, {"start": 1552, "end": 1566, "label": "ADR", "text": "Hallucinations"}, {"start": 1567, "end": 1577, "label": "ADR", "text": "Somnolence"}, {"start": 1578, "end": 1589, "label": "ADR", "text": "Mood swings"}, {"start": 1590, "end": 1604, "label": "ADR", "text": "Slurred speech"}, {"start": 1605, "end": 1643, "label": "ADR", "text": "Skin and subcutaneous tissue disorders"}, {"start": 1650, "end": 1668, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1674, "end": 1685, "label": "DRUG", "text": "Chloroquine"}, {"start": 1691, "end": 1704, "label": "DRUG", "text": "Ciprofloxacin"}, {"start": 1710, "end": 1722, "label": "ADR", "text": "Azithromycin"}, {"start": 1728, "end": 1736, "label": "DRUG", "text": "Tramadol"}, {"start": 1737, "end": 1748, "label": "DRUG", "text": "Paracetamol"}, {"start": 1754, "end": 1765, "label": "DRUG", "text": "Amoxicillin"}, {"start": 1767, "end": 1783, "label": "DRUG", "text": "Clavulanic acid"}, {"start": 1824, "end": 1858, "label": "ADR", "text": "thoracic and mediastinal disorders"}, {"start": 1865, "end": 1883, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1902, "end": 1920, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 1926, "end": 1937, "label": "DRUG", "text": "Chloroquine"}, {"start": 1942, "end": 1955, "label": "DRUG", "text": "Azithromycin"}, {"start": 1961, "end": 1994, "label": "DRUG", "text": "Aminophylline/Magnesium sulphate"}, {"start": 2023, "end": 2036, "label": "ADR", "text": "Eye disorders"}, {"start": 2043, "end": 2061, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 2067, "end": 2078, "label": "DRUG", "text": "Chloroquine"}, {"start": 2082, "end": 2096, "label": "ADR", "text": "Vision blurred"}, {"start": 2097, "end": 2105, "label": "ADR", "text": "Eye pain"}, {"start": 2106, "end": 2152, "label": "ADR", "text": "Injury, poisoning and procedural complications"}, {"start": 2159, "end": 2170, "label": "DRUG", "text": "Chloroquine"}, {"start": 2175, "end": 2189, "label": "DRUG", "text": "Azithromycin"}, {"start": 2194, "end": 2204, "label": "DRUG", "text": "Amiodarone"}, {"start": 2209, "end": 2222, "label": "DRUG", "text": "Esomeprazole"}, {"start": 2344, "end": 2362, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 2363, "end": 2376, "label": "DRUG", "text": "Azithromycin"}, {"start": 2381, "end": 2392, "label": "DRUG", "text": "Chloroquine"}, {"start": 2455, "end": 2473, "label": "DRUG", "text": "Hydroxychloroquine"}, {"start": 2531, "end": 2542, "label": "DRUG", "text": "Chloroquine"}, {"start": 2628, "end": 2637, "label": "DRUG", "text": "diarrhoea"}, {"start": 2644, "end": 2653, "label": "DRUG", "text": "dizziness"}, {"start": 2662, "end": 2670, "label": "DRUG", "text": "pruritus"}], "input_ids": [2, 8375, 4414, 16, 7580, 2433, 4414, 1930, 3335, 4414, 1930, 4183, 3200, 2961, 1985, 1920, 2559, 2501, 5467, 2568, 28317, 18, 2545, 8046, 1918, 4093, 2001, 1927, 28863, 1930, 2601, 1927, 4195, 2015, 1005, 12, 5947, 1966, 10188, 1930, 4401, 13, 2239, 18, 1927, 28863, 12, 9, 13, 9407, 4195, 12, 2529, 1927, 28863, 13, 8375, 4414, 4553, 12, 2950, 18, 28, 13, 8275, 11600, 1037, 15520, 12, 26, 13, 16, 3835, 25818, 11560, 2053, 19, 13148, 20415, 12, 23, 13, 16, 8275, 11600, 1037, 15520, 19, 28350, 12, 23, 13, 16, 20813, 12, 24, 13, 16, 28350, 12, 21, 13, 16, 6111, 45, 12, 21, 13, 16, 3004, 9512, 11046, 19, 24019, 12502, 3026, 12, 21, 13, 16, 28350, 12, 22, 13, 16, 11885, 19, 27223, 3825, 4365, 14302, 1921, 12, 21, 13, 20998, 3633, 28440, 2526, 3594, 6146, 13602, 1947, 2526, 3594, 5199, 1028, 2175, 2517, 8398, 28440, 2526, 15335, 1028, 15525, 4739, 1941, 1009, 30232, 4151, 6907, 2029, 5243, 3594, 1009, 3239, 15525, 1957, 2433, 4414, 3952, 12, 2641, 18, 28, 13, 8275, 11600, 1037, 15520, 12, 27, 13, 16, 20813, 12, 25, 13, 16, 28350, 12, 22, 13, 16, 16647, 12, 21, 13, 16, 8275, 11600, 1037, 15520, 19, 28350, 12, 22, 13, 16, 3835, 25818, 11560, 2053, 19, 13148, 20415, 12, 21, 13, 24009, 1027, 10611, 9044, 1015, 4265, 12492, 14443, 2808, 4131, 5590, 2971, 18737, 2012, 2106, 24327, 4904, 14687, 7317, 4414, 1930, 4183, 3200, 2961, 3745, 12, 2590, 18, 29, 13, 8275, 11600, 1037, 15520, 12, 27, 13, 16, 20813, 12, 25, 13, 16, 6902, 4907, 19319, 12, 21, 13, 16, 7997, 12, 21, 13, 6187, 8572, 1006, 7923, 4574, 23081, 3553, 2783, 2126, 1028, 6088, 28476, 26983, 1009, 30338, 2116, 7969, 3883, 2475, 1009, 2172, 2220, 6047, 1009, 4223, 1932, 12654, 1009, 6016, 2677, 2182, 15353, 25111, 4414, 3242, 12, 2119, 18, 29, 13, 8275, 11600, 1037, 15520, 12, 25, 13, 16, 8275, 11600, 1037, 15520, 19, 28350, 12, 23, 13, 16, 20813, 12, 21, 13, 16, 3835, 25818, 11560, 2053, 19, 13148, 20415, 12, 21, 13, 16, 28350, 12, 21, 13, 15771, 29063, 1015, 6777, 1957, 17397, 24900, 3481, 5524, 24722, 17397, 15353, 4483, 1031, 3594, 15353, 4483, 1031, 15335, 30484, 25419, 1997, 9641, 7539, 8877, 7171, 6146, 3883, 12, 5947, 1966, 10188, 1930, 4401, 13, 2529, 1927, 2919, 20490, 13460, 2013, 4195, 12, 2529, 1927, 2919, 13, 7652, 4414, 1026, 12, 28, 18, 29, 13, 8275, 11600, 1037, 15520, 12, 26, 13, 16, 20813, 12, 22, 13, 16, 8275, 11600, 1037, 15520, 19, 28350, 12, 21, 13, 16882, 1006, 7289, 18369, 5742, 24900, 29067, 2456, 15895, 12474, 12492, 1986, 24775, 12030, 1036, 5277, 18858, 1919, 8560, 26560, 6856, 1930, 8634, 2960, 4414, 1026, 12, 28, 18, 29, 13, 8275, 11600, 1037, 15520, 12, 22, 13, 16, 20813, 12, 22, 13, 16, 18502, 12, 22, 13, 16, 28350, 12, 21, 13, 16, 23179, 28280, 19, 27021, 12, 21, 13, 16, 24987, 19, 19887, 5617, 19730, 2687, 12, 21, 13, 27496, 1016, 29375, 6951, 12418, 6102, 3027, 4904, 3307, 12341, 16, 10670, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 4, 4, 4, 4, 0, 0, 3, 4, 4, 3, 4, 4, 0, 3, 4, 4, 0, 3, 4, 4, 4, 4, 4, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 3, 4, 0, 3, 4, 0, 3, 4, 4, 3, 4, 4, 4, 0, 4, 4, 4, 4, 3, 4, 4, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 3, 4, 4, 0, 3, 4, 4, 0, 3, 4, 4, 0, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 4, 4, 4, 4, 3, 4, 4, 4, 3, 4, 4, 4, 4, 0, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 1, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, -100], "source_type": "cohort_study"}
{"id": "e0082b78455b", "text": "In a study by Monforte et al [4], 21% of those who discontinued therapy did so because of toxicity while Tayal et al found that 28.9% of patients were non compliant due to adverse events [8].In a study done in India, 90.6% of all the patients on HAART developed an adverse drug reaction and there were 618 episodes in various systems, the abdominal and central nervous systems were the most affected [8].", "entities": [], "input_ids": [2, 1922, 43, 2161, 2007, 2399, 9800, 1021, 2140, 1969, 37, 24, 39, 16, 2900, 9, 1927, 2690, 2746, 16087, 3181, 2811, 2577, 2882, 1927, 5532, 2679, 17321, 1923, 2140, 1969, 2435, 1988, 3158, 18, 29, 9, 1927, 2132, 1985, 2447, 22181, 2810, 1942, 5246, 3916, 37, 28, 39, 18, 1922, 43, 2161, 5404, 1922, 9288, 16, 3865, 18, 26, 9, 1927, 2136, 1920, 2132, 1990, 18711, 3530, 1925, 5246, 2838, 3227, 1930, 2276, 1985, 5473, 1025, 9232, 1922, 3425, 3771, 16, 1920, 6900, 1930, 4101, 7580, 3771, 1985, 1920, 2501, 4218, 37, 28, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "b19b708da04f", "text": "A total of 2,042 Persons living with HIV (PLHIV) were on HAART; 191 (9.4%) had ever had an adverse drug reaction, while 1,851 (90.7%) had never had an adverse drug reaction.", "entities": [], "input_ids": [2, 43, 2698, 1927, 22, 16, 25413, 7618, 5818, 1956, 3525, 12, 2123, 7969, 1020, 13, 1985, 1990, 18711, 31, 18162, 12, 29, 18, 24, 9, 13, 2430, 4264, 2430, 1925, 5246, 2838, 3227, 16, 2679, 21, 16, 5140, 1009, 12, 3865, 18, 27, 9, 13, 2430, 5211, 2430, 1925, 5246, 2838, 3227, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "1288efc29ff7", "text": "The objective of this study is to describe the pattern of spontaneous adverse drug reaction (ADR) reports received from healthcare professionals in patients who tested positive for SARSCoV-2 in Ghana and the lessons learnt particularly for lowand middle-income countries.", "entities": [], "input_ids": [2, 1920, 4470, 1927, 2052, 2161, 1977, 1942, 5993, 1920, 3114, 1927, 6242, 5246, 2838, 3227, 12, 17645, 13, 4710, 4004, 2037, 5841, 9229, 1922, 2132, 2746, 3620, 2843, 1958, 20466, 4879, 1020, 17, 22, 1922, 20685, 1930, 1920, 20789, 12048, 1031, 4443, 1958, 2330, 2153, 5576, 17, 6793, 5085, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6c5c8cd05cb9", "text": "For instance, the mRNA vaccines like Pfizer-BioNTech and Moderna have been linked to Guillain-Barré Syndrome (GBS), myocarditis and pericarditis [17–19].", "entities": [{"start": 37, "end": 52, "label": "DRUG", "text": "Pfizer-BioNTech"}, {"start": 57, "end": 64, "label": "DRUG", "text": "Moderna"}, {"start": 85, "end": 108, "label": "ADR", "text": "Guillain-Barré Syndrome"}, {"start": 110, "end": 113, "label": "ADR", "text": "GBS"}, {"start": 115, "end": 127, "label": "ADR", "text": "myocarditis"}, {"start": 132, "end": 144, "label": "ADR", "text": "pericarditis"}], "input_ids": [2, 1958, 7303, 16, 1920, 3616, 9375, 3189, 21932, 17, 3718, 4905, 2305, 1930, 10174, 1019, 2162, 2252, 4624, 1942, 22833, 5148, 1921, 17, 19423, 4741, 12, 17783, 13, 16, 27169, 1930, 10796, 3082, 3600, 37, 2752, 229, 2282, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 0, 1, 2, 0, 0, 0, 0, 3, 4, 4, 4, 4, 4, 0, 3, 0, 0, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "361295b984d7", "text": "HCWs/HCSs with exposures assessed as medium or low risk were administered either lamivudine/zidovudine (3TC/AZT) (dual therapy) for 28 days or lamivudine/zidovudine (3TC/AZT) for 3 days.", "entities": [{"start": 0, "end": 9, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 81, "end": 91, "label": "DRUG", "text": "lamivudine"}, {"start": 92, "end": 102, "label": "DRUG", "text": "zidovudine"}, {"start": 104, "end": 107, "label": "DRUG", "text": "3TC"}, {"start": 108, "end": 111, "label": "DRUG", "text": "AZT"}, {"start": 143, "end": 153, "label": "DRUG", "text": "lamivudine"}, {"start": 154, "end": 164, "label": "DRUG", "text": "zidovudine"}, {"start": 166, "end": 169, "label": "DRUG", "text": "3TC"}, {"start": 170, "end": 173, "label": "DRUG", "text": "AZT"}], "input_ids": [2, 4387, 8327, 19, 19760, 1036, 1956, 10043, 3683, 1966, 3649, 2014, 2330, 2565, 1985, 5254, 3108, 30208, 19, 28666, 22389, 1020, 20597, 12, 25464, 1030, 19, 28301, 13, 12, 7064, 3181, 13, 1958, 3158, 3000, 2014, 30208, 19, 28666, 22389, 1020, 20597, 12, 25464, 1030, 19, 28301, 13, 1958, 23, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "8dac0c4052a2", "text": "Extremes of age (i.e., ages falling outside the reproductive age group), level of education, marital status, and WHO clinical stage were not significantly associated with the development of an adverse drug reaction in these patients (Table 3).", "entities": [], "input_ids": [2, 26308, 1927, 2632, 12, 51, 18, 47, 18, 16, 7684, 16701, 7008, 1920, 7986, 2632, 2210, 13, 16, 2237, 1927, 4767, 16, 13245, 3642, 16, 1930, 2746, 2535, 3587, 1985, 2084, 2567, 2458, 1956, 1920, 2740, 1927, 1925, 5246, 2838, 3227, 1922, 2144, 2132, 12, 2545, 23, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "d08f6048ce7e", "text": "Patients in WHO clinical stage I were 102(5%), stage II 633(31%), WHO clinical stage III made up close to half of all attendants, 1001 (49%) and stage IV 306(15%).Adverse drug reactionsThe most common adverse reaction in our patients was anaemia, comprising almost half of the total number of episodes (45.6%), with diarrhoea taking a close second place (Table 2).", "entities": [{"start": 238, "end": 245, "label": "ADR", "text": "anaemia"}, {"start": 316, "end": 325, "label": "ADR", "text": "diarrhoea"}], "input_ids": [2, 2132, 1922, 2746, 2535, 3587, 51, 1985, 10049, 12, 25, 9, 13, 16, 3587, 2890, 27154, 12, 3470, 9, 13, 16, 2746, 2535, 3587, 4337, 3915, 2353, 5428, 1942, 4768, 1927, 2136, 10396, 2356, 16, 2813, 1009, 12, 4343, 9, 13, 1930, 3587, 4370, 24217, 12, 2461, 9, 13, 18, 5246, 2838, 5298, 20536, 2501, 3059, 5246, 3227, 1922, 2342, 2132, 1982, 19682, 16, 10351, 5365, 4768, 1927, 1920, 2698, 2529, 1927, 9232, 12, 3607, 18, 26, 9, 13, 16, 1956, 20998, 6303, 43, 5428, 2812, 4368, 12, 2545, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "bd9e05ef43b8", "text": "Food and Drugs Administration (FDA) and the European Medicine Agency (EMA) based on results from randomised clinical trials.5,6,7 The European Medicine Agency is currently reviewing dexamethasone for possible approval based on the results from the RECOVERY trial.5,8 There are ongoing studies to find effective therapeutics and vaccines for COVID-19.9In Ghana, the Ministry of Health has developed the Provisional Standard Treatment Guidelines for Novel Coronavirus Infection to use repurposed medicines, namely hydroxychloroquine, chloroquine, azithromycin, doxycycline, methylprednisolone, tocilizumab and remdesivir (if available) for the treatment of patients with COVID-19 based on emerging data from various studies including clinical trials as well as existing standard treatments for supportive care.10 The drugs for the treatment of COVID-19 were approved in line with the Ghana FDA's Guidelines for Emergency Use Authorization of Medical Products which authorises the FDA to assess and list unregistered medical product in consultation with the Ministry of Health for use primarily during public health emergencies of international concern.11 These products and their uses are not approved, cleared, or registered under section 118 of the Public Health Act (Act 851).12 The FDA guideline also requires that safety and effectiveness data are collated during the period of the emergency use authorisation to inform the continuous use of these products.11 There are also a number of drugs for supportive treatment using existing therapies based on the 7th edition of the 2017 Standard Treatment Guidelines.13Although, the drugs issued with emergency use authorisation except remdesivir have been approved and used in Ghana for other disease conditions, none has been used in the context of COVID-19, so, there is lack of information on the effect of these drugs in the treatment of this disease.", "entities": [{"start": 512, "end": 530, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 532, "end": 543, "label": "DRUG", "text": "chloroquine"}, {"start": 545, "end": 557, "label": "DRUG", "text": "azithromycin"}, {"start": 559, "end": 570, "label": "DRUG", "text": "doxycycline"}, {"start": 571, "end": 590, "label": "DRUG", "text": "methylprednisolone"}, {"start": 592, "end": 603, "label": "DRUG", "text": "tocilizumab"}, {"start": 607, "end": 618, "label": "DRUG", "text": "remdesivir"}], "input_ids": [2, 3959, 1930, 4195, 4183, 12, 11394, 13, 1930, 1920, 6785, 5380, 11920, 12, 23444, 13, 2454, 1990, 2274, 2037, 12090, 2535, 3848, 18, 25, 16, 26, 16, 27, 1920, 6785, 5380, 11920, 1977, 5077, 17036, 12681, 1958, 3216, 8382, 2454, 1990, 1920, 2274, 2037, 1920, 5241, 3046, 18, 25, 16, 28, 2276, 2032, 8234, 2351, 1942, 5387, 3655, 12552, 1930, 9375, 1958, 6083, 1960, 17, 2282, 18, 29, 1921, 20685, 16, 1920, 11592, 1927, 2436, 2258, 3530, 1920, 11148, 1923, 2970, 2311, 5522, 1958, 4008, 5548, 10703, 2909, 1942, 2485, 3073, 1949, 3740, 12864, 16, 8129, 8275, 11600, 1037, 15520, 16, 20813, 16, 28350, 16, 16647, 16, 30087, 16, 21682, 5912, 19240, 3368, 1014, 1930, 2500, 7980, 20614, 12, 2647, 3322, 13, 1958, 1920, 2311, 1927, 2132, 1956, 6083, 1960, 17, 2282, 2454, 1990, 8484, 2230, 2037, 3425, 2351, 2710, 2535, 3848, 1966, 2486, 1966, 6124, 2970, 4930, 1958, 13029, 2859, 18, 2119, 1920, 4195, 1958, 1920, 2311, 1927, 6083, 1960, 17, 2282, 1985, 4871, 1922, 2823, 1956, 1920, 20685, 11394, 11, 61, 5522, 1958, 7877, 2485, 6799, 2466, 1927, 3423, 4461, 2154, 6799, 6290, 1920, 11394, 1942, 2634, 1930, 6069, 13497, 6121, 2156, 7752, 3423, 4863, 1922, 13060, 1956, 1920, 11592, 1927, 2436, 1958, 2485, 5985, 2409, 4462, 2436, 14569, 15895, 2062, 1927, 6019, 8353, 18, 2513, 2144, 4461, 1930, 2310, 7947, 2032, 2084, 4871, 16, 15392, 16, 2014, 10012, 2441, 3314, 10297, 1927, 1920, 4462, 2436, 4033, 12, 4033, 5140, 1009, 13, 18, 2369, 1920, 11394, 12954, 2222, 5474, 1988, 5407, 1930, 6001, 2230, 2032, 2674, 1981, 2409, 1920, 3047, 1927, 1920, 7877, 2485, 6799, 6284, 1942, 2780, 1920, 4798, 2485, 1927, 2144, 4461, 18, 2513, 2276, 2032, 2222, 43, 2529, 1927, 4195, 1958, 13029, 2311, 2193, 6124, 6565, 2454, 1990, 1920, 23146, 17407, 1927, 1920, 5664, 2970, 2311, 5522, 18, 2590, 8726, 2534, 16, 1920, 4195, 22459, 1956, 7877, 2485, 6799, 6284, 5574, 2500, 7980, 20614, 2162, 2252, 4871, 1930, 2251, 1922, 20685, 1958, 2303, 2573, 2961, 16, 6046, 2258, 2252, 2251, 1922, 1920, 4491, 1927, 6083, 1960, 17, 2282, 16, 2577, 16, 2276, 1977, 3630, 1927, 2988, 1990, 1920, 2495, 1927, 2144, 4195, 1922, 1920, 2311, 1927, 2052, 2573, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 1, 0, 1, 0, 2, 0, 1, 2, 2, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "b7b21baee49c", "text": "Causality assessment reports on all serious AEFIs which occurred over the same period were obtained from the FDA’s Joint COVID-19 Vaccine Safety Review Committee [32].", "entities": [], "input_ids": [2, 19140, 4076, 4710, 1990, 2136, 7433, 10194, 19894, 1036, 2154, 4807, 2338, 1920, 2841, 3047, 1985, 2926, 2037, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 37, 3323, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "0a5870df058f", "text": "As of 30th June 2022, 17,409,005 doses had been administered in Ghana as follows; AtraZeneca, 10,096,925; Sputnik-V, 17,982; Moderna, 1,065,357; Pfizer-BioNTech, 3,910,669 and Johnson and Johnson, 2,318,072 [26].Eligibility criteriaThis study included AEFIs in the FDA’s safety database received from healthcare professionals and vaccine recipients aged 18 years or older who had received at least one dose of any of the five COVID-19 vaccines deployed during the pandemic.", "entities": [{"start": 82, "end": 92, "label": "DRUG", "text": "AtraZeneca"}, {"start": 106, "end": 115, "label": "DRUG", "text": "Sputnik-V"}, {"start": 124, "end": 132, "label": "DRUG", "text": "Moderna"}, {"start": 145, "end": 160, "label": "DRUG", "text": "Pfizer-BioNTech"}, {"start": 176, "end": 195, "label": "DRUG", "text": "Johnson and Johnson"}], "input_ids": [2, 1966, 1927, 2627, 1963, 10343, 17401, 1028, 16, 2752, 16, 28536, 16, 9163, 5312, 2430, 2252, 5254, 1922, 20685, 1966, 6052, 31, 20319, 7490, 19384, 16, 2119, 16, 7102, 1016, 16, 6224, 1015, 31, 13113, 23705, 17, 64, 16, 2752, 16, 5613, 1028, 31, 10174, 1019, 16, 21, 16, 6604, 1015, 16, 26099, 31, 21932, 17, 3718, 4905, 2305, 16, 23, 16, 6550, 1008, 16, 4970, 1026, 1930, 13890, 1930, 13890, 16, 22, 16, 24543, 16, 6627, 1028, 37, 3179, 39, 18, 13747, 4164, 22523, 1036, 2161, 3063, 10194, 19894, 1036, 1922, 1920, 11394, 234, 61, 5407, 5039, 4004, 2037, 5841, 9229, 1930, 5955, 9336, 5177, 2654, 2739, 2014, 4706, 2746, 2430, 4004, 2019, 3464, 2340, 3253, 1927, 2967, 1927, 1920, 3628, 6083, 1960, 17, 2282, 9375, 20224, 2409, 1920, 16913, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "a3f2faf11bd9", "text": "There was no statistical significant difference in terms of adherence between exposed HCWs/HCSs administered 3TC/AZT for 28 days and exposed HCWs/HCSs administered 3TC/AZT/LPV-RTV for 28 days (p = 0.660).Table 4Factors associated with adherence in exposed HCWs/HCSs on HIV post-exposure prophylaxisCharacteristicAdherence Status1 Crude hazard ratio [95 % CI] p-valueAdjusted hazard ratio [95 % CI] p-valueAdheredDefaultedDrug regimen3TC/AZT −28 days42331.001.003TC/AZT-3 days10101.79 [1.25–2.56]0.0021.75 [1.16–2.66]0.0083TC/AZT/LPV-RTV −28 days32201.10 [0.69–1.74]0.6881.02 [0.56–1.88]0.938GenderFemale102291.00Male73240.97 [0.72–1.31]0.824--Age range (years)18–30129321.0031–4034160.85 [0.58–1.24]0.39541–50640.75 [0.33–1.70]0.489>51611.07 [0.47–2.43]0.872--Risk assessmentLow103111.001.00Medium36200.71 [0.49–1.04]0.0790.91 [0.60–1.39]0.672High36220.69 [0.47–1.00]0.0521.05 [0.56–2.00]0.871Type of exposurePercutaneous165461.00Mucocutaneous1070.75 [0.40–1.42]0.382--ProfessionNurses65171.00HCS1951.00 [0.60–1.67]0.996Laboratory Staff970.71 [0.35–1.43]0.335Medical Doctors59180.97 [0.68–1.38]0.850Ward Attendants2361.00 [0.62–1.61]0.998-- 1N = 228, exposed HCWs/HCSs lost to follow (n = 36) and exposed HCWs/HCSs who truncated their schedule due to source patient testing HIV negative (n = 16) were excluded; 3TC = lamivudine; AZT = zidovudine; LPV-RTV = lopinavir-ritonavir; CI = confidence intervalIn a separate analysis to determine the association between the two study outcomes (report of adverse events and adherence), exposed HCWs/HCSs who never reported of adverse events were 57 % more likely to adhere to their medication schedule compared with exposed HCWs/HCSs who reported of at least one adverse event (HR = 1.57 [95 % CI, 1.17-2.11], p = 0.003).", "entities": [{"start": 85, "end": 95, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 109, "end": 112, "label": "DRUG", "text": "3TC"}, {"start": 113, "end": 116, "label": "DRUG", "text": "AZT"}, {"start": 141, "end": 150, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 164, "end": 167, "label": "DRUG", "text": "3TC"}, {"start": 168, "end": 171, "label": "DRUG", "text": "AZT"}, {"start": 172, "end": 180, "label": "DRUG", "text": "LPV-RTV"}, {"start": 433, "end": 436, "label": "DRUG", "text": "3TC"}, {"start": 437, "end": 440, "label": "DRUG", "text": "AZT"}, {"start": 461, "end": 464, "label": "DRUG", "text": "3TC"}, {"start": 465, "end": 468, "label": "DRUG", "text": "AZT"}, {"start": 521, "end": 524, "label": "DRUG", "text": "3TC"}, {"start": 525, "end": 528, "label": "DRUG", "text": "AZT"}, {"start": 529, "end": 537, "label": "DRUG", "text": "LPV-RTV"}, {"start": 597, "end": 603, "label": "PATIENT_DEMO", "text": "Female"}, {"start": 612, "end": 616, "label": "PATIENT_DEMO", "text": "Male"}, {"start": 1310, "end": 1314, "label": "DRUG", "text": "3TC"}, {"start": 1317, "end": 1327, "label": "DRUG", "text": "lamivudine"}, {"start": 1329, "end": 1332, "label": "DRUG", "text": "AZT"}, {"start": 1335, "end": 1345, "label": "DRUG", "text": "zidovudine"}, {"start": 1347, "end": 1355, "label": "DRUG", "text": "LPV-RTV"}, {"start": 1357, "end": 1366, "label": "DRUG", "text": "lopinavir"}, {"start": 1367, "end": 1376, "label": "DRUG", "text": "ritonavir"}, {"start": 1535, "end": 1544, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 1665, "end": 1675, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}], "input_ids": [2, 2276, 1982, 2239, 3850, 2228, 3175, 1922, 4430, 1927, 7015, 2192, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 1958, 3158, 3000, 1930, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 12, 58, 33, 20, 18, 25829, 13, 18, 2545, 15338, 19002, 2458, 1956, 7015, 1922, 4616, 4387, 8327, 19, 19760, 1036, 1990, 3525, 2753, 17, 3395, 12725, 25588, 5524, 2341, 18842, 2156, 6102, 6018, 1959, 15895, 1021, 3642, 1009, 10289, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 15833, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 23187, 7435, 7726, 10450, 7435, 14411, 8607, 1010, 6916, 19, 28301, 13342, 1025, 3000, 6852, 6498, 1009, 18, 3472, 18, 10438, 6916, 19, 28301, 17, 23, 3000, 13100, 6924, 18, 5637, 37, 21, 18, 2637, 229, 22, 18, 4489, 39, 20, 18, 9299, 1009, 18, 4089, 37, 21, 18, 2641, 229, 22, 18, 4970, 39, 20, 18, 13587, 1010, 6916, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 13342, 1025, 3000, 6763, 23437, 18, 2119, 37, 20, 18, 5349, 229, 21, 18, 5446, 39, 20, 18, 5117, 11425, 18, 5725, 37, 20, 18, 4489, 229, 21, 18, 5744, 39, 20, 18, 6156, 1025, 21429, 1915, 10140, 9578, 12474, 11636, 4539, 1009, 18, 2827, 9578, 1021, 8966, 4561, 1008, 18, 5749, 37, 20, 18, 4395, 229, 21, 18, 3470, 39, 20, 18, 6175, 1006, 17, 17, 2632, 3109, 12, 2739, 13, 2654, 229, 21663, 9995, 4716, 18, 10438, 1009, 229, 28136, 8099, 5127, 18, 5140, 37, 20, 18, 4804, 229, 21, 18, 2686, 39, 20, 18, 27731, 8099, 229, 29202, 4241, 18, 4089, 37, 20, 18, 3401, 229, 21, 18, 3895, 39, 20, 18, 3427, 1026, 34, 4892, 9171, 1009, 18, 6627, 37, 20, 18, 4261, 229, 22, 18, 3941, 39, 20, 18, 5783, 1028, 17, 17, 2565, 4076, 16496, 14726, 20628, 18, 3472, 18, 2827, 5476, 1989, 5677, 11943, 18, 5858, 37, 20, 18, 4343, 229, 21, 18, 5228, 39, 20, 18, 6627, 5124, 18, 6550, 37, 20, 18, 3276, 229, 21, 18, 3886, 39, 20, 18, 4838, 1028, 23216, 5677, 4460, 1008, 18, 5349, 37, 20, 18, 4261, 229, 21, 18, 2827, 39, 20, 18, 2914, 4716, 18, 2914, 37, 20, 18, 4489, 229, 22, 18, 2827, 39, 20, 18, 5783, 1009, 13686, 1927, 3395, 2116, 18021, 3285, 1021, 2080, 21597, 7772, 1009, 18, 2827, 23010, 4879, 18021, 3285, 1021, 2080, 16376, 1008, 18, 4089, 37, 20, 18, 3040, 229, 21, 18, 3858, 39, 20, 18, 27991, 17, 17, 6112, 1022, 4549, 22680, 7912, 9948, 18, 2827, 7727, 12030, 8803, 1009, 18, 2827, 37, 20, 18, 3276, 229, 21, 18, 4838, 39, 20, 18, 4922, 1016, 11792, 8846, 27708, 6651, 8528, 1008, 18, 5858, 37, 20, 18, 3259, 229, 21, 18, 3941, 39, 20, 18, 23106, 5476, 5657, 11849, 7308, 15884, 18, 5749, 37, 20, 18, 5117, 229, 21, 18, 3738, 39, 20, 18, 23196, 3118, 10396, 2356, 29266, 1009, 18, 2827, 37, 20, 18, 5374, 229, 21, 18, 5473, 39, 20, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "982afc3e24b9", "text": "The highest cumulative incidence of 2,914 per 100,000 persons vaccinated was observed among Sputnik V vaccine recipients, while recipients of the Pfizer vaccine reported the least cumulative incidence of 1.5 per 100,000 (Table 3).10.1371/journal.pgph.0003770.t003Table 3Cumulative incidence of AEFIs from the spontaneous reports.VaccineTotal number of Doses GivenNumber of Spontaneous AEFI ReportsIncidence per 100,000 personsAstraZeneca10,096,9253,59035.55537948Moderna1,065,357615.725780184Pfizer3,910,669571.457551125Sputnik17,9825242,914.025136Janssen2,318,072632.717775807Total17,409,0054,29524.67114002", "entities": [{"start": 92, "end": 101, "label": "DRUG", "text": "Sputnik V"}, {"start": 145, "end": 153, "label": "DRUG", "text": "Pfizer"}, {"start": 426, "end": 437, "label": "DRUG", "text": "AstraZeneca"}, {"start": 463, "end": 470, "label": "DRUG", "text": "Moderna"}, {"start": 492, "end": 498, "label": "DRUG", "text": "Pfizer"}, {"start": 520, "end": 527, "label": "DRUG", "text": "Sputnik"}], "input_ids": [2, 1920, 4554, 8274, 4332, 1927, 22, 16, 6550, 1006, 2079, 2813, 16, 3240, 7618, 13122, 1982, 2528, 2706, 13113, 23705, 64, 5955, 9336, 16, 2679, 9336, 1927, 1920, 21932, 5955, 2568, 1920, 3464, 8274, 4332, 1927, 21, 18, 25, 2079, 2813, 16, 3240, 12, 2545, 23, 13, 18, 2119, 18, 28687, 19, 5776, 18, 22534, 1023, 18, 25209, 7658, 1008, 18, 14575, 1010, 11577, 7550, 1989, 7797, 4332, 1927, 10194, 19894, 1036, 2037, 1920, 6242, 4710, 18, 5955, 4575, 2381, 2529, 1927, 5312, 3258, 1022, 22660, 1927, 6242, 10194, 19894, 4710, 4006, 2655, 2079, 2813, 16, 3240, 7618, 23593, 27168, 19384, 2930, 16, 7102, 1016, 16, 6224, 3786, 16, 24886, 5798, 18, 24098, 5494, 11226, 1025, 7993, 1915, 2175, 1009, 16, 6604, 1015, 16, 26099, 9171, 1015, 18, 4395, 5071, 4476, 21794, 1034, 19894, 14151, 1010, 16, 6550, 1008, 16, 4970, 8803, 9948, 18, 30321, 7054, 28135, 1015, 3508, 1984, 23705, 3952, 16, 5613, 4198, 29234, 16, 6550, 1006, 18, 15008, 22744, 23236, 5590, 1917, 1028, 16, 24543, 16, 6627, 4684, 6763, 18, 5858, 7658, 8245, 4476, 1027, 4575, 2381, 3952, 16, 28536, 16, 9163, 1006, 16, 21102, 4561, 18, 4838, 19843, 22536, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "3758e9d86c94", "text": "It is worth mentioning that because the reports were received from the spontaneous reporting pathway, this observation may not be a true reflection of what pertains to Ghana due to the general underreporting of AEFIs in Ghana.The most common AEFIs recorded across the 5 COVID-19 vaccines were headache, pain, pyrexia, chills, and injection site pain.", "entities": [{"start": 293, "end": 301, "label": "ADR", "text": "headache"}, {"start": 303, "end": 307, "label": "ADR", "text": "pain"}, {"start": 309, "end": 316, "label": "ADR", "text": "pyrexia"}, {"start": 318, "end": 324, "label": "ADR", "text": "chills"}, {"start": 330, "end": 349, "label": "ADR", "text": "injection site pain"}], "input_ids": [2, 2176, 1977, 10267, 28622, 1988, 2882, 1920, 4710, 1985, 4004, 2037, 1920, 6242, 6605, 3374, 16, 2052, 5275, 2278, 2084, 1998, 43, 6228, 13001, 1927, 4663, 15978, 1036, 1942, 20685, 2810, 1942, 1920, 3335, 2441, 20483, 2718, 1941, 1927, 10194, 19894, 1036, 1922, 20685, 18, 1920, 2501, 3059, 10194, 19894, 1036, 4562, 3436, 1920, 25, 6083, 1960, 17, 2282, 9375, 1985, 12187, 16, 3594, 16, 26889, 18068, 1019, 16, 7368, 11560, 1036, 16, 1930, 4107, 3200, 3594, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 4, 4, 0, 3, 4, 4, 0, 0, 3, 4, 4, 0, -100], "source_type": "cohort_study"}
{"id": "6c7ef066a93e", "text": "There was no significant difference (p = 0.817) in the reporting of adverse events between exposed HCWs/HCSs administered 3TC/AZT for 28 days and exposed HCWs/HCSs administered 3TC/AZT/LPV-RTV for 28 days in the multivariate analysis.Table 2Factors associated with reported adverse events in 228 exposed HCWs/HCSs on HIV post-exposure prophylaxisCharacteristicAdverse events status1 Crude hazard ratio [95 % CI] p-valueAdjusted hazard ratio [95 % CI] p-valuePresentAbsentDrug regimen3TC/AZT −28 days6871.001.003TC/AZT-3 days28730.31 [0.20–0.48]<0.0010.30 [0.18–0.48]<0.0013TC/AZT/LPV-RTV-28 days5021.06 [0.74–1.53]0.7521.06 [0.65–1.72]0.817Gender-Female81501.00Male65321.08 [0.78–1.50]0.629Type of exposure-Percutaneous131801.00Mucocutaneous1521.42 [0.83–2.43]0.197Age category (yrs)-18–30101601.0031–4032181.02 [0.69–1.52]0.92141–50821.28 [0.62–2.62]0.508>51521.14 [0.46–2.80]0.777Risk assessmentLow51631.001.00Medium40161.60 [1.06–2.42]0.0270.95 [0.61–1.49]0.885High5532.12 [1.45–3.10]<0.0010.97 [0.57–1.66]0.922Profession-Nurses51311.00HCS14100.94 [0.52–1.69]0.832Laboratory Staff1511.51 [0.85–2.68]0.162Medical Doctors46310.96 [0.65–1.43]0.843Ward Attendants2091.11 [0.66–1.86]0.695 1N = 228, exposed HCWs/HCSs lost to follow (n = 36) and exposed HCWs/HCSs who truncated their schedule due to source patient testing HIV negative (n = 16) were excluded; 3TC = lamivudine; AZT = zidovudine; LPV-RTV = lopinavir-ritonavir; CI = confidence intervalDescription of reported adverse eventsThe most frequently observed type of adverse event reported in all the three PEP regimens was gastrointestinal in nature (Table 3).", "entities": [{"start": 98, "end": 109, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 122, "end": 125, "label": "DRUG", "text": "3TC"}, {"start": 126, "end": 130, "label": "DRUG", "text": "AZT"}, {"start": 154, "end": 164, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 177, "end": 180, "label": "DRUG", "text": "3TC"}, {"start": 181, "end": 184, "label": "DRUG", "text": "AZT"}, {"start": 185, "end": 192, "label": "DRUG", "text": "LPV-RTV"}, {"start": 304, "end": 313, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 1204, "end": 1214, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 1251, "end": 1261, "label": "PATIENT_DEMO", "text": "HCWs/HCSs"}, {"start": 1357, "end": 1361, "label": "DRUG", "text": "3TC"}, {"start": 1363, "end": 1373, "label": "DRUG", "text": "lamivudine"}, {"start": 1375, "end": 1379, "label": "DRUG", "text": "AZT"}, {"start": 1381, "end": 1391, "label": "DRUG", "text": "zidovudine"}, {"start": 1392, "end": 1400, "label": "DRUG", "text": "LPV-RTV"}, {"start": 1403, "end": 1412, "label": "DRUG", "text": "lopinavir"}, {"start": 1413, "end": 1422, "label": "DRUG", "text": "ritonavir"}], "input_ids": [2, 2276, 1982, 2239, 2228, 3175, 12, 58, 33, 20, 18, 6206, 1027, 13, 1922, 1920, 6605, 1927, 5246, 3916, 2192, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 1958, 3158, 3000, 1930, 4616, 4387, 8327, 19, 19760, 1036, 5254, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 1922, 1920, 6884, 2333, 18, 2545, 13775, 19002, 2458, 1956, 2568, 5246, 3916, 1922, 19650, 4616, 4387, 8327, 19, 19760, 1036, 1990, 3525, 2753, 17, 3395, 12725, 25588, 5524, 2341, 18842, 2156, 6102, 17332, 2045, 1021, 3916, 3642, 1009, 10289, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 15833, 7320, 3400, 37, 3002, 9, 3371, 39, 58, 17, 3113, 2724, 10653, 2083, 1939, 20556, 8607, 1010, 6916, 19, 28301, 13342, 1025, 3000, 6735, 9948, 18, 3472, 18, 10438, 6916, 19, 28301, 17, 23, 3000, 30416, 4294, 18, 3470, 37, 20, 18, 2036, 229, 20, 18, 3427, 39, 32, 20, 18, 3472, 1008, 18, 2627, 37, 20, 18, 2654, 229, 20, 18, 3427, 39, 32, 20, 18, 3472, 1010, 6916, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 17, 3158, 3000, 3382, 4716, 18, 6604, 37, 20, 18, 5446, 229, 21, 18, 4522, 39, 20, 18, 4089, 4716, 18, 6604, 37, 20, 18, 4459, 229, 21, 18, 4395, 39, 20, 18, 6206, 1027, 21429, 1915, 17, 4232, 11425, 3382, 1009, 18, 2827, 9578, 1021, 5964, 6763, 1009, 18, 6709, 37, 20, 18, 5440, 229, 21, 18, 2761, 39, 20, 18, 5374, 1026, 13686, 1927, 3395, 17, 12826, 22977, 4476, 1009, 18, 2827, 23010, 4879, 18021, 3285, 1021, 2080, 22249, 1009, 18, 3858, 37, 20, 18, 5893, 229, 22, 18, 3941, 39, 20, 18, 5876, 2170, 6891, 12, 25397, 13, 17, 2654, 229, 21663, 6924, 5127, 1009, 18, 10438, 1009, 229, 28136, 4716, 11425, 18, 5725, 37, 20, 18, 5349, 229, 21, 18, 4764, 39, 20, 18, 6224, 27311, 229, 2761, 11715, 1009, 18, 3158, 37, 20, 18, 5374, 229, 22, 18, 5374, 39, 20, 18, 2761, 1025, 34, 25585, 4716, 18, 2607, 37, 20, 18, 4182, 229, 22, 18, 3729, 39, 20, 18, 5517, 1027, 13950, 1040, 4076, 16496, 7912, 7576, 1009, 18, 3472, 18, 2827, 5476, 1989, 4241, 26792, 18, 3276, 37, 21, 18, 6604, 229, 22, 18, 3858, 39, 20, 18, 19310, 1008, 18, 3002, 37, 20, 18, 5473, 229, 21, 18, 4343, 39, 20, 18, 5744, 1015, 23216, 7054, 6763, 18, 2369, 37, 21, 18, 3607, 229, 23, 18, 2119, 39, 32, 20, 18, 3472, 1008, 18, 5749, 37, 20, 18, 4786, 229, 21, 18, 4970, 39, 20, 18, 6224, 17999, 28716, 2881, 17, 8203, 7912, 6800, 1009, 18, 2827, 7727, 12030, 8099, 2283, 18, 5650, 37, 20, 18, 4764, 229, 21, 18, 5349, 39, 20, 18, 5893, 1028, 11792, 8846, 27708, 6651, 23375, 1009, 18, 4892, 37, 20, 18, 5140, 229, 22, 18, 5117, 39, 20, 18, 15333, 5476, 5657, 11849, 7772, 6800, 1008, 18, 4746, 37, 20, 18, 4459, 229, 21, 18, 3941, 39, 20, 18, 5686, 1010, 3118, 10396, 2356, 26434, 1009, 18, 2513, 37, 20, 18, 4970, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "720976deed62", "text": "The first serious ICSR was received from a 26-year-old male COVID-19 patient who was given azithromycin and hydroxychloroquine and on the same day (17th April 2020), the patient had supraventricular tachycardia, chest discomfort and abdominal pain which all started the same day the suspected drugs were administered.", "entities": [{"start": 42, "end": 59, "label": "PATIENT_DEMO", "text": "26-year-old male"}, {"start": 90, "end": 103, "label": "DRUG", "text": "azithromycin"}, {"start": 107, "end": 126, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 182, "end": 210, "label": "ADR", "text": "supraventricular tachycardia"}, {"start": 212, "end": 229, "label": "ADR", "text": "chest discomfort"}, {"start": 232, "end": 248, "label": "ADR", "text": "abdominal pain"}], "input_ids": [2, 1920, 2561, 7433, 13772, 1005, 1982, 4004, 2037, 43, 3179, 17, 2476, 17, 4156, 4005, 6083, 1960, 17, 2282, 2774, 2746, 1982, 3258, 28350, 1930, 8275, 11600, 1037, 15520, 1930, 1990, 1920, 2841, 3007, 12, 2752, 1963, 11071, 22656, 13, 16, 1920, 2774, 2430, 21038, 24722, 17397, 16, 8475, 15335, 1930, 6900, 3594, 2154, 2136, 8074, 1920, 2841, 3007, 1920, 9407, 4195, 1985, 5254, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 3, 4, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "7622ae322740", "text": "Unfortunately, information on prior COVID-19 infections among the Ghanaian vaccine recipients was not obtained at the time of reporting; hence, the observed disparity cannot be properly assessed.About 6.8% of those who reported AEFIs had a history of a chronic medical condition with hypertension, allergies, ulcers, and diabetes as the most common among them.", "entities": [{"start": 284, "end": 296, "label": "ADR", "text": "hypertension"}, {"start": 298, "end": 307, "label": "ADR", "text": "allergies"}, {"start": 308, "end": 315, "label": "ADR", "text": "ulcers"}, {"start": 321, "end": 330, "label": "ADR", "text": "diabetes"}], "input_ids": [2, 10714, 16, 2988, 1990, 3432, 6083, 1960, 17, 2282, 5024, 2706, 1920, 20685, 3122, 5955, 9336, 1982, 2084, 2926, 2019, 1920, 2367, 1927, 6605, 31, 5566, 16, 1920, 2528, 17503, 5156, 1998, 12846, 3683, 18, 3001, 26, 18, 28, 9, 1927, 2690, 2746, 2568, 10194, 19894, 1036, 2430, 43, 4403, 1927, 43, 3724, 3423, 2625, 1956, 5579, 16, 26722, 16, 16225, 16, 1930, 4032, 1966, 1920, 2501, 3059, 2706, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 4, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "3d08c042700a", "text": "Although current WHO guidelines for resource-limited settings recommend haemoglobin and liver enzymes investigations only if symptoms develop, earlier monitoring may be advisable, especially against the background of high prevalence of Hepatitis B(HBV) infection such as exists in Ghana [17].In those first four and a half years of HAART, peripheral neuropathy was uncommon in our cohort unlike other cohorts [9].", "entities": [{"start": 339, "end": 360, "label": "ADR", "text": "peripheral neuropathy"}], "input_ids": [2, 2876, 3214, 2746, 5522, 1958, 7965, 17, 3892, 6457, 5732, 19395, 1930, 3568, 5038, 7873, 2444, 2647, 3601, 2392, 16, 5556, 5378, 2278, 1998, 14683, 2115, 16, 4369, 3316, 1920, 3872, 1927, 2149, 4077, 1927, 7977, 44, 12, 8738, 13, 2909, 2427, 1966, 8655, 1922, 20685, 37, 2752, 39, 18, 1922, 2690, 2561, 3006, 1930, 43, 4768, 2739, 1927, 18711, 16, 5009, 13177, 1982, 14403, 1922, 2342, 4382, 7945, 2303, 8509, 37, 29, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "697b67f0b1c6", "text": "Of these, 5 were diagnosed as febrile illness related to the AstraZeneca vaccine and 1 incident of cerebrovascular accident also associated with AstraZeneca.", "entities": [{"start": 30, "end": 45, "label": "ADR", "text": "febrile illness"}, {"start": 61, "end": 72, "label": "DRUG", "text": "AstraZeneca"}, {"start": 96, "end": 123, "label": "ADR", "text": "of cerebrovascular accident"}, {"start": 145, "end": 156, "label": "DRUG", "text": "AstraZeneca"}], "input_ids": [2, 1927, 2144, 16, 25, 1985, 5377, 1966, 18850, 6455, 2712, 1942, 1920, 20329, 27168, 19384, 5955, 1930, 21, 9706, 1927, 16221, 17713, 2222, 2458, 1956, 20329, 27168, 19384, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 1, 2, 2, 0, -100], "source_type": "cohort_study"}
{"id": "f1ad3aa80656", "text": "The objective of the Safety Monitoring Plan is to outline the procedures for stimulated pharmacovigilance during the COVID-19 pandemic to ensure that healthcare professionals report all suspected adverse drug reactions associated with medicines issued with Emergency Use Authorization and all other medicines used for the treatment of patients diagnosed with COVID-19.", "entities": [], "input_ids": [2, 1920, 4470, 1927, 1920, 5407, 5378, 4720, 1977, 1942, 17744, 1920, 4869, 1958, 5449, 4602, 25210, 6121, 17576, 1972, 2409, 1920, 6083, 1960, 17, 2282, 16913, 1942, 6486, 1988, 5841, 9229, 3809, 2136, 9407, 5246, 2838, 5298, 2458, 1956, 12864, 22459, 1956, 7877, 2485, 6799, 2466, 1930, 2136, 2303, 12864, 2251, 1958, 1920, 2311, 1927, 2132, 5377, 1956, 6083, 1960, 17, 2282, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6f2d340dda21", "text": "A French study found that of adverse drug reactions received for the use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19 within a month, 120 reports of cardiac adverse drug reactions were received for which 103(86%) were associated with hydroxychloroquine and 60% with azithromycin,15 it was however not clear if these products were administered alone or in combination with other drugs.A Cochrane review by the World Health Organization revealed that the current evidence on the safety and efficacy of hydroxychloroquine for the treatment of COVID-19 is limited and of very low certainty.16 The hydroxychloroquine arms of the RECOVERY and SOLIDARITY trials have been suspended17,18 and countries like the United States of America and France have stopped the use of hydroxychloroquine in COVID-19.19,20 At the time of writing this paper, hydroxychloroquine and chloroquine are being used in lower-middle income countries, including, India, Brazil and Ghana for COVID-19. 10,21,22There is, therefore, the need to gather some data on the safety of the use of these products to inform their continuous use during the pandemic.", "entities": [{"start": 76, "end": 94, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 95, "end": 108, "label": "DRUG", "text": "azithromycin"}, {"start": 110, "end": 119, "label": "DRUG", "text": "lopinavir"}, {"start": 120, "end": 129, "label": "DRUG", "text": "ritonavir"}, {"start": 134, "end": 145, "label": "DRUG", "text": "chloroquine"}, {"start": 188, "end": 220, "label": "ADR", "text": "cardiac adverse drug reactions"}, {"start": 274, "end": 292, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 305, "end": 318, "label": "DRUG", "text": "azithromycin"}, {"start": 540, "end": 558, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 633, "end": 651, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 803, "end": 821, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 875, "end": 893, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 898, "end": 909, "label": "DRUG", "text": "chloroquine"}], "input_ids": [2, 43, 12941, 2161, 2435, 1988, 1927, 5246, 2838, 5298, 4004, 1958, 1920, 2485, 1927, 8275, 11600, 1037, 15520, 16, 28350, 16, 3004, 9512, 11046, 17, 24019, 12502, 3026, 1930, 20813, 1922, 6083, 1960, 17, 2282, 2651, 43, 2935, 16, 6103, 4710, 1927, 4435, 5246, 2838, 5298, 1985, 4004, 1958, 2154, 9373, 12, 5713, 9, 13, 1985, 2458, 1956, 8275, 11600, 1037, 15520, 1930, 3276, 9, 1956, 28350, 16, 2461, 2176, 1982, 2406, 2084, 4021, 2647, 2144, 4461, 1985, 5254, 4298, 2014, 1922, 3921, 1956, 2303, 4195, 18, 43, 13917, 3043, 2007, 1920, 4867, 2436, 5901, 3404, 1988, 1920, 3214, 3095, 1990, 1920, 5407, 1930, 4348, 1927, 8275, 11600, 1037, 15520, 1958, 1920, 2311, 1927, 6083, 1960, 17, 2282, 1977, 3892, 1930, 1927, 3345, 2330, 23227, 18, 2641, 1920, 8275, 11600, 1037, 15520, 9715, 1927, 1920, 5241, 1930, 5358, 15385, 3848, 2162, 2252, 11095, 3952, 16, 2654, 1930, 5085, 3189, 1920, 6128, 4376, 1927, 10390, 1930, 10707, 2162, 12032, 1920, 2485, 1927, 8275, 11600, 1037, 15520, 1922, 6083, 1960, 17, 2282, 18, 2282, 16, 2036, 2019, 1920, 2367, 1927, 9095, 2052, 4648, 16, 8275, 11600, 1037, 15520, 1930, 20813, 2032, 3301, 2251, 1922, 2826, 17, 5576, 6793, 5085, 16, 2710, 16, 9288, 16, 9912, 1930, 20685, 1958, 6083, 1960, 17, 2282, 18, 2119, 16, 2900, 16, 2950, 2098, 1021, 1977, 16, 2955, 16, 1920, 2942, 1942, 12533, 2673, 2230, 1990, 1920, 5407, 1927, 1920, 2485, 1927, 2144, 4461, 1942, 2780, 2310, 4798, 2485, 2409, 1920, 16913, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 2, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "488bc4ce1b20", "text": "This high level of background anaemia is in turn exacerbated by the use of Zidovudine, which features prominently in our first-line regimens.", "entities": [{"start": 30, "end": 37, "label": "ADR", "text": "anaemia"}, {"start": 75, "end": 85, "label": "DRUG", "text": "Zidovudine"}], "input_ids": [2, 2052, 2149, 2237, 1927, 3872, 19682, 1977, 1922, 5165, 19159, 2007, 1920, 2485, 1927, 28666, 22389, 1020, 20597, 16, 2154, 4075, 26713, 1922, 2342, 2561, 17, 2823, 9922, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "adba0e72bdf9", "text": "The third case of serious adverse event of fatigue, headache and weakness involving an exposed female HCW of 42 years was also stabilized and discharged (after three days hospitalisation) with appropriate counselling to continue and complete the course of 28 days.This study could not establish any association between the report of at least one adverse events and factors such as gender, age, profession, outcome of risk assessment and type of exposure in the multivariate analysis although other studies have associated adverse events with gender [17].", "entities": [{"start": 18, "end": 25, "label": "SEVERITY", "text": "serious"}, {"start": 43, "end": 50, "label": "ADR", "text": "fatigue"}, {"start": 52, "end": 60, "label": "ADR", "text": "headache"}, {"start": 64, "end": 74, "label": "ADR", "text": "weakness"}, {"start": 94, "end": 118, "label": "PATIENT_DEMO", "text": "female HCW of 42 years"}], "input_ids": [2, 1920, 4563, 3087, 1927, 7433, 5246, 4817, 1927, 8656, 16, 12187, 1930, 12175, 5884, 1925, 4616, 4232, 4387, 1018, 1927, 3858, 2739, 1982, 2222, 12017, 1930, 14062, 12, 2256, 2559, 3000, 26185, 13, 1956, 4703, 19765, 1942, 9085, 1930, 4080, 1920, 4914, 1927, 3158, 3000, 18, 2052, 2161, 2578, 2084, 5389, 2967, 3279, 2192, 1920, 3809, 1927, 2019, 3464, 2340, 5246, 3916, 1930, 2790, 2427, 1966, 5125, 16, 2632, 16, 6112, 16, 3924, 1927, 2565, 4076, 1930, 2601, 1927, 3395, 1922, 1920, 6884, 2333, 2876, 2303, 2351, 2162, 2458, 5246, 3916, 1956, 5125, 37, 2752, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 5, 0, 0, 0, 3, 0, 3, 0, 4, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "7036c8008ec0", "text": "However, a causality assessment indicated that few serious AEFIs were rated vaccine product-related reactions.", "entities": [], "input_ids": [2, 2406, 16, 43, 19140, 4076, 3391, 1988, 3855, 7433, 10194, 19894, 1036, 1985, 10036, 5955, 4863, 17, 2712, 5298, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ec5334d132f8", "text": "Worth noting was the case of dark pigmentation (hyper pigmentation) of finger and toe nails reported by a patient on 3TC/AZT/LPV-RTV for 28 days which incidentally has been reported in some other studies as a cutaneous adverse reaction of zidovudine (AZT), mostly in patients on chronic treatment of HIV [28].", "entities": [{"start": 29, "end": 46, "label": "ADR", "text": "dark pigmentation"}, {"start": 48, "end": 66, "label": "ADR", "text": "hyper pigmentation"}, {"start": 117, "end": 120, "label": "DRUG", "text": "3TC"}, {"start": 121, "end": 124, "label": "DRUG", "text": "AZT"}, {"start": 125, "end": 133, "label": "DRUG", "text": "LPV-RTV"}, {"start": 239, "end": 249, "label": "DRUG", "text": "zidovudine"}, {"start": 251, "end": 254, "label": "DRUG", "text": "AZT"}], "input_ids": [2, 10267, 16415, 1982, 1920, 3087, 1927, 6190, 20542, 12, 4194, 20542, 13, 1927, 8497, 1930, 22820, 20695, 1036, 2568, 2007, 43, 2774, 1990, 25464, 1030, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 1958, 3158, 3000, 2154, 21942, 1954, 2258, 2252, 2568, 1922, 2673, 2303, 2351, 1966, 43, 11276, 5246, 3227, 1927, 28666, 22389, 1020, 20597, 12, 28301, 13, 16, 6969, 1922, 2132, 1990, 3724, 2311, 1927, 3525, 37, 3158, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "4a6be321438b", "text": "However, class-wide and individual side effects have been described.", "entities": [], "input_ids": [2, 2406, 16, 2921, 17, 4743, 1930, 2725, 4159, 2564, 2162, 2252, 2910, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ba10a926c4db", "text": "There are also concerns worldwide about cardiac adverse drug reactions with potential drugs for the treatment of COVID-1914, particularly chloroquine or hydroxychloroquine alone or in combination with azithromycin.", "entities": [{"start": 39, "end": 70, "label": "ADR", "text": "cardiac adverse drug reactions"}, {"start": 138, "end": 149, "label": "DRUG", "text": "chloroquine"}, {"start": 153, "end": 171, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 200, "end": 213, "label": "DRUG", "text": "azithromycin"}], "input_ids": [2, 2276, 2032, 2222, 8103, 8563, 3001, 4435, 5246, 2838, 5298, 1956, 2889, 4195, 1958, 1920, 2311, 1927, 6083, 1960, 17, 18162, 1006, 16, 4443, 20813, 2014, 8275, 11600, 1037, 15520, 4298, 2014, 1922, 3921, 1956, 28350, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 2, 0, -100], "source_type": "cohort_study"}
{"id": "996c372b58a8", "text": "Anaemia was by far the most common adverse event in our patients.", "entities": [{"start": 0, "end": 7, "label": "ADR", "text": "Anaemia"}], "input_ids": [2, 19682, 1982, 2007, 5108, 1920, 2501, 3059, 5246, 4817, 1922, 2342, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "0b484186f820", "text": "The second case which resulted in hospitalisation for seven days involved a 29-year old exposed pregnant female HCW (in the first trimester of pregnancy) who reported of abdominal pains, profuse diarrhoea, fatigue, nausea and bleeding which later resulted in spontaneous abortion.", "entities": [{"start": 76, "end": 115, "label": "PATIENT_DEMO", "text": "29-year old exposed pregnant female HCW"}, {"start": 170, "end": 185, "label": "ADR", "text": "abdominal pains"}, {"start": 195, "end": 204, "label": "ADR", "text": "diarrhoea"}, {"start": 206, "end": 213, "label": "ADR", "text": "fatigue"}, {"start": 215, "end": 221, "label": "ADR", "text": "nausea"}, {"start": 226, "end": 234, "label": "ADR", "text": "bleeding"}, {"start": 259, "end": 279, "label": "ADR", "text": "spontaneous abortion"}], "input_ids": [2, 1920, 2812, 3087, 2154, 4306, 1922, 26185, 1958, 5260, 3000, 3286, 43, 3230, 17, 2476, 4156, 4616, 7808, 4232, 4387, 1018, 12, 1922, 1920, 2561, 14315, 1927, 5284, 13, 2746, 2568, 1927, 6900, 3594, 1036, 16, 3150, 2517, 20998, 16, 8656, 16, 13759, 1930, 7633, 2154, 3690, 4306, 1922, 6242, 15660, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "cohort_study"}
{"id": "c35e10e1c13b", "text": "Predictors of adverse drug reactionsFemale gender was a statistically significant independent predictor of an adverse drug reaction in our data (unadjusted OR: 1.52, p = 0.01; adjusted OR: 1.66, p = 0.01, CI:1.16-2,36).", "entities": [], "input_ids": [2, 7450, 1927, 5246, 2838, 5298, 10140, 9578, 1021, 5125, 1982, 43, 4388, 2228, 3484, 7837, 1927, 1925, 5246, 2838, 3227, 1922, 2342, 2230, 12, 16307, 2014, 30, 21, 18, 4764, 16, 58, 33, 20, 18, 3287, 31, 4967, 2014, 30, 21, 18, 4970, 16, 58, 33, 20, 18, 3287, 16, 3371, 30, 21, 18, 2641, 17, 22, 16, 3480, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "6214bb6a0344", "text": "DiscussionOverall, the cumulative incidence of AEFIs among those vaccinated as of 30th June 2022 in the spontaneous reports was 24.7 per 100,000 persons.The highest AEFI incidence among the 5 vaccines administered nationwide was observed among those who received the Sputnik V vaccine whereas Pfizer recorded the lowest.", "entities": [{"start": 267, "end": 276, "label": "DRUG", "text": "Sputnik V"}, {"start": 292, "end": 300, "label": "DRUG", "text": "Pfizer"}], "input_ids": [2, 7248, 2731, 2214, 16, 1920, 8274, 4332, 1927, 10194, 19894, 1036, 2706, 2690, 13122, 1966, 1927, 2627, 1963, 10343, 17401, 1028, 1922, 1920, 6242, 4710, 1982, 2686, 18, 27, 2079, 2813, 16, 3240, 7618, 18, 1920, 4554, 10194, 19894, 4332, 2706, 1920, 25, 9375, 5254, 19006, 1982, 2528, 2706, 2690, 2746, 4004, 1920, 13113, 23705, 64, 5955, 3417, 21932, 4562, 1920, 6738, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 2, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "cc7a5a4ca256", "text": "It is also used to evaluate and to check that the particular treatment is the cause of an observed adverse drug reaction or not and to estimate the strength of the relationship between drug(s) exposure and occurrence of ADRs.Causality assessment of ADR reports received done by the Food and Drugs Authority's Technical Advisory Committee on Safety of Medicines (TAC-SM) using the WHO-UMC system for standardised case causality assessment.25 The TAC-SM routinely performs causality assessment for all ADRs received by the FDA on a bimonthly basis.", "entities": [], "input_ids": [2, 2176, 1977, 2222, 2251, 1942, 4323, 1930, 1942, 5588, 1988, 1920, 3278, 2311, 1977, 1920, 3936, 1927, 1925, 2528, 5246, 2838, 3227, 2014, 2084, 1930, 1942, 5383, 1920, 4568, 1927, 1920, 3303, 2192, 2838, 12, 61, 13, 3395, 1930, 6564, 1927, 28863, 18, 19140, 4076, 1927, 17645, 4710, 4004, 5404, 2007, 1920, 3959, 1930, 4195, 18791, 11, 61, 7423, 18989, 6182, 1990, 5407, 1927, 12864, 12, 9214, 17, 2426, 13, 2193, 1920, 2746, 17, 8736, 1030, 2433, 1958, 18380, 3087, 19140, 4076, 18, 2637, 1920, 9214, 17, 2426, 11094, 17436, 19140, 4076, 1958, 2136, 28863, 4004, 2007, 1920, 11394, 1990, 43, 11753, 4202, 7806, 1012, 4859, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "2f305c7c7d67", "text": "This includes Catarrh, ageusia, burning sensation in the body, loss of consciousness, erythema, hypoacusis, dyspnoea etc.Table 3 shows the Cumulative Incidence of AEFIs from the spontaneous reports per the total number of vaccine doses administered among Ghanaians by vaccine type.", "entities": [{"start": 14, "end": 21, "label": "ADR", "text": "Catarrh"}, {"start": 23, "end": 30, "label": "ADR", "text": "ageusia"}, {"start": 32, "end": 49, "label": "ADR", "text": "burning sensation"}, {"start": 62, "end": 84, "label": "ADR", "text": "loss of consciousness"}, {"start": 86, "end": 94, "label": "ADR", "text": "erythema"}, {"start": 95, "end": 106, "label": "ADR", "text": "hypoacusis"}, {"start": 108, "end": 116, "label": "ADR", "text": "dyspnoea"}], "input_ids": [2, 2052, 5921, 13248, 5004, 16, 2632, 24327, 1019, 16, 22873, 15826, 1922, 1920, 3362, 16, 3257, 1927, 16897, 16, 23349, 16, 14395, 1948, 24327, 1036, 16, 14633, 26447, 8289, 18, 2545, 23, 3661, 1920, 8274, 4332, 1927, 10194, 19894, 1036, 2037, 1920, 6242, 4710, 2079, 1920, 2698, 2529, 1927, 5955, 5312, 5254, 2706, 20685, 9813, 2007, 5955, 2601, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 4, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 4, 4, 4, 0, 3, 0, 4, 4, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "52f999fefa9a", "text": "A vast majority of the reported exposures in general were percutaneous (93 %, n = 260) with needle stick injuries being the most reported means of exposure (85 %, n = 237).Table 1Baseline characteristics of 280 HCWs/HCSs reporting occupational exposures and administered HIV post-exposure prophylaxis at an urban teaching hospital in Accra, Ghana, 2005–20103TC/AZT-3 days3TC/AZT-28 days3TC/AZT/LPV-RTV −28 days N = 145 N = 82 N = 53n, %1 n, %1 n, %1 Gender Male46 (31.7)41 (50.0)25 (47.2) Female99 (68.3)41 (50.0)28 (52.8)Age category (yrs) 18–30119 (82.1)49 (59.8)37 (69.8) 31–4021 (14.5)24 (29.3)10 (18.9) 41–503 (2.1)5 (6.1)5 (9.4) >502 (1.4)4 (4.9)1 (1.9)Outcome of risk assessment of exposure Low125 (86.2)29 (35.4)5 (9.4) Medium20 (13.8)39 (47.6)4 (7.6) High-14 (17.1)44 (83.0)Profession Medical Doctors40 (27.6)27 (32.9)22 (41.5) Nurses64 (44.1)26 (31.7)19 (35.8) Laboratory Staff4 (2.8)8 (9.8)5 (9.4) Ward Attendants13 (9.0)13 (15.9)4 (7.5) Healthcare Students24 (16.6)8 (9.8)3 (5.7)Type of exposure Mucocutaneous7 (4.8)3 (3.7)10 (18.9) Percutaneous138 (95.2)79 (96.3)43 (81.1)Year of exposure 200526 (17.9)14 (17.1)12 (22.6) 200630 (20.7)10 (12.2)4 (7.5) 200723 (15.9)15 (18.3)10 (18.9) 200824 (16.6)16 (19.5)6 (11.3) 200927 (18.6)15 (18.3)15 (28.3) 201015 (10.3)12 (14.6)6 (11.3)Means of exposure Bloody cut1 (0.7)1 (1,2)1 (1.9) Canula4 (2.8)2 (2.4)16 (30.2) Dental instrument1 (0.7)-- Needle stick133 (91.7)77 (93.9)27 (50.9) Scalpel blade-1 (1.2)2 (3.8) Scratching1 (0.7)-- Knife cut1 (0.7)-- Splash2 (1.4)1 (1.2)7 (12.2) Unknown object2 (1.4)-- 1% are column percentages within each super row; 3TC = lamivudine; AZT = zidovudine; LPV-RTV = lopinavir-ritonavirReporting of adverse eventsOut of a total of 228 HCWs/HCSs administered HIV PEP and followed up, 146 (64 %) reported at least one adverse event made up of three spontaneous reports and 143 reports from active surveillance.", "entities": [{"start": 211, "end": 219, "label": "PATIENT_DEMO", "text": "HCWs/HCS"}, {"start": 357, "end": 360, "label": "DRUG", "text": "3TC"}, {"start": 361, "end": 364, "label": "DRUG", "text": "AZT"}, {"start": 371, "end": 374, "label": "DRUG", "text": "3TC"}, {"start": 375, "end": 378, "label": "DRUG", "text": "AZT"}, {"start": 386, "end": 389, "label": "DRUG", "text": "3TC"}, {"start": 390, "end": 393, "label": "DRUG", "text": "AZT"}, {"start": 394, "end": 401, "label": "DRUG", "text": "LPV-RTV"}, {"start": 457, "end": 461, "label": "PATIENT_DEMO", "text": "Male"}, {"start": 489, "end": 495, "label": "PATIENT_DEMO", "text": "Female"}, {"start": 1607, "end": 1610, "label": "DRUG", "text": "3TC"}, {"start": 1612, "end": 1623, "label": "DRUG", "text": "lamivudine"}, {"start": 1625, "end": 1628, "label": "DRUG", "text": "AZT"}, {"start": 1631, "end": 1641, "label": "DRUG", "text": "zidovudine"}, {"start": 1642, "end": 1650, "label": "DRUG", "text": "LPV-RTV"}, {"start": 1653, "end": 1672, "label": "DRUG", "text": "lopinavir-ritonavir"}, {"start": 1721, "end": 1729, "label": "PATIENT_DEMO", "text": "HCWs/HCS"}], "input_ids": [2, 43, 10983, 4827, 1927, 1920, 2568, 10043, 1922, 3335, 1985, 12826, 12, 6156, 9, 16, 56, 33, 15019, 13, 1956, 9351, 19774, 8209, 3301, 1920, 2501, 2568, 4457, 1927, 3395, 12, 5140, 9, 16, 56, 33, 20528, 13, 18, 2545, 5462, 2051, 3701, 3779, 1927, 13512, 4387, 8327, 19, 19760, 1036, 6605, 10485, 10043, 1930, 5254, 3525, 2753, 17, 3395, 12725, 2019, 1925, 7244, 10655, 3461, 1922, 14467, 1019, 16, 20685, 16, 4083, 229, 3657, 1010, 6916, 19, 28301, 17, 23, 3000, 1010, 6916, 19, 28301, 17, 3158, 3000, 1010, 6916, 19, 28301, 19, 8182, 1020, 17, 4341, 1020, 13342, 1025, 3000, 56, 33, 11491, 56, 33, 6175, 56, 33, 4522, 1022, 16, 9, 21, 56, 16, 9, 21, 56, 16, 9, 21, 5125, 4005, 7772, 12, 3470, 18, 27, 13, 4353, 12, 2761, 18, 20, 13, 2637, 12, 4261, 18, 22, 13, 4232, 6576, 12, 5117, 18, 23, 13, 4353, 12, 2761, 18, 20, 13, 3158, 12, 4764, 18, 28, 13, 2632, 6891, 12, 25397, 13, 2654, 229, 21663, 4136, 12, 6175, 18, 21, 13, 4343, 12, 4777, 18, 28, 13, 3191, 12, 5349, 18, 28, 13, 3470, 229, 27245, 1009, 12, 2607, 18, 25, 13, 2686, 12, 3230, 18, 23, 13, 2119, 12, 2654, 18, 29, 13, 4353, 229, 27531, 12, 22, 18, 21, 13, 25, 12, 26, 18, 21, 13, 25, 12, 29, 18, 24, 13, 34, 30398, 12, 21, 18, 24, 13, 24, 12, 24, 18, 29, 13, 21, 12, 21, 18, 29, 13, 3924, 1927, 2565, 4076, 1927, 3395, 2330, 15174, 12, 5713, 18, 22, 13, 3230, 12, 3259, 18, 24, 13, 25, 12, 29, 18, 24, 13, 3649, 3520, 12, 2590, 18, 28, 13, 3886, 12, 4261, 18, 26, 13, 24, 12, 27, 18, 26, 13, 2149, 17, 2607, 12, 2752, 18, 21, 13, 4044, 12, 5893, 18, 20, 13, 6112, 3423, 11849, 4241, 12, 3225, 18, 26, 13, 3225, 12, 3323, 18, 29, 13, 2950, 12, 4353, 18, 25, 13, 8203, 8760, 12, 4044, 18, 21, 13, 3179, 12, 3470, 18, 27, 13, 2282, 12, 3259, 18, 28, 13, 4542, 6651, 1006, 12, 22, 18, 28, 13, 28, 12, 29, 18, 28, 13, 25, 12, 29, 18, 24, 13, 14125, 10396, 2356, 3633, 12, 29, 18, 20, 13, 2590, 12, 2461, 18, 29, 13, 24, 12, 27, 18, 25, 13, 5841, 5187, 4561, 12, 2641, 18, 26, 13, 28, 12, 29, 18, 28, 13, 23, 12, 25, 18, 27, 13, 2601, 1927, 3395, 3422, 29011, 1027, 12, 24, 18, 28, 13, 23, 12, 23, 18, 27, 13, 2119, 12, 2654, 18, 29, 13, 12826, 18701, 12, 3002, 18, 22, 13, 5637, 12, 4746, 18, 23, 13, 3941, 12, 6206, 18, 21, 13, 2476, 1927, 3395, 4083, 4684, 12, 2752, 18, 29, 13, 2607, 12, 2752, 18, 21, 13, 2369, 12, 2950, 18, 26, 13, 3956, 4294, 12, 2036, 18, 27, 13, 2119, 12, 2369, 18, 22, 13, 24, 12, 27, 18, 25, 13, 3826, 4553, 12, 2461, 18, 29, 13, 2461, 12, 2654, 18, 23, 13, 2119, 12, 2654, 18, 29, 13, 3767, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 2, 0, 1, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ce2b85fe755e", "text": "This finding corroborates a study by Kant et al., [35] which also showed a low incidence of AEFIs to Pfizer vaccine compared with persons who received AstraZeneca, Moderna and Janssen COVID-19 vaccines in The Netherlands.", "entities": [{"start": 100, "end": 108, "label": "DRUG", "text": "Pfizer"}, {"start": 151, "end": 162, "label": "DRUG", "text": "AstraZeneca"}, {"start": 164, "end": 171, "label": "DRUG", "text": "Moderna"}, {"start": 175, "end": 184, "label": "DRUG", "text": "Janssen"}], "input_ids": [2, 2052, 2849, 22965, 1036, 43, 2161, 2007, 12916, 1031, 2140, 1969, 18, 16, 37, 3259, 39, 2154, 2222, 2594, 43, 2330, 4332, 1927, 10194, 19894, 1036, 1942, 21932, 5955, 2452, 1956, 7618, 2746, 4004, 20329, 27168, 19384, 16, 10174, 1019, 1930, 29455, 6083, 1960, 17, 2282, 9375, 1922, 1920, 11449, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "ba30728895eb", "text": "The symptoms of oculogyric crisis significantly improved 1 h after the IM injection.", "entities": [{"start": 16, "end": 33, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 1920, 3601, 1927, 25669, 2021, 19872, 17263, 2567, 4305, 21, 50, 2256, 1920, 2042, 4107, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "9d2d66e5a908", "text": "Therefore, the patient received antimalarial therapy artemether/lumefantrine, Coartem® (Novartis Pharma AG, Basel, Switzerland), at a dose of 80/480 mg and to be taken after 8 h on day one and twice daily thereafter for 2 days.Just after initiation of treatment, the patient complained of double vision, involuntary upward eye deviation, and inability to close both eyes (Fig. 1a).", "entities": [{"start": 52, "end": 76, "label": "DRUG", "text": "artemether/lumefantrine"}, {"start": 78, "end": 85, "label": "DRUG", "text": "Coartem"}, {"start": 289, "end": 302, "label": "ADR", "text": "double vision"}, {"start": 304, "end": 336, "label": "ADR", "text": "involuntary upward eye deviation"}, {"start": 342, "end": 370, "label": "ADR", "text": "inability to close both eyes"}], "input_ids": [2, 2955, 16, 1920, 2774, 4004, 27290, 3181, 20897, 23568, 1915, 19, 5491, 7726, 2031, 5773, 16, 10027, 7446, 1987, 1076, 12, 22102, 24552, 2260, 16, 25672, 16, 13651, 13, 16, 2019, 43, 3253, 1927, 3729, 19, 17628, 2786, 1930, 1942, 1998, 4208, 2256, 28, 50, 1990, 3007, 2340, 1930, 6470, 4692, 11598, 1958, 22, 3000, 18, 6244, 2256, 6035, 1927, 2311, 16, 1920, 2774, 26199, 1927, 4825, 9266, 16, 28493, 19617, 5723, 6015, 16, 1930, 11752, 1942, 5428, 2321, 7127, 12, 2095, 18, 5123, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 4, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "38e20e0ca98d", "text": "It is still not entirely clear what the cause of the suspected glomerulonephritis was as evidenced by the red cell cast on urine microscopy as there is no clear association with naphthalene, alum or diclofenac in literature.", "entities": [{"start": 62, "end": 82, "label": "ADR", "text": "glomerulonephritis"}, {"start": 105, "end": 119, "label": "ADR", "text": "red cell cast"}, {"start": 178, "end": 189, "label": "DRUG", "text": "naphthalene"}, {"start": 190, "end": 195, "label": "DRUG", "text": "alum"}, {"start": 198, "end": 210, "label": "DRUG", "text": "diclofenac"}], "input_ids": [2, 2176, 1977, 3974, 2084, 11668, 4021, 4663, 1920, 3936, 1927, 1920, 9407, 27057, 1982, 1966, 11400, 2007, 1920, 2312, 2024, 12273, 1990, 6960, 5441, 1966, 2276, 1977, 2239, 4021, 3279, 1956, 26795, 2880, 16, 20155, 2014, 27304, 1922, 4431, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 2, 0, 2, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "d0fd14509c04", "text": "An initial diagnosis of: 1) Acute Kidney injury secondary to toxic acute tubular necrosis; 2) Naphthalene induced intravascular haemolytic anaemia; 3) Urethritis/Urinary tract infection were made.", "entities": [{"start": 27, "end": 48, "label": "ADR", "text": "Acute Kidney injury"}, {"start": 61, "end": 89, "label": "ADR", "text": "toxic acute tubular necrosis"}, {"start": 94, "end": 105, "label": "DRUG", "text": "Naphthalene"}, {"start": 114, "end": 146, "label": "ADR", "text": "intravascular haemolytic anaemia"}], "input_ids": [2, 1925, 3754, 3574, 1927, 30, 21, 13, 3939, 5245, 4047, 4067, 1942, 6161, 3939, 11755, 7476, 31, 22, 13, 26795, 2880, 2719, 19871, 7105, 6586, 19682, 31, 23, 13, 19221, 16900, 19, 7075, 6482, 2909, 1985, 3915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 0, 3, 4, 4, 4, 0, 0, 0, 1, 2, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "c4ba1c49cd3f", "text": "Paroxysmal tonic upward gaze is characterized by episodes of sustained conjugate upward deviation of the eyes and can be differentiated from oculogyric crisis by the presence of neck flexion and concomitant episodic ataxia [10].Considering the important key points including the medication history and the clinical findings of the patient, a diagnosis of AL (Coartem)-induced oculogyric crisis was made.", "entities": [{"start": 355, "end": 367, "label": "DRUG", "text": "AL (Coartem)"}, {"start": 375, "end": 393, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 28033, 16887, 19617, 16212, 1977, 4378, 2007, 9232, 1927, 7637, 13074, 19617, 6015, 1927, 1920, 7127, 1930, 2112, 1998, 7512, 2037, 25669, 2021, 19872, 17263, 2007, 1920, 2990, 1927, 7467, 13326, 1930, 8537, 16843, 17698, 37, 2119, 39, 18, 6300, 1920, 2715, 3834, 4273, 2710, 1920, 6093, 4403, 1930, 1920, 2535, 3056, 1927, 1920, 2774, 16, 43, 3574, 1927, 1969, 12, 10027, 7446, 1987, 13, 17, 2719, 25669, 2021, 19872, 17263, 1982, 3915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 0, 4, 4, 4, 4, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "2b523168311f", "text": "Based on the above-mentioned findings, the patient was diagnosed with Coartem-induced oculogyric crisis.", "entities": [{"start": 70, "end": 77, "label": "DRUG", "text": "Coartem"}, {"start": 86, "end": 103, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2454, 1990, 1920, 3538, 17, 6996, 3056, 16, 1920, 2774, 1982, 5377, 1956, 10027, 7446, 1987, 17, 2719, 25669, 2021, 19872, 17263, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "case_report"}
{"id": "a1b02f8dec2f", "text": "Two days prior to presentation at our facility, he visited a pharmacy with complaints of fever measuring 37.9 °C, general body pains, and weakness.", "entities": [{"start": 89, "end": 94, "label": "ADR", "text": "fever"}, {"start": 114, "end": 132, "label": "ADR", "text": "general body pains"}, {"start": 137, "end": 146, "label": "ADR", "text": "weakness"}], "input_ids": [2, 2288, 3000, 3432, 1942, 6544, 2019, 2342, 8598, 16, 2234, 17365, 43, 14429, 1956, 14782, 1927, 9087, 6711, 3191, 18, 29, 3881, 16, 3335, 3362, 3594, 1036, 16, 1930, 12175, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 4, 0, -100], "source_type": "case_report"}
{"id": "119eb1c0efe4", "text": "Aluminium toxicity has been well described in literature as a cause of encephalopathy, osteomalacia and microcytic anaemia especially in patients who have been on chronic dialysis.", "entities": [{"start": 0, "end": 10, "label": "DRUG", "text": "Aluminium"}, {"start": 70, "end": 85, "label": "ADR", "text": "encephalopathy"}, {"start": 87, "end": 99, "label": "ADR", "text": "osteomalacia"}, {"start": 104, "end": 123, "label": "ADR", "text": "microcytic anaemia"}, {"start": 136, "end": 180, "label": "PATIENT_DEMO", "text": "patients who have been on chronic dialysis."}], "input_ids": [2, 30094, 5532, 2258, 2252, 2486, 2910, 1922, 4431, 1966, 43, 3936, 1927, 19393, 16, 4416, 4229, 20243, 1930, 10572, 4274, 19682, 4369, 1922, 2132, 2746, 2162, 2252, 1990, 3724, 9787, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 3, 4, 4, 0, 3, 4, 4, 0, 0, 8, 8, 8, 8, 8, 8, 8, 8, -100], "source_type": "case_report"}
{"id": "1532e73edd25", "text": "One serious side effect is prolongation of the QT interval.", "entities": [], "input_ids": [2, 2340, 7433, 4159, 2495, 1977, 20334, 1927, 1920, 8877, 4979, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "c0f606d3c970", "text": "The presence of granular cast suggests ATN which could be due to the use of the NSAID diclofenac and or the presence of infection.", "entities": [{"start": 86, "end": 96, "label": "DRUG", "text": "diclofenac"}], "input_ids": [2, 1920, 2990, 1927, 16284, 12273, 4015, 2019, 1022, 2154, 2578, 1998, 2810, 1942, 1920, 2485, 1927, 1920, 24194, 27304, 1930, 2014, 1920, 2990, 1927, 2909, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "1d23490f06db", "text": "ADRs can also be a side effect of other medications, such as antiemetic, antipsychotic, antidepressant, antiepileptic, and antimalarial medications, which produce ADRs due to dopaminergic-cholinergic imbalance in the basal ganglia [3].", "entities": [], "input_ids": [2, 28863, 2112, 2222, 1998, 43, 4159, 2495, 1927, 2303, 7719, 16, 2427, 1966, 2246, 17800, 2002, 16, 17581, 16, 14183, 16, 29132, 16, 1930, 27290, 7719, 16, 2154, 5074, 28863, 2810, 1942, 12214, 17, 13908, 14093, 1922, 1920, 5342, 13086, 37, 23, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "906af5619fd9", "text": "Patient however then developed pulmonary oedema which was managed with IV furosemide (80mg twice daily which was increased to 80mg three times daily).", "entities": [{"start": 31, "end": 47, "label": "ADR", "text": "pulmonary oedema"}, {"start": 73, "end": 84, "label": "DRUG", "text": "furosemide"}], "input_ids": [2, 2774, 2406, 2759, 3530, 5352, 24110, 2154, 1982, 11155, 1956, 4370, 30509, 12, 3729, 9759, 6470, 4692, 2154, 1982, 2502, 1942, 3729, 9759, 2559, 3586, 4692, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "af5ad0d53d68", "text": "C46H58Cl3NO6 for Lumefantrine (b)Oculogyric crisis is defined as rare nonlife-threatening neurological manifestation that causes spasmodic movements of the eyeballs into a fixed position that may last from seconds to hours [3, 8].", "entities": [{"start": 17, "end": 29, "label": "DRUG", "text": "Lumefantrine"}, {"start": 33, "end": 50, "label": "ADR", "text": "Oculogyric crisis"}, {"start": 70, "end": 89, "label": "SEVERITY", "text": "nonlife-threatening"}], "input_ids": [2, 10872, 1016, 1023, 7532, 11195, 11873, 1016, 1958, 5491, 7726, 2031, 5773, 12, 44, 13, 25669, 2021, 19872, 17263, 1977, 3608, 1966, 5844, 2447, 17855, 17, 13281, 7605, 15570, 1988, 5092, 24431, 12486, 8264, 1927, 1920, 5723, 16344, 1036, 2460, 43, 4779, 3507, 1988, 2278, 4691, 2037, 9362, 1942, 3967, 37, 23, 16, 28, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 5, 6, 6, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "c64d3fbd3570", "text": "The incidence of Coartem-induced oculogyric crisis has not been reported in the literature, whereas other antimalarial drugs such as artesunate/amodiaquine were reported to cause ADRs in children [3].AL is thought to be highly effective in treating uncomplicated malaria in children and the frequency of associated side effects is not higher that other available artemisinin-based combination therapies [5].", "entities": [{"start": 17, "end": 24, "label": "DRUG", "text": "Coartem"}, {"start": 33, "end": 50, "label": "ADR", "text": "oculogyric crisis"}, {"start": 133, "end": 156, "label": "DRUG", "text": "artesunate/amodiaquine"}, {"start": 187, "end": 195, "label": "PATIENT_DEMO", "text": "children"}, {"start": 200, "end": 202, "label": "DRUG", "text": "AL"}], "input_ids": [2, 1920, 4332, 1927, 10027, 7446, 1987, 17, 2719, 25669, 2021, 19872, 17263, 2258, 2084, 2252, 2568, 1922, 1920, 4431, 16, 3417, 2303, 27290, 4195, 2427, 1966, 20897, 20490, 5791, 1021, 19, 2150, 13968, 15520, 1985, 2568, 1942, 3936, 28863, 1922, 3069, 37, 23, 39, 18, 1969, 1977, 6212, 1942, 1998, 3626, 3655, 1922, 8247, 22050, 7505, 1922, 3069, 1930, 1920, 3528, 1927, 2458, 4159, 2564, 1977, 2084, 2580, 1988, 2303, 3322, 27730, 17, 2454, 3921, 6565, 37, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 1, 2, 2, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "342c37290033", "text": "Both eyes exhibited conjugate upward deviation, and the patient was unable to fully close both eyes (oculogyric crisis).", "entities": [{"start": 19, "end": 46, "label": "ADR", "text": "conjugate upward deviation"}, {"start": 101, "end": 118, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2321, 7127, 5065, 13074, 19617, 6015, 16, 1930, 1920, 2774, 1982, 8082, 1942, 5437, 5428, 2321, 7127, 12, 25669, 2021, 19872, 17263, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, -100], "source_type": "case_report"}
{"id": "9587ecf2481a", "text": "He was admitted at a peripheral hospital at the onset of his symptoms for three days and was managed as a case of severe anaemia secondary to intravascular haemolysis from naphthalene containing herbal preparation.", "entities": [{"start": 120, "end": 128, "label": "ADR", "text": "anaemia"}, {"start": 141, "end": 166, "label": "ADR", "text": "intravascular haemolysis"}, {"start": 171, "end": 184, "label": "DRUG", "text": "naphthalene"}], "input_ids": [2, 2234, 1982, 9723, 2019, 43, 5009, 3461, 2019, 1920, 4727, 1927, 4167, 3601, 1958, 2559, 3000, 1930, 1982, 11155, 1966, 43, 3087, 1927, 4010, 19682, 4067, 1942, 19871, 7105, 6892, 2037, 26795, 2880, 3165, 15953, 6040, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 4, 4, 0, 2, 2, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "38f9e3011206", "text": "It binds to the proximal tubular cells via the megalin-cubilin receptors where it leads to direct cytotoxicity of the tubular cells, associated with renal vasoconstriction and also leads to formation of intratubular cast with interaction with Tamm-Horsfall's protein which obstructs the tubules leading to the formation of muddy brown granular cast as seen in our patient [5].Our patient was also given a non-steroidal anti-inflammatory drug (NSAID) diclofenac at the peripheral hospital which has various effects on the kidney.", "entities": [{"start": 98, "end": 131, "label": "ADR", "text": "cytotoxicity of the tubular cells"}, {"start": 148, "end": 171, "label": "ADR", "text": "renal vasoconstriction"}, {"start": 322, "end": 349, "label": "ADR", "text": "muddy brown granular cast"}, {"start": 449, "end": 460, "label": "DRUG", "text": "diclofenac"}], "input_ids": [2, 2176, 6876, 1942, 1920, 6863, 11755, 2094, 3454, 1920, 20418, 7782, 17, 11585, 16207, 4086, 2597, 2176, 5029, 1942, 3083, 8470, 1927, 1920, 11755, 2094, 16, 2458, 1956, 4604, 21843, 1930, 2222, 5029, 1942, 3337, 1927, 5153, 1031, 2255, 2168, 12273, 1956, 2835, 1956, 9066, 1035, 17, 8951, 13482, 11, 61, 2213, 2154, 7937, 2434, 1036, 1920, 14876, 4523, 1942, 1920, 3337, 1927, 23910, 14458, 8084, 16284, 12273, 1966, 3945, 1922, 2342, 2774, 37, 25, 39, 18, 2342, 2774, 1982, 2222, 3258, 43, 2447, 17, 24932, 2246, 17, 3769, 2838, 12, 24194, 13, 27304, 2019, 1920, 5009, 3461, 2154, 2258, 3425, 2564, 1990, 1920, 5245, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "c516ec6bba67", "text": "He arrived at the Emergency Department fully conscious but looked pale, temperature 36.80C, blood pressure 83/60mmHg, pulse rate was 111 beats per minute, respiratory rate was 16 cycle per minute, random blood glucose was 13.6mmol/L, oxygen saturation of 98% in room air, his chest was clinically clear and had no peripheral oedema.", "entities": [], "input_ids": [2, 2234, 26894, 2019, 1920, 7877, 6143, 5437, 11993, 2308, 15462, 16222, 16, 3449, 3480, 18, 3729, 1030, 16, 2877, 3772, 5893, 19, 3276, 7445, 7998, 16, 7110, 2769, 1982, 10118, 19380, 2079, 8623, 16, 5481, 2769, 1982, 2641, 4048, 2079, 8623, 16, 3332, 2877, 3817, 1982, 2590, 18, 23235, 12492, 1024, 19, 54, 16, 4612, 10113, 1927, 5613, 9, 1922, 4921, 4433, 16, 4167, 8475, 1982, 5908, 4021, 1930, 2430, 2239, 5009, 24110, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "1a1848ff560b", "text": "ConclusionsA literature search demonstrated no published articles on Coartem-induced oculogyric crisis in Ghana, where malaria is endemic.", "entities": [{"start": 69, "end": 76, "label": "DRUG", "text": "Coartem"}, {"start": 85, "end": 102, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 4355, 1019, 4431, 4603, 3161, 2239, 4586, 7670, 1990, 10027, 7446, 1987, 17, 2719, 25669, 2021, 19872, 17263, 1922, 20685, 16, 2597, 7505, 1977, 12310, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "a0b0cc7b5c67", "text": "The management of drug-induced oculogyric crisis includes discontinuation or, if not possible, reducing the dose of the opposing agent.", "entities": [{"start": 31, "end": 48, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 1920, 4280, 1927, 2838, 17, 2719, 25669, 2021, 19872, 17263, 5921, 14775, 2014, 16, 2647, 2084, 3216, 16, 5526, 1920, 3253, 1927, 1920, 17218, 5899, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "5dfbabf634aa", "text": "Versive seizures are phenomenologically similar to oculogyric crisis, yet they are fundamentally different [3, 9].", "entities": [], "input_ids": [2, 3162, 2320, 10060, 2032, 30459, 1954, 2551, 1942, 25669, 2021, 19872, 17263, 16, 4898, 2611, 2032, 23638, 2413, 37, 23, 16, 29, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "a254c06672ce", "text": "Patient and observationA 26 year old African male university student with no known medical condition presented to the Emergency Department of the Komfo Anokye Teaching Hospital (KATH) with a 4-day history of jaundice, cola like urine and reduced urine volume associated with palpitation, dizziness and easy fatigability.", "entities": [{"start": 24, "end": 49, "label": "PATIENT_DEMO", "text": "26 year old African male"}, {"start": 49, "end": 68, "label": "PATIENT_DEMO", "text": "university student"}, {"start": 208, "end": 216, "label": "ADR", "text": "jaundice"}, {"start": 218, "end": 233, "label": "ADR", "text": "cola like urine"}, {"start": 238, "end": 258, "label": "ADR", "text": "reduced urine volume"}, {"start": 275, "end": 286, "label": "ADR", "text": "palpitation"}, {"start": 288, "end": 297, "label": "ADR", "text": "dizziness"}, {"start": 301, "end": 319, "label": "ADR", "text": "easy fatigability"}], "input_ids": [2, 2774, 1930, 5275, 1019, 3179, 2476, 4156, 7050, 4005, 3926, 6481, 1956, 2239, 3171, 3423, 2625, 3549, 1942, 1920, 7877, 6143, 1927, 1920, 6235, 1035, 15282, 28976, 6716, 1021, 10655, 3461, 12, 14164, 1023, 13, 1956, 43, 24, 17, 3007, 4403, 1927, 25314, 16, 2503, 1019, 3189, 6960, 1930, 3028, 6960, 3776, 2458, 1956, 15771, 3644, 16, 24009, 1930, 9040, 8393, 2550, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 0, 3, 4, 4, 0, 0, 3, 4, 0, 3, 0, 4, 4, 4, 0, -100], "source_type": "case_report"}
{"id": "9e93bc49c6b2", "text": "Serology for Hepatitis B, Hepatitis C and retroviral infection were also negative.", "entities": [], "input_ids": [2, 25442, 1958, 7977, 44, 16, 7977, 45, 1930, 16599, 2909, 1985, 2222, 3136, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "c4fc23447cab", "text": "He was commenced on acute intermittent haemodialysis on account of refractory hyperkalaemia and pulmonary oedema.", "entities": [{"start": 67, "end": 77, "label": "ADR", "text": "refractory"}, {"start": 78, "end": 91, "label": "ADR", "text": "hyperkalaemia"}, {"start": 96, "end": 112, "label": "ADR", "text": "pulmonary oedema"}], "input_ids": [2, 2234, 1982, 26779, 1990, 3939, 13252, 7105, 14594, 1990, 5042, 1927, 10923, 4194, 7640, 5148, 3847, 1930, 5352, 24110, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 4, 4, 4, 0, 3, 4, 0, -100], "source_type": "case_report"}
{"id": "31b2c31505bd", "text": "BackgroundArtemether/lumefantrine (AL), sold under the brand name Coartem, is the most common artemisinin-based combination therapy recommended by the World Health Organization.", "entities": [{"start": 10, "end": 33, "label": "DRUG", "text": "Artemether/lumefantrine"}, {"start": 35, "end": 37, "label": "DRUG", "text": "AL"}, {"start": 66, "end": 73, "label": "DRUG", "text": "Coartem"}], "input_ids": [2, 3872, 5263, 17800, 2098, 19, 5491, 7726, 2031, 5773, 12, 1969, 13, 16, 26042, 2441, 1920, 17154, 9533, 10027, 7446, 1987, 16, 1977, 1920, 2501, 3059, 27730, 17, 2454, 3921, 3181, 6198, 2007, 1920, 4867, 2436, 5901, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "16d2295082d0", "text": "Our patient presented with hypotension which increased his risk of AKI.", "entities": [], "input_ids": [2, 2342, 2774, 3549, 1956, 16453, 2154, 2502, 4167, 2565, 1927, 12637, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "e1f79cf2556d", "text": "Common side effects include muscle and joint pain, fever, loss of appetite, and headache.", "entities": [{"start": 28, "end": 49, "label": "ADR", "text": "muscle and joint pain"}, {"start": 51, "end": 56, "label": "ADR", "text": "fever"}, {"start": 58, "end": 74, "label": "ADR", "text": "loss of appetite"}, {"start": 80, "end": 88, "label": "ADR", "text": "headache"}], "input_ids": [2, 3059, 4159, 2564, 3951, 3760, 1930, 6047, 3594, 16, 9087, 16, 3257, 1927, 17990, 16, 1930, 12187, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 4, 4, 0, 3, 0, 3, 4, 4, 0, 0, 3, 0, -100], "source_type": "case_report"}
{"id": "5179eedff5e8", "text": "Oculogyric crisis must be excluded from versive seizures, eye movement tics, paroxysmal tonic upgaze syndrome, and retinal disease.", "entities": [], "input_ids": [2, 25669, 2021, 19872, 17263, 4902, 1998, 5450, 2037, 3162, 2320, 10060, 16, 5723, 5829, 18298, 1036, 16, 28033, 16887, 2353, 4223, 6931, 4741, 16, 1930, 6943, 2573, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "92526e3c1933", "text": "Therefore, the aim of this case report is bring to fore the association of AL as a cause of drug-induced oculogyric crisis.", "entities": [{"start": 75, "end": 77, "label": "DRUG", "text": "AL"}, {"start": 105, "end": 122, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2955, 16, 1920, 3774, 1927, 2052, 3087, 3809, 1977, 12228, 1942, 9023, 1920, 3279, 1927, 1969, 1966, 43, 3936, 1927, 2838, 17, 2719, 25669, 2021, 19872, 17263, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "case_report"}
{"id": "00a121a6e027", "text": "This case brings to light the dangers of treatment of simple conditions with complementary medicines and the need for thorough investigations for all cases of acute kidney injury (AKI) and the valuable use of urine microscopy in the management of kidney disease in low resource countries like Ghana.", "entities": [], "input_ids": [2, 2052, 3087, 21490, 1942, 3696, 1920, 15378, 1036, 1927, 2311, 1927, 5288, 2961, 1956, 8862, 12864, 1930, 1920, 2942, 1958, 10959, 7873, 1958, 2136, 2919, 1927, 3939, 5245, 4047, 12, 12637, 13, 1930, 1920, 8619, 2485, 1927, 6960, 5441, 1922, 1920, 4280, 1927, 5245, 2573, 1922, 2330, 7965, 5085, 3189, 20685, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "430d91c7e352", "text": "When a patient exhibits a neurological disorder, such as oculogyric crisis, with normal conscious state and normal vital signs, special attention should be given to obtaining a history of recently administered medications.", "entities": [{"start": 57, "end": 74, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2469, 43, 2774, 9826, 43, 7605, 4770, 16, 2427, 1966, 25669, 2021, 19872, 17263, 16, 1956, 2791, 11993, 3360, 1930, 2791, 8970, 6879, 16, 5180, 4976, 3066, 1998, 3258, 1942, 11125, 43, 4403, 1927, 3998, 5254, 7719, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "898b08457f7b", "text": "The patient without symptoms following treatment (b)Upon the examination of the eyes, the pupils were isocoric and reactive to light.", "entities": [], "input_ids": [2, 1920, 2774, 2979, 3601, 2894, 2311, 12, 44, 13, 4073, 1920, 4981, 1927, 1920, 7127, 16, 1920, 29697, 1985, 24179, 18151, 1930, 6079, 1942, 3696, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "55d69c97098a", "text": "His urine output for the first 24 hours was 100mls but he was not in pulmonary oedema.On day 2 of admission, his daily IV fluid input was increased to 3.5L in 24 hours.", "entities": [], "input_ids": [2, 4167, 6960, 6647, 1958, 1920, 2561, 2686, 3967, 1982, 2813, 8772, 1036, 2308, 2234, 1982, 2084, 1922, 5352, 24110, 18, 1990, 3007, 22, 1927, 7682, 16, 4167, 4692, 4370, 5466, 5877, 1982, 2502, 1942, 23, 18, 25, 1024, 1922, 2686, 3967, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "46d0a4a195a0", "text": "NSAID have been described as a risk for acute kidney injury through via mechanisms such as ischemic ATN, glomerulopathies, acute interstitial nephritis, and fluid overload [6].", "entities": [{"start": 39, "end": 59, "label": "ADR", "text": "acute kidney injury"}, {"start": 91, "end": 103, "label": "ADR", "text": "ischemic ATN"}, {"start": 104, "end": 121, "label": "ADR", "text": "glomerulopathies"}, {"start": 123, "end": 151, "label": "ADR", "text": "acute interstitial nephritis"}, {"start": 157, "end": 171, "label": "ADR", "text": "fluid overload"}], "input_ids": [2, 24194, 2162, 2252, 2910, 1966, 43, 2565, 1958, 3939, 5245, 4047, 2596, 3454, 3531, 2427, 1966, 7427, 2019, 1022, 16, 19268, 16038, 16, 3939, 11584, 25064, 16, 1930, 5466, 14491, 37, 26, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 0, 0, 0, 0, 3, 4, 4, 0, 4, 4, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "3cb53a140237", "text": "He was put on Intravenous (IV) artesunate, IV ceftriazone 2g, Intramuscular (IM) diclofenac 75mg and tablet acetamenophen 1g three times a day then referred to KATH for haemotransfusion and possible haemodialysis when he was noted to have reduced urine output with rising serum creatinine up to 2315umol/L.", "entities": [{"start": 31, "end": 41, "label": "DRUG", "text": "artesunate"}, {"start": 45, "end": 57, "label": "DRUG", "text": "ceftriazone"}, {"start": 81, "end": 91, "label": "DRUG", "text": "diclofenac"}, {"start": 107, "end": 121, "label": "DRUG", "text": "acetamenophen"}, {"start": 238, "end": 259, "label": "ADR", "text": "reduced urine output"}, {"start": 264, "end": 288, "label": "ADR", "text": "rising serum creatinine"}], "input_ids": [2, 2234, 1982, 5366, 1990, 7307, 12, 4370, 13, 20897, 20490, 5791, 1021, 16, 4370, 28052, 7736, 2290, 16424, 16, 16774, 12, 2042, 13, 27304, 4089, 9759, 1930, 17127, 4118, 14684, 12218, 15957, 2559, 3586, 43, 3007, 2759, 6656, 1942, 14164, 1023, 1958, 7105, 8435, 9049, 1930, 3216, 7105, 14594, 2469, 2234, 1982, 5040, 1942, 2162, 3028, 6960, 6647, 1956, 15238, 3256, 9374, 2353, 1942, 10577, 1015, 1989, 1945, 19, 54, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "29f9a2208bd8", "text": "When a patient exhibits the symptoms of a neurological disorder, such as oculogyric crisis, with conscious state and normal vital signs, special attention should be given to recently administered medications.", "entities": [{"start": 73, "end": 90, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2469, 43, 2774, 9826, 1920, 3601, 1927, 43, 7605, 4770, 16, 2427, 1966, 25669, 2021, 19872, 17263, 16, 1956, 11993, 3360, 1930, 2791, 8970, 6879, 16, 5180, 4976, 3066, 1998, 3258, 1942, 3998, 5254, 7719, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "b57fb2e1f129", "text": "The mainstay treatment for oculogyric crisis is anticholinergics [6].", "entities": [{"start": 27, "end": 44, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 1920, 30124, 2311, 1958, 25669, 2021, 19872, 17263, 1977, 5851, 12074, 12745, 1036, 37, 26, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
{"id": "3884b03b8c98", "text": "The scope of this guideline outlines the type of report to be submitted to the FDA, the required details, the reporting process, the confidentiality of adverse reaction reports, the procedure for submitting follow up information on previously submitted reports, steps to avoid duplicate reporting and timelines for submitting reports.", "entities": [], "input_ids": [2, 1920, 11440, 1927, 2052, 12954, 25400, 1920, 2601, 1927, 3809, 1942, 1998, 10568, 1942, 1920, 11394, 16, 1920, 3414, 6331, 16, 1920, 6605, 2585, 16, 1920, 21936, 1927, 5246, 3227, 4710, 16, 1920, 4360, 1958, 19608, 2104, 2396, 2353, 2988, 1990, 3024, 10568, 4710, 16, 5983, 1942, 5161, 12508, 6605, 1930, 27783, 1036, 1958, 19608, 2104, 4710, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "0df4d0c7fe0a", "text": "A detailed description of the suspected adverse drug reaction. 9.", "entities": [], "input_ids": [2, 43, 5720, 8418, 1927, 1920, 9407, 5246, 2838, 3227, 18, 29, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "1233426000c5", "text": "It is very important that follow up reports are identified and linked to the original report. 3.1.7 Reporting During Clinical Trials For safety reporting in clinical trials, please refer to the Food and Drugs Authority’s Guidelines for Authorization of Clinical Trials of Medicines, Food Supplements, Vaccines and Medical Devices in Ghana (FDA/SMC/CTD/GL-ACT/2013/01). 3.1.8 Duplication of Report If the Local Representative Marketing Authorization Holder is aware that a person has reported a reaction of one of its products directly to the Food and Drugs Authority: The Local Representative or Manufacturer/ Marketing Authorization Holder should still report the adverse reaction informing the Authority that the report is a duplicate of a previous report.", "entities": [], "input_ids": [2, 2176, 1977, 3345, 2715, 1988, 2396, 2353, 4710, 2032, 2899, 1930, 4624, 1942, 1920, 5538, 3809, 18, 23, 18, 21, 18, 27, 6605, 2409, 2535, 3848, 1958, 5407, 6605, 1922, 2535, 3848, 16, 11586, 3333, 1942, 1920, 3959, 1930, 4195, 18791, 234, 61, 5522, 1958, 6799, 2466, 1927, 2535, 3848, 1927, 12864, 16, 3959, 13856, 16, 9375, 1930, 3423, 6985, 1922, 20685, 12, 11394, 19, 16312, 19, 15898, 19, 2393, 17, 4033, 19, 3871, 19, 3287, 13, 18, 23, 18, 21, 18, 28, 12630, 1927, 3809, 2647, 1920, 3076, 5051, 19584, 6799, 2466, 24879, 1977, 11207, 1988, 43, 5952, 2258, 2568, 43, 3227, 1927, 2340, 1927, 2496, 4461, 4103, 1942, 1920, 3959, 1930, 4195, 18791, 30, 1920, 3076, 5051, 2014, 6075, 19, 19584, 6799, 2466, 24879, 3066, 3974, 3809, 1920, 5246, 3227, 28778, 1920, 18791, 1988, 1920, 3809, 1977, 43, 12508, 1927, 43, 2555, 3809, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "6b27263a35b5", "text": "This is not the same as “serious,” which is based on patient/event outcome or action criteria. “Spontaneous Report or Spontaneous Notification” Unsolicited communication by a patient, a consumer or healthcare professional to the Authority, marketing authorization holder or local representative or an organization that describes a suspected adverse reaction in a patient, a consumer who is given one or more", "entities": [], "input_ids": [2, 2052, 1977, 2084, 1920, 2841, 1966, 236, 7433, 16, 237, 2154, 1977, 2454, 1990, 2774, 19, 4817, 3924, 2014, 4615, 4164, 18, 236, 6242, 3809, 2014, 6242, 27844, 237, 6398, 4485, 2599, 6396, 2007, 43, 2774, 16, 43, 15863, 2014, 5841, 8578, 1942, 1920, 18791, 16, 19584, 6799, 2466, 24879, 2014, 3076, 5051, 2014, 1925, 5901, 1988, 9845, 43, 9407, 5246, 3227, 1922, 43, 2774, 16, 43, 15863, 2746, 1977, 3258, 2340, 2014, 2253, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "95a1602cdf2b", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 10 of 28 “Risk Management Plan” A systematic approach and set of pharmacovigilance activities and interventions designed to identify, characterize, prevent or minimize risks relating to medical products, and the assessment of effectiveness of those interventions and how these risks will be communicated to the Authority and the general population. “Serious Adverse Drug Reaction or Adverse Event” A serious adverse event or reaction is any untoward medical occurrence that at any dose: • Results in death • Is life threatening • Requires inpatient hospitalisation or results in prolongation of existing hospitalisation; • Results in persistent or significant disability/incapacity; • Is a congenital anomaly/birth defect; • Is a medically important event or reaction. (NOTE: The term \"life-threatening\" in the definition of \"serious\" refers to an event/reaction in which the patient was at risk of death at the time of the event/reaction; it does not refer to an event/ reaction which hypothetically might have caused death if it were more severe); Medical and scientific judgment should be exercised in deciding whether other situations should be considered serious such as important medical events that might not be immediately life-threatening or result in death or hospitalisation but might jeopardise the patient or might require intervention to prevent one of the other outcomes listed in the definition above.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 2119, 1927, 3158, 236, 2565, 4280, 4720, 237, 43, 5614, 2998, 1930, 2735, 1927, 4602, 25210, 6121, 17576, 1972, 4209, 1930, 4984, 4609, 1942, 3512, 16, 8063, 16, 4625, 2014, 9491, 7481, 13056, 1942, 3423, 4461, 16, 1930, 1920, 4076, 1927, 6001, 1927, 2690, 4984, 1930, 2307, 2144, 7481, 2832, 1998, 18606, 1007, 1942, 1920, 18791, 1930, 1920, 3335, 2973, 18, 236, 7433, 5246, 2838, 3227, 2014, 5246, 4817, 237, 43, 7433, 5246, 4817, 2014, 3227, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 1988, 2019, 2967, 3253, 30, 241, 2274, 1922, 3539, 241, 1977, 3308, 13281, 241, 5474, 12037, 26185, 2014, 2274, 1922, 20334, 1927, 6124, 26185, 31, 241, 2274, 1922, 7733, 2014, 2228, 8015, 19, 22689, 28278, 3145, 31, 241, 1977, 43, 9901, 20950, 19, 5043, 7374, 31, 241, 1977, 43, 19971, 2715, 4817, 2014, 3227, 18, 12, 4725, 30, 1920, 2576, 6, 3308, 17, 13281, 6, 1922, 1920, 6600, 1927, 6, 7433, 6, 11238, 1942, 1925, 4817, 19, 3227, 1922, 2154, 1920, 2774, 1982, 2019, 2565, 1927, 3539, 2019, 1920, 2367, 1927, 1920, 4817, 19, 3227, 31, 2176, 3731, 2084, 3333, 1942, 1925, 4817, 19, 3227, 2154, 15148, 1954, 3284, 2162, 4189, 3539, 2647, 2176, 1985, 2253, 4010, 13, 31, 3423, 1930, 5478, 17449, 3066, 1998, 27776, 1922, 25844, 3053, 2303, 9370, 3066, 1998, 3311, 7433, 2427, 1966, 2715, 3423, 3916, 1988, 3284, 2084, 1998, 6183, 3308, 17, 13281, 2014, 3211, 1922, 3539, 2014, 26185, 2308, 3284, 8988, 23091, 15783, 1021, 1920, 2774, 2014, 3284, 4350, 3280, 1942, 4625, 2340, 1927, 1920, 2303, 3685, 7663, 1922, 1920, 6600, 3538, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "33dea22e8346", "text": "Internet or Digital media under the management of MAH should be screened regularly for adverse reaction reports and report to the Authority within the specified timelines.", "entities": [], "input_ids": [2, 10767, 2014, 8225, 4996, 2441, 1920, 4280, 1927, 18770, 3066, 1998, 8582, 13487, 1958, 5246, 3227, 4710, 1930, 3809, 1942, 1920, 18791, 2651, 1920, 9296, 27783, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "90c8e8ee7ee1", "text": "Treatment provided for the adverse reaction (if any). 12.", "entities": [], "input_ids": [2, 2311, 3675, 1958, 1920, 5246, 3227, 12, 2647, 2967, 13, 18, 2369, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "c1ade4ffdef9", "text": "Causality assessment of Adverse Drug Reaction (ADR) reports presented to the TAC by the Authority. d.", "entities": [], "input_ids": [2, 19140, 4076, 1927, 5246, 2838, 3227, 12, 17645, 13, 4710, 3549, 1942, 1920, 9214, 2007, 1920, 18791, 18, 46, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "f63628b3b435", "text": "Which has been marketed in Ghana for a period of not less than ten (10) years or any other period to be determined by the Authority from time to time, for public health reasons “Overdose” Accidental or intentional use of drug or medicine in an amount that is higher than is normally used. “Periodic Benefit Risk Evaluation Report (PBRER)” An update of the world-wide marketing experience of a product at defined times with focus on formal evaluation of benefit in special population at defined times during postregistration period. “Periodic Safety Update Report (PSUR)” A regular update of the world-wide safety experience of a product at defined times during post-registration period. “Pharmacovigilance” The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems.", "entities": [], "input_ids": [2, 2154, 2258, 2252, 28392, 1922, 20685, 1958, 43, 3047, 1927, 2084, 2941, 2254, 5656, 12, 2119, 13, 2739, 2014, 2967, 2303, 3047, 1942, 1998, 3180, 2007, 1920, 18791, 2037, 2367, 1942, 2367, 16, 1958, 4462, 2436, 6662, 236, 21090, 237, 24842, 2014, 23309, 2485, 1927, 2838, 2014, 5380, 1922, 1925, 4351, 1988, 1977, 2580, 2254, 1977, 7885, 2251, 18, 236, 12922, 5580, 2565, 4391, 3809, 12, 29542, 1915, 13, 237, 1925, 15623, 1927, 1920, 4867, 17, 4743, 19584, 4848, 1927, 43, 4863, 2019, 3608, 3586, 1956, 3691, 1990, 7007, 4391, 1927, 5580, 1922, 5180, 2973, 2019, 3608, 3586, 2409, 2753, 3127, 3934, 3047, 18, 236, 12922, 5407, 15623, 3809, 12, 2742, 1949, 13, 237, 43, 6314, 15623, 1927, 1920, 4867, 17, 4743, 5407, 4848, 1927, 43, 4863, 2019, 3608, 3586, 2409, 2753, 17, 10216, 3047, 18, 236, 4602, 25210, 6121, 17576, 1972, 237, 1920, 5530, 1930, 4209, 13056, 1942, 1920, 3805, 16, 4076, 16, 4339, 1930, 5455, 1927, 5246, 2564, 2014, 2967, 2303, 3216, 2838, 17, 2712, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "50851c380676", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 7 of 28 2.0 Definitions and Abbreviations In these guidelines, unless the context otherwise states: “Adverse Drug Reaction Report” An adverse drug reaction report is a detailed record of all relevant data associated with the use of a medicine in a subject or patient. “Adverse Drug Reaction (ADR) / Adverse Reaction” A response to a medicinal product which is noxious and unintended including lack of efficacy and which occurs at any dosage and can arise from: • The use of product within the terms of the marketing authorization • The use of product outside the terms of the marketing authorization, including overdose, off-label use, misuse, abuse and medication errors; • Occupational exposure A reaction, contrary to an event is characterized by the occurrence of a suspected causal relationship between the drug and the reaction, as determined by the reporter or a reviewing health care professional.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 27, 1927, 3158, 22, 18, 20, 11952, 1930, 11347, 1922, 2144, 5522, 16, 10292, 1920, 4491, 7631, 4376, 30, 236, 5246, 2838, 3227, 3809, 237, 1925, 5246, 2838, 3227, 3809, 1977, 43, 5720, 3727, 1927, 2136, 4494, 2230, 2458, 1956, 1920, 2485, 1927, 43, 5380, 1922, 43, 5198, 2014, 2774, 18, 236, 5246, 2838, 3227, 12, 17645, 13, 19, 5246, 3227, 237, 43, 2644, 1942, 43, 15033, 4863, 2154, 1977, 24218, 1930, 23956, 2710, 3630, 1927, 4348, 1930, 2154, 5110, 2019, 2967, 9998, 1930, 2112, 10149, 2037, 30, 241, 1920, 2485, 1927, 4863, 2651, 1920, 4430, 1927, 1920, 19584, 6799, 2466, 241, 1920, 2485, 1927, 4863, 7008, 1920, 4430, 1927, 1920, 19584, 6799, 2466, 16, 2710, 21090, 16, 4013, 17, 3954, 2485, 16, 22179, 16, 7764, 1930, 6093, 6109, 31, 241, 10485, 3395, 43, 3227, 16, 10346, 1942, 1925, 4817, 1977, 4378, 2007, 1920, 6564, 1927, 43, 9407, 9263, 3303, 2192, 1920, 2838, 1930, 1920, 3227, 16, 1966, 3180, 2007, 1920, 6734, 2014, 43, 17036, 2436, 2859, 8578, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "a887f8cbde8f", "text": "All spontaneous reports are, therefore, suspected adverse drug reactions. “Adverse Event (or adverse experience)” “Adverse event/experience” is any untoward medical occurrence in a patient or clinical trial subject administered a product that may present during treatment with a medicine but which does not necessarily have a causal relationship with this treatment. “Adverse Events Following Immunization (AEFI)” An Adverse Event Following Immunization is any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine.", "entities": [], "input_ids": [2, 2136, 6242, 4710, 2032, 16, 2955, 16, 9407, 5246, 2838, 5298, 18, 236, 5246, 4817, 12, 2014, 5246, 4848, 13, 237, 236, 5246, 4817, 19, 4848, 237, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 1922, 43, 2774, 2014, 2535, 3046, 5198, 5254, 43, 4863, 1988, 2278, 2481, 2409, 2311, 1956, 43, 5380, 2308, 2154, 3731, 2084, 9409, 2162, 43, 9263, 3303, 1956, 2052, 2311, 18, 236, 5246, 3916, 2894, 10139, 12, 10194, 19894, 13, 237, 1925, 5246, 4817, 2894, 10139, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 2154, 6052, 10139, 1930, 2154, 3731, 2084, 9409, 2162, 43, 9263, 3303, 1956, 1920, 10070, 1927, 1920, 5955, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "987bca8d6fb9", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 23 of 28 4.4 Feedback on Reports Received 4.4.1 Adverse Reaction Reports The FDA shall acknowledge receipt of the adverse reaction report within 14 days of receipt.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 3020, 1927, 3158, 24, 18, 24, 6491, 1990, 4710, 4004, 24, 18, 24, 18, 21, 5246, 3227, 4710, 1920, 11394, 22096, 11737, 18481, 1927, 1920, 5246, 3227, 3809, 2651, 2607, 3000, 1927, 18481, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "fa590ff03426", "text": "Overdosage ........................................................................................................ 22 4.4 Feedback on Reports Received ............................................................................... 23 4.4.1 Adverse Reaction Reports ................................................................................. 23 4.4.2 Risk Management Plans, PSURs (or PBRERs) ................................................. 23 5.0 SANCTIONS ......................................................................................................... 24 6.0.", "entities": [], "input_ids": [2, 17612, 5360, 2106, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 2950, 24, 18, 24, 6491, 1990, 4710, 4004, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 3020, 24, 18, 24, 18, 21, 5246, 3227, 4710, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 3020, 24, 18, 24, 18, 22, 2565, 4280, 11876, 16, 2742, 2920, 12, 2014, 29542, 2045, 13, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 3020, 25, 18, 20, 6867, 2236, 1036, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 2686, 26, 18, 20, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "f4de6e57b566", "text": "Local Representative or Marketing Authorization Holder shall submit all relevant information available at the time of initial notification of an adverse drug reaction report.", "entities": [], "input_ids": [2, 3076, 5051, 2014, 19584, 6799, 2466, 24879, 22096, 19608, 2136, 4494, 2988, 3322, 2019, 1920, 2367, 1927, 3754, 27844, 1927, 1925, 5246, 2838, 3227, 3809, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "ec3ec8b6eda8", "text": "The feedback of evaluation of the adverse reaction reports shall be communicated to the reporter within one month of such evaluation by the Authority. 4.4.2 Risk Management Plans, PSURs (or PBRERs) The FDA shall acknowledge receipt of the report and preliminary evaluation comments communicated to the Local Representative or the Marketing Authorization Holder within 28 days of receipt of the report.", "entities": [], "input_ids": [2, 1920, 6491, 1927, 4391, 1927, 1920, 5246, 3227, 4710, 22096, 1998, 18606, 1007, 1942, 1920, 6734, 2651, 2340, 2935, 1927, 2427, 4391, 2007, 1920, 18791, 18, 24, 18, 24, 18, 22, 2565, 4280, 11876, 16, 2742, 2920, 12, 2014, 29542, 2045, 13, 1920, 11394, 22096, 11737, 18481, 1927, 1920, 3809, 1930, 8458, 4391, 12212, 18606, 1007, 1942, 1920, 3076, 5051, 2014, 1920, 19584, 6799, 2466, 24879, 2651, 3158, 3000, 1927, 18481, 1927, 1920, 3809, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "290c60949728", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 11 of 28 medicines and which is not derived from a study or any organized data collection systems where adverse event reporting is actively sought. “Unexpected Adverse Reaction” An unexpected adverse reaction is one in which the nature, specificity, severity and outcome is not consistent with the applicable product information (i.e., with the approved package inserts for registered medicines, or the investigator’s brochure or other product information for unregistered medicines.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 2513, 1927, 3158, 12864, 1930, 2154, 1977, 2084, 3595, 2037, 43, 2161, 2014, 2967, 11275, 2230, 4957, 3771, 2597, 5246, 4817, 6605, 1977, 11182, 8758, 18, 236, 9892, 5246, 3227, 237, 1925, 9892, 5246, 3227, 1977, 2340, 1922, 2154, 1920, 4899, 16, 4896, 16, 5155, 1930, 3924, 1977, 2084, 3499, 1956, 1920, 10045, 4863, 2988, 12, 51, 18, 47, 18, 16, 1956, 1920, 4871, 8511, 17520, 1958, 10012, 12864, 16, 2014, 1920, 12687, 234, 61, 4188, 2072, 2027, 2014, 2303, 4863, 2988, 1958, 13497, 6121, 2156, 7752, 12864, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "cbde4b926718", "text": "The original words/description (verbatim) used by the initial reporter to describe the adverse reaction should be provided.", "entities": [], "input_ids": [2, 1920, 5538, 6906, 19, 8418, 12, 25015, 1035, 13, 2251, 2007, 1920, 3754, 6734, 1942, 5993, 1920, 5246, 3227, 3066, 1998, 3675, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "2e1d5b1b4946", "text": "The Local Representative or Marketing Authorization Holder is required to submit the name or initials, address and telephone number and qualification of the initial reporter on the adverse drug reaction report form.", "entities": [], "input_ids": [2, 1920, 3076, 5051, 2014, 19584, 6799, 2466, 24879, 1977, 3414, 1942, 19608, 1920, 9533, 2014, 3754, 1036, 16, 4640, 1930, 12718, 2529, 1930, 3159, 3123, 1927, 1920, 3754, 6734, 1990, 1920, 5246, 2838, 3227, 3809, 2386, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "8e5cbb21f74f", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 8 of 28 Drug abuse is a persistent or sporadic, intentional excessive use of medicines, which is accompanied by a harmful physical or psychological effect. “Expedited Reporting” This is the immediate reporting and in not more than 7 calendar days of a serious adverse reaction to the Authority. “Food supplements” Concentrated sources of nutrients or other substances produced in a pharmaceutical dosage form such as tablets, gelatin capsules (soft or hard), sachets, syrups and powders.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 28, 1927, 3158, 2838, 7764, 1977, 43, 7733, 2014, 13088, 16, 23309, 9122, 2485, 1927, 12864, 16, 2154, 1977, 7936, 2007, 43, 13635, 3841, 2014, 6674, 2495, 18, 236, 28101, 2599, 6605, 237, 2052, 1977, 1920, 8426, 6605, 1930, 1922, 2084, 2253, 2254, 27, 23948, 3000, 1927, 43, 7433, 5246, 3227, 1942, 1920, 18791, 18, 236, 3959, 13856, 237, 9421, 5777, 1927, 11312, 2014, 2303, 10054, 4152, 1922, 43, 11106, 9998, 2386, 2427, 1966, 16576, 16, 13200, 20206, 12, 3793, 2014, 6986, 13, 16, 10791, 4116, 1973, 16, 11458, 25372, 1930, 25019, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "83ac33f50630", "text": "Lack of Efficacy Every case of lack of efficacy should be reported to the Authority using the Adverse Reaction reporting form or the Consumer Reporting form (BlueForm) or the Consumer Complaint Forms that are available at the Food and Drugs Authority Offices.", "entities": [], "input_ids": [2, 3630, 1927, 4348, 4808, 3087, 1927, 3630, 1927, 4348, 3066, 1998, 2568, 1942, 1920, 18791, 2193, 1920, 5246, 3227, 6605, 2386, 2014, 1920, 15863, 6605, 2386, 12, 4735, 2231, 13, 2014, 1920, 15863, 24442, 4952, 1988, 2032, 3322, 2019, 1920, 3959, 1930, 4195, 18791, 29756, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "cae04594fb27", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 26 of 28 APPENDIX APPENDIX I- Adverse Reaction Reporting Form APPENDIX II-Patient Reporting Form", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 3179, 1927, 3158, 9504, 9504, 51, 17, 5246, 3227, 6605, 2386, 9504, 2890, 17, 2774, 6605, 2386, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "cf60739f02ab", "text": "Additional information, not available at the time of the initial report, should be provided in the form of follow-up reports. 3.1.4 How to Report To report a suspected ADR for products marketed in Ghana, Health care Professionals should complete a copy of the Adverse Reaction Reporting Form (Appendix I).", "entities": [], "input_ids": [2, 3281, 2988, 16, 2084, 3322, 2019, 1920, 2367, 1927, 1920, 3754, 3809, 16, 3066, 1998, 3675, 1922, 1920, 2386, 1927, 2396, 17, 2353, 4710, 18, 23, 18, 21, 18, 24, 2307, 1942, 3809, 1942, 3809, 43, 9407, 17645, 1958, 4461, 28392, 1922, 20685, 16, 2436, 2859, 9229, 3066, 4080, 43, 6983, 1927, 1920, 5246, 3227, 6605, 2386, 12, 9504, 51, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "200078e653c6", "text": "If the article describes identifiable patients, adverse reaction report(s) should be completed for each patient and the publication authors considered as the primary source.", "entities": [], "input_ids": [2, 2647, 1920, 5868, 9845, 19486, 2132, 16, 5246, 3227, 3809, 12, 61, 13, 3066, 1998, 5721, 1958, 2362, 2774, 1930, 1920, 7292, 3875, 3311, 1966, 1920, 3065, 4585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
{"id": "4579e056bf0e", "text": "During the new oral polio vaccination campaign (nOPV2), five potential safety concerns were identified, including cases of anaemia (5 reports), jaundice (4 reports), aggression (2 reports), difficulty breathing (2 reports), and thigh pain (1 report).", "entities": [{"start": 123, "end": 130, "label": "ADR", "text": "anaemia"}, {"start": 144, "end": 152, "label": "ADR", "text": "jaundice"}, {"start": 165, "end": 176, "label": "ADR", "text": "aggression"}, {"start": 190, "end": 211, "label": "ADR", "text": "difficulty breathing"}, {"start": 227, "end": 238, "label": "ADR", "text": "thigh pain"}], "input_ids": [2, 2409, 1920, 2814, 4726, 11464, 1037, 7507, 13986, 12, 30272, 15755, 13, 16, 3628, 2889, 5407, 8103, 1985, 2899, 16, 2710, 2919, 1927, 19682, 12, 25, 4710, 13, 16, 25314, 12, 24, 4710, 13, 16, 13116, 12, 22, 4710, 13, 16, 8791, 11995, 12, 22, 4710, 13, 16, 1930, 19125, 3594, 12, 21, 3809, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "fda_annual_report"}
{"id": "c6d8c5e0f989", "text": "For product quality monitoring exercise in 2023, the FDA tested various products, resulting in a 53% pass rate for bleach products in Q1; a 63% pass rate for anti-diabetics, anti-hypertensive drugs, chlorpromazine 50mg injection, lithium carbonate 300mg, clozapine 100mg, benztropine 2mg from Rock Chemist, haloperidol injection from Max Health Pharmaceuticals Limited, amodiaquine 150mg + sulphadoxine/pyrimethamine 500/25mg tablets (batch 23001) supplied by Kina Pharma, and some anti-malarials in Q2; a 33% pass rate for bleach, paracetamol/vitamin C fixed dose combinations, haloperidol, and fluphenazine injection in Q3; and a 69% pass rate for vaccines, psychotropics, antihypertensives, antidiabetics, and antimalarials in Q4. 5427 89.6% 3932 92.5% 5555 93.2% 41% 1% NUMBER OF SAMPLES RECEIVED % TESTED 2021 2022 2023 % DIFF BETWEEN 2023 & 2022", "entities": [{"start": 198, "end": 213, "label": "DRUG", "text": "chlorpromazine"}, {"start": 229, "end": 248, "label": "DRUG", "text": "lithium carbonate"}, {"start": 254, "end": 265, "label": "DRUG", "text": "clozapine"}, {"start": 272, "end": 284, "label": "DRUG", "text": "benztropine"}, {"start": 307, "end": 318, "label": "DRUG", "text": "haloperidol"}, {"start": 370, "end": 381, "label": "DRUG", "text": "amodiaquine"}, {"start": 390, "end": 417, "label": "DRUG", "text": "sulphadoxine/pyrimethamine"}, {"start": 532, "end": 543, "label": "DRUG", "text": "paracetamol"}, {"start": 544, "end": 554, "label": "DRUG", "text": "vitamin C"}, {"start": 578, "end": 590, "label": "DRUG", "text": "haloperidol"}, {"start": 596, "end": 608, "label": "DRUG", "text": "fluphenazine"}], "input_ids": [2, 1958, 4863, 3455, 5378, 4975, 1922, 17401, 1010, 16, 1920, 11394, 3620, 3425, 4461, 16, 3864, 1922, 43, 4522, 9, 4675, 2769, 1958, 6189, 2155, 4461, 1922, 22027, 31, 43, 4968, 9, 4675, 2769, 1958, 2246, 17, 22127, 16, 2246, 17, 11706, 4195, 16, 4891, 2216, 3368, 22030, 2912, 2761, 9759, 4107, 16, 14330, 17724, 5255, 9759, 16, 24424, 2813, 9759, 16, 7334, 1997, 2011, 2053, 23732, 1029, 2037, 9093, 2975, 2184, 16, 25107, 4107, 2037, 7531, 2436, 15985, 3892, 16, 2150, 13968, 15520, 5493, 9759, 15, 13528, 12595, 25204, 19, 17015, 3184, 3812, 4599, 19, 2637, 9759, 16576, 12, 10778, 14980, 6924, 13, 13164, 2007, 3498, 1019, 24552, 16, 1930, 2673, 2246, 17, 29535, 1036, 1922, 22808, 31, 43, 3401, 9, 4675, 2769, 1958, 6189, 2155, 16, 27021, 19, 6111, 45, 4779, 3253, 7763, 16, 25107, 16, 1930, 2848, 17616, 10119, 4107, 1922, 25760, 31, 1930, 43, 5349, 9, 4675, 2769, 1958, 9375, 16, 26545, 1036, 16, 16439, 1036, 16, 26818, 1036, 16, 1930, 27290, 1036, 1922, 59, 1006, 18, 4584, 4282, 5792, 18, 26, 9, 28179, 1028, 6224, 18, 25, 9, 24098, 1015, 6156, 18, 22, 9, 4353, 9, 21, 9, 2529, 1927, 2785, 4004, 9, 3620, 17401, 1009, 17401, 1028, 17401, 1010, 9, 3228, 2192, 17401, 1010, 10, 17401, 1028, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 0, 0, 0, 0, 2, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_annual_report"}
{"id": "d3576317b790", "text": "Five potential safety concerns were identified under the period under review: anaemia (5 reports), jaundice (4 reports), aggression (2 reports), difficulty breathing (2 reports), and thigh pain (1 report).", "entities": [{"start": 78, "end": 85, "label": "ADR", "text": "anaemia"}, {"start": 99, "end": 107, "label": "ADR", "text": "jaundice"}, {"start": 120, "end": 131, "label": "ADR", "text": "aggression"}, {"start": 145, "end": 165, "label": "ADR", "text": "difficulty breathing"}, {"start": 182, "end": 193, "label": "ADR", "text": "thigh pain"}], "input_ids": [2, 3628, 2889, 5407, 8103, 1985, 2899, 2441, 1920, 3047, 2441, 3043, 30, 19682, 12, 25, 4710, 13, 16, 25314, 12, 24, 4710, 13, 16, 13116, 12, 22, 4710, 13, 16, 8791, 11995, 12, 22, 4710, 13, 16, 1930, 19125, 3594, 12, 21, 3809, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "fda_annual_report"}
{"id": "28991a0ea539", "text": "Feedback on causality assessment is sent through the same channel of reporting to the primary reporter and the patient or general public.", "entities": [], "input_ids": [2, 6491, 1990, 19140, 4076, 1977, 8437, 2596, 1920, 2841, 4999, 1927, 6605, 1942, 1920, 3065, 6734, 1930, 1920, 2774, 2014, 3335, 4462, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "cce99b2087ec", "text": "The reports are subsequently processed for causality assessment (whether the suspected ADR was linked to the drug or not) by a group of experts in varying medical fields called the Technical Advisory Committee (TAC) [18, 25].", "entities": [], "input_ids": [2, 1920, 4710, 2032, 5326, 7078, 1958, 19140, 4076, 12, 3053, 1920, 9407, 17645, 1982, 4624, 1942, 1920, 2838, 2014, 2084, 13, 2007, 43, 2210, 1927, 11702, 1922, 7155, 3423, 7385, 6043, 1920, 7423, 18989, 6182, 12, 9214, 13, 37, 2654, 16, 2637, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "1faf679e4a8b", "text": "Timeliness of report submission, timeliness of investigation and causality assessment as well as timeliness of feedback was assessed.Stability was assessed by considering the backlog of data not entered into the database, the sustainability of the system when Institutional Contact Persons (ICPs) were changed, unscheduled outages and downtimes for the system’s computer and electronic resources, back-up of data, and the actual amount of time required for the system to release meaningful data.", "entities": [], "input_ids": [2, 27783, 5590, 1927, 3809, 18893, 16, 27783, 5590, 1927, 5630, 1930, 19140, 4076, 1966, 2486, 1966, 27783, 5590, 1927, 6491, 1982, 3683, 18, 5057, 1982, 3683, 2007, 6300, 1920, 3231, 22284, 1927, 2230, 2084, 10725, 2460, 1920, 5039, 16, 1920, 20232, 1927, 1920, 2433, 2469, 6540, 5217, 7618, 12, 13215, 1036, 13, 1985, 7003, 16, 6398, 25430, 11252, 2397, 2662, 1930, 3292, 8452, 1958, 1920, 2433, 234, 61, 7058, 1930, 7703, 6151, 16, 3231, 17, 2353, 1927, 2230, 16, 1930, 1920, 7432, 4351, 1927, 2367, 3414, 1958, 1920, 2433, 1942, 4012, 10698, 2230, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "be5f547e9f25", "text": "The 1,188 reports came from Public Health Programs (PHPs) such as School Deworming Program, the Girls Iron-Folate Tablet Supplementation (GIFTS) Programme and Ivermectin Mass Drug Administration.10.1371/journal.pone.0291482.g002Fig 2ADRs reported to NPC per year vs those not reported to NPC.Fig 3 shows the ADR reporting rate per million population for both Ho Municipal and the national data for the period of evaluation.", "entities": [{"start": 101, "end": 113, "label": "DRUG", "text": "Iron-Folate"}, {"start": 159, "end": 169, "label": "DRUG", "text": "Ivermectin"}], "input_ids": [2, 1920, 21, 16, 16359, 4710, 12411, 2037, 4462, 2436, 6144, 12, 24939, 1036, 13, 2427, 1966, 5097, 2028, 16620, 1941, 3688, 16, 1920, 9201, 5680, 17, 13761, 17127, 8746, 12, 13219, 1036, 13, 9481, 1930, 4370, 2166, 5922, 3411, 2838, 4183, 18, 2119, 18, 28687, 19, 5776, 18, 15065, 1021, 18, 21310, 23026, 1028, 18, 17287, 11636, 9344, 5251, 20285, 2568, 1942, 13585, 2079, 2476, 3201, 2690, 2084, 2568, 1942, 13585, 18, 2095, 23, 3661, 1920, 17645, 6605, 2769, 2079, 7068, 2973, 1958, 2321, 6673, 22779, 1930, 1920, 3852, 2230, 1958, 1920, 3047, 1927, 4391, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "b6a3e66a42e1", "text": "Reports that were sent to the NPC were compared to the WHO target.Causality assessments for the reports were done by an independent group of experts at the national level using WHO-UMC System for Standardized Case Causality Assessment Scale [29].", "entities": [], "input_ids": [2, 4710, 1988, 1985, 8437, 1942, 1920, 13585, 1985, 2452, 1942, 1920, 2746, 2758, 18, 19140, 8593, 1958, 1920, 4710, 1985, 5404, 2007, 1925, 3484, 2210, 1927, 11702, 2019, 1920, 3852, 2237, 2193, 2746, 17, 8736, 1030, 2433, 1958, 7496, 3087, 19140, 4076, 3536, 37, 3230, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "bad884bce3fd", "text": "The Minister of Health, Ghana, eventually issued an instruction through Executive Instrument 167 for the restriction of importation, manufacturer and registration of codeine-containing cough syrups [27].", "entities": [{"start": 165, "end": 173, "label": "DRUG", "text": "codeine"}], "input_ids": [2, 1920, 9696, 2156, 1915, 1927, 2436, 16, 20685, 16, 10042, 22459, 1925, 6401, 2596, 11627, 7389, 14997, 1958, 1920, 7587, 1927, 2582, 1943, 16, 6075, 1930, 10216, 1927, 7815, 2053, 17, 3165, 13588, 11458, 25372, 37, 3225, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "da78045de65d", "text": "At the level of the MHD, there was no existing committee for causality assessment.10.1371/journal.pone.0291482.g005Fig 5Ho Municipality ADR reporting trend, 2015–2019.There were 36 reports sent to the NPC; 35 were ADR reports and 1 product quality.", "entities": [], "input_ids": [2, 2019, 1920, 2237, 1927, 1920, 5146, 1007, 16, 2276, 1982, 2239, 6124, 6182, 1958, 19140, 4076, 18, 2119, 18, 28687, 19, 5776, 18, 15065, 1021, 18, 21310, 23026, 1028, 18, 17287, 15264, 9344, 13437, 1037, 26895, 17645, 6605, 5045, 16, 4299, 229, 14064, 18, 2276, 1985, 3480, 4710, 8437, 1942, 1920, 13585, 31, 3259, 1985, 17645, 4710, 1930, 21, 4863, 3455, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "8621f5e1ee52", "text": "Major side effects of codeine use such as bloating, blurred vision, chills, confusion, darkened urine, shortness of breath, difficulty in breathing, weak pulse, the feeling of warmth, fever, indigestion, and loss of appetite had been reported.", "entities": [{"start": 22, "end": 29, "label": "DRUG", "text": "codeine"}, {"start": 41, "end": 50, "label": "ADR", "text": "bloating"}, {"start": 52, "end": 66, "label": "ADR", "text": "blurred vision"}, {"start": 68, "end": 74, "label": "ADR", "text": "chills"}, {"start": 75, "end": 85, "label": "ADR", "text": "confusion"}, {"start": 87, "end": 101, "label": "ADR", "text": "darkened urine"}, {"start": 102, "end": 122, "label": "ADR", "text": "shortness of breath"}, {"start": 123, "end": 147, "label": "ADR", "text": "difficulty in breathing"}, {"start": 148, "end": 159, "label": "ADR", "text": "weak pulse"}, {"start": 161, "end": 182, "label": "ADR", "text": "the feeling of warmth"}, {"start": 184, "end": 189, "label": "ADR", "text": "fever"}, {"start": 190, "end": 202, "label": "ADR", "text": "indigestion"}, {"start": 208, "end": 224, "label": "ADR", "text": "loss of appetite"}], "input_ids": [2, 3044, 4159, 2564, 1927, 7815, 2053, 2485, 2427, 1966, 16635, 2287, 16, 2266, 19294, 9266, 16, 7368, 11560, 1036, 16, 18272, 16, 6190, 5106, 6960, 16, 3662, 2971, 1927, 8735, 16, 8791, 1922, 11995, 16, 5015, 7110, 16, 1920, 14452, 1927, 10142, 1963, 16, 9087, 16, 14719, 2158, 2001, 16, 1930, 3257, 1927, 17990, 2430, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 1, 2, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 3, 4, 4, 0, 4, 0, 3, 4, 4, 0, 4, 4, 4, 4, 0, 4, 4, 4, 0, 4, 4, 0, 3, 4, 4, 4, 4, 0, 3, 0, 4, 4, 4, 0, 0, 3, 4, 4, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "75ff6c61932f", "text": "Fig 1 indicates the Data and Information Flow Chart of the ADR Surveillance System in the Ho Municipality.10.1371/journal.pone.0291482.g001Fig 1National data and information flow chart of the ADR Surveillance System used by Ho Municipality.Reporting of ADRsUp to 97.2% (1,192/1,227) of suspected ADRs that occurred between 2015 and 2019 were not reported to the NPC.", "entities": [], "input_ids": [2, 2095, 21, 4538, 1920, 2230, 1930, 2988, 3426, 12583, 1927, 1920, 17645, 7889, 2433, 1922, 1920, 6673, 26895, 18, 2119, 18, 28687, 19, 5776, 18, 15065, 1021, 18, 21310, 23026, 1028, 18, 17287, 6924, 9344, 18600, 2676, 2230, 1930, 2988, 3426, 12583, 1927, 1920, 17645, 7889, 2433, 2251, 2007, 6673, 26895, 18, 6605, 1927, 28863, 3481, 1942, 5749, 18, 22, 9, 12, 21, 16, 15249, 19, 21, 16, 19797, 13, 1927, 9407, 28863, 1988, 4807, 2192, 4299, 1930, 14064, 1985, 2084, 2568, 1942, 1920, 13585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "a343ba81cfd0", "text": "It is noteworthy that all suspected ADRs, regardless of causality assessment classification, are stored in an electronic database for future data mining and signal generation.", "entities": [], "input_ids": [2, 2176, 1977, 13884, 1988, 2136, 9407, 28863, 16, 7447, 1927, 19140, 4076, 5492, 16, 2032, 6574, 1922, 1925, 7703, 5039, 1958, 4115, 2230, 16633, 1930, 2733, 4841, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "fa2cc2dc54ae", "text": "All the 35 ADR reports were assessed for causality as indicated in Fig 6 with the majority (54.3%) graded as ‘Possible’.10.1371/journal.pone.0291482.g006Fig 6Causality assessment of ADR reports from the Ho Municipality, 2015–2019.While the reports from the Ho Municipality did not have a direct influence on the risk of ADR concerns that were discovered throughout the reporting period, when combined with other information, a signal was formed about the widespread abuse of cough syrups containing codeine.", "entities": [{"start": 498, "end": 506, "label": "DRUG", "text": "codeine"}], "input_ids": [2, 2136, 1920, 3259, 17645, 4710, 1985, 3683, 1958, 19140, 1966, 3391, 1922, 2095, 26, 1956, 1920, 4827, 12, 4584, 18, 23, 9, 13, 13175, 1966, 233, 3216, 234, 18, 2119, 18, 28687, 19, 5776, 18, 15065, 1021, 18, 21310, 23026, 1028, 18, 17287, 14265, 9344, 10784, 26973, 5951, 4076, 1927, 17645, 4710, 2037, 1920, 6673, 26895, 16, 4299, 229, 14064, 18, 2679, 1920, 4710, 2037, 1920, 6673, 26895, 2811, 2084, 2162, 43, 3083, 4039, 1990, 1920, 2565, 1927, 17645, 8103, 1988, 1985, 8117, 5264, 1920, 6605, 3047, 16, 2469, 4252, 1956, 2303, 2988, 16, 43, 2733, 1982, 5333, 3001, 1920, 9360, 7764, 1927, 13588, 11458, 25372, 3165, 7815, 2053, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "2b7ae6c39be4", "text": "Up to 88.9% (32/36) were drug-related, covering a wide range of groups of medications.", "entities": [], "input_ids": [2, 2353, 1942, 5744, 18, 29, 9, 12, 3323, 19, 3480, 13, 1985, 2838, 17, 2712, 16, 12275, 43, 4743, 3109, 1927, 2671, 1927, 7719, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "4e4e5035174f", "text": "An ADR was considered missing if it was detected in a health facility or MHD but not reported to the NPC within the calendar year These were suspected ADR reports captured by a healthcare professional for onward submission to the NPC for causality assessment.For the purpose of this study, a suspected ADR is considered reported when the ADR form reaches the NPC.", "entities": [], "input_ids": [2, 1925, 17645, 1982, 3311, 6814, 2647, 2176, 1982, 3330, 1922, 43, 2436, 8598, 2014, 5146, 1007, 2308, 2084, 2568, 1942, 1920, 13585, 2651, 1920, 23948, 2476, 2144, 1985, 9407, 17645, 4710, 9025, 2007, 43, 5841, 8578, 1958, 1990, 3118, 18893, 1942, 1920, 13585, 1958, 19140, 4076, 18, 1958, 1920, 5120, 1927, 2052, 2161, 16, 43, 9407, 17645, 1977, 3311, 2568, 2469, 1920, 17645, 2386, 14698, 1920, 13585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "4fd4a2fc7b88", "text": "A similar study among community pharmacists reported that only 16% of those who had seen a patient with a suspected ADR in 2015 reported it [14].In Ghana, the Food Drugs Authority (FDA) acts as the National Pharmacovigilance Centre (NPC) and is responsible for ensuring the safety of pharmaceuticals on the market, collecting and managing ADR reports, as well as communicating safety concerns to healthcare professionals, patients, and other stakeholders.", "entities": [], "input_ids": [2, 43, 2551, 2161, 2706, 4413, 18019, 2568, 1988, 2444, 2641, 9, 1927, 2690, 2746, 2430, 3945, 43, 2774, 1956, 43, 9407, 17645, 1922, 4299, 2568, 2176, 37, 2607, 39, 18, 1922, 20685, 16, 1920, 3959, 4195, 18791, 12, 11394, 13, 8016, 1966, 1920, 3852, 4602, 25210, 6121, 17576, 1972, 8141, 12, 13585, 13, 1930, 1977, 5061, 1958, 14435, 1920, 5407, 1927, 15985, 1990, 1920, 10878, 16, 13607, 1930, 14432, 17645, 4710, 16, 1966, 2486, 1966, 23763, 5407, 8103, 1942, 5841, 9229, 16, 2132, 16, 1930, 2303, 15087, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "411dd9bfe52a", "text": "The WHO-UMC causality assessment method considers clinical-pharmacological aspects and quality of documentation in assessing case reports for adverse drug reactions.", "entities": [], "input_ids": [2, 1920, 2746, 17, 8736, 1030, 19140, 4076, 2417, 18834, 2535, 17, 7683, 6082, 1930, 3455, 1927, 14924, 1922, 7665, 3087, 4710, 1958, 5246, 2838, 5298, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "fa9c40f4aefb", "text": "The causality assessment scale was recorded.Representativeness was assessed using the characteristics of the population under surveillance–age, sex, geographic location, healthcare facility reporting.", "entities": [], "input_ids": [2, 1920, 19140, 4076, 3536, 1982, 4562, 18, 5051, 2971, 1982, 3683, 2193, 1920, 3779, 1927, 1920, 2973, 2441, 7889, 229, 2632, 16, 3486, 16, 10579, 5185, 16, 5841, 8598, 6605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "eda76fb6defd", "text": "Reporting of ADRsUp to 97.2% (1,192/1,227) of suspected ADRs that occurred between 2015 and 2019 were not reported to the NPC.", "entities": [], "input_ids": [2, 6605, 1927, 28863, 3481, 1942, 5749, 18, 22, 9, 12, 21, 16, 15249, 19, 21, 16, 19797, 13, 1927, 9407, 28863, 1988, 4807, 2192, 4299, 1930, 14064, 1985, 2084, 2568, 1942, 1920, 13585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "81d68b77c1b6", "text": "Patients report to healthcare professionals (primary reporters) of any untoward experience after taking a medicine; the details of the experience are verified and recorded on the reporting form (BlueForm®) as suspected ADR.", "entities": [], "input_ids": [2, 2132, 3809, 1942, 5841, 9229, 12, 3065, 21656, 13, 1927, 2967, 18472, 20572, 8544, 4848, 2256, 6303, 43, 5380, 31, 1920, 6331, 1927, 1920, 4848, 2032, 8759, 1930, 4562, 1990, 1920, 6605, 2386, 12, 4735, 2231, 1076, 13, 1966, 9407, 17645, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "342db23bc31f", "text": "Although this suggests a high rate of false positives, it is important to acknowledge the significant impact of ADRs on healthcare costs and hospital admissions [1–6] Therefore, it is crucial to continually evaluate and enhance the system’s performance to accurately identify ADRs and reduce false positives.Causality assessments for the reports were done by an independent group of experts at the national level using WHO-UMC System for Standardized Case Causality Assessment Scale [29].", "entities": [], "input_ids": [2, 2876, 2052, 4015, 43, 2149, 2769, 1927, 7198, 15196, 16, 2176, 1977, 2715, 1942, 11737, 1920, 2228, 3829, 1927, 28863, 1990, 5841, 5982, 1930, 3461, 13730, 37, 21, 229, 26, 39, 2955, 16, 2176, 1977, 6608, 1942, 27109, 4323, 1930, 4826, 1920, 2433, 234, 61, 3604, 1942, 8941, 3512, 28863, 1930, 4412, 7198, 15196, 18, 19140, 8593, 1958, 1920, 4710, 1985, 5404, 2007, 1925, 3484, 2210, 1927, 11702, 2019, 1920, 3852, 2237, 2193, 2746, 17, 8736, 1030, 2433, 1958, 7496, 3087, 19140, 4076, 3536, 37, 3230, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "fa4157156391", "text": "Timeliness of report submission, timeliness of investigation and causality assessment as well as timeliness of feedback was assessed.Stability was assessed by considering the backlog of data not entered into the database, the sustainability of the system when Institutional Contact Persons (ICPs) were changed, unscheduled outages and downtimes for the system’s computer and electronic resources, back-up of data, and the actual amount of time required for the system to release meaningful data.Assessing the usefulness of the ADRSSThe usefulness was assessed by reviewing the objectives of the system and its effect on public health interventions–policy decisions that have been implemented to promote the safe use of drugs.", "entities": [], "input_ids": [2, 27783, 5590, 1927, 3809, 18893, 16, 27783, 5590, 1927, 5630, 1930, 19140, 4076, 1966, 2486, 1966, 27783, 5590, 1927, 6491, 1982, 3683, 18, 5057, 1982, 3683, 2007, 6300, 1920, 3231, 22284, 1927, 2230, 2084, 10725, 2460, 1920, 5039, 16, 1920, 20232, 1927, 1920, 2433, 2469, 6540, 5217, 7618, 12, 13215, 1036, 13, 1985, 7003, 16, 6398, 25430, 11252, 2397, 2662, 1930, 3292, 8452, 1958, 1920, 2433, 234, 61, 7058, 1930, 7703, 6151, 16, 3231, 17, 2353, 1927, 2230, 16, 1930, 1920, 7432, 4351, 1927, 2367, 3414, 1958, 1920, 2433, 1942, 4012, 10698, 2230, 18, 7665, 1920, 13991, 1927, 1920, 28863, 2156, 4116, 13991, 1982, 3683, 2007, 17036, 1920, 7634, 1927, 1920, 2433, 1930, 2496, 2495, 1990, 4462, 2436, 4984, 229, 7299, 8693, 1988, 2162, 2252, 7397, 1942, 5527, 1920, 7672, 2485, 1927, 4195, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "d0a357971fb5", "text": "This indicated a lack of understanding of the surveillance system and how it operated, which is a significant factor linked to poor reporting of ADRs by health professionals, according to Khan et al., 2013 [31].All suspected ADRs received were subjected to causality assessments using the WHO-UMC scale [29], and reporters were given feedback.", "entities": [], "input_ids": [2, 2052, 3391, 43, 3630, 1927, 4339, 1927, 1920, 7889, 2433, 1930, 2307, 2176, 10497, 16, 2154, 1977, 43, 2228, 2991, 4624, 1942, 3930, 6605, 1927, 28863, 2007, 2436, 9229, 16, 3147, 1942, 8855, 1928, 2140, 1969, 18, 16, 3871, 37, 3470, 39, 18, 2136, 9407, 28863, 4004, 1985, 6243, 1942, 19140, 8593, 2193, 1920, 2746, 17, 8736, 1030, 3536, 37, 3230, 39, 16, 1930, 21656, 1985, 3258, 6491, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "a1c3611226b2", "text": "A suspected ADR that was documented by the healthcare provider or patient and sent to the MHD but did not end up in NPC is not considered reported.", "entities": [], "input_ids": [2, 43, 9407, 17645, 1988, 1982, 6974, 2007, 1920, 5841, 10989, 2014, 2774, 1930, 8437, 1942, 1920, 5146, 1007, 2308, 2811, 2084, 2482, 2353, 1922, 13585, 1977, 2084, 3311, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
{"id": "87aeb0631c5d_aug_arte", "text": "Others however thought that the components of artemether-lumefantrine were too high for them and, therefore, the side effects.", "entities": [{"start": 45, "end": 68, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4991, 2406, 6212, 1988, 1920, 4178, 1927, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1985, 7405, 2149, 1958, 3581, 1930, 16, 2955, 16, 1920, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "87aeb0631c5d_aug_dihy", "text": "Others however thought that the components of dihydroartemisinin-piperaquine were too high for them and, therefore, the side effects.", "entities": [{"start": 45, "end": 68, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4991, 2406, 6212, 1988, 1920, 4178, 1927, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1985, 7405, 2149, 1958, 3581, 1930, 16, 2955, 16, 1920, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "87aeb0631c5d_aug_chlo", "text": "Others however thought that the components of chloroquine were too high for them and, therefore, the side effects.", "entities": [{"start": 45, "end": 68, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4991, 2406, 6212, 1988, 1920, 4178, 1927, 20813, 1985, 7405, 2149, 1958, 3581, 1930, 16, 2955, 16, 1920, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "526199857826_aug_arte", "text": "Some patients shared their experiences in the excerpts below.“I was given artemether-lumefantrine and when I started taking the drug I could not do anything because my whole body was weak” (IDI: 29-year old male patient).The other side effects reported were vomiting, chest pains, itching, loss of appetite, poor vision and shivering.", "entities": [{"start": 74, "end": 97, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 165, "end": 187, "label": "ADR", "text": "my whole body was weak"}, {"start": 194, "end": 219, "label": "PATIENT_DEMO", "text": "29-year old male patient"}, {"start": 258, "end": 266, "label": "ADR", "text": "vomiting"}, {"start": 268, "end": 279, "label": "ADR", "text": "chest pains"}, {"start": 281, "end": 288, "label": "ADR", "text": "itching"}, {"start": 290, "end": 306, "label": "ADR", "text": "loss of appetite"}, {"start": 307, "end": 319, "label": "ADR", "text": "poor vision"}, {"start": 324, "end": 333, "label": "ADR", "text": "shivering"}], "input_ids": [2, 2673, 2132, 7115, 2310, 7651, 1922, 1920, 5585, 11119, 1973, 4535, 18, 236, 51, 1982, 3258, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1930, 2469, 51, 8074, 6303, 1920, 2838, 51, 2578, 2084, 2608, 22491, 2882, 3057, 4292, 3362, 1982, 5015, 237, 12, 11407, 30, 3230, 17, 2476, 4156, 4005, 2774, 13, 18, 1920, 2303, 4159, 2564, 2568, 1985, 13954, 16, 8475, 3594, 1036, 16, 20687, 1941, 16, 3257, 1927, 17990, 16, 3930, 9266, 1930, 20837, 2004, 1941, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 4, 4, 0, 3, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "526199857826_aug_dihy", "text": "Some patients shared their experiences in the excerpts below.“I was given dihydroartemisinin-piperaquine and when I started taking the drug I could not do anything because my whole body was weak” (IDI: 29-year old male patient).The other side effects reported were vomiting, chest pains, itching, loss of appetite, poor vision and shivering.", "entities": [{"start": 74, "end": 97, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 172, "end": 194, "label": "ADR", "text": "my whole body was weak"}, {"start": 201, "end": 226, "label": "PATIENT_DEMO", "text": "29-year old male patient"}, {"start": 265, "end": 273, "label": "ADR", "text": "vomiting"}, {"start": 275, "end": 286, "label": "ADR", "text": "chest pains"}, {"start": 288, "end": 295, "label": "ADR", "text": "itching"}, {"start": 297, "end": 313, "label": "ADR", "text": "loss of appetite"}, {"start": 314, "end": 326, "label": "ADR", "text": "poor vision"}, {"start": 331, "end": 340, "label": "ADR", "text": "shivering"}], "input_ids": [2, 2673, 2132, 7115, 2310, 7651, 1922, 1920, 5585, 11119, 1973, 4535, 18, 236, 51, 1982, 3258, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1930, 2469, 51, 8074, 6303, 1920, 2838, 51, 2578, 2084, 2608, 22491, 2882, 3057, 4292, 3362, 1982, 5015, 237, 12, 11407, 30, 3230, 17, 2476, 4156, 4005, 2774, 13, 18, 1920, 2303, 4159, 2564, 2568, 1985, 13954, 16, 8475, 3594, 1036, 16, 20687, 1941, 16, 3257, 1927, 17990, 16, 3930, 9266, 1930, 20837, 2004, 1941, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 4, 4, 0, 3, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "526199857826_aug_chlo", "text": "Some patients shared their experiences in the excerpts below.“I was given chloroquine and when I started taking the drug I could not do anything because my whole body was weak” (IDI: 29-year old male patient).The other side effects reported were vomiting, chest pains, itching, loss of appetite, poor vision and shivering.", "entities": [{"start": 74, "end": 97, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 153, "end": 175, "label": "ADR", "text": "my whole body was weak"}, {"start": 182, "end": 207, "label": "PATIENT_DEMO", "text": "29-year old male patient"}, {"start": 246, "end": 254, "label": "ADR", "text": "vomiting"}, {"start": 256, "end": 267, "label": "ADR", "text": "chest pains"}, {"start": 269, "end": 276, "label": "ADR", "text": "itching"}, {"start": 278, "end": 294, "label": "ADR", "text": "loss of appetite"}, {"start": 295, "end": 307, "label": "ADR", "text": "poor vision"}, {"start": 312, "end": 321, "label": "ADR", "text": "shivering"}], "input_ids": [2, 2673, 2132, 7115, 2310, 7651, 1922, 1920, 5585, 11119, 1973, 4535, 18, 236, 51, 1982, 3258, 20813, 1930, 2469, 51, 8074, 6303, 1920, 2838, 51, 2578, 2084, 2608, 22491, 2882, 3057, 4292, 3362, 1982, 5015, 237, 12, 11407, 30, 3230, 17, 2476, 4156, 4005, 2774, 13, 18, 1920, 2303, 4159, 2564, 2568, 1985, 13954, 16, 8475, 3594, 1036, 16, 20687, 1941, 16, 3257, 1927, 17990, 16, 3930, 9266, 1930, 20837, 2004, 1941, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 4, 4, 0, 3, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_aug_arte", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking artemether-lumefantrine“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 32-year old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 128, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 147, "end": 169, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 177, "end": 188, "label": "ADR", "text": "chest pains"}, {"start": 194, "end": 202, "label": "ADR", "text": "vomited"}, {"start": 210, "end": 236, "label": "PATIENT_DEMO", "text": "32-year old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_aug_dihy", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking dihydroartemisinin-piperaquine“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 32-year old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 135, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}, {"start": 154, "end": 176, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 184, "end": 195, "label": "ADR", "text": "chest pains"}, {"start": 201, "end": 209, "label": "ADR", "text": "vomited"}, {"start": 217, "end": 243, "label": "PATIENT_DEMO", "text": "32-year old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_aug_chlo", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking chloroquine“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 32-year old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 116, "label": "DRUG", "text": "chloroquine"}, {"start": 135, "end": 157, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 165, "end": 176, "label": "ADR", "text": "chest pains"}, {"start": 182, "end": 190, "label": "ADR", "text": "vomited"}, {"start": 198, "end": 224, "label": "PATIENT_DEMO", "text": "32-year old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20813, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3323, 17, 2476, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_aug_arte", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the artemether-lumefantrine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 188, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 196, "end": 207, "label": "ADR", "text": "chest pains"}, {"start": 214, "end": 221, "label": "ADR", "text": "vomited"}, {"start": 228, "end": 255, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 255, "end": 272, "label": "ADR", "text": "Swollen testicles"}, {"start": 312, "end": 335, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_aug_dihy", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the dihydroartemisinin-piperaquine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 195, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}, {"start": 203, "end": 214, "label": "ADR", "text": "chest pains"}, {"start": 221, "end": 228, "label": "ADR", "text": "vomited"}, {"start": 235, "end": 262, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 262, "end": 279, "label": "ADR", "text": "Swollen testicles"}, {"start": 319, "end": 342, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_aug_chlo", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the chloroquine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 176, "label": "DRUG", "text": "chloroquine"}, {"start": 184, "end": 195, "label": "ADR", "text": "chest pains"}, {"start": 202, "end": 209, "label": "ADR", "text": "vomited"}, {"start": 216, "end": 243, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 243, "end": 260, "label": "ADR", "text": "Swollen testicles"}, {"start": 300, "end": 323, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20813, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "f29b4b315333_aug_arte", "text": "Experience of side-effects of ACTThe findings revealed that participants who took artemether-lumefantrine to treat malaria reported most side effects.", "entities": [{"start": 82, "end": 105, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4848, 1927, 4159, 17, 2564, 1927, 4033, 20536, 3056, 3404, 1988, 3003, 2746, 8659, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1942, 2297, 7505, 2568, 2501, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f29b4b315333_aug_dihy", "text": "Experience of side-effects of ACTThe findings revealed that participants who took dihydroartemisinin-piperaquine to treat malaria reported most side effects.", "entities": [{"start": 82, "end": 105, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4848, 1927, 4159, 17, 2564, 1927, 4033, 20536, 3056, 3404, 1988, 3003, 2746, 8659, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1942, 2297, 7505, 2568, 2501, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f29b4b315333_aug_chlo", "text": "Experience of side-effects of ACTThe findings revealed that participants who took chloroquine to treat malaria reported most side effects.", "entities": [{"start": 82, "end": 105, "label": "DRUG", "text": "artesunate-amodiaqiune"}], "input_ids": [2, 4848, 1927, 4159, 17, 2564, 1927, 4033, 20536, 3056, 3404, 1988, 3003, 2746, 8659, 20813, 1942, 2297, 7505, 2568, 2501, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5d7510510656_aug_arte", "text": "Majority of the patients who took artemether-lumefantrine and artemether-lumefantrine, respectively, reported to have experienced side effects such as body weakness, dizziness, itching and abdominal pain [5–14].", "entities": [{"start": 34, "end": 57, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 61, "end": 85, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 151, "end": 164, "label": "ADR", "text": "body weakness"}, {"start": 166, "end": 175, "label": "ADR", "text": "dizziness"}, {"start": 177, "end": 184, "label": "ADR", "text": "itching"}, {"start": 189, "end": 203, "label": "ADR", "text": "abdominal pain"}], "input_ids": [2, 4827, 1927, 1920, 2132, 2746, 8659, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1930, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 16, 2763, 16, 2568, 1942, 2162, 6090, 4159, 2564, 2427, 1966, 3362, 12175, 16, 24009, 16, 20687, 1941, 1930, 6900, 3594, 37, 25, 229, 2607, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5d7510510656_aug_dihy", "text": "Majority of the patients who took dihydroartemisinin-piperaquine and artemether-lumefantrine, respectively, reported to have experienced side effects such as body weakness, dizziness, itching and abdominal pain [5–14].", "entities": [{"start": 34, "end": 57, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 68, "end": 92, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 158, "end": 171, "label": "ADR", "text": "body weakness"}, {"start": 173, "end": 182, "label": "ADR", "text": "dizziness"}, {"start": 184, "end": 191, "label": "ADR", "text": "itching"}, {"start": 196, "end": 210, "label": "ADR", "text": "abdominal pain"}], "input_ids": [2, 4827, 1927, 1920, 2132, 2746, 8659, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1930, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 16, 2763, 16, 2568, 1942, 2162, 6090, 4159, 2564, 2427, 1966, 3362, 12175, 16, 24009, 16, 20687, 1941, 1930, 6900, 3594, 37, 25, 229, 2607, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5d7510510656_aug_chlo", "text": "Majority of the patients who took chloroquine and artemether-lumefantrine, respectively, reported to have experienced side effects such as body weakness, dizziness, itching and abdominal pain [5–14].", "entities": [{"start": 34, "end": 57, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 49, "end": 73, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 139, "end": 152, "label": "ADR", "text": "body weakness"}, {"start": 154, "end": 163, "label": "ADR", "text": "dizziness"}, {"start": 165, "end": 172, "label": "ADR", "text": "itching"}, {"start": 177, "end": 191, "label": "ADR", "text": "abdominal pain"}], "input_ids": [2, 4827, 1927, 1920, 2132, 2746, 8659, 20813, 1930, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 16, 2763, 16, 2568, 1942, 2162, 6090, 4159, 2564, 2427, 1966, 3362, 12175, 16, 24009, 16, 20687, 1941, 1930, 6900, 3594, 37, 25, 229, 2607, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "31334088b6d7_aug_arte", "text": "In this study however, views expressed are slightly different because most patients attributed all the side effects to the use of artemether-lumefantrine compared to other combinations.According to Asante et al., side effects such as headache, inability for some patients to control the neck and tongue were reported by patients who used ACT [5].", "entities": [{"start": 130, "end": 153, "label": "DRUG", "text": "artemether-lumefantrine"}, {"start": 234, "end": 242, "label": "ADR", "text": "headache"}, {"start": 244, "end": 302, "label": "ADR", "text": "inability for some patients to control the neck and tongue"}], "input_ids": [2, 1922, 2052, 2161, 2406, 16, 9792, 3198, 2032, 5733, 2413, 2882, 2501, 2132, 6898, 2136, 1920, 4159, 2564, 1942, 1920, 2485, 1927, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 2452, 1942, 2303, 7763, 18, 3147, 1942, 15634, 4905, 1021, 2140, 1969, 18, 16, 4159, 2564, 2427, 1966, 12187, 16, 11752, 1958, 2673, 2132, 1942, 2285, 1920, 7467, 1930, 14761, 1985, 2568, 2007, 2132, 2746, 2251, 4033, 37, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "31334088b6d7_aug_dihy", "text": "In this study however, views expressed are slightly different because most patients attributed all the side effects to the use of dihydroartemisinin-piperaquine compared to other combinations.According to Asante et al., side effects such as headache, inability for some patients to control the neck and tongue were reported by patients who used ACT [5].", "entities": [{"start": 130, "end": 160, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}, {"start": 241, "end": 249, "label": "ADR", "text": "headache"}, {"start": 251, "end": 309, "label": "ADR", "text": "inability for some patients to control the neck and tongue"}], "input_ids": [2, 1922, 2052, 2161, 2406, 16, 9792, 3198, 2032, 5733, 2413, 2882, 2501, 2132, 6898, 2136, 1920, 4159, 2564, 1942, 1920, 2485, 1927, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 2452, 1942, 2303, 7763, 18, 3147, 1942, 15634, 4905, 1021, 2140, 1969, 18, 16, 4159, 2564, 2427, 1966, 12187, 16, 11752, 1958, 2673, 2132, 1942, 2285, 1920, 7467, 1930, 14761, 1985, 2568, 2007, 2132, 2746, 2251, 4033, 37, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "31334088b6d7_aug_chlo", "text": "In this study however, views expressed are slightly different because most patients attributed all the side effects to the use of chloroquine compared to other combinations.According to Asante et al., side effects such as headache, inability for some patients to control the neck and tongue were reported by patients who used ACT [5].", "entities": [{"start": 130, "end": 141, "label": "DRUG", "text": "chloroquine"}, {"start": 222, "end": 230, "label": "ADR", "text": "headache"}, {"start": 232, "end": 290, "label": "ADR", "text": "inability for some patients to control the neck and tongue"}], "input_ids": [2, 1922, 2052, 2161, 2406, 16, 9792, 3198, 2032, 5733, 2413, 2882, 2501, 2132, 6898, 2136, 1920, 4159, 2564, 1942, 1920, 2485, 1927, 20813, 2452, 1942, 2303, 7763, 18, 3147, 1942, 15634, 4905, 1021, 2140, 1969, 18, 16, 4159, 2564, 2427, 1966, 12187, 16, 11752, 1958, 2673, 2132, 1942, 2285, 1920, 7467, 1930, 14761, 1985, 2568, 2007, 2132, 2746, 2251, 4033, 37, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c20e7da61ee6_aug_arte", "text": "When the artemether-lumefantrine was first introduced in Ghana, many patients who used it had several side effects because the components of the drug were very high [7].", "entities": [{"start": 9, "end": 32, "label": "DRUG", "text": "artemether-lumefantrine"}], "input_ids": [2, 2469, 1920, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1982, 2561, 6373, 1922, 20685, 16, 3086, 2132, 2746, 2251, 2176, 2430, 2980, 4159, 2564, 2882, 1920, 4178, 1927, 1920, 2838, 1985, 3345, 2149, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c20e7da61ee6_aug_dihy", "text": "When the dihydroartemisinin-piperaquine was first introduced in Ghana, many patients who used it had several side effects because the components of the drug were very high [7].", "entities": [{"start": 9, "end": 39, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}], "input_ids": [2, 2469, 1920, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1982, 2561, 6373, 1922, 20685, 16, 3086, 2132, 2746, 2251, 2176, 2430, 2980, 4159, 2564, 2882, 1920, 4178, 1927, 1920, 2838, 1985, 3345, 2149, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "c20e7da61ee6_aug_chlo", "text": "When the chloroquine was first introduced in Ghana, many patients who used it had several side effects because the components of the drug were very high [7].", "entities": [{"start": 9, "end": 20, "label": "DRUG", "text": "chloroquine"}], "input_ids": [2, 2469, 1920, 20813, 1982, 2561, 6373, 1922, 20685, 16, 3086, 2132, 2746, 2251, 2176, 2430, 2980, 4159, 2564, 2882, 1920, 4178, 1927, 1920, 2838, 1985, 3345, 2149, 37, 27, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "76cd3a824efd_aug_arte", "text": "Opinions from patients who use artemether-lumefantrine in this study suggested that the components are still high and that could be the reason why they are still experiencing these side effects.", "entities": [{"start": 31, "end": 54, "label": "DRUG", "text": "artemether-lumefantrine"}], "input_ids": [2, 17689, 2037, 2132, 2746, 2485, 20897, 23568, 1915, 17, 5491, 7726, 2031, 5773, 1922, 2052, 2161, 3978, 1988, 1920, 4178, 2032, 3974, 2149, 1930, 1988, 2578, 1998, 1920, 5070, 7348, 2611, 2032, 3974, 12511, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "76cd3a824efd_aug_dihy", "text": "Opinions from patients who use dihydroartemisinin-piperaquine in this study suggested that the components are still high and that could be the reason why they are still experiencing these side effects.", "entities": [{"start": 31, "end": 61, "label": "DRUG", "text": "dihydroartemisinin-piperaquine"}], "input_ids": [2, 17689, 2037, 2132, 2746, 2485, 11842, 5263, 18940, 15020, 17, 16057, 15287, 19616, 1922, 2052, 2161, 3978, 1988, 1920, 4178, 2032, 3974, 2149, 1930, 1988, 2578, 1998, 1920, 5070, 7348, 2611, 2032, 3974, 12511, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "76cd3a824efd_aug_chlo", "text": "Opinions from patients who use chloroquine in this study suggested that the components are still high and that could be the reason why they are still experiencing these side effects.", "entities": [{"start": 31, "end": 42, "label": "DRUG", "text": "chloroquine"}], "input_ids": [2, 17689, 2037, 2132, 2746, 2485, 20813, 1922, 2052, 2161, 3978, 1988, 1920, 4178, 2032, 3974, 2149, 1930, 1988, 2578, 1998, 1920, 5070, 7348, 2611, 2032, 3974, 12511, 2144, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_demoaug_27-year-", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking artesunate-amodiaquine.“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 27-year-old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 128, "label": "DRUG", "text": "artesunate-amodiaquine."}, {"start": 147, "end": 169, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 177, "end": 188, "label": "ADR", "text": "chest pains"}, {"start": 194, "end": 202, "label": "ADR", "text": "vomited"}, {"start": 210, "end": 236, "label": "PATIENT_DEMO", "text": "27-year-old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 18, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3225, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_demoaug_44-year-", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking artesunate-amodiaquine.“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 44-year-old female patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 128, "label": "DRUG", "text": "artesunate-amodiaquine."}, {"start": 147, "end": 169, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 177, "end": 188, "label": "ADR", "text": "chest pains"}, {"start": 194, "end": 202, "label": "ADR", "text": "vomited"}, {"start": 210, "end": 236, "label": "PATIENT_DEMO", "text": "44-year-old female patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 18, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 4044, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "5ca17c31a09a_demoaug_32-year-", "text": "Some participants said they experienced an unusual heart beat and their health deteriorated after taking artesunate-amodiaquine.“….When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI: 32-year-old male patient).Other uncommon side effects of ACT were also reported by one of the participants.", "entities": [{"start": 43, "end": 61, "label": "ADR", "text": "unusual heart beat"}, {"start": 105, "end": 128, "label": "DRUG", "text": "artesunate-amodiaquine."}, {"start": 147, "end": 169, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 177, "end": 188, "label": "ADR", "text": "chest pains"}, {"start": 194, "end": 202, "label": "ADR", "text": "vomited"}, {"start": 210, "end": 234, "label": "PATIENT_DEMO", "text": "32-year-old male patient"}], "input_ids": [2, 2673, 3003, 12029, 2611, 6090, 1925, 12236, 4003, 17984, 1930, 2310, 2436, 28236, 2256, 6303, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 18, 236, 244, 18, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 30, 3323, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 2303, 14403, 4159, 2564, 1927, 4033, 1985, 2222, 2568, 2007, 2340, 1927, 1920, 3003, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6518fc1325ac_demoaug_27-year-", "text": "We got this experience from our father who died of malaria” (IDI: 27-year-old female patient).Similar views were shared by health professionals and chemical shop owners on the side effects patients with malaria experience from using ACT.", "entities": [{"start": 66, "end": 93, "label": "PATIENT_DEMO", "text": "27-year-old female patient)"}], "input_ids": [2, 2038, 14643, 2052, 4848, 2037, 2342, 14854, 2746, 8545, 1927, 7505, 237, 12, 11407, 30, 3225, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 2551, 9792, 1985, 7115, 2007, 2436, 9229, 1930, 4399, 25160, 15373, 1990, 1920, 4159, 2564, 2132, 1956, 7505, 4848, 2037, 2193, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6518fc1325ac_demoaug_44-year-", "text": "We got this experience from our father who died of malaria” (IDI: 44-year-old female patient).Similar views were shared by health professionals and chemical shop owners on the side effects patients with malaria experience from using ACT.", "entities": [{"start": 66, "end": 93, "label": "PATIENT_DEMO", "text": "44-year-old female patient)"}], "input_ids": [2, 2038, 14643, 2052, 4848, 2037, 2342, 14854, 2746, 8545, 1927, 7505, 237, 12, 11407, 30, 4044, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 2551, 9792, 1985, 7115, 2007, 2436, 9229, 1930, 4399, 25160, 15373, 1990, 1920, 4159, 2564, 2132, 1956, 7505, 4848, 2037, 2193, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6518fc1325ac_demoaug_32-year-", "text": "We got this experience from our father who died of malaria” (IDI: 32-year-old male patient).Similar views were shared by health professionals and chemical shop owners on the side effects patients with malaria experience from using ACT.", "entities": [{"start": 66, "end": 91, "label": "PATIENT_DEMO", "text": "32-year-old male patient)"}], "input_ids": [2, 2038, 14643, 2052, 4848, 2037, 2342, 14854, 2746, 8545, 1927, 7505, 237, 12, 11407, 30, 3323, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 2551, 9792, 1985, 7115, 2007, 2436, 9229, 1930, 4399, 25160, 15373, 1990, 1920, 4159, 2564, 2132, 1956, 7505, 4848, 2037, 2193, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_demoaug_33_year_", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-33 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "33 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 254, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 254, "end": 271, "label": "ADR", "text": "Swollen testicles"}, {"start": 311, "end": 334, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3401, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_demoaug_45_year_", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-45 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-32 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "45 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 254, "label": "PATIENT_DEMO", "text": "32 year old female patient)"}, {"start": 254, "end": 271, "label": "ADR", "text": "Swollen testicles"}, {"start": 311, "end": 334, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3607, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_demoaug_27_year_", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-27 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 254, "label": "PATIENT_DEMO", "text": "27 year old female patient)"}, {"start": 254, "end": 271, "label": "ADR", "text": "Swollen testicles"}, {"start": 311, "end": 334, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3225, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_demoaug_44_year_", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-44 year old female patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 254, "label": "PATIENT_DEMO", "text": "44 year old female patient)"}, {"start": 254, "end": 271, "label": "ADR", "text": "Swollen testicles"}, {"start": 311, "end": 334, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 4044, 2476, 4156, 4232, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "2183591be115_demoaug_32_year_", "text": "Some people complain of poor vision and difficulty to hear or they experience some noise in their ears” (IDI-38 year old health worker)Chest pains “…When I took the artesunate-amodiaquine, I had chest pains and I vomited” (IDI-32 year old male patient)Swollen testicles “…others especially the men have their testes and body swollen.", "entities": [{"start": 24, "end": 35, "label": "ADR", "text": "poor vision"}, {"start": 40, "end": 58, "label": "ADR", "text": "difficulty to hear"}, {"start": 109, "end": 134, "label": "PATIENT_DEMO", "text": "38 year old health worker"}, {"start": 135, "end": 146, "label": "ADR", "text": "Chest pains"}, {"start": 165, "end": 187, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 195, "end": 206, "label": "ADR", "text": "chest pains"}, {"start": 213, "end": 220, "label": "ADR", "text": "vomited"}, {"start": 227, "end": 252, "label": "PATIENT_DEMO", "text": "32 year old male patient)"}, {"start": 252, "end": 269, "label": "ADR", "text": "Swollen testicles"}, {"start": 309, "end": 332, "label": "ADR", "text": "testes and body swollen"}], "input_ids": [2, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 4848, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3738, 2476, 4156, 2436, 16187, 13, 8475, 3594, 1036, 236, 244, 2469, 51, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 51, 2430, 8475, 3594, 1036, 1930, 51, 13463, 2599, 237, 12, 11407, 17, 3323, 2476, 4156, 4005, 2774, 13, 23561, 2648, 6193, 236, 244, 4991, 4369, 1920, 3925, 2162, 2310, 16880, 1930, 3362, 23561, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_27_year_", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-27 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 164, "label": "PATIENT_DEMO", "text": "27 year old female patient"}, {"start": 165, "end": 181, "label": "ADR", "text": "Loss of appetite"}, {"start": 188, "end": 196, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 206, "end": 228, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 237, "end": 241, "label": "ADR", "text": "weak"}, {"start": 246, "end": 269, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 3225, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_44_year_", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-44 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 164, "label": "PATIENT_DEMO", "text": "44 year old female patient"}, {"start": 165, "end": 181, "label": "ADR", "text": "Loss of appetite"}, {"start": 188, "end": 196, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 206, "end": 228, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 237, "end": 241, "label": "ADR", "text": "weak"}, {"start": 246, "end": 269, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 4044, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_32_year_", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-32 year old male patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 162, "label": "PATIENT_DEMO", "text": "32 year old male patient"}, {"start": 163, "end": 179, "label": "ADR", "text": "Loss of appetite"}, {"start": 186, "end": 194, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 204, "end": 226, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 235, "end": 239, "label": "ADR", "text": "weak"}, {"start": 244, "end": 267, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 3323, 2476, 4156, 4005, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_my_son", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-32 year old female patient)Loss of appetite “When my son took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 164, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 165, "end": 181, "label": "ADR", "text": "Loss of appetite"}, {"start": 188, "end": 194, "label": "PATIENT_DEMO", "text": "my son"}, {"start": 204, "end": 226, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 235, "end": 239, "label": "ADR", "text": "weak"}, {"start": 244, "end": 267, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 9337, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_my_daugh", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be serious” (IDI-32 year old female patient)Loss of appetite “When my daughter took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 131, "label": "SEVERITY", "text": "serious"}, {"start": 138, "end": 164, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 165, "end": 181, "label": "ADR", "text": "Loss of appetite"}, {"start": 188, "end": 199, "label": "PATIENT_DEMO", "text": "my daughter"}, {"start": 209, "end": 231, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 240, "end": 244, "label": "ADR", "text": "weak"}, {"start": 249, "end": 272, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 7433, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 16229, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "4908fb42d3ae_demoaug_31_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-31 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 96, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "31 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 187, "label": "ADR", "text": "poor vision"}, {"start": 212, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 248, "label": "ADR", "text": "difficulty to hear"}, {"start": 265, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3470, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4908fb42d3ae_demoaug_43_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-43 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 96, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "43 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 187, "label": "ADR", "text": "poor vision"}, {"start": 212, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 248, "label": "ADR", "text": "difficulty to hear"}, {"start": 265, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3941, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4908fb42d3ae_demoaug_29_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-29 year old health worker)Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 96, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 187, "label": "ADR", "text": "poor vision"}, {"start": 212, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 248, "label": "ADR", "text": "difficulty to hear"}, {"start": 265, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "29 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3230, 2476, 4156, 2436, 16187, 13, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "4908fb42d3ae_demoaug_48_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-48 year old health worker)Consultation content during out-patient visitsThe consultation content between clinician and client in the Out-Patient Department (OPD) focused mainly on drug administration to the neglect of drug efficacy and side effects.", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 96, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 187, "label": "ADR", "text": "poor vision"}, {"start": 212, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 248, "label": "ADR", "text": "difficulty to hear"}, {"start": 265, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "48 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3427, 2476, 4156, 2436, 16187, 13, 13060, 3919, 2409, 2397, 17, 2774, 7870, 20536, 13060, 3919, 2192, 12934, 1930, 14805, 1922, 1920, 2397, 17, 2774, 6143, 12, 2494, 1007, 13, 5625, 4994, 1990, 2838, 4183, 1942, 1920, 18256, 1927, 2838, 4348, 1930, 4159, 2564, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a7160f7ff54d_demoaug_30-year-", "text": "This is my second time of going there (health facility) and they have not told me anything on the side effects I will get when I use the drug”(IDI: 30-year-old female patient).The providers confirmed that in addition to giving instructions on the dosing regimen, they are required to provide information on side effects to patients and to explain to them why it was important for them to report any side effects they experience with the drug to the nearest health facility.", "entities": [{"start": 148, "end": 174, "label": "PATIENT_DEMO", "text": "30-year-old female patient"}], "input_ids": [2, 2052, 1977, 3057, 2812, 2367, 1927, 12250, 2276, 12, 2436, 8598, 13, 1930, 2611, 2162, 2084, 18313, 2142, 22491, 1990, 1920, 4159, 2564, 51, 2832, 7691, 2469, 51, 2485, 1920, 2838, 237, 12, 11407, 30, 2627, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 1920, 8044, 3982, 1988, 1922, 2459, 1942, 10382, 7186, 1990, 1920, 10654, 8607, 16, 2611, 2032, 3414, 1942, 3394, 2988, 1990, 4159, 2564, 1942, 2132, 1930, 1942, 5895, 1942, 3581, 7348, 2176, 1982, 2715, 1958, 3581, 1942, 3809, 2967, 4159, 2564, 2611, 4848, 1956, 1920, 2838, 1942, 1920, 13851, 2436, 8598, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a7160f7ff54d_demoaug_42-year-", "text": "This is my second time of going there (health facility) and they have not told me anything on the side effects I will get when I use the drug”(IDI: 42-year-old female patient).The providers confirmed that in addition to giving instructions on the dosing regimen, they are required to provide information on side effects to patients and to explain to them why it was important for them to report any side effects they experience with the drug to the nearest health facility.", "entities": [{"start": 148, "end": 174, "label": "PATIENT_DEMO", "text": "42-year-old female patient"}], "input_ids": [2, 2052, 1977, 3057, 2812, 2367, 1927, 12250, 2276, 12, 2436, 8598, 13, 1930, 2611, 2162, 2084, 18313, 2142, 22491, 1990, 1920, 4159, 2564, 51, 2832, 7691, 2469, 51, 2485, 1920, 2838, 237, 12, 11407, 30, 3858, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 1920, 8044, 3982, 1988, 1922, 2459, 1942, 10382, 7186, 1990, 1920, 10654, 8607, 16, 2611, 2032, 3414, 1942, 3394, 2988, 1990, 4159, 2564, 1942, 2132, 1930, 1942, 5895, 1942, 3581, 7348, 2176, 1982, 2715, 1958, 3581, 1942, 3809, 2967, 4159, 2564, 2611, 4848, 1956, 1920, 2838, 1942, 1920, 13851, 2436, 8598, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "a7160f7ff54d_demoaug_25-year-", "text": "This is my second time of going there (health facility) and they have not told me anything on the side effects I will get when I use the drug”(IDI: 25-year-old male patient).The providers confirmed that in addition to giving instructions on the dosing regimen, they are required to provide information on side effects to patients and to explain to them why it was important for them to report any side effects they experience with the drug to the nearest health facility.", "entities": [{"start": 148, "end": 172, "label": "PATIENT_DEMO", "text": "25-year-old male patient"}], "input_ids": [2, 2052, 1977, 3057, 2812, 2367, 1927, 12250, 2276, 12, 2436, 8598, 13, 1930, 2611, 2162, 2084, 18313, 2142, 22491, 1990, 1920, 4159, 2564, 51, 2832, 7691, 2469, 51, 2485, 1920, 2838, 237, 12, 11407, 30, 2637, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 1920, 8044, 3982, 1988, 1922, 2459, 1942, 10382, 7186, 1990, 1920, 10654, 8607, 16, 2611, 2032, 3414, 1942, 3394, 2988, 1990, 4159, 2564, 1942, 2132, 1930, 1942, 5895, 1942, 3581, 7348, 2176, 1982, 2715, 1958, 3581, 1942, 3809, 2967, 4159, 2564, 2611, 4848, 1956, 1920, 2838, 1942, 1920, 13851, 2436, 8598, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "b78cb8a22a5a_demoaug_37-year-", "text": "Patients preferred to endure such side effects at home rather than report them to the health facility with the reason that every drug has a side effect and therefore it was normal to experience them.“The reason is that I know the way it works and that made me not to go back and I was waiting to see what would happen after the third day….So because I know how the drug works is the reason why I did not go back to tell them” (IDI: 37-year-old female patient).Participants also identified long queues at the OPD that led to long waiting-time before receiving care as a critical factor that affect the reporting of adverse events.", "entities": [{"start": 432, "end": 458, "label": "PATIENT_DEMO", "text": "37-year-old female patient"}], "input_ids": [2, 2132, 8579, 1942, 2482, 2027, 2427, 4159, 2564, 2019, 4502, 4356, 2254, 3809, 3581, 1942, 1920, 2436, 8598, 1956, 1920, 5070, 1988, 4808, 2838, 2258, 43, 4159, 2495, 1930, 2955, 2176, 1982, 2791, 1942, 4848, 3581, 18, 236, 1920, 5070, 1977, 1988, 51, 3758, 1920, 4222, 2176, 10997, 1930, 1988, 3915, 2142, 2084, 1942, 3611, 3231, 1930, 51, 1982, 15215, 1942, 3365, 4663, 2962, 20492, 2256, 1920, 4563, 3007, 244, 18, 2577, 2882, 51, 3758, 2307, 1920, 2838, 10997, 1977, 1920, 5070, 7348, 51, 2811, 2084, 3611, 3231, 1942, 17812, 3581, 237, 12, 11407, 30, 3191, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3003, 2222, 2899, 2815, 10730, 2291, 2019, 1920, 2494, 1007, 1988, 4866, 1942, 2815, 15215, 17, 2367, 3119, 5962, 2859, 1966, 43, 4140, 2991, 1988, 4081, 1920, 6605, 1927, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "b78cb8a22a5a_demoaug_26-year-", "text": "Patients preferred to endure such side effects at home rather than report them to the health facility with the reason that every drug has a side effect and therefore it was normal to experience them.“The reason is that I know the way it works and that made me not to go back and I was waiting to see what would happen after the third day….So because I know how the drug works is the reason why I did not go back to tell them” (IDI: 26-year-old female patient).Participants also identified long queues at the OPD that led to long waiting-time before receiving care as a critical factor that affect the reporting of adverse events.", "entities": [{"start": 432, "end": 458, "label": "PATIENT_DEMO", "text": "26-year-old female patient"}], "input_ids": [2, 2132, 8579, 1942, 2482, 2027, 2427, 4159, 2564, 2019, 4502, 4356, 2254, 3809, 3581, 1942, 1920, 2436, 8598, 1956, 1920, 5070, 1988, 4808, 2838, 2258, 43, 4159, 2495, 1930, 2955, 2176, 1982, 2791, 1942, 4848, 3581, 18, 236, 1920, 5070, 1977, 1988, 51, 3758, 1920, 4222, 2176, 10997, 1930, 1988, 3915, 2142, 2084, 1942, 3611, 3231, 1930, 51, 1982, 15215, 1942, 3365, 4663, 2962, 20492, 2256, 1920, 4563, 3007, 244, 18, 2577, 2882, 51, 3758, 2307, 1920, 2838, 10997, 1977, 1920, 5070, 7348, 51, 2811, 2084, 3611, 3231, 1942, 17812, 3581, 237, 12, 11407, 30, 3179, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3003, 2222, 2899, 2815, 10730, 2291, 2019, 1920, 2494, 1007, 1988, 4866, 1942, 2815, 15215, 17, 2367, 3119, 5962, 2859, 1966, 43, 4140, 2991, 1988, 4081, 1920, 6605, 1927, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "b78cb8a22a5a_demoaug_30-year-", "text": "Patients preferred to endure such side effects at home rather than report them to the health facility with the reason that every drug has a side effect and therefore it was normal to experience them.“The reason is that I know the way it works and that made me not to go back and I was waiting to see what would happen after the third day….So because I know how the drug works is the reason why I did not go back to tell them” (IDI: 30-year-old male patient).Participants also identified long queues at the OPD that led to long waiting-time before receiving care as a critical factor that affect the reporting of adverse events.", "entities": [{"start": 432, "end": 456, "label": "PATIENT_DEMO", "text": "30-year-old male patient"}], "input_ids": [2, 2132, 8579, 1942, 2482, 2027, 2427, 4159, 2564, 2019, 4502, 4356, 2254, 3809, 3581, 1942, 1920, 2436, 8598, 1956, 1920, 5070, 1988, 4808, 2838, 2258, 43, 4159, 2495, 1930, 2955, 2176, 1982, 2791, 1942, 4848, 3581, 18, 236, 1920, 5070, 1977, 1988, 51, 3758, 1920, 4222, 2176, 10997, 1930, 1988, 3915, 2142, 2084, 1942, 3611, 3231, 1930, 51, 1982, 15215, 1942, 3365, 4663, 2962, 20492, 2256, 1920, 4563, 3007, 244, 18, 2577, 2882, 51, 3758, 2307, 1920, 2838, 10997, 1977, 1920, 5070, 7348, 51, 2811, 2084, 3611, 3231, 1942, 17812, 3581, 237, 12, 11407, 30, 2627, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 3003, 2222, 2899, 2815, 10730, 2291, 2019, 1920, 2494, 1007, 1988, 4866, 1942, 2815, 15215, 17, 2367, 3119, 5962, 2859, 1966, 43, 4140, 2991, 1988, 4081, 1920, 6605, 1927, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f5524806320b_demoaug_34-year-", "text": "And others will say that if I am strong enough to go to the facility why don’t I just go to the market and manage my business, so mostly that is the reason why they don’t come” (IDI: 34-year-old health worker).Other patients said that previous reports of side effects yielded no benefits to them.", "entities": [{"start": 183, "end": 208, "label": "PATIENT_DEMO", "text": "34-year-old health worker"}], "input_ids": [2, 1930, 4991, 2832, 12471, 1988, 2647, 51, 2150, 3206, 7867, 1942, 3611, 1942, 1920, 8598, 7348, 4330, 234, 62, 51, 6244, 3611, 1942, 1920, 10878, 1930, 12193, 3057, 16885, 16, 2577, 6969, 1988, 1977, 1920, 5070, 7348, 2611, 4330, 234, 62, 10449, 237, 12, 11407, 30, 3540, 17, 2476, 17, 4156, 2436, 16187, 13, 18, 2303, 2132, 12029, 1988, 2555, 4710, 1927, 4159, 2564, 8193, 2239, 6382, 1942, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f5524806320b_demoaug_41-year-", "text": "And others will say that if I am strong enough to go to the facility why don’t I just go to the market and manage my business, so mostly that is the reason why they don’t come” (IDI: 41-year-old health worker).Other patients said that previous reports of side effects yielded no benefits to them.", "entities": [{"start": 183, "end": 208, "label": "PATIENT_DEMO", "text": "41-year-old health worker"}], "input_ids": [2, 1930, 4991, 2832, 12471, 1988, 2647, 51, 2150, 3206, 7867, 1942, 3611, 1942, 1920, 8598, 7348, 4330, 234, 62, 51, 6244, 3611, 1942, 1920, 10878, 1930, 12193, 3057, 16885, 16, 2577, 6969, 1988, 1977, 1920, 5070, 7348, 2611, 4330, 234, 62, 10449, 237, 12, 11407, 30, 4353, 17, 2476, 17, 4156, 2436, 16187, 13, 18, 2303, 2132, 12029, 1988, 2555, 4710, 1927, 4159, 2564, 8193, 2239, 6382, 1942, 3581, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316_demoaug_33-year-", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 33-year-old female patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 41-year old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 447, "label": "PATIENT_DEMO", "text": "33-year-old female patient"}, {"start": 923, "end": 948, "label": "PATIENT_DEMO", "text": "41-year old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3401, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 4353, 17, 2476, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316_demoaug_45-year-", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 45-year-old female patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 41-year old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 447, "label": "PATIENT_DEMO", "text": "45-year-old female patient"}, {"start": 923, "end": 948, "label": "PATIENT_DEMO", "text": "41-year old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3607, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 4353, 17, 2476, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316_demoaug_38-year-", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 38-year-old male patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 41-year old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 445, "label": "PATIENT_DEMO", "text": "38-year-old male patient"}, {"start": 921, "end": 946, "label": "PATIENT_DEMO", "text": "41-year old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3738, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 4353, 17, 2476, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316_demoaug_35-year-", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 38-year old female patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 35-year-old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 447, "label": "PATIENT_DEMO", "text": "38-year old female patient"}, {"start": 923, "end": 948, "label": "PATIENT_DEMO", "text": "35-year-old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3738, 17, 2476, 4156, 4232, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 3259, 17, 2476, 17, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "f1f269598316_demoaug_50-year-", "text": "Most of the patients were of the view that health education should be given to patients in order to encourage them to report these side effects.“…drug store attendants and the health workers at the hospitals should often inform patients of the possible side effects and also tell them to come back if they experience serious side effects after taking the drugs so that they can test you and see what the problem is”(IDI: 38-year old female patient).The health workers said that most people were ignorance and at such did not know that they were supposed to come back and report and if patients were reminded continuously each time they were given ACT, it would have a positive impact on adverse event reporting in the study area.“…we (health workers) should have patience towards our clients and try to educate them about the side effects and also encourage them to report when they get these side effects at home….” (IDI: 50-year-old health worker).Most of the patients said that it was important for health workers to have patience and behave nicely toward their clients in a manner that would encourage them to always feel free to visit the health facility anytime they have health problems.", "entities": [{"start": 421, "end": 447, "label": "PATIENT_DEMO", "text": "38-year old female patient"}, {"start": 923, "end": 948, "label": "PATIENT_DEMO", "text": "50-year-old health worker"}], "input_ids": [2, 2501, 1927, 1920, 2132, 1985, 1927, 1920, 4263, 1988, 2436, 4767, 3066, 1998, 3258, 1942, 2132, 1922, 3238, 1942, 14549, 3581, 1942, 3809, 2144, 4159, 2564, 18, 236, 244, 2838, 14582, 10396, 2356, 1930, 1920, 2436, 7066, 2019, 1920, 7252, 3066, 3868, 2780, 2132, 1927, 1920, 3216, 4159, 2564, 1930, 2222, 17812, 3581, 1942, 10449, 3231, 2647, 2611, 4848, 7433, 4159, 2564, 2256, 6303, 1920, 4195, 2577, 1988, 2611, 2112, 2648, 6253, 1930, 3365, 4663, 1920, 4915, 1977, 237, 12, 11407, 30, 3738, 17, 2476, 4156, 4232, 2774, 13, 18, 1920, 2436, 7066, 12029, 1988, 2501, 4329, 1985, 12046, 8846, 15895, 1021, 1930, 2019, 2427, 2811, 2084, 3758, 1988, 2611, 1985, 18310, 1942, 10449, 3231, 1930, 3809, 1930, 2647, 2132, 1985, 20821, 1919, 10446, 2362, 2367, 2611, 1985, 3258, 4033, 16, 2176, 2962, 2162, 43, 2843, 3829, 1990, 5246, 4817, 6605, 1922, 1920, 2161, 3403, 18, 236, 244, 2038, 12, 2436, 7066, 13, 3066, 2162, 2091, 2055, 5681, 2342, 13608, 1930, 15699, 1942, 4066, 2010, 3581, 3001, 1920, 4159, 2564, 1930, 2222, 14549, 3581, 1942, 3809, 2469, 2611, 7691, 2144, 4159, 2564, 2019, 4502, 244, 18, 237, 12, 11407, 30, 2761, 17, 2476, 17, 4156, 2436, 16187, 13, 18, 2501, 1927, 1920, 2132, 12029, 1988, 2176, 1982, 2715, 1958, 2436, 7066, 1942, 2162, 2091, 2055, 1930, 20199, 23607, 1954, 4205, 2310, 13608, 1922, 43, 5222, 1988, 2962, 14549, 3581, 1942, 6789, 9248, 3294, 1942, 7421, 1920, 2436, 8598, 2967, 6995, 2611, 2162, 2436, 4951, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_30-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 30-year-old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "30-year-old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2627, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_42-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 42-year-old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "42-year-old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 3858, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_25-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year-old male patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 163, "label": "PATIENT_DEMO", "text": "25-year-old male patient"}, {"start": 532, "end": 558, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_44-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 44-year-old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "44-year-old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 4044, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_28-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 28-year-old female patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "28-year-old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3158, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "6b8bc3594012_demoaug_39-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year-old male patient).LimitationsThough, this study provides information on factors affecting adverse events reporting of ACT, some limitation however must be considered.", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 558, "label": "PATIENT_DEMO", "text": "39-year-old male patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 5780, 1963, 2534, 16, 2052, 2161, 4558, 2988, 1990, 2790, 7359, 5246, 3916, 6605, 1927, 4033, 16, 2673, 7789, 2406, 4902, 1998, 3311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "94d48abf79be_demoaug_31_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-31 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 97, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "31 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 188, "label": "ADR", "text": "poor vision"}, {"start": 213, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 247, "label": "ADR", "text": "difficulty to hear"}, {"start": 266, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3470, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, -100], "source_type": "qualitative_interview"}
{"id": "94d48abf79be_demoaug_43_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-43 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-36 year old health worker)", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 97, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "43 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 188, "label": "ADR", "text": "poor vision"}, {"start": 213, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 247, "label": "ADR", "text": "difficulty to hear"}, {"start": 266, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "36 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3941, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3480, 2476, 4156, 2436, 16187, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, -100], "source_type": "qualitative_interview"}
{"id": "94d48abf79be_demoaug_29_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-29 year old health worker)", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 97, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 188, "label": "ADR", "text": "poor vision"}, {"start": 213, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 247, "label": "ADR", "text": "difficulty to hear"}, {"start": 266, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "29 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3230, 2476, 4156, 2436, 16187, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, -100], "source_type": "qualitative_interview"}
{"id": "94d48abf79be_demoaug_48_year_", "text": "For me, immediately I put it into my mouth, I become very weak… when I took it the first time, I lost appetite and I was also very weak” (IDI-26 year old Mother).Shivering and poor vision “Some people complain of poor vision and difficulty to hear or they hear some noise in their ears” (IDI-48 year old health worker)", "entities": [{"start": 53, "end": 62, "label": "ADR", "text": "very weak"}, {"start": 97, "end": 110, "label": "ADR", "text": "lost appetite"}, {"start": 126, "end": 135, "label": "ADR", "text": "very weak"}, {"start": 142, "end": 160, "label": "PATIENT_DEMO", "text": "26 year old Mother"}, {"start": 162, "end": 171, "label": "ADR", "text": "Shivering"}, {"start": 176, "end": 188, "label": "ADR", "text": "poor vision"}, {"start": 213, "end": 224, "label": "ADR", "text": "poor vision"}, {"start": 229, "end": 247, "label": "ADR", "text": "difficulty to hear"}, {"start": 266, "end": 285, "label": "ADR", "text": "noise in their ears"}, {"start": 292, "end": 317, "label": "PATIENT_DEMO", "text": "48 year old health worker"}], "input_ids": [2, 1958, 2142, 16, 6183, 51, 5366, 2176, 2460, 3057, 11701, 16, 51, 5433, 3345, 5015, 244, 2469, 51, 8659, 2176, 1920, 2561, 2367, 16, 51, 7621, 17990, 1930, 51, 1982, 2222, 3345, 5015, 237, 12, 11407, 17, 3179, 2476, 4156, 7999, 13, 18, 20837, 2004, 1941, 1930, 3930, 9266, 236, 2673, 4329, 6581, 2005, 1927, 3930, 9266, 1930, 8791, 1942, 3563, 2014, 2611, 3563, 2673, 6036, 1922, 2310, 19332, 237, 12, 11407, 17, 3427, 2476, 4156, 2436, 16187, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, -100], "source_type": "qualitative_interview"}
{"id": "fd3d11df49fd_demoaug_52-year-", "text": "So we have to monitor the person and make sure that he/she takes the drug correctly and if the same side effects are presented then you have to change treatment for the person and see” (IDI: 52-year-old pharmacist).", "entities": [{"start": 191, "end": 213, "label": "PATIENT_DEMO", "text": "52-year-old pharmacist"}], "input_ids": [2, 2577, 2038, 2162, 1942, 8434, 1920, 5952, 1930, 5144, 16320, 1988, 2234, 19, 4693, 9620, 1920, 2838, 10329, 1930, 2647, 1920, 2841, 4159, 2564, 2032, 3549, 2759, 6253, 2162, 1942, 3185, 2311, 1958, 1920, 5952, 1930, 3365, 237, 12, 11407, 30, 4764, 17, 2476, 17, 4156, 23400, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "fd3d11df49fd_demoaug_38-year-", "text": "So we have to monitor the person and make sure that he/she takes the drug correctly and if the same side effects are presented then you have to change treatment for the person and see” (IDI: 38-year-old pharmacist).", "entities": [{"start": 191, "end": 213, "label": "PATIENT_DEMO", "text": "38-year-old pharmacist"}], "input_ids": [2, 2577, 2038, 2162, 1942, 8434, 1920, 5952, 1930, 5144, 16320, 1988, 2234, 19, 4693, 9620, 1920, 2838, 10329, 1930, 2647, 1920, 2841, 4159, 2564, 2032, 3549, 2759, 6253, 2162, 1942, 3185, 2311, 1958, 1920, 5952, 1930, 3365, 237, 12, 11407, 30, 3738, 17, 2476, 17, 4156, 23400, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2df3dddb42fd_demoaug_31-year-", "text": "This is the one other reason why such people who get these side effects do not report”(IDI: 31-year-old female patient).", "entities": [{"start": 92, "end": 118, "label": "PATIENT_DEMO", "text": "31-year-old female patient"}], "input_ids": [2, 2052, 1977, 1920, 2340, 2303, 5070, 7348, 2427, 4329, 2746, 7691, 2144, 4159, 2564, 2608, 2084, 3809, 237, 12, 11407, 30, 3470, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2df3dddb42fd_demoaug_43-year-", "text": "This is the one other reason why such people who get these side effects do not report”(IDI: 43-year-old female patient).", "entities": [{"start": 92, "end": 118, "label": "PATIENT_DEMO", "text": "43-year-old female patient"}], "input_ids": [2, 2052, 1977, 1920, 2340, 2303, 5070, 7348, 2427, 4329, 2746, 7691, 2144, 4159, 2564, 2608, 2084, 3809, 237, 12, 11407, 30, 3941, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "2df3dddb42fd_demoaug_26-year-", "text": "This is the one other reason why such people who get these side effects do not report”(IDI: 26-year-old male patient).", "entities": [{"start": 92, "end": 116, "label": "PATIENT_DEMO", "text": "26-year-old male patient"}], "input_ids": [2, 2052, 1977, 1920, 2340, 2303, 5070, 7348, 2427, 4329, 2746, 7691, 2144, 4159, 2564, 2608, 2084, 3809, 237, 12, 11407, 30, 3179, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_30-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 30-year-old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "30-year-old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2627, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_42-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 42-year-old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "42-year-old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 3858, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_25-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year-old male patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year old female patient).", "entities": [{"start": 139, "end": 163, "label": "PATIENT_DEMO", "text": "25-year-old male patient"}, {"start": 532, "end": 558, "label": "PATIENT_DEMO", "text": "39-year old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_44-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 44-year-old female patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "44-year-old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 4044, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_28-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 28-year-old female patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 560, "label": "PATIENT_DEMO", "text": "28-year-old female patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3158, 17, 2476, 17, 4156, 4232, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "496a76f8d88a_demoaug_39-year-", "text": "They should tell the people to feel free and come back to the health facility anything they take these drugs and get side effects….” (IDI: 25-year old female patient).“…The doctors should make it such that when you take the drugs and get side effects you should walk straight to the doctor and complain to him, it should not look like you are coming for the first time where you would go and follow line for long before you see the doctor to give your complain about the side effects you got from using the drugs they gave you” (IDI: 39-year-old male patient).", "entities": [{"start": 139, "end": 165, "label": "PATIENT_DEMO", "text": "25-year old female patient"}, {"start": 534, "end": 558, "label": "PATIENT_DEMO", "text": "39-year-old male patient"}], "input_ids": [2, 2611, 3066, 17812, 1920, 4329, 1942, 9248, 3294, 1930, 10449, 3231, 1942, 1920, 2436, 8598, 22491, 2611, 6132, 2144, 4195, 1930, 7691, 4159, 2564, 244, 18, 237, 12, 11407, 30, 2637, 17, 2476, 4156, 4232, 2774, 13, 18, 236, 244, 1920, 11849, 3066, 5144, 2176, 2427, 1988, 2469, 6253, 6132, 1920, 4195, 1930, 7691, 4159, 2564, 6253, 3066, 6846, 10312, 1942, 1920, 11622, 1930, 6581, 2005, 1942, 13135, 16, 2176, 3066, 2084, 8120, 3189, 6253, 2032, 15796, 1958, 1920, 2561, 2367, 2597, 6253, 2962, 3611, 1930, 2396, 2823, 1958, 2815, 3119, 6253, 3365, 1920, 11622, 1942, 7031, 10186, 6581, 2005, 3001, 1920, 4159, 2564, 6253, 14643, 2037, 2193, 1920, 4195, 2611, 7981, 6253, 237, 12, 11407, 30, 3886, 17, 2476, 17, 4156, 4005, 2774, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "0147141bff35_demoaug_31-year-", "text": "The first serious ICSR was received from a 31-year-old male COVID-19 patient who was given azithromycin and hydroxychloroquine and on the same day (17th April 2020), the patient had supraventricular tachycardia, chest discomfort and abdominal pain which all started the same day the suspected drugs were administered.Concomitant drugs were started the same day as the suspected drugs were zinc, enoxaparin injection, vitamin C and ceftriaxone.", "entities": [{"start": 43, "end": 59, "label": "PATIENT_DEMO", "text": "31-year-old male"}, {"start": 90, "end": 103, "label": "DRUG", "text": "azithromycin"}, {"start": 108, "end": 126, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 181, "end": 210, "label": "ADR", "text": "supraventricular tachycardia"}, {"start": 212, "end": 228, "label": "ADR", "text": "chest discomfort"}, {"start": 233, "end": 247, "label": "ADR", "text": "abdominal pain"}, {"start": 388, "end": 393, "label": "DRUG", "text": "zinc"}, {"start": 395, "end": 405, "label": "DRUG", "text": "enoxaparin"}, {"start": 417, "end": 426, "label": "DRUG", "text": "vitamin C"}, {"start": 431, "end": 442, "label": "DRUG", "text": "ceftriaxone"}], "input_ids": [2, 1920, 2561, 7433, 13772, 1005, 1982, 4004, 2037, 43, 3470, 17, 2476, 17, 4156, 4005, 6083, 1960, 17, 2282, 2774, 2746, 1982, 3258, 28350, 1930, 8275, 11600, 1037, 15520, 1930, 1990, 1920, 2841, 3007, 12, 2752, 1963, 11071, 22656, 13, 16, 1920, 2774, 2430, 21038, 24722, 17397, 16, 8475, 15335, 1930, 6900, 3594, 2154, 2136, 8074, 1920, 2841, 3007, 1920, 9407, 4195, 1985, 5254, 18, 8537, 4195, 1985, 8074, 1920, 2841, 3007, 1966, 1920, 9407, 4195, 1985, 7997, 16, 2066, 2325, 29398, 5572, 4107, 16, 6111, 45, 1930, 28248, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 1, 2, 0, 1, 0, -100], "source_type": "cohort_study"}
{"id": "0147141bff35_demoaug_43-year-", "text": "The first serious ICSR was received from a 43-year-old male COVID-19 patient who was given azithromycin and hydroxychloroquine and on the same day (17th April 2020), the patient had supraventricular tachycardia, chest discomfort and abdominal pain which all started the same day the suspected drugs were administered.Concomitant drugs were started the same day as the suspected drugs were zinc, enoxaparin injection, vitamin C and ceftriaxone.", "entities": [{"start": 43, "end": 59, "label": "PATIENT_DEMO", "text": "43-year-old male"}, {"start": 90, "end": 103, "label": "DRUG", "text": "azithromycin"}, {"start": 108, "end": 126, "label": "DRUG", "text": "hydroxychloroquine"}, {"start": 181, "end": 210, "label": "ADR", "text": "supraventricular tachycardia"}, {"start": 212, "end": 228, "label": "ADR", "text": "chest discomfort"}, {"start": 233, "end": 247, "label": "ADR", "text": "abdominal pain"}, {"start": 388, "end": 393, "label": "DRUG", "text": "zinc"}, {"start": 395, "end": 405, "label": "DRUG", "text": "enoxaparin"}, {"start": 417, "end": 426, "label": "DRUG", "text": "vitamin C"}, {"start": 431, "end": 442, "label": "DRUG", "text": "ceftriaxone"}], "input_ids": [2, 1920, 2561, 7433, 13772, 1005, 1982, 4004, 2037, 43, 3941, 17, 2476, 17, 4156, 4005, 6083, 1960, 17, 2282, 2774, 2746, 1982, 3258, 28350, 1930, 8275, 11600, 1037, 15520, 1930, 1990, 1920, 2841, 3007, 12, 2752, 1963, 11071, 22656, 13, 16, 1920, 2774, 2430, 21038, 24722, 17397, 16, 8475, 15335, 1930, 6900, 3594, 2154, 2136, 8074, 1920, 2841, 3007, 1920, 9407, 4195, 1985, 5254, 18, 8537, 4195, 1985, 8074, 1920, 2841, 3007, 1966, 1920, 9407, 4195, 1985, 7997, 16, 2066, 2325, 29398, 5572, 4107, 16, 6111, 45, 1930, 28248, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 3, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 2, 2, 0, 0, 1, 2, 0, 1, 0, -100], "source_type": "cohort_study"}
{"id": "0b484186f820_demoaug_34-year-", "text": "The second case which resulted in hospitalisation for seven days involved a 34-year-old exposed pregnant female HCW (in the first trimester of pregnancy) who reported of abdominal pains, profuse diarrhoea, fatigue, nausea and bleeding which later resulted in spontaneous abortion.", "entities": [{"start": 76, "end": 115, "label": "PATIENT_DEMO", "text": "34-year-old exposed pregnant female HCW"}, {"start": 170, "end": 185, "label": "ADR", "text": "abdominal pains"}, {"start": 195, "end": 204, "label": "ADR", "text": "diarrhoea"}, {"start": 206, "end": 213, "label": "ADR", "text": "fatigue"}, {"start": 215, "end": 221, "label": "ADR", "text": "nausea"}, {"start": 226, "end": 234, "label": "ADR", "text": "bleeding"}, {"start": 259, "end": 279, "label": "ADR", "text": "spontaneous abortion"}], "input_ids": [2, 1920, 2812, 3087, 2154, 4306, 1922, 26185, 1958, 5260, 3000, 3286, 43, 3540, 17, 2476, 17, 4156, 4616, 7808, 4232, 4387, 1018, 12, 1922, 1920, 2561, 14315, 1927, 5284, 13, 2746, 2568, 1927, 6900, 3594, 1036, 16, 3150, 2517, 20998, 16, 8656, 16, 13759, 1930, 7633, 2154, 3690, 4306, 1922, 6242, 15660, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "cohort_study"}
{"id": "0b484186f820_demoaug_41-year-", "text": "The second case which resulted in hospitalisation for seven days involved a 41-year-old exposed pregnant female HCW (in the first trimester of pregnancy) who reported of abdominal pains, profuse diarrhoea, fatigue, nausea and bleeding which later resulted in spontaneous abortion.", "entities": [{"start": 76, "end": 115, "label": "PATIENT_DEMO", "text": "41-year-old exposed pregnant female HCW"}, {"start": 170, "end": 185, "label": "ADR", "text": "abdominal pains"}, {"start": 195, "end": 204, "label": "ADR", "text": "diarrhoea"}, {"start": 206, "end": 213, "label": "ADR", "text": "fatigue"}, {"start": 215, "end": 221, "label": "ADR", "text": "nausea"}, {"start": 226, "end": 234, "label": "ADR", "text": "bleeding"}, {"start": 259, "end": 279, "label": "ADR", "text": "spontaneous abortion"}], "input_ids": [2, 1920, 2812, 3087, 2154, 4306, 1922, 26185, 1958, 5260, 3000, 3286, 43, 4353, 17, 2476, 17, 4156, 4616, 7808, 4232, 4387, 1018, 12, 1922, 1920, 2561, 14315, 1927, 5284, 13, 2746, 2568, 1927, 6900, 3594, 1036, 16, 3150, 2517, 20998, 16, 8656, 16, 13759, 1930, 7633, 2154, 3690, 4306, 1922, 6242, 15660, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 8, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "cohort_study"}
{"id": "silver_a138a5c7a1", "text": "6 ADVERSE REACTIONS The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1) ]", "entities": [], "input_ids": [2, 26, 5246, 5298, 1920, 2894, 2032, 5601, 1922, 2253, 3966, 1922, 2303, 4828, 1927, 1920, 7411, 30, 21219, 8933, 5298, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cb336968da", "text": "Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2) ]", "entities": [], "input_ids": [2, 4010, 11276, 5246, 5298, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 22, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_af03b55291", "text": "[see Warnings and Precautions (5.3) ]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0e0db6ef46", "text": "Hepatic Dysfunction [see Warnings and Precautions (5.4) ]", "entities": [], "input_ids": [2, 6095, 5273, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a0b2152a41", "text": "Clostridioides difficile Associated Diarrhea (CDAD)", "entities": [], "input_ids": [2, 17938, 13756, 12363, 19148, 2458, 11904, 12, 2464, 2015, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a0b1058465", "text": "[see Warnings and Precautions (5.5) ]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8864a68801", "text": "The most frequently reported adverse reactions were diarrhea/loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%).", "entities": [{"label": "ADR", "start": 109, "end": 118, "text": "urticaria"}, {"label": "ADR", "start": 125, "end": 133, "text": "vomiting"}, {"label": "ADR", "start": 80, "end": 86, "text": "nausea"}], "input_ids": [2, 1920, 2501, 5467, 2568, 5246, 5298, 1985, 11904, 19, 21425, 14839, 1036, 12, 29, 9, 13, 16, 13759, 12, 23, 9, 13, 16, 4407, 18469, 1918, 1930, 27986, 6148, 12, 23, 9, 13, 16, 13954, 12, 21, 9, 13, 1930, 7715, 11566, 3600, 12, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_90a89ee8ef", "text": "(6.1) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .", "entities": [], "input_ids": [2, 12, 26, 18, 21, 13, 1942, 3809, 9407, 5246, 5298, 16, 5217, 11826, 17428, 10249, 1037, 24552, 3785, 16, 2043, 18, 2019, 21, 17, 5713, 1016, 17, 23196, 17, 22891, 1016, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9dae86fde4", "text": "6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.", "entities": [], "input_ids": [2, 26, 18, 21, 2535, 3046, 4848, 2882, 2535, 3848, 2032, 3609, 2441, 5673, 7155, 2961, 16, 5246, 3227, 3389, 2528, 1922, 1920, 2535, 3848, 1927, 43, 2838, 5156, 1998, 4103, 2452, 1942, 3389, 1922, 1920, 2535, 3848, 1927, 3741, 2838, 1930, 2278, 2084, 5840, 1920, 3389, 2528, 1922, 4695, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8864a68801", "text": "The most frequently reported adverse reactions were diarrhea/loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%).", "entities": [{"label": "ADR", "start": 109, "end": 118, "text": "urticaria"}, {"label": "ADR", "start": 125, "end": 133, "text": "vomiting"}, {"label": "ADR", "start": 80, "end": 86, "text": "nausea"}], "input_ids": [2, 1920, 2501, 5467, 2568, 5246, 5298, 1985, 11904, 19, 21425, 14839, 1036, 12, 29, 9, 13, 16, 13759, 12, 23, 9, 13, 16, 4407, 18469, 1918, 1930, 27986, 6148, 12, 23, 9, 13, 16, 13954, 12, 21, 9, 13, 1930, 7715, 11566, 3600, 12, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5a3024d348", "text": "Less than 3% of patients discontinued therapy because of drug-related adverse reactions.", "entities": [], "input_ids": [2, 2941, 2254, 23, 9, 1927, 2132, 16087, 3181, 2882, 1927, 2838, 17, 2712, 5246, 5298, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a39afdda4d", "text": "The overall incidence of adverse reactions, and in particular diarrhea, increased with the higher recommended dose.", "entities": [], "input_ids": [2, 1920, 3399, 4332, 1927, 5246, 5298, 16, 1930, 1922, 3278, 11904, 16, 2502, 1956, 1920, 2580, 6198, 3253, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b08e5bc024", "text": "Other less frequently reported adverse reactions (less than 1%) include: Abdominal discomfort, flatulence, and headache.", "entities": [{"label": "ADR", "start": 111, "end": 119, "text": "headache"}], "input_ids": [2, 2303, 2941, 5467, 2568, 5246, 5298, 12, 2941, 2254, 21, 9, 13, 3951, 30, 6900, 15335, 16, 9778, 25916, 16, 1930, 12187, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_198c0f7e9a", "text": "In pediatric patients (aged 2 months to 12 years), 1 U.S./Canadian clinical trial was conducted which compared 45/6.4 mg/kg/day (divided every 12 hours) of amoxicillin and clavulanate potassium for 10 days versus 40/10 mg/kg/day (divided every 8 hours) of amoxicillin and clavulanate potassium for 10 days in the treatment of acute otitis media.", "entities": [{"label": "DRUG", "start": 156, "end": 167, "text": "amoxicillin"}, {"label": "DRUG", "start": 256, "end": 267, "text": "amoxicillin"}], "input_ids": [2, 1922, 7460, 2132, 12, 5177, 22, 3221, 1942, 2369, 2739, 13, 16, 21, 63, 18, 61, 18, 19, 13870, 2535, 3046, 1982, 3609, 2154, 2452, 3607, 19, 26, 18, 24, 2786, 19, 3621, 19, 3007, 12, 5831, 4808, 2369, 3967, 13, 1927, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 1958, 2119, 3000, 4072, 3040, 19, 2119, 2786, 19, 3621, 19, 3007, 12, 5831, 4808, 28, 3967, 13, 1927, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 1958, 2119, 3000, 1922, 1920, 2311, 1927, 3939, 28145, 4996, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7881b00d31", "text": "A total of 575 patients were enrolled, and only the suspension formulations were used in this trial.", "entities": [], "input_ids": [2, 43, 2698, 1927, 4786, 1015, 2132, 1985, 7316, 16, 1930, 2444, 1920, 8971, 11950, 1985, 2251, 1922, 2052, 3046, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2b76151ebd", "text": "Overall, the adverse reactions seen were comparable to that noted above; however, there were differences in the rates of diarrhea, skin rashes/urticaria, and diaper area rashes [see Clinical Studies (14.2) ] .", "entities": [{"label": "ADR", "start": 143, "end": 152, "text": "urticaria"}], "input_ids": [2, 3399, 16, 1920, 5246, 5298, 3945, 1985, 5596, 1942, 1988, 5040, 3538, 31, 2406, 16, 2276, 1985, 2886, 1922, 1920, 3389, 1927, 11904, 16, 4407, 18469, 1918, 19, 27986, 6148, 16, 1930, 27314, 1915, 3403, 18469, 1918, 37, 3365, 2535, 2351, 12, 2607, 18, 22, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_dfb1a55f9a", "text": "In addition to adverse reactions reported from clinical trials, the following have been identified during postmarketing use of amoxicillin and clavulanate potassium.", "entities": [{"label": "DRUG", "start": 127, "end": 138, "text": "amoxicillin"}], "input_ids": [2, 1922, 2459, 1942, 5246, 5298, 2568, 2037, 2535, 3848, 16, 1920, 2894, 2162, 2252, 2899, 2409, 11160, 2566, 6649, 2485, 1927, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f8b5893128", "text": "Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made.", "entities": [], "input_ids": [2, 2882, 2611, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 5435, 3081, 16, 5280, 1927, 3528, 5156, 1998, 3915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0e3b675064", "text": "These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to amoxicillin and clavulanate potassium.", "entities": [{"label": "DRUG", "start": 145, "end": 156, "text": "amoxicillin"}], "input_ids": [2, 2144, 3916, 2162, 2252, 6724, 1958, 6125, 2810, 1942, 43, 3921, 1927, 2310, 7433, 2971, 16, 3528, 1927, 6605, 16, 2014, 2889, 9263, 10393, 1942, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cfaccdc68b", "text": "Gastrointestinal: Drug-induced enterocolitis syndrome (DIES), indigestion, gastritis, stomatitis, glossitis, black “hairy” tongue, mucocutaneous candidiasis, enterocolitis, and hemorrhagic/pseudomembranous colitis.", "entities": [], "input_ids": [2, 8375, 30, 2838, 17, 2719, 5553, 23338, 3678, 4741, 12, 21354, 13, 16, 14719, 2158, 2001, 16, 24253, 16, 9347, 6219, 16, 30402, 3678, 16, 5010, 236, 7018, 1012, 237, 14761, 16, 3422, 29011, 29469, 16, 5553, 23338, 3678, 16, 1930, 16052, 19, 11520, 3870, 17010, 17182, 2080, 12087, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_77db5b7b76", "text": "Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment", "entities": [], "input_ids": [2, 4727, 1927, 11520, 3870, 17010, 17182, 2080, 12087, 3601, 2278, 4704, 2409, 2014, 2256, 13021, 2311, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_867d8a0b1d", "text": "[see Warnings and Precautions (5.5) ] .", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b88aa7f85f", "text": "Immune: Hypersensitivity reactions, anaphylactic/anaphylactoid reactions (including shock), angioedema, serum sickness-like reactions (urticaria or skin rash accompanied by arthritis, arthralgia, myalgia, and frequently fever), hypersensitivity vasculitis [see Warnings and Precautions (5.1 )].", "entities": [{"label": "ADR", "start": 8, "end": 24, "text": "Hypersensitivity"}, {"label": "ADR", "start": 228, "end": 244, "text": "hypersensitivity"}, {"label": "ADR", "start": 184, "end": 194, "text": "arthralgia"}, {"label": "ADR", "start": 135, "end": 144, "text": "urticaria"}, {"label": "ADR", "start": 196, "end": 203, "text": "myalgia"}, {"label": "ADR", "start": 153, "end": 157, "text": "rash"}], "input_ids": [2, 3743, 30, 14625, 5298, 16, 21219, 8933, 19, 21219, 2131, 2642, 5298, 12, 2710, 7418, 13, 16, 29220, 16670, 16, 3256, 21375, 17, 3189, 5298, 12, 27986, 6148, 2014, 4407, 18469, 7936, 2007, 8884, 16, 9273, 7317, 11966, 16, 3057, 20394, 2126, 16, 1930, 5467, 9087, 13, 16, 14625, 21548, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 3, 0, 0, 0, 0, 3, 4, 4, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0b475d9ede", "text": "Skin and Appendages: Rashes, pruritus, urticaria, erythema multiforme, SJS, TEN, DRESS, AGEP, exfoliative dermatitis, and linear IgA bullous dermatosis.", "entities": [{"label": "ADR", "start": 39, "end": 48, "text": "urticaria"}, {"label": "ADR", "start": 29, "end": 37, "text": "pruritus"}], "input_ids": [2, 4407, 1930, 7958, 2662, 30, 18469, 1918, 16, 27496, 16, 27986, 6148, 16, 23349, 15453, 2076, 1021, 16, 13550, 1036, 16, 5656, 16, 18100, 16, 2632, 1034, 16, 28972, 2178, 18006, 16, 1930, 4258, 12114, 14267, 2080, 13467, 2475, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d22dc9f572", "text": "Liver: Hepatic dysfunction, including hepatitis and cholestatic jaundice, increases in serum transaminases (AST and/or ALT), serum bilirubin, and/or alkaline phosphatase, has been reported with amoxicillin and clavulanate potassium.", "entities": [{"label": "ADR", "start": 64, "end": 72, "text": "jaundice"}, {"label": "DRUG", "start": 194, "end": 205, "text": "amoxicillin"}], "input_ids": [2, 3568, 30, 6095, 5273, 16, 2710, 7977, 1930, 21211, 2479, 25314, 16, 4041, 1922, 3256, 24376, 1036, 12, 5988, 1930, 19, 2014, 8387, 13, 16, 3256, 15702, 16, 1930, 19, 2014, 10746, 8167, 16, 2258, 2252, 2568, 1956, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_290e18dc24", "text": "It has been reported more commonly in the elderly, in males, or in patients on prolonged treatment.", "entities": [], "input_ids": [2, 2176, 2258, 2252, 2568, 2253, 5384, 1922, 1920, 7354, 16, 1922, 5129, 16, 2014, 1922, 2132, 1990, 7171, 2311, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5079be49cd", "text": "The histologic findings on liver biopsy have consisted of predominantly cholestatic, hepatocellular, or mixed cholestatic hepatocellular changes.", "entities": [], "input_ids": [2, 1920, 12434, 3056, 1990, 3568, 6831, 2162, 6994, 1927, 7700, 21211, 2479, 16, 12457, 16, 2014, 4985, 21211, 2479, 12457, 2840, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_782a36bd53", "text": "The onset of signs/symptoms of hepatic dysfunction may occur during or several weeks after therapy has been discontinued.", "entities": [], "input_ids": [2, 1920, 4727, 1927, 6879, 19, 3601, 1927, 6095, 5273, 2278, 4704, 2409, 2014, 2980, 3625, 2256, 3181, 2258, 2252, 16087, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8680ee892d", "text": "The hepatic dysfunction, which may be severe, is usually reversible.", "entities": [], "input_ids": [2, 1920, 6095, 5273, 16, 2154, 2278, 1998, 4010, 16, 1977, 5394, 10743, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_725dfb0a43", "text": "[see Contraindications (4.2) , Warnings and Precautions (5.4) ] .", "entities": [], "input_ids": [2, 37, 3365, 27465, 12, 24, 18, 22, 13, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_aaca584eea", "text": "Renal: Interstitial nephritis, hematuria, and crystalluria have been reported", "entities": [], "input_ids": [2, 4604, 30, 11584, 25064, 16, 30267, 16, 1930, 7009, 8754, 2162, 2252, 2568, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e54ed7ec76", "text": "[see Overdosage (10) ] .", "entities": [], "input_ids": [2, 37, 3365, 17612, 5360, 2106, 12, 2119, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d2962daa28", "text": "Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported.", "entities": [{"label": "ADR", "start": 65, "end": 81, "text": "thrombocytopenia"}, {"label": "ADR", "start": 139, "end": 154, "text": "agranulocytosis"}, {"label": "ADR", "start": 123, "end": 133, "text": "leukopenia"}, {"label": "ADR", "start": 29, "end": 35, "text": "Anemia"}, {"label": "ADR", "start": 57, "end": 63, "text": "anemia"}], "input_ids": [2, 25482, 1930, 13388, 3771, 30, 10679, 16, 2710, 21515, 10679, 16, 17100, 16, 15864, 4907, 19730, 25945, 9280, 16, 26887, 16, 5104, 12903, 16, 1930, 23171, 1928, 1944, 7349, 2162, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4fe51d7ecf", "text": "These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.", "entities": [{"label": "ADR", "start": 92, "end": 108, "text": "hypersensitivity"}], "input_ids": [2, 2144, 5298, 2032, 5394, 10743, 1990, 14775, 1927, 3181, 1930, 2032, 9283, 1942, 1998, 14625, 12616, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_59b09dc1a7", "text": "Thrombocytosis was noted in less than 1% of the patients treated with amoxicillin and clavulanate potassium.", "entities": [{"label": "DRUG", "start": 70, "end": 81, "text": "amoxicillin"}], "input_ids": [2, 15864, 2475, 1982, 5040, 1922, 2941, 2254, 21, 9, 1927, 1920, 2132, 2868, 1956, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1cff846d14", "text": "There have been reports of increased prothrombin time in patients receiving amoxicillin and clavulanate potassium and anticoagulant therapy concomitantly", "entities": [{"label": "DRUG", "start": 76, "end": 87, "text": "amoxicillin"}], "input_ids": [2, 2276, 2162, 2252, 4710, 1927, 2502, 23976, 2367, 1922, 2132, 5962, 24987, 1930, 19887, 5617, 5791, 1021, 9057, 1930, 18509, 3181, 19842, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b1357c8526", "text": "[see Drug Interactions (7.2) ] .", "entities": [], "input_ids": [2, 37, 3365, 2838, 3719, 12, 27, 18, 22, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_82c60a3cb0", "text": "Central Nervous System: Agitation, anxiety, behavioral changes, aseptic meningitis, confusion, convulsions, dizziness, insomnia, and reversible hyperactivity have been reported.", "entities": [{"label": "ADR", "start": 108, "end": 117, "text": "dizziness"}, {"label": "ADR", "start": 119, "end": 127, "text": "insomnia"}], "input_ids": [2, 4101, 7580, 2433, 30, 18389, 16, 5592, 16, 5343, 2840, 16, 27369, 16780, 16, 18272, 16, 4772, 19389, 16, 24009, 16, 16882, 16, 1930, 10743, 15534, 2162, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ad369a40e3", "text": "Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been reported.", "entities": [], "input_ids": [2, 5682, 9631, 3646, 30, 10007, 2863, 18778, 1943, 12, 8084, 16, 7463, 16, 2014, 7984, 4166, 13, 2258, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a72e78fa4f", "text": "Most reports occurred in pediatric patients.", "entities": [], "input_ids": [2, 2501, 4710, 4807, 1922, 7460, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ef466293ee", "text": "Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.", "entities": [], "input_ids": [2, 2863, 18778, 1943, 1982, 3028, 2014, 11412, 1956, 19668, 1941, 2014, 7915, 17833, 1922, 2501, 2919, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7c97fa768e", "text": "ADVERSE REACTIONS Ceftriaxone is generally well tolerated.", "entities": [{"label": "DRUG", "start": 18, "end": 29, "text": "Ceftriaxone"}], "input_ids": [2, 5246, 5298, 28248, 1977, 4933, 2486, 11117, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1c95dd62be", "text": "In clinical trials, the following adverse reactions, which were considered to be related to ceftriaxone therapy or of uncertain etiology, were observed: LOCAL REACTIONS — pain, induration and tenderness was 1% overall.", "entities": [{"label": "DRUG", "start": 92, "end": 103, "text": "ceftriaxone"}], "input_ids": [2, 1922, 2535, 3848, 16, 1920, 2894, 5246, 5298, 16, 2154, 1985, 3311, 1942, 1998, 2712, 1942, 28248, 3181, 2014, 1927, 7323, 10383, 16, 1985, 2528, 30, 3076, 5298, 230, 3594, 16, 2063, 4806, 1930, 25900, 1982, 21, 9, 3399, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f0a79d3bf7", "text": "Phlebitis was reported in <1% after IV administration.", "entities": [], "input_ids": [2, 27965, 3678, 1982, 2568, 1922, 32, 21, 9, 2256, 4370, 4183, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a53b0545fb", "text": "Less frequently reported (<1%) were pruritus, fever or chills.", "entities": [{"label": "ADR", "start": 36, "end": 44, "text": "pruritus"}], "input_ids": [2, 2941, 5467, 2568, 12, 32, 21, 9, 13, 1985, 27496, 16, 9087, 2014, 7368, 11560, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b0c04dacae", "text": "HEMATOLOGIC — eosinophilia (6%), thrombocytosis (5.1%) and leukopenia (2.1%).", "entities": [{"label": "ADR", "start": 59, "end": 69, "text": "leukopenia"}], "input_ids": [2, 18251, 230, 26887, 12, 26, 9, 13, 16, 15864, 2475, 12, 25, 18, 21, 9, 13, 1930, 5104, 12903, 12, 22, 18, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bf3966d73f", "text": "Less frequently reported (<1%) were anemia, hemolytic anemia, neutropenia, lymphopenia, thrombocytopenia and prolongation of the prothrombin time.", "entities": [{"label": "ADR", "start": 88, "end": 104, "text": "thrombocytopenia"}, {"label": "ADR", "start": 62, "end": 73, "text": "neutropenia"}, {"label": "ADR", "start": 36, "end": 42, "text": "anemia"}, {"label": "ADR", "start": 54, "end": 60, "text": "anemia"}], "input_ids": [2, 2941, 5467, 2568, 12, 32, 21, 9, 13, 1985, 10679, 16, 21515, 10679, 16, 18005, 16, 3541, 12903, 16, 17100, 1930, 20334, 1927, 1920, 23976, 2367, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 3, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a5f9c1822e", "text": "Less frequently reported (<1%) were nausea or vomiting, and dysgeusia.", "entities": [{"label": "ADR", "start": 46, "end": 54, "text": "vomiting"}, {"label": "ADR", "start": 36, "end": 42, "text": "nausea"}], "input_ids": [2, 2941, 5467, 2568, 12, 32, 21, 9, 13, 1985, 13759, 2014, 13954, 16, 1930, 3890, 2106, 24327, 1019, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f714f75b30", "text": "The onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment (see WARNINGS ).", "entities": [], "input_ids": [2, 1920, 4727, 1927, 11520, 3870, 17010, 17182, 2080, 12087, 3601, 2278, 4704, 2409, 2014, 2256, 13021, 2311, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_67e2c51391", "text": "HEPATIC — elevations of SGOT (3.1%) or SGPT (3.3%).", "entities": [], "input_ids": [2, 6095, 230, 17554, 1927, 10075, 1991, 12, 23, 18, 21, 9, 13, 2014, 10075, 2410, 12, 23, 18, 23, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_af17db6acc", "text": "Less frequently reported (<1%) were elevations of alkaline phosphatase and bilirubin.", "entities": [], "input_ids": [2, 2941, 5467, 2568, 12, 32, 21, 9, 13, 1985, 17554, 1927, 10746, 8167, 1930, 15702, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_c9baaa5792", "text": "RENAL — elevations of the BUN (1.2%).", "entities": [], "input_ids": [2, 4604, 230, 17554, 1927, 1920, 20162, 12, 21, 18, 22, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cbbcfdcd92", "text": "Less frequently reported (<1%) were elevations of creatinine and the presence of casts in the urine.", "entities": [], "input_ids": [2, 2941, 5467, 2568, 12, 32, 21, 9, 13, 1985, 17554, 1927, 9374, 1930, 1920, 2990, 1927, 12273, 1036, 1922, 1920, 6960, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a7e914d88a", "text": "CENTRAL NERVOUS SYSTEM — headache or dizziness were reported occasionally (<1%).", "entities": [{"label": "ADR", "start": 37, "end": 46, "text": "dizziness"}, {"label": "ADR", "start": 25, "end": 33, "text": "headache"}], "input_ids": [2, 4101, 7580, 2433, 230, 12187, 2014, 24009, 1985, 2568, 14647, 12, 32, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3a092d6dc6", "text": "GENITOURINARY — moniliasis or vaginitis were reported occasionally (<1%).", "entities": [], "input_ids": [2, 2065, 8752, 13076, 2141, 230, 2399, 25600, 8362, 2014, 7715, 11566, 3600, 1985, 2568, 14647, 12, 32, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7c90b72719", "text": "MISCELLANEOUS — diaphoresis and flushing were reported occasionally (<1%).", "entities": [], "input_ids": [2, 5682, 9631, 3646, 230, 13471, 8300, 1930, 2848, 6150, 1941, 1985, 2568, 14647, 12, 32, 21, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7e86a29d7e", "text": "Other rarely observed adverse reactions (<0.1%) include abdominal pain, agranulocytosis, allergic pneumonitis, anaphylaxis, basophilia, biliary lithiasis, bronchospasm, colitis, dyspepsia, epistaxis, flatulence, gallbladder sludge, glycosuria, hematuria, jaundice, leukocytosis, lymphocytosis, monocytosis, nephrolithiasis, palpitations, a decrease in the prothrombin time, renal precipitations, seizures, and serum sickness.", "entities": [{"label": "ADR", "start": 72, "end": 87, "text": "agranulocytosis"}, {"label": "ADR", "start": 56, "end": 70, "text": "abdominal pain"}, {"label": "ADR", "start": 324, "end": 336, "text": "palpitations"}, {"label": "ADR", "start": 111, "end": 122, "text": "anaphylaxis"}, {"label": "ADR", "start": 255, "end": 263, "text": "jaundice"}], "input_ids": [2, 2303, 9671, 2528, 5246, 5298, 12, 32, 20, 18, 21, 9, 13, 3951, 6900, 3594, 16, 23171, 1928, 1944, 7349, 16, 10519, 24560, 3678, 16, 26726, 16, 24701, 2126, 16, 13210, 10945, 11550, 16, 7777, 26544, 16, 12087, 16, 14633, 9431, 2126, 16, 17184, 8665, 16, 9778, 25916, 16, 19358, 19435, 16, 7533, 8754, 16, 30267, 16, 25314, 16, 5104, 7349, 16, 3541, 7349, 16, 18204, 2475, 16, 7737, 2226, 29016, 16, 15771, 29063, 16, 43, 3714, 1922, 1920, 23976, 2367, 16, 4604, 10649, 1036, 16, 10060, 16, 1930, 3256, 21375, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_752c176e4e", "text": "In addition to the adverse reactions reported during clinical trials, the following adverse experiences have been reported during clinical practice in patients treated with ceftriaxone.", "entities": [{"label": "DRUG", "start": 173, "end": 184, "text": "ceftriaxone"}], "input_ids": [2, 1922, 2459, 1942, 1920, 5246, 5298, 2568, 2409, 2535, 3848, 16, 1920, 2894, 5246, 7651, 2162, 2252, 2568, 2409, 2535, 4695, 1922, 2132, 2868, 1956, 28248, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e601c7a66d", "text": "Data are generally insufficient to allow an estimate of incidence or to establish causation.", "entities": [], "input_ids": [2, 2230, 2032, 4933, 9406, 1942, 3235, 1925, 5383, 1927, 4332, 2014, 1942, 5389, 28984, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6c5768a758", "text": "A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy have been reported in neonates receiving ceftriaxone and calcium-containing fluids.", "entities": [{"label": "DRUG", "start": 164, "end": 175, "text": "ceftriaxone"}], "input_ids": [2, 43, 2858, 2529, 1927, 2919, 1927, 11990, 3685, 1922, 2154, 43, 14631, 3485, 1982, 2528, 1922, 1920, 9193, 1930, 11770, 2019, 16740, 2162, 2252, 2568, 1922, 13250, 5962, 28248, 1930, 5016, 17, 3165, 13315, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1e71cfdcbc", "text": "In some of these cases, the same intravenous infusion line was used for both ceftriaxone and calcium-containing fluids and in some a precipitate was observed in the intravenous infusion line.", "entities": [{"label": "DRUG", "start": 77, "end": 88, "text": "ceftriaxone"}], "input_ids": [2, 1922, 2673, 1927, 2144, 2919, 16, 1920, 2841, 7307, 7386, 2823, 1982, 2251, 1958, 2321, 28248, 1930, 5016, 17, 3165, 13315, 1930, 1922, 2673, 43, 18290, 1982, 2528, 1922, 1920, 7307, 7386, 2823, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ac7cddcc5d", "text": "At least one fatality has been reported in a neonate in whom ceftriaxone and calcium-containing fluids were administered at different time points via different intravenous lines; no crystalline material was observed at autopsy in this neonate.", "entities": [{"label": "DRUG", "start": 61, "end": 72, "text": "ceftriaxone"}], "input_ids": [2, 2019, 3464, 2340, 25073, 2258, 2252, 2568, 1922, 43, 27586, 1922, 8566, 28248, 1930, 5016, 17, 3165, 13315, 1985, 5254, 2019, 2413, 2367, 4273, 3454, 2413, 7307, 3557, 31, 2239, 14631, 3485, 1982, 2528, 2019, 16740, 1922, 2052, 27586, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_67d1694b82", "text": "There have been no similar reports in patients other than neonates.", "entities": [], "input_ids": [2, 2276, 2162, 2252, 2239, 2551, 4710, 1922, 2132, 2303, 2254, 13250, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_58cf98e333", "text": "IMMUNE SYSTEM DISORDER – Acute myocardial ischemia with or without myocardial infarction may occur as part of an allergic reaction.", "entities": [{"label": "DRUG", "start": 99, "end": 101, "text": "as"}], "input_ids": [2, 3743, 2433, 4770, 229, 3939, 6497, 7716, 1956, 2014, 2979, 6497, 8358, 2278, 4704, 1966, 3131, 1927, 1925, 10519, 3227, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9e71e2557b", "text": "GASTROINTESTINAL – stomatitis and glossitis.", "entities": [], "input_ids": [2, 8375, 229, 9347, 6219, 1930, 30402, 3678, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_954741f5ea", "text": "DERMATOLOGIC – exanthema, allergic dermatitis, urticaria, edema.", "entities": [{"label": "ADR", "start": 47, "end": 56, "text": "urticaria"}], "input_ids": [2, 13467, 4467, 229, 1975, 7744, 6666, 16, 10519, 18006, 16, 27986, 6148, 16, 10144, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_15d185f5b2", "text": "As with many medications, isolated cases of severe cutaneous adverse reactions (erythema multiforme, Stevens-Johnson syndrome or Lyell’s syndrome/toxic epidermal necrolysis) have been reported.", "entities": [{"label": "ADR", "start": 146, "end": 172, "text": "toxic epidermal necrolysis"}, {"label": "ADR", "start": 101, "end": 125, "text": "Stevens-Johnson syndrome"}, {"label": "DRUG", "start": 0, "end": 2, "text": "As"}], "input_ids": [2, 1966, 1956, 3086, 7719, 16, 3937, 2919, 1927, 4010, 11276, 5246, 5298, 12, 23349, 15453, 2076, 1021, 16, 26913, 2099, 17, 13890, 4741, 2014, 7518, 1992, 234, 61, 4741, 19, 6161, 9844, 10341, 27004, 13, 2162, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d1192b635c", "text": "NEUROLOGIC – Encephalopathy, seizures, myoclonus, and non-convulsive status epilepticus (see WARNINGS AND PRECAUTIONS ).", "entities": [], "input_ids": [2, 14314, 229, 19393, 16, 10060, 16, 15924, 2223, 1916, 1957, 16, 1930, 2447, 17, 4772, 13042, 3642, 16304, 1957, 12, 3365, 18149, 1036, 1930, 30363, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cb2299994e", "text": "In addition to the adverse reactions listed above which have been observed in patients treated with ceftriaxone, the following adverse reactions and altered laboratory test results have been reported for cephalosporin class antibiotics: Adverse Reactions Allergic reactions, drug fever, serum sickness-like reaction, renal dysfunction, toxic nephropathy, reversible hyperactivity, hypertonia, hepatic dysfunction including cholestasis, aplastic anemia, hemorrhage, fall in prothrombin activity, and superinfection.", "entities": [{"label": "ADR", "start": 445, "end": 451, "text": "anemia"}, {"label": "DRUG", "start": 100, "end": 111, "text": "ceftriaxone"}], "input_ids": [2, 1922, 2459, 1942, 1920, 5246, 5298, 7663, 3538, 2154, 2162, 2252, 2528, 1922, 2132, 2868, 1956, 28248, 16, 1920, 2894, 5246, 5298, 1930, 5520, 4542, 2648, 2274, 2162, 2252, 2568, 1958, 25091, 1921, 2921, 7560, 30, 5246, 5298, 10519, 5298, 16, 2838, 9087, 16, 3256, 21375, 17, 3189, 3227, 16, 4604, 5273, 16, 6161, 15582, 16, 10743, 15534, 16, 4506, 6114, 16, 6095, 5273, 2710, 30086, 16, 18373, 4054, 10679, 16, 10489, 16, 6462, 1922, 23976, 2455, 16, 1930, 3356, 18674, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ea88b789da", "text": "Altered Laboratory Tests Positive direct Coombs’ test, false-positive test for urinary glucose, and elevated LDH.", "entities": [], "input_ids": [2, 5520, 4542, 4026, 2843, 3083, 18601, 2083, 234, 2648, 16, 7198, 17, 2843, 2648, 1958, 7075, 3817, 16, 1930, 4664, 12713, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1490c39ff2", "text": "Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced (see DOSAGE AND ADMINISTRATION ).", "entities": [], "input_ids": [2, 2980, 25091, 2925, 2162, 2252, 6835, 1922, 14074, 10060, 16, 4443, 1922, 2132, 1956, 4604, 6159, 2469, 1920, 9998, 1982, 2084, 3028, 12, 3365, 9998, 1930, 4183, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_33cf88a33f", "text": "If seizures associated with drug therapy occur, the drug should be discontinued.", "entities": [], "input_ids": [2, 2647, 10060, 2458, 1956, 2838, 3181, 4704, 16, 1920, 2838, 3066, 1998, 16087, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8c38081949", "text": "Anticonvulsant therapy can be given if clinically indicated.", "entities": [], "input_ids": [2, 26572, 2031, 3181, 2112, 1998, 3258, 2647, 5908, 3391, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e161dce541", "text": "The following adverse reactions have been identified during post-approval use of chloroquine or other 4-aminoqunoline compounds.", "entities": [{"label": "DRUG", "start": 81, "end": 92, "text": "chloroquine"}], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2899, 2409, 2753, 17, 8382, 2485, 1927, 20813, 2014, 2303, 24, 17, 3835, 2048, 11873, 3701, 4300, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_fe4f63552d", "text": "Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.", "entities": [], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 7323, 3081, 16, 2176, 1977, 2084, 6789, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 2838, 3395, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2e98a11d5f", "text": "Ocular disorders: Maculopathy and macular degeneration have been reported and may be irreversible.", "entities": [], "input_ids": [2, 10046, 4414, 30, 3433, 1944, 6522, 1930, 14453, 9174, 2162, 2252, 2568, 1930, 2278, 1998, 14104, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0652634418", "text": "Irreversible retinopathy with retinal pigmentation changes (bull’s eye appearance) and visual field defects (paracentral scotomas) in patients receiving long-term or high-dosage 4-aminoquinoline therapy have been reported (see WARNINGS).", "entities": [{"label": "ADR", "start": 13, "end": 24, "text": "retinopathy"}], "input_ids": [2, 14104, 15508, 1956, 6943, 20542, 2840, 12, 14267, 234, 61, 5723, 7818, 13, 1930, 3737, 3559, 6007, 12, 13344, 16455, 17162, 4956, 13, 1922, 2132, 5962, 2815, 17, 2576, 2014, 2149, 17, 9998, 24, 17, 3835, 11072, 8419, 3181, 2162, 2252, 2568, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_eab9693ad5", "text": "Visual disturbances (blurring of vision and difficulty of focusing or accommodation); nyctalopia; scotomatous vision with field defects of paracentral, pericentral ring types, and typically temporal scotomas (e.g., difficulty in reading with words tending to disappear, seeing half an object, misty vision, and fog before the eyes) have been reported.", "entities": [], "input_ids": [2, 3737, 12654, 12, 2266, 29728, 1927, 9266, 1930, 8791, 1927, 10058, 2014, 24723, 13, 31, 8932, 2341, 20807, 10984, 1019, 31, 17162, 13844, 9266, 1956, 3559, 6007, 1927, 13344, 16455, 16, 10796, 16455, 6335, 3584, 16, 1930, 5745, 5338, 17162, 4956, 12, 47, 18, 49, 18, 16, 8791, 1922, 7461, 1956, 6906, 5370, 1941, 1942, 10392, 16, 23124, 4768, 1925, 8032, 16, 17244, 1012, 9266, 16, 1930, 22475, 3119, 1920, 7127, 13, 2162, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1e9ae9485f", "text": "Reversible corneal opacities have also been reported.", "entities": [], "input_ids": [2, 10743, 9990, 19888, 2569, 2162, 2222, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4bf1ce4318", "text": "Immune system disorders: Urticaria, anaphylactic reaction including angioedema.", "entities": [{"label": "ADR", "start": 36, "end": 57, "text": "anaphylactic reaction"}, {"label": "ADR", "start": 25, "end": 34, "text": "Urticaria"}], "input_ids": [2, 3743, 2433, 4414, 30, 27986, 6148, 16, 21219, 8933, 3227, 2710, 29220, 16670, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2bef724bb6", "text": "Ear and labyrinth disorders: Nerve type deafness; tinnitus, reduced hearing in patients with preexisting auditory damage.", "entities": [], "input_ids": [2, 4352, 1930, 2857, 13133, 1963, 4414, 30, 5507, 2601, 25371, 31, 19176, 16, 3028, 8512, 1922, 2132, 1956, 21604, 8401, 4293, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e9240ed4b1", "text": "Musculoskeletal and connective tissue-disorders: Sensorimotor disorders, skeletal muscle myopathy or neuromyopathy leading to progressive weakness and atrophy of proximal muscle groups, depression of tendon reflexes and abnormal nerve conduction.", "entities": [{"label": "ADR", "start": 89, "end": 97, "text": "myopathy"}], "input_ids": [2, 15322, 1930, 14948, 2960, 17, 4414, 30, 18395, 4414, 16, 7345, 3760, 25017, 2014, 11408, 25749, 9112, 1012, 4523, 1942, 7529, 12175, 1930, 10260, 1927, 6863, 3760, 2671, 16, 4621, 1927, 11780, 24064, 1930, 4552, 5507, 12382, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_dbb44132ac", "text": "Gastrointestinal disorders: Hepatitis, increased liver enzymes, anorexia, nausea, vomiting, diarrhea, abdominal cramps.", "entities": [{"label": "ADR", "start": 82, "end": 90, "text": "vomiting"}, {"label": "ADR", "start": 74, "end": 80, "text": "nausea"}], "input_ids": [2, 8375, 4414, 30, 7977, 16, 2502, 3568, 5038, 16, 21810, 16, 13759, 16, 13954, 16, 11904, 16, 6900, 24422, 6588, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_908af0d3bb", "text": "Skin and subcutaneous tissue disorders: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis.", "entities": [{"label": "ADR", "start": 87, "end": 113, "text": "toxic epidermal necrolysis"}, {"label": "ADR", "start": 61, "end": 85, "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 4407, 1930, 8634, 2960, 4414, 30, 23349, 15453, 2076, 1021, 16, 26913, 2099, 17, 13890, 4741, 16, 6161, 9844, 10341, 27004, 16, 28972, 2178, 18006, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bdbe6ed220", "text": "Pleomorphic skin eruptions, skin and mucosal pigmentary changes; lichen planus-like eruptions, pruritus,; drug rash with eosinophilia and systemic symptoms (DRESS syndrome); photosensitivity and hair loss and bleaching of hair pigment.", "entities": [{"label": "ADR", "start": 95, "end": 103, "text": "pruritus"}, {"label": "ADR", "start": 111, "end": 115, "text": "rash"}], "input_ids": [2, 6483, 16449, 4407, 25655, 1036, 16, 4407, 1930, 9565, 12905, 2141, 2840, 31, 28088, 4720, 1957, 17, 3189, 25655, 1036, 16, 27496, 16, 31, 2838, 18469, 1956, 26887, 1930, 5510, 3601, 12, 18100, 4741, 13, 31, 27462, 3273, 1930, 7018, 3257, 1930, 22759, 1927, 7018, 12905, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_86680a5bd4", "text": "Blood and lymphatic system disorders:", "entities": [], "input_ids": [2, 2877, 1930, 13388, 2433, 4414, 30, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_af550101c9", "text": "Pancytopenia, aplastic anemia, reversible agranulocytosis, thrombocytopenia and neutropenia.", "entities": [{"label": "ADR", "start": 59, "end": 75, "text": "thrombocytopenia"}, {"label": "ADR", "start": 42, "end": 57, "text": "agranulocytosis"}, {"label": "ADR", "start": 0, "end": 12, "text": "Pancytopenia"}, {"label": "ADR", "start": 80, "end": 91, "text": "neutropenia"}, {"label": "ADR", "start": 23, "end": 29, "text": "anemia"}], "input_ids": [2, 5001, 2355, 12903, 16, 18373, 4054, 10679, 16, 10743, 23171, 1928, 1944, 7349, 16, 17100, 1930, 18005, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 4, 4, 0, 0, 0, 3, 0, 0, 3, 4, 4, 4, 0, 3, 0, 3, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_eb54765ec7", "text": "Hemolytic anemia in G6PD deficient patients (see PRECAUTIONS).", "entities": [{"label": "ADR", "start": 10, "end": 16, "text": "anemia"}], "input_ids": [2, 21515, 10679, 1922, 25631, 5778, 2132, 12, 3365, 30363, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8caf8fd983", "text": "Nervous system disorders: Convulsions, mild and transient headache, polyneuropathy, acute extrapyramidal disorders (such as dystonia, dyskinesia, tongue protrusion, torticollis) (see WARNINGS and OVERDOSAGE).", "entities": [{"label": "ADR", "start": 58, "end": 66, "text": "headache"}, {"label": "DRUG", "start": 121, "end": 123, "text": "as"}], "input_ids": [2, 7580, 2433, 4414, 30, 4772, 19389, 16, 5809, 1930, 6809, 12187, 16, 15176, 3708, 13117, 16, 3939, 21346, 3553, 25238, 1923, 4414, 12, 2427, 1966, 23357, 16, 3890, 26682, 16, 14761, 24384, 16, 23832, 5670, 11560, 1937, 13, 12, 3365, 18149, 1036, 1930, 17612, 5360, 2106, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_46f1f081c3", "text": "Neuropsychiatric disorders: Neuropsychiatric changes including psychosis, delirium, anxiety, agitation, insomnia, confusion, hallucinations, personality changes, depression, suicidal behavior, suicidal ideation, affect/emotional lability, irritability, nervousness, nightmares/sleep terrors, depression, delusions, paranoia, and mania.", "entities": [{"label": "ADR", "start": 104, "end": 112, "text": "insomnia"}], "input_ids": [2, 19305, 4414, 30, 19305, 2840, 2710, 15489, 16, 18166, 16, 5592, 16, 18389, 16, 16882, 16, 18272, 16, 27013, 16, 10111, 2840, 16, 4621, 16, 14759, 3379, 16, 14759, 19920, 16, 4081, 19, 6687, 2857, 2275, 16, 29534, 16, 7580, 2971, 16, 9609, 19252, 1918, 19, 5006, 11420, 2133, 16, 4621, 16, 2723, 3910, 16, 26124, 26822, 1019, 16, 1930, 28864, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0f74a5a1a2", "text": "Cardiac disorders: Hypotension, electrocardiographic changes (particularly, inversion or depression of the T-wave with widening of the QRS complex), and cardiomyopathy (which may result in cardiac failure and in some cases a fatal outcome).", "entities": [{"label": "ADR", "start": 19, "end": 30, "text": "Hypotension"}], "input_ids": [2, 4435, 4414, 30, 16453, 16, 15894, 4158, 2840, 12, 4443, 16, 14825, 2014, 4621, 1927, 1920, 62, 17, 5913, 1956, 4743, 2989, 1927, 1920, 22355, 2796, 13, 16, 1930, 14141, 12, 2154, 2278, 3211, 1922, 4435, 4574, 1930, 1922, 2673, 2919, 43, 11990, 3924, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cea12582a6", "text": "Cardiac arrhythmias, conduction disorders such as bundle branch block / atrio-ventricular block, QT interval prolongation, torsade de pointes, ventricular tachycardia and ventricular fibrillation have been reported with therapeutic doses of chloroquine as well as with overdose.", "entities": [{"label": "ADR", "start": 155, "end": 166, "text": "tachycardia"}, {"label": "DRUG", "start": 241, "end": 252, "text": "chloroquine"}, {"label": "DRUG", "start": 47, "end": 49, "text": "as"}, {"label": "DRUG", "start": 253, "end": 255, "text": "as"}, {"label": "DRUG", "start": 261, "end": 263, "text": "as"}], "input_ids": [2, 4435, 16934, 16, 12382, 4414, 2427, 1966, 14142, 6089, 3367, 19, 26500, 1037, 17, 6493, 3367, 16, 8877, 4979, 20334, 16, 14823, 2873, 2028, 3575, 1918, 16, 6493, 17397, 1930, 6493, 13671, 2162, 2252, 2568, 1956, 4272, 5312, 1927, 20813, 1966, 2486, 1966, 1956, 21090, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3171373664", "text": "The risk is greater if chloroquine is administered at high doses.", "entities": [{"label": "DRUG", "start": 23, "end": 34, "text": "chloroquine"}], "input_ids": [2, 1920, 2565, 1977, 3430, 2647, 20813, 1977, 5254, 2019, 2149, 5312, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9745ca2097", "text": "Fatal cases have been reported (see WARNINGS, Cardiac Effects and OVERDOSAGE).", "entities": [], "input_ids": [2, 11990, 2919, 2162, 2252, 2568, 12, 3365, 18149, 1036, 16, 4435, 2564, 1930, 17612, 5360, 2106, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d12096b31c", "text": "Metabolic and Nutritional disorders: Hypoglycemia (see WARNINGS).", "entities": [{"label": "ADR", "start": 37, "end": 49, "text": "Hypoglycemia"}], "input_ids": [2, 4487, 1930, 9369, 4414, 30, 16093, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b436d54224", "text": "To report SUSPECTED ADVERSE REACTIONS, contact Avet Pharmaceuticals at 1-866-901-DRUG (3784), or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "entities": [], "input_ids": [2, 1942, 3809, 9407, 5246, 5298, 16, 5217, 2781, 1946, 15985, 2019, 21, 17, 5713, 1016, 17, 3865, 1009, 17, 2838, 12, 25907, 1006, 13, 16, 2014, 1920, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_379528edcc", "text": "ADVERSE REACTIONS Due to oral doxycycline’s virtually complete absorption, side effects of the lower bowel, particularly diarrhea, have been infrequent.", "entities": [{"label": "DRUG", "start": 30, "end": 41, "text": "doxycycline"}], "input_ids": [2, 5246, 5298, 2810, 1942, 4726, 16647, 234, 61, 13224, 4080, 6726, 16, 4159, 2564, 1927, 1920, 2826, 9472, 16, 4443, 11904, 16, 2162, 2252, 21587, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_337e145d4a", "text": "The following adverse reactions have been observed in patients receiving tetracyclines: Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis.", "entities": [{"label": "ADR", "start": 124, "end": 132, "text": "vomiting"}, {"label": "ADR", "start": 116, "end": 122, "text": "nausea"}], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2528, 1922, 2132, 5962, 16179, 1036, 30, 8375, 30, 21810, 16, 13759, 16, 13954, 16, 11904, 16, 30402, 3678, 16, 20690, 16, 5553, 23338, 3678, 16, 3769, 4518, 12, 1956, 2399, 25600, 1024, 27342, 13, 1922, 1920, 28976, 2432, 2915, 3031, 16, 1930, 14605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_82bd8a3e5f", "text": "Hepatotoxicity has been reported rarely.", "entities": [{"label": "ADR", "start": 0, "end": 14, "text": "Hepatotoxicity"}], "input_ids": [2, 24126, 2258, 2252, 2568, 9671, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bb36921fa2", "text": "These reactions have been caused by both the oral and parenteral administration of tetracyclines.", "entities": [], "input_ids": [2, 2144, 5298, 2162, 2252, 4189, 2007, 2321, 1920, 4726, 1930, 20301, 4183, 1927, 16179, 1036, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d98a519fb8", "text": "Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported.", "entities": [], "input_ids": [2, 12176, 2863, 18778, 1943, 1927, 1920, 4160, 11047, 17071, 1929, 16, 10743, 4073, 2838, 14775, 1930, 8578, 7915, 17833, 2258, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0db7a46a99", "text": "Permanent tooth discoloration and enamel hypoplasia may occur with drugs of the tetracycline class when used during tooth development (See WARNINGS ).", "entities": [], "input_ids": [2, 11047, 10007, 2863, 18778, 1943, 1930, 16145, 25502, 2278, 4704, 1956, 4195, 1927, 1920, 16179, 2921, 2469, 2251, 2409, 10007, 2740, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8a7c7a2d24", "text": "Rare instances of esophagitis and esophageal ulcerations have been reported in patients receiving capsule and tablet forms of the drugs in the tetracycline class.", "entities": [], "input_ids": [2, 5844, 12421, 1927, 12901, 3678, 1930, 10744, 23509, 1036, 2162, 2252, 2568, 1922, 2132, 5962, 12174, 1930, 17127, 4952, 1927, 1920, 4195, 1922, 1920, 16179, 2921, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b06f98efe8", "text": "Most of these patients took medications immediately before going to bed (See DOSAGE AND ADMINISTRATION ).", "entities": [], "input_ids": [2, 2501, 1927, 2144, 2132, 8659, 7719, 6183, 3119, 12250, 1942, 7497, 12, 3365, 9998, 1930, 4183, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e336057c53", "text": "Skin: toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, fixed drug eruption, skin hyperpigmentation, maculopapular and erythematous rashes.", "entities": [{"label": "ADR", "start": 6, "end": 32, "text": "toxic epidermal necrolysis"}, {"label": "ADR", "start": 34, "end": 58, "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 4407, 30, 6161, 9844, 10341, 27004, 16, 26913, 2099, 17, 13890, 4741, 16, 23349, 15453, 2076, 1021, 16, 4779, 2838, 25655, 16, 4407, 4194, 10984, 18266, 18326, 16, 3433, 1944, 8228, 1034, 2168, 1930, 19216, 2080, 18469, 1918, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 4, 4, 4, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0ab4a2a6c0", "text": "Exfoliative dermatitis has been reported but is uncommon.", "entities": [], "input_ids": [2, 28972, 2178, 18006, 2258, 2252, 2568, 2308, 1977, 14403, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_609aab1b24", "text": "Photosensitivity is discussed above (See WARNINGS ).", "entities": [], "input_ids": [2, 27462, 3273, 1977, 5601, 3538, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5ce33288a4", "text": "Renal toxicity: Rise in BUN has been reported and is apparently dose related (See WARNINGS ).", "entities": [], "input_ids": [2, 4604, 5532, 30, 7164, 1922, 20162, 2258, 2252, 2568, 1930, 1977, 10535, 3253, 2712, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_456e06ed7e", "text": "Immune: Hypersensitivity reactions including urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, serum sickness, pericarditis, exacerbation of systemic lupus erythematosus, drug reaction with eosinophilia and systemic symptoms (DRESS), and Jarisch-Herxheimer reaction has been reported in the setting of spirochete infections treated with doxycycline.", "entities": [{"label": "ADR", "start": 8, "end": 24, "text": "Hypersensitivity"}, {"label": "ADR", "start": 77, "end": 88, "text": "anaphylaxis"}, {"label": "ADR", "start": 45, "end": 54, "text": "urticaria"}, {"label": "DRUG", "start": 355, "end": 366, "text": "doxycycline"}], "input_ids": [2, 3743, 30, 14625, 5298, 2710, 27986, 6148, 16, 29220, 2912, 18916, 2002, 10144, 16, 26726, 16, 21219, 2131, 2642, 25945, 9280, 16, 3256, 21375, 16, 10796, 3082, 3600, 16, 17021, 1927, 5510, 13711, 22045, 16, 2838, 3227, 1956, 26887, 1930, 5510, 3601, 12, 18100, 13, 16, 1930, 21775, 21171, 17, 3656, 1039, 8986, 3227, 2258, 2252, 2568, 1922, 1920, 4308, 1927, 22075, 15404, 2057, 5024, 2868, 1956, 16647, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_54f086af83", "text": "Blood: Hemolytic anemia, thrombocytopenia, neutropenia, and eosinophilia have been reported.", "entities": [{"label": "ADR", "start": 25, "end": 41, "text": "thrombocytopenia"}, {"label": "ADR", "start": 43, "end": 54, "text": "neutropenia"}, {"label": "ADR", "start": 17, "end": 23, "text": "anemia"}], "input_ids": [2, 2877, 30, 21515, 10679, 16, 17100, 16, 18005, 16, 1930, 26887, 2162, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a4dc981d22", "text": "Psychiatric: Depression, anxiety, suicidal ideation, insomnia, abnormal dreams, hallucination.", "entities": [{"label": "ADR", "start": 53, "end": 61, "text": "insomnia"}], "input_ids": [2, 7652, 30, 4621, 16, 5592, 16, 14759, 19920, 16, 16882, 16, 4552, 24243, 1036, 16, 20958, 2636, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3a49805fe1", "text": "Other: Bulging fontanels in infants and intracranial hypertension in adults (See WARNINGS ).", "entities": [], "input_ids": [2, 2303, 30, 6512, 6066, 23160, 3285, 3222, 1922, 5969, 1930, 12179, 5579, 1922, 4440, 12, 3365, 18149, 1036, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_90cf639abb", "text": "When given over prolonged periods, tetracyclines have been reported to produce brown-black microscopic discoloration of the thyroid gland.", "entities": [], "input_ids": [2, 2469, 3258, 2338, 7171, 6696, 16, 16179, 1036, 2162, 2252, 2568, 1942, 5074, 8084, 17, 5010, 10372, 2863, 18778, 1943, 1927, 1920, 6918, 8359, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cc8ae7bf02", "text": "No abnormalities of thyroid function studies are known to occur.", "entities": [], "input_ids": [2, 2239, 6754, 1927, 6918, 2347, 2351, 2032, 3171, 1942, 4704, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_fa4ba70a8b", "text": "To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-800-962-8364, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "entities": [], "input_ids": [2, 1942, 3809, 9407, 5246, 5298, 16, 5217, 10220, 16386, 1019, 15985, 3785, 2043, 18, 2019, 21, 17, 9658, 17, 4746, 1028, 17, 5893, 8760, 16, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bff6fff0cc", "text": "The following adverse reactions are described in greater detail in other sections: Cardiomyopathy and Ventricular Arrhythmias", "entities": [], "input_ids": [2, 1920, 2894, 5246, 5298, 2032, 2910, 1922, 3430, 3966, 1922, 2303, 4828, 30, 14141, 1930, 6493, 16934, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3c97ee61ab", "text": "[see Warnings and Precautions (5.1) ]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2c04f18850", "text": "Retinal Toxicity [see Warnings and Precautions (5.2) ]", "entities": [], "input_ids": [2, 6943, 5532, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 22, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e3090e138a", "text": "Serious Skin Reactions [see Warnings and Precautions (5.3) ]", "entities": [], "input_ids": [2, 7433, 4407, 5298, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_dec730cc18", "text": "Worsening of Psoriasis [see Warnings and Precautions (5.4) ]", "entities": [], "input_ids": [2, 15473, 1927, 14109, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7b26e6a003", "text": "Risks Associated with Use in Porphyria [see Warnings and Precautions (5.5) ]", "entities": [], "input_ids": [2, 7481, 2458, 1956, 2485, 1922, 17376, 3553, 2126, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8df7153ee3", "text": "Hematologic Toxicity [see Warnings and Precautions (5.6) ]", "entities": [], "input_ids": [2, 18251, 5532, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 26, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6d9b19eef6", "text": "Hemolytic Anemia Associated with G6PD", "entities": [{"label": "ADR", "start": 10, "end": 16, "text": "Anemia"}], "input_ids": [2, 21515, 10679, 2458, 1956, 25631, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8103d10950", "text": "[see Warnings and Precautions (5.7) ]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 27, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_18287861fc", "text": "Skeletal Muscle Myopathy or Neuropathy [see Warnings and Precautions (5.8) ]", "entities": [{"label": "ADR", "start": 16, "end": 24, "text": "Myopathy"}], "input_ids": [2, 7345, 3760, 25017, 2014, 13177, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 28, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2aed79cb2c", "text": "Neuropsychiatric Reactions Including Suicidality [see Warnings and Precautions (5.9) ]", "entities": [], "input_ids": [2, 19305, 5298, 2710, 14759, 1999, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 29, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_c7b7dbb05e", "text": "Hypoglycemia [see Warnings and Precautions (5.10) ]", "entities": [{"label": "ADR", "start": 0, "end": 12, "text": "Hypoglycemia"}], "input_ids": [2, 16093, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 2119, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6c6b4c62ec", "text": "Renal Toxicity [see Warnings and Precautions (5.11) ]", "entities": [], "input_ids": [2, 4604, 5532, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 2513, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_621a1deb51", "text": "The following adverse reactions have been identified during post-approval use of 4 aminoquinoline drugs, including hydroxychloroquine sulfate.", "entities": [{"label": "DRUG", "start": 115, "end": 141, "text": "hydroxychloroquine sulfate"}], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2899, 2409, 2753, 17, 8382, 2485, 1927, 24, 3835, 11072, 8419, 4195, 16, 2710, 8275, 11600, 1037, 15520, 8767, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5b8728114e", "text": "Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure: Blood and lymphatic system disorders : Bone marrow depression, anemia, aplastic anemia, agranulocytosis, leukopenia, thrombocytopenia Cardiac disorders: Cardiomyopathy, cardiac failure, QT-interval prolongation, ventricular tachycardia, torsades de pointes, atrioventricular block, bundle branch block, sick sinus syndrome, pulmonary hypertension Ear and labyrinth disorders: Vertigo, tinnitus, nystagmus, sensorineural hearing loss Eye disorders: Retinopathy, retinal pigmentation changes (typically bull's eye appearance), visual field defects (paracentral scotomas), macular degeneration, corneal edema, corneal opacities, decreased dark adaptation Gastrointestinal disorders:", "entities": [{"label": "ADR", "start": 319, "end": 335, "text": "thrombocytopenia"}, {"label": "ADR", "start": 290, "end": 305, "text": "agranulocytosis"}, {"label": "ADR", "start": 650, "end": 661, "text": "Retinopathy"}, {"label": "ADR", "start": 426, "end": 437, "text": "tachycardia"}, {"label": "ADR", "start": 307, "end": 317, "text": "leukopenia"}, {"label": "ADR", "start": 265, "end": 271, "text": "anemia"}, {"label": "ADR", "start": 282, "end": 288, "text": "anemia"}], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 7323, 3081, 16, 2176, 1977, 2084, 6789, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 2838, 3395, 30, 2877, 1930, 13388, 2433, 4414, 30, 3622, 6599, 4621, 16, 10679, 16, 18373, 4054, 10679, 16, 23171, 1928, 1944, 7349, 16, 5104, 12903, 16, 17100, 4435, 4414, 30, 14141, 16, 4435, 4574, 16, 8877, 17, 4979, 20334, 16, 6493, 17397, 16, 14823, 6363, 2028, 3575, 1918, 16, 28355, 3367, 16, 14142, 6089, 3367, 16, 11258, 9414, 4741, 16, 5352, 5579, 4352, 1930, 2857, 13133, 1963, 4414, 30, 3566, 28870, 16, 19176, 16, 26133, 11431, 1957, 16, 6443, 2053, 2741, 8512, 3257, 5723, 4414, 30, 15508, 16, 6943, 20542, 2840, 12, 5745, 14267, 11, 61, 5723, 7818, 13, 16, 3737, 3559, 6007, 12, 13344, 16455, 17162, 4956, 13, 16, 14453, 9174, 16, 9990, 10144, 16, 9990, 19888, 2569, 16, 3261, 6190, 7810, 8375, 4414, 30, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 3, 0, 3, 4, 4, 4, 0, 3, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4c85ddb460", "text": "Nausea, vomiting, diarrhea, abdominal pain General disorders: Fatigue Hepatobiliary disorders: Abnormal liver function tests, fulminant hepatic failure Immune system disorders: Urticaria, angioedema, bronchospasm Metabolism and nutrition disorders: Anorexia, hypoglycemia, weight loss Musculoskeletal and connective tissue disorders: Proximal myopathy, depressed tendon reflexes, abnormal nerve conduction Nervous system disorders: Ataxia, dizziness, headache, seizure, extrapyramidal disorders (dystonia, dyskinesia, tremor)", "entities": [{"label": "ADR", "start": 136, "end": 151, "text": "hepatic failure"}, {"label": "ADR", "start": 28, "end": 42, "text": "abdominal pain"}, {"label": "ADR", "start": 259, "end": 271, "text": "hypoglycemia"}, {"label": "ADR", "start": 440, "end": 449, "text": "dizziness"}, {"label": "ADR", "start": 177, "end": 186, "text": "Urticaria"}, {"label": "ADR", "start": 451, "end": 459, "text": "headache"}, {"label": "ADR", "start": 343, "end": 351, "text": "myopathy"}, {"label": "ADR", "start": 8, "end": 16, "text": "vomiting"}, {"label": "ADR", "start": 62, "end": 69, "text": "Fatigue"}, {"label": "ADR", "start": 0, "end": 6, "text": "Nausea"}], "input_ids": [2, 13759, 16, 13954, 16, 11904, 16, 6900, 3594, 3335, 4414, 30, 8656, 5746, 30187, 4414, 30, 4552, 3568, 2347, 4026, 16, 5257, 8547, 2031, 6095, 4574, 3743, 2433, 4414, 30, 27986, 6148, 16, 29220, 16670, 16, 7777, 26544, 4714, 1930, 8699, 4414, 30, 21810, 16, 16093, 16, 3388, 3257, 15322, 1930, 14948, 2960, 4414, 30, 6863, 25017, 16, 11365, 11780, 24064, 16, 4552, 5507, 12382, 7580, 2433, 4414, 30, 17698, 16, 24009, 16, 12187, 16, 11015, 16, 21346, 3553, 25238, 1923, 4414, 12, 23357, 16, 3890, 26682, 16, 18388, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 3, 0, 0, 0, 3, 4, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bee7bf907e", "text": "Neuropsychiatric disorders: Affect/emotional lability, irritability, nervousness, psychosis, suicidal ideation, suicidal behavior, depression, hallucinations, anxiety, agitation, confusion, delusions, paranoia, mania and sleep disorders (insomnia, night terrors, nightmares) Skin and subcutaneous tissue disorders: Alopecia, hair color changes, rash, pruritus, photosensitivity, psoriasis exacerbation, hyperpigmentation, exfoliative dermatitis, erythema multiforme, acute generalized exanthematous pustulosis, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS syndrome), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)", "entities": [{"label": "ADR", "start": 611, "end": 637, "text": "toxic epidermal necrolysis"}, {"label": "ADR", "start": 579, "end": 603, "text": "Stevens-Johnson syndrome"}, {"label": "ADR", "start": 351, "end": 359, "text": "pruritus"}, {"label": "ADR", "start": 238, "end": 246, "text": "insomnia"}, {"label": "ADR", "start": 345, "end": 349, "text": "rash"}, {"label": "ADR", "start": 516, "end": 520, "text": "Rash"}], "input_ids": [2, 19305, 4414, 30, 4081, 19, 6687, 2857, 2275, 16, 29534, 16, 7580, 2971, 16, 15489, 16, 14759, 19920, 16, 14759, 3379, 16, 4621, 16, 27013, 16, 5592, 16, 18389, 16, 18272, 16, 2723, 3910, 16, 26124, 26822, 1019, 16, 28864, 1930, 5006, 4414, 12, 16882, 16, 9609, 11420, 2133, 16, 9609, 19252, 1918, 13, 4407, 1930, 8634, 2960, 4414, 30, 29640, 16, 7018, 4677, 2840, 16, 18469, 16, 27496, 16, 27462, 3273, 16, 14109, 17021, 16, 4194, 10984, 18266, 18326, 16, 28972, 2178, 18006, 16, 23349, 15453, 2076, 1021, 16, 3939, 9612, 1975, 7744, 30362, 24093, 1031, 8071, 16, 2838, 18469, 1956, 26887, 1930, 5510, 3601, 12, 18100, 4741, 13, 16, 26913, 2099, 17, 13890, 4741, 12, 13550, 1036, 13, 16, 6161, 9844, 10341, 27004, 12, 5656, 13, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8afae462f9", "text": "The most common adverse reactions reported are: nausea, vomiting, diarrhea, and abdominal pain.", "entities": [{"label": "ADR", "start": 80, "end": 94, "text": "abdominal pain"}, {"label": "ADR", "start": 56, "end": 64, "text": "vomiting"}, {"label": "ADR", "start": 48, "end": 54, "text": "nausea"}], "input_ids": [2, 1920, 2501, 3059, 5246, 5298, 2568, 2032, 30, 13759, 16, 13954, 16, 11904, 16, 1930, 6900, 3594, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ceca48d424", "text": "(6) To report SUSPECTED ADVERSE REACTIONS, contact Zydus Pharmaceuticals (USA) Inc. at 1-877-993-8779 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .", "entities": [], "input_ids": [2, 12, 26, 13, 1942, 3809, 9407, 5246, 5298, 16, 5217, 68, 2584, 1957, 15985, 12, 3785, 13, 2043, 18, 2019, 21, 17, 5783, 1027, 17, 4922, 1010, 17, 5783, 9364, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e2fdb5fc56", "text": "6 ADVERSE REACTIONS The following adverse reactions are discussed in other sections of the labeling: Exacerbations of hepatitis B [see Boxed Warning, Warnings and Precautions ( 5.1 )].", "entities": [], "input_ids": [2, 26, 5246, 5298, 1920, 2894, 5246, 5298, 2032, 5601, 1922, 2303, 4828, 1927, 1920, 7411, 30, 19152, 1927, 7977, 44, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8d40a0cf53", "text": "Lactic acidosis and severe hepatomegaly with steatosis [see Warnings and Precautions ( 5. 2)].", "entities": [{"label": "ADR", "start": 0, "end": 15, "text": "Lactic acidosis"}], "input_ids": [2, 16562, 19051, 1930, 4010, 5746, 19323, 1956, 16387, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 22, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4011dc728b", "text": "[see Warnings and Precautions ( 5.3 )].", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b979b1da9d", "text": "[see Warnings and Precautions ( 5.4 )].", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f26ddda6ad", "text": "The most common reported adverse reactions (incidence greater than or equal to 15%) in adults were headache, nausea, malaise and fatigue, nasal signs and symptoms, diarrhea, and cough.", "entities": [{"label": "ADR", "start": 99, "end": 107, "text": "headache"}, {"label": "ADR", "start": 129, "end": 136, "text": "fatigue"}, {"label": "ADR", "start": 109, "end": 115, "text": "nausea"}], "input_ids": [2, 1920, 2501, 3059, 2568, 5246, 5298, 12, 4332, 3430, 2254, 2014, 5557, 1942, 2461, 9, 13, 1922, 4440, 1985, 12187, 16, 13759, 16, 3054, 5504, 4127, 1930, 8656, 16, 9305, 6879, 1930, 3601, 16, 11904, 16, 1930, 13588, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_124fdf9e4d", "text": "The most common reported adverse reactions (incidence greater than or equal to 15%) in pediatric subjects were fever and cough.", "entities": [], "input_ids": [2, 1920, 2501, 3059, 2568, 5246, 5298, 12, 4332, 3430, 2254, 2014, 5557, 1942, 2461, 9, 13, 1922, 7460, 3297, 1985, 9087, 1930, 13588, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_44ece27c08", "text": "To report SUSPECTED ADVERSE REACTIONS, contact Apotex Inc. at 1-800-706-5575 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "entities": [], "input_ids": [2, 1942, 3809, 9407, 5246, 5298, 16, 5217, 11466, 4583, 2043, 18, 2019, 21, 17, 9658, 17, 3895, 1016, 17, 4288, 8245, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_825c1576fe", "text": "6.1 Clinical Trials Experience Clinical Trials Experience in Adult Subjects Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.", "entities": [], "input_ids": [2, 26, 18, 21, 2535, 3848, 4848, 2535, 3848, 4848, 1922, 4160, 3297, 2882, 2535, 3848, 2032, 3609, 2441, 5673, 7155, 2961, 16, 5246, 3227, 3389, 2528, 1922, 1920, 2535, 3848, 1927, 43, 2838, 5156, 1998, 4103, 2452, 1956, 3389, 1922, 1920, 2535, 3848, 1927, 3741, 2838, 1930, 2278, 2084, 5840, 1920, 3389, 2528, 1922, 2535, 4695, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e1435c5e86", "text": "The safety profile of lamivudine tablets in adults is primarily based on 3,568 HIV-1-infected subjects in 7 clinical trials.", "entities": [{"label": "DRUG", "start": 22, "end": 32, "text": "lamivudine"}], "input_ids": [2, 1920, 5407, 5174, 1927, 30208, 16576, 1922, 4440, 1977, 5985, 2454, 1990, 23, 16, 24195, 3525, 17, 21, 17, 4014, 3297, 1922, 27, 2535, 3848, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_264c3ef59e", "text": "The most common adverse reactions are headache, nausea, malaise, fatigue, nasal signs and symptoms, diarrhea, and cough.", "entities": [{"label": "ADR", "start": 38, "end": 46, "text": "headache"}, {"label": "ADR", "start": 65, "end": 72, "text": "fatigue"}, {"label": "ADR", "start": 48, "end": 54, "text": "nausea"}], "input_ids": [2, 1920, 2501, 3059, 5246, 5298, 2032, 12187, 16, 13759, 16, 3054, 5504, 4127, 16, 8656, 16, 9305, 6879, 1930, 3601, 16, 11904, 16, 1930, 13588, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0c442f7f0f", "text": "Selected clinical adverse reactions in greater than or equal to 5% of subjects during therapy with lamivudine 150 mg twice daily plus RETROVIR ® 200 mg 3 times daily for up to 24 weeks are listed in Table 3.", "entities": [{"label": "DRUG", "start": 99, "end": 109, "text": "lamivudine"}, {"label": "DRUG", "start": 134, "end": 142, "text": "RETROVIR"}], "input_ids": [2, 3790, 2535, 5246, 5298, 1922, 3430, 2254, 2014, 5557, 1942, 25, 9, 1927, 3297, 2409, 3181, 1956, 30208, 5493, 2786, 6470, 4692, 5390, 7332, 3026, 87, 2191, 2786, 23, 3586, 4692, 1958, 2353, 1942, 2686, 3625, 2032, 7663, 1922, 2545, 23, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9c6acb1bb0", "text": "a Either zidovudine monotherapy or zidovudine in combination with zalcitabine.", "entities": [{"label": "DRUG", "start": 9, "end": 19, "text": "zidovudine"}, {"label": "DRUG", "start": 35, "end": 45, "text": "zidovudine"}], "input_ids": [2, 43, 3108, 28666, 22389, 1020, 20597, 13767, 2014, 28666, 22389, 1020, 20597, 1922, 3921, 1956, 26112, 8293, 12696, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 2, 2, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9adc27a00e", "text": "Pancreatitis Pancreatitis was observed in 9 out of 2,613 adult subjects (0.3%) who received lamivudine tablets in controlled clinical trials EPV20001, NUCA3001, NUCB3001, NUCA3002, NUCB3002, and NUCB3007", "entities": [{"label": "DRUG", "start": 92, "end": 102, "text": "lamivudine"}], "input_ids": [2, 14605, 14605, 1982, 2528, 1922, 29, 2397, 1927, 22, 16, 5473, 1010, 4160, 3297, 12, 20, 18, 23, 9, 13, 2746, 4004, 30208, 16576, 1922, 4642, 2535, 3848, 2630, 15755, 6787, 1009, 16, 25020, 12779, 18201, 16, 25020, 13965, 18201, 16, 25020, 12779, 22536, 16, 25020, 13965, 22536, 16, 1930, 25020, 13965, 21982, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b979b1da9d", "text": "[see Warnings and Precautions ( 5.4 )].", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_86115c22df", "text": "Once Daily The types and frequencies of clinical adverse reactions reported in subjects receiving lamivudine tablets 300 mg once daily or lamivudine tablets 150 mg twice daily (in 3-drug combination regimens in EPV20001 and EPV40001) for 48 weeks were similar.", "entities": [{"label": "DRUG", "start": 98, "end": 108, "text": "lamivudine"}, {"label": "DRUG", "start": 138, "end": 148, "text": "lamivudine"}], "input_ids": [2, 5361, 4692, 1920, 3584, 1930, 6458, 1927, 2535, 5246, 5298, 2568, 1922, 3297, 5962, 30208, 16576, 5255, 2786, 5361, 4692, 2014, 30208, 16576, 5493, 2786, 6470, 4692, 12, 1922, 23, 17, 2838, 3921, 9922, 1922, 2630, 15755, 6787, 1009, 1930, 2630, 1020, 10893, 6924, 13, 1958, 3427, 3625, 1985, 2551, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9eb630a4b8", "text": "Selected laboratory abnormalities observed during therapy are summarized in Table 4.", "entities": [], "input_ids": [2, 3790, 4542, 6754, 2528, 2409, 3181, 2032, 8440, 1922, 2545, 24, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a4b4f253fd", "text": "a The median duration on study was 12 months.", "entities": [], "input_ids": [2, 43, 1920, 4181, 4392, 1990, 2161, 1982, 2369, 3221, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_86c7f104fb", "text": "b Either zidovudine monotherapy or zidovudine in combination with zalcitabine.", "entities": [{"label": "DRUG", "start": 9, "end": 19, "text": "zidovudine"}, {"label": "DRUG", "start": 35, "end": 45, "text": "zidovudine"}], "input_ids": [2, 44, 3108, 28666, 22389, 1020, 20597, 13767, 2014, 28666, 22389, 1020, 20597, 1922, 3921, 1956, 26112, 8293, 12696, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 1, 2, 2, 2, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2461fcfd52", "text": "c Current therapy was either zidovudine, zidovudine plus didanosine, or zidovudine plus zalcitabine.", "entities": [{"label": "DRUG", "start": 29, "end": 39, "text": "zidovudine"}, {"label": "DRUG", "start": 41, "end": 51, "text": "zidovudine"}, {"label": "DRUG", "start": 72, "end": 82, "text": "zidovudine"}], "input_ids": [2, 45, 3214, 3181, 1982, 3108, 28666, 22389, 1020, 20597, 16, 28666, 22389, 1020, 20597, 5390, 2811, 9286, 6777, 1021, 16, 2014, 28666, 22389, 1020, 20597, 5390, 26112, 8293, 12696, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e55e5ce910", "text": "ULN = Upper limit of normal.", "entities": [], "input_ids": [2, 3570, 1022, 33, 5199, 4411, 1927, 2791, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4f943d6925", "text": "The frequencies of selected laboratory abnormalities reported in subjects receiving lamivudine 300 mg once daily or lamivudine 150 mg twice daily (in 3-drug combination regimens in EPV20001 and EPV40001) were similar.", "entities": [{"label": "DRUG", "start": 84, "end": 94, "text": "lamivudine"}, {"label": "DRUG", "start": 116, "end": 126, "text": "lamivudine"}], "input_ids": [2, 1920, 6458, 1927, 3790, 4542, 6754, 2568, 1922, 3297, 5962, 30208, 5255, 2786, 5361, 4692, 2014, 30208, 5493, 2786, 6470, 4692, 12, 1922, 23, 17, 2838, 3921, 9922, 1922, 2630, 15755, 6787, 1009, 1930, 2630, 1020, 10893, 6924, 13, 1985, 2551, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_86cf49ab61", "text": "Clinical Trials Experience in Pediatric Subjects Lamivudine oral solution has been studied in 638 pediatric subjects aged 3 months to 18 years in 3 clinical trials.", "entities": [{"label": "DRUG", "start": 49, "end": 59, "text": "Lamivudine"}], "input_ids": [2, 2535, 3848, 4848, 1922, 7460, 3297, 30208, 4726, 3331, 2258, 2252, 3942, 1922, 4968, 1025, 7460, 3297, 5177, 23, 3221, 1942, 2654, 2739, 1922, 23, 2535, 3848, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_532aba7776", "text": "Selected clinical adverse reactions and physical findings with a greater than or equal to 5% frequency during therapy with lamivudine 4 mg per kg twice daily plus RETROVIR 160 mg per m 2 3 times daily in therapy-naive (less than or equal to 56 days of antiretroviral therapy) pediatric subjects are listed in Table 5.", "entities": [{"label": "DRUG", "start": 123, "end": 133, "text": "lamivudine"}, {"label": "DRUG", "start": 163, "end": 171, "text": "RETROVIR"}], "input_ids": [2, 3790, 2535, 5246, 5298, 1930, 3841, 3056, 1956, 43, 3430, 2254, 2014, 5557, 1942, 25, 9, 3528, 2409, 3181, 1956, 30208, 24, 2786, 2079, 3621, 6470, 4692, 5390, 7332, 3026, 9608, 2786, 2079, 55, 22, 23, 3586, 4692, 1922, 3181, 17, 7879, 12, 2941, 2254, 2014, 5557, 1942, 4489, 3000, 1927, 14255, 3181, 13, 7460, 3297, 2032, 7663, 1922, 2545, 25, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_791e7a903f", "text": "a Includes pain, discharge, erythema, or swelling of an ear.", "entities": [], "input_ids": [2, 43, 5921, 3594, 16, 7695, 16, 23349, 16, 2014, 11438, 1927, 1925, 4352, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9fb79e6b90", "text": "Pancreatitis Pancreatitis, which has been fatal in some cases, has been observed in antiretroviral nucleoside-experienced pediatric subjects receiving lamivudine alone or in combination with other antiretroviral agents.", "entities": [{"label": "DRUG", "start": 151, "end": 161, "text": "lamivudine"}], "input_ids": [2, 14605, 14605, 16, 2154, 2258, 2252, 11990, 1922, 2673, 2919, 16, 2258, 2252, 2528, 1922, 14255, 18015, 17, 6090, 7460, 3297, 5962, 30208, 4298, 2014, 1922, 3921, 1956, 2303, 14255, 4820, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f26675c608", "text": "In an open-label dose-escalation trial (NUCA2002), 14 subjects (14%) developed pancreatitis while receiving monotherapy with lamivudine.", "entities": [{"label": "DRUG", "start": 125, "end": 135, "text": "lamivudine"}], "input_ids": [2, 1922, 1925, 4437, 17, 3954, 3253, 17, 20720, 3046, 12, 25020, 8398, 22536, 13, 16, 2607, 3297, 12, 2607, 9, 13, 3530, 14605, 2679, 5962, 13767, 1956, 30208, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_22fac91593", "text": "Three of these subjects died of complications of pancreatitis.", "entities": [], "input_ids": [2, 2559, 1927, 2144, 3297, 8545, 1927, 5021, 1927, 14605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9d69478342", "text": "In a second open-label trial (NUCA2005), 12 subjects (18%) developed pancreatitis.", "entities": [], "input_ids": [2, 1922, 43, 2812, 4437, 17, 3954, 3046, 12, 25020, 8398, 24316, 13, 16, 2369, 3297, 12, 2654, 9, 13, 3530, 14605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bf09de3578", "text": "In Trial ACTG300, pancreatitis was not observed in 236 subjects randomized to lamivudine plus RETROVIR.", "entities": [{"label": "DRUG", "start": 78, "end": 88, "text": "lamivudine"}, {"label": "DRUG", "start": 94, "end": 102, "text": "RETROVIR"}], "input_ids": [2, 1922, 3046, 4033, 21712, 2283, 16, 14605, 1982, 2084, 2528, 1922, 20098, 3297, 5542, 1942, 30208, 5390, 7332, 3026, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_9bfefb5041", "text": "Pancreatitis was observed in 1 subject in this trial who received open-label lamivudine in combination with RETROVIR and ritonavir following discontinuation of didanosine monotherapy", "entities": [{"label": "DRUG", "start": 77, "end": 87, "text": "lamivudine"}, {"label": "DRUG", "start": 121, "end": 130, "text": "ritonavir"}, {"label": "DRUG", "start": 108, "end": 116, "text": "RETROVIR"}], "input_ids": [2, 14605, 1982, 2528, 1922, 21, 5198, 1922, 2052, 3046, 2746, 4004, 4437, 17, 3954, 30208, 1922, 3921, 1956, 7332, 3026, 1930, 24019, 12502, 3026, 2894, 14775, 1927, 2811, 9286, 6777, 1021, 13767, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b979b1da9d", "text": "[see Warnings and Precautions ( 5.4 )].", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_abd20bac31", "text": "Paresthesias and Peripheral Neuropathies Paresthesias and peripheral neuropathies were reported in 15 subjects (15%) in Trial NUCA2002, 6 subjects (9%) in Trial NUCA2005, and 2 subjects (less than 1%) in Trial ACTG300.", "entities": [], "input_ids": [2, 2096, 29259, 1036, 1930, 5009, 8798, 2062, 2096, 29259, 1036, 1930, 5009, 8798, 2062, 1985, 2568, 1922, 2461, 3297, 12, 2461, 9, 13, 1922, 3046, 25020, 8398, 22536, 16, 26, 3297, 12, 29, 9, 13, 1922, 3046, 25020, 8398, 24316, 16, 1930, 22, 3297, 12, 2941, 2254, 21, 9, 13, 1922, 3046, 4033, 21712, 2283, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e4ea1c90e5", "text": "Selected laboratory abnormalities experienced by therapy-naive (less than or equal to 56 days of antiretroviral therapy) pediatric subjects are listed in Table 6.", "entities": [], "input_ids": [2, 3790, 4542, 6754, 6090, 2007, 3181, 17, 7879, 12, 2941, 2254, 2014, 5557, 1942, 4489, 3000, 1927, 14255, 3181, 13, 7460, 3297, 2032, 7663, 1922, 2545, 26, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e55e5ce910", "text": "ULN = Upper limit of normal.", "entities": [], "input_ids": [2, 3570, 1022, 33, 5199, 4411, 1927, 2791, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_30e9c5f3e7", "text": "Pediatric Subjects Once-Daily versus Twice-Daily Dosing (COL105677): The safety of once-daily compared with twice-daily dosing of lamivudine was assessed in the ARROW trial.", "entities": [{"label": "DRUG", "start": 130, "end": 140, "text": "lamivudine"}], "input_ids": [2, 7460, 3297, 5361, 17, 4692, 4072, 6470, 17, 4692, 10654, 12, 2503, 14234, 29738, 13, 30, 1920, 5407, 1927, 5361, 17, 4692, 2452, 1956, 6470, 17, 4692, 10654, 1927, 30208, 1982, 3683, 1922, 1920, 5583, 3046, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4aff58cef6", "text": "Primary safety assessment in the ARROW trial was based on Grade 3 and Grade 4 adverse events.", "entities": [], "input_ids": [2, 3065, 5407, 4076, 1922, 1920, 5583, 3046, 1982, 2454, 1990, 4927, 23, 1930, 4927, 24, 5246, 3916, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2ac87da516", "text": "The frequency of Grade 3 and 4 adverse events was similar among subjects randomized to once-daily dosing compared with subjects randomized to twice-daily dosing.", "entities": [], "input_ids": [2, 1920, 3528, 1927, 4927, 23, 1930, 24, 5246, 3916, 1982, 2551, 2706, 3297, 5542, 1942, 5361, 17, 4692, 10654, 2452, 1956, 3297, 5542, 1942, 6470, 17, 4692, 10654, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ca99b3e521", "text": "One event of Grade 4 hepatitis in the once-daily cohort was considered as uncertain causality by the investigator and all other Grade 3 or 4 adverse events were considered not related by the investigator.", "entities": [{"label": "DRUG", "start": 71, "end": 73, "text": "as"}], "input_ids": [2, 2340, 4817, 1927, 4927, 24, 7977, 1922, 1920, 5361, 17, 4692, 4382, 1982, 3311, 1966, 7323, 19140, 2007, 1920, 12687, 1930, 2136, 2303, 4927, 23, 2014, 24, 5246, 3916, 1985, 3311, 2084, 2712, 2007, 1920, 12687, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e5c8b785a9", "text": "Neonates Limited short-term safety information is available from 2 small, uncontrolled trials in South Africa in neonates receiving lamivudine with or without zidovudine for the first week of life following maternal treatment starting at Week 38 or 36 of gestation [see Clinical Pharmacology ( 12.3 )] .", "entities": [{"label": "DRUG", "start": 159, "end": 169, "text": "zidovudine"}, {"label": "DRUG", "start": 132, "end": 142, "text": "lamivudine"}], "input_ids": [2, 13250, 3892, 3662, 17, 2576, 5407, 2988, 1977, 3322, 2037, 22, 2858, 16, 15734, 3848, 1922, 6061, 8460, 1922, 13250, 5962, 30208, 1956, 2014, 2979, 28666, 22389, 1020, 20597, 1958, 1920, 2561, 2982, 1927, 3308, 2894, 5509, 2311, 6801, 2019, 2982, 3738, 2014, 3480, 1927, 10879, 37, 3365, 2535, 18374, 12, 2369, 18, 23, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6ea62ca9cf", "text": "Selected adverse reactions reported in these neonates included increased liver function tests, anemia, diarrhea, electrolyte disturbances, hypoglycemia, jaundice and hepatomegaly, rash, respiratory infections, and sepsis; 3 neonates died (1 from gastroenteritis with acidosis and convulsions, 1 from traumatic injury, and 1 from unknown causes).", "entities": [{"label": "ADR", "start": 139, "end": 151, "text": "hypoglycemia"}, {"label": "ADR", "start": 153, "end": 161, "text": "jaundice"}, {"label": "ADR", "start": 95, "end": 101, "text": "anemia"}, {"label": "ADR", "start": 180, "end": 184, "text": "rash"}], "input_ids": [2, 3790, 5246, 5298, 2568, 1922, 2144, 13250, 3063, 2502, 3568, 2347, 4026, 16, 10679, 16, 11904, 16, 15428, 12654, 16, 16093, 16, 25314, 1930, 5746, 19323, 16, 18469, 16, 5481, 5024, 16, 1930, 9019, 31, 23, 13250, 8545, 12, 21, 2037, 28189, 1956, 19051, 1930, 4772, 19389, 16, 21, 2037, 10242, 4047, 16, 1930, 21, 2037, 5435, 5092, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e9f68a86d6", "text": "Two other nonfatal gastroenteritis or diarrhea cases were reported, including 1 with convulsions; 1 infant had transient renal insufficiency associated with dehydration.", "entities": [], "input_ids": [2, 2288, 2303, 19136, 4607, 28189, 2014, 11904, 2919, 1985, 2568, 16, 2710, 21, 1956, 4772, 19389, 31, 21, 8125, 2430, 6809, 4604, 14566, 2458, 1956, 16585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a189318f9b", "text": "The absence of control groups limits assessments of causality, but it should be assumed that perinatally exposed infants may be at risk for adverse reactions comparable to those reported in pediatric and adult HIV-1-infected patients treated with lamivudine-containing combination regimens.", "entities": [], "input_ids": [2, 1920, 3905, 1927, 2285, 2671, 8183, 8593, 1927, 19140, 16, 2308, 2176, 3066, 1998, 7696, 1988, 13833, 1954, 4616, 5969, 2278, 1998, 2019, 2565, 1958, 5246, 5298, 5596, 1942, 2690, 2568, 1922, 7460, 1930, 4160, 3525, 17, 21, 17, 4014, 2132, 2868, 1956, 30208, 17, 3165, 3921, 9922, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_93b308681f", "text": "Long-term effects of in utero and infant lamivudine exposure are not known.", "entities": [{"label": "DRUG", "start": 41, "end": 51, "text": "lamivudine"}], "input_ids": [2, 2815, 17, 2576, 2564, 1927, 1922, 19738, 1930, 8125, 30208, 3395, 2032, 2084, 3171, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1c7968e843", "text": "The following adverse reactions have been identified during post-approval use of lamivudine tablets.", "entities": [{"label": "DRUG", "start": 81, "end": 91, "text": "lamivudine"}], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2899, 2409, 2753, 17, 8382, 2485, 1927, 30208, 16576, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_74b37345fd", "text": "Because these reactions are reported voluntarily from a population of unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.", "entities": [], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 5435, 3081, 16, 2176, 1977, 2084, 6789, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 2838, 3395, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_69d6321c34", "text": "These reactions have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to lamivudine.", "entities": [{"label": "DRUG", "start": 148, "end": 158, "text": "lamivudine"}], "input_ids": [2, 2144, 5298, 2162, 2252, 6724, 1958, 6125, 2810, 1942, 43, 3921, 1927, 2310, 7433, 2971, 16, 3528, 1927, 6605, 16, 2014, 2889, 9263, 10393, 1942, 30208, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8799c295fb", "text": "Body as a Whole Redistribution/accumulation of body fat .", "entities": [{"label": "DRUG", "start": 5, "end": 7, "text": "as"}], "input_ids": [2, 3362, 1966, 43, 4292, 19265, 19, 4858, 1927, 3362, 3777, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_28f32d4fb5", "text": "Hemic and Lymphatic Anemia (including pure red cell aplasia and severe anemias progressing on therapy).", "entities": [{"label": "ADR", "start": 20, "end": 26, "text": "Anemia"}], "input_ids": [2, 25482, 1930, 13388, 10679, 12, 2710, 7358, 2312, 2024, 18373, 6646, 1930, 4010, 10679, 1036, 23612, 1990, 3181, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6d9074e038", "text": "Hepatic and Pancreatic Lactic acidosis and hepatic steatosis [see Warnings and Precautions ( 5.2 )] , posttreatment exacerbations of hepatitis B", "entities": [{"label": "ADR", "start": 23, "end": 38, "text": "Lactic acidosis"}], "input_ids": [2, 6095, 1930, 6356, 16562, 19051, 1930, 6095, 16387, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 22, 13, 39, 16, 26562, 19152, 1927, 7977, 44, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a0b775b37b", "text": "[see Warnings and Precautions ( 5.1 )] .", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1ea7f03f28", "text": "Musculoskeletal Muscle weakness, CPK elevation, rhabdomyolysis.", "entities": [{"label": "ADR", "start": 48, "end": 62, "text": "rhabdomyolysis"}], "input_ids": [2, 15322, 3760, 12175, 16, 4244, 1040, 8644, 16, 25369, 6892, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_69bfdf728c", "text": "6 ADVERSE REACTIONS The following adverse reactions are discussed in greater detail in other sections of the labeling.", "entities": [], "input_ids": [2, 26, 5246, 5298, 1920, 2894, 5246, 5298, 2032, 5601, 1922, 3430, 3966, 1922, 2303, 4828, 1927, 1920, 7411, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1fde5c9ec0", "text": "QT Interval Prolongation, PR Interval Prolongation", "entities": [], "input_ids": [2, 8877, 4979, 20334, 16, 2033, 4979, 20334, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6d8813ad08", "text": "[see Warnings and Precautions ( 5.5 , 5.6 )]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 16, 25, 18, 26, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_fc83e5d8e8", "text": "Drug Interactions [see Warnings and Precautions ( 5.1 )]", "entities": [], "input_ids": [2, 2838, 3719, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7992004323", "text": "Pancreatitis [see Warnings and Precautions ( 5.3 )]", "entities": [], "input_ids": [2, 14605, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6cd73659ff", "text": "Hepatotoxicity [see Warnings and Precautions ( 5.4 )]", "entities": [{"label": "ADR", "start": 0, "end": 14, "text": "Hepatotoxicity"}], "input_ids": [2, 24126, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8bcc285fd1", "text": "Commonly reported adverse reactions to KALETRA included diarrhea, nausea, vomiting, hypertriglyceridemia and hypercholesterolemia.", "entities": [{"label": "ADR", "start": 74, "end": 82, "text": "vomiting"}, {"label": "ADR", "start": 66, "end": 72, "text": "nausea"}, {"label": "DRUG", "start": 39, "end": 46, "text": "KALETRA"}], "input_ids": [2, 5384, 2568, 5246, 5298, 1942, 17338, 21193, 3063, 11904, 16, 13759, 16, 13954, 16, 30166, 12704, 1930, 22862, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_43491d0abb", "text": "To report SUSPECTED ADVERSE REACTIONS, contact AbbVie Inc. at 1-800-633-9110 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.", "entities": [], "input_ids": [2, 1942, 3809, 9407, 5246, 5298, 16, 5217, 17846, 12248, 2043, 18, 2019, 21, 17, 9658, 17, 27154, 17, 6550, 2930, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 26, 18, 21, 2535, 3848, 4848, 2882, 2535, 3848, 2032, 3609, 2441, 5673, 7155, 2961, 16, 5246, 5298, 3389, 2528, 1922, 1920, 2535, 3848, 1927, 43, 2838, 5156, 1998, 4103, 2452, 1942, 3389, 1922, 1920, 2535, 3848, 1927, 3741, 2838, 1930, 2278, 2084, 5840, 1920, 3389, 2528, 1922, 2535, 4695, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ef4b632a10", "text": "Adverse Reactions in Adults The safety of KALETRA has been investigated in about 2,600 patients in Phase II-IV clinical trials, of which about 700 have received a dose of 800/200 mg (6 capsules or 4 tablets) once daily.", "entities": [{"label": "DRUG", "start": 42, "end": 49, "text": "KALETRA"}], "input_ids": [2, 5246, 5298, 1922, 4440, 1920, 5407, 1927, 17338, 21193, 2258, 2252, 3845, 1922, 3001, 22, 16, 8333, 2132, 1922, 3193, 2890, 17, 4370, 2535, 3848, 16, 1927, 2154, 3001, 11851, 2162, 4004, 43, 3253, 1927, 9658, 19, 2191, 2786, 12, 26, 20206, 2014, 24, 16576, 13, 5361, 4692, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_60bb390876", "text": "Along with nucleoside reverse transcriptase inhibitors (NRTIs), in some studies, KALETRA was used in combination with efavirenz or nevirapine.", "entities": [{"label": "DRUG", "start": 131, "end": 141, "text": "nevirapine"}, {"label": "DRUG", "start": 118, "end": 127, "text": "efavirenz"}, {"label": "DRUG", "start": 81, "end": 88, "text": "KALETRA"}], "input_ids": [2, 4231, 1956, 18015, 5267, 13335, 4472, 12, 5214, 3600, 13, 16, 1922, 2673, 2351, 16, 17338, 21193, 1982, 2251, 1922, 3921, 1956, 8485, 11046, 4389, 2014, 27360, 11979, 12184, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1f1b074409", "text": "In clinical studies the incidence of diarrhea in patients treated with either KALETRA capsules or tablets was greater in those patients treated once daily than in those patients treated twice daily.", "entities": [{"label": "DRUG", "start": 78, "end": 85, "text": "KALETRA"}], "input_ids": [2, 1922, 2535, 2351, 1920, 4332, 1927, 11904, 1922, 2132, 2868, 1956, 3108, 17338, 21193, 20206, 2014, 16576, 1982, 3430, 1922, 2690, 2132, 2868, 5361, 4692, 2254, 1922, 2690, 2132, 2868, 6470, 4692, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_72b4190df6", "text": "Any grade of diarrhea was reported by at least half of patients taking once daily Kaletra capsules or tablets.", "entities": [{"label": "DRUG", "start": 82, "end": 89, "text": "Kaletra"}], "input_ids": [2, 2967, 4927, 1927, 11904, 1982, 2568, 2007, 2019, 3464, 4768, 1927, 2132, 6303, 5361, 4692, 17338, 21193, 20206, 2014, 16576, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8edac70b42", "text": "At the time of treatment discontinuation, 4.2-6.3% of patients taking once daily Kaletra and 1.8-3.7% of those taking twice daily Kaletra reported ongoing diarrhea.", "entities": [{"label": "DRUG", "start": 81, "end": 88, "text": "Kaletra"}, {"label": "DRUG", "start": 130, "end": 137, "text": "Kaletra"}], "input_ids": [2, 2019, 1920, 2367, 1927, 2311, 14775, 16, 24, 18, 22, 17, 26, 18, 23, 9, 1927, 2132, 6303, 5361, 4692, 17338, 21193, 1930, 21, 18, 28, 17, 23, 18, 27, 9, 1927, 2690, 6303, 6470, 4692, 17338, 21193, 2568, 8234, 11904, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8bcc285fd1", "text": "Commonly reported adverse reactions to KALETRA included diarrhea, nausea, vomiting, hypertriglyceridemia and hypercholesterolemia.", "entities": [{"label": "ADR", "start": 74, "end": 82, "text": "vomiting"}, {"label": "ADR", "start": 66, "end": 72, "text": "nausea"}, {"label": "DRUG", "start": 39, "end": 46, "text": "KALETRA"}], "input_ids": [2, 5384, 2568, 5246, 5298, 1942, 17338, 21193, 3063, 11904, 16, 13759, 16, 13954, 16, 30166, 12704, 1930, 22862, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_42c2edaeac", "text": "Diarrhea, nausea and vomiting may occur at the beginning of the treatment while hypertriglyceridemia and hypercholesterolemia may occur later.", "entities": [{"label": "ADR", "start": 21, "end": 29, "text": "vomiting"}, {"label": "ADR", "start": 10, "end": 16, "text": "nausea"}], "input_ids": [2, 11904, 16, 13759, 1930, 13954, 2278, 4704, 2019, 1920, 7828, 1927, 1920, 2311, 2679, 30166, 12704, 1930, 22862, 2278, 4704, 3690, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b28f63a77c", "text": "The following have been identified as adverse reactions of moderate or severe intensity (Table 8): Table 8.", "entities": [{"label": "DRUG", "start": 35, "end": 37, "text": "as"}], "input_ids": [2, 1920, 2894, 2162, 2252, 2899, 1966, 5246, 5298, 1927, 5086, 2014, 4010, 4266, 12, 2545, 28, 13, 30, 2545, 28, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a57e851640", "text": "Adverse Reactions of Moderate or Severe Intensity Occurring in at Least 0.1% of Adult Patients Receiving KALETRA in Combined Phase II/IV Studies (N=2,612) Laboratory Abnormalities in Adults", "entities": [{"label": "DRUG", "start": 105, "end": 112, "text": "KALETRA"}], "input_ids": [2, 5246, 5298, 1927, 5086, 2014, 4010, 4266, 6966, 1922, 2019, 3464, 20, 18, 21, 9, 1927, 4160, 2132, 5962, 17338, 21193, 1922, 4252, 3193, 2890, 19, 4370, 2351, 12, 56, 33, 22, 16, 5473, 1028, 13, 4542, 6754, 1922, 4440, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b7cbe61d5e", "text": "The percentages of adult patients treated with combination therapy with Grade 3-4 laboratory abnormalities are presented in Table 9 (treatment-naïve patients) and Table 10 (treatment-experienced patients).", "entities": [], "input_ids": [2, 1920, 9655, 1927, 4160, 2132, 2868, 1956, 3921, 3181, 1956, 4927, 23, 17, 24, 4542, 6754, 2032, 3549, 1922, 2545, 29, 12, 2311, 17, 7879, 2132, 13, 1930, 2545, 2119, 12, 2311, 17, 6090, 2132, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0aa6c9badb", "text": "Grade 3-4 Laboratory Abnormalities Reported in ≥ 2% of Adult Antiretroviral-Naïve Patients Table 10.", "entities": [], "input_ids": [2, 4927, 23, 17, 24, 4542, 6754, 2568, 1922, 374, 22, 9, 1927, 4160, 14255, 17, 7879, 2132, 2545, 2119, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d48bddd94b", "text": "Grade 3-4 Laboratory Abnormalities Reported in ≥ 2% of Adult Protease Inhibitor-Experienced Patients Adverse Reactions in Pediatric Patients KALETRA oral solution dosed up to 300/75 mg/m 2 has been studied in 100 pediatric patients 6 months to 12 years of age.", "entities": [{"label": "DRUG", "start": 141, "end": 148, "text": "KALETRA"}], "input_ids": [2, 4927, 23, 17, 24, 4542, 6754, 2568, 1922, 374, 22, 9, 1927, 4160, 7154, 4106, 17, 6090, 2132, 5246, 5298, 1922, 7460, 2132, 17338, 21193, 4726, 3331, 25922, 2353, 1942, 5255, 19, 4089, 2786, 19, 55, 22, 2258, 2252, 3942, 1922, 2813, 7460, 2132, 26, 3221, 1942, 2369, 2739, 1927, 2632, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a2265f2133", "text": "The adverse reaction profile seen during Study 940 was similar to that for adult patients.", "entities": [], "input_ids": [2, 1920, 5246, 3227, 5174, 3945, 2409, 2161, 5650, 1008, 1982, 2551, 1942, 1988, 1958, 4160, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3475e62b57", "text": "Dysgeusia (22%), vomiting (21%), and diarrhea (12%) were the most common adverse reactions of any severity reported in pediatric patients treated with combination therapy for up to 48 weeks in Study 940.", "entities": [{"label": "ADR", "start": 17, "end": 25, "text": "vomiting"}], "input_ids": [2, 3890, 2106, 24327, 1019, 12, 2950, 9, 13, 16, 13954, 12, 2900, 9, 13, 16, 1930, 11904, 12, 2369, 9, 13, 1985, 1920, 2501, 3059, 5246, 5298, 1927, 2967, 5155, 2568, 1922, 7460, 2132, 2868, 1956, 3921, 3181, 1958, 2353, 1942, 3427, 3625, 1922, 2161, 5650, 1008, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e860c83b2b", "text": "A total of 8 patients experienced adverse reactions of moderate to severe intensity.", "entities": [], "input_ids": [2, 43, 2698, 1927, 28, 2132, 6090, 5246, 5298, 1927, 5086, 1942, 4010, 4266, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a8e6c5991f", "text": "The adverse reactions meeting these criteria and reported for the 8 subjects include: hypersensitivity (characterized by fever, rash and jaundice), pyrexia, viral infection, constipation, hepatomegaly, pancreatitis, vomiting, alanine aminotransferase increased, dry skin, rash, and dysgeusia.", "entities": [{"label": "ADR", "start": 86, "end": 102, "text": "hypersensitivity"}, {"label": "ADR", "start": 216, "end": 224, "text": "vomiting"}, {"label": "ADR", "start": 137, "end": 145, "text": "jaundice"}, {"label": "ADR", "start": 148, "end": 155, "text": "pyrexia"}, {"label": "ADR", "start": 128, "end": 132, "text": "rash"}, {"label": "ADR", "start": 272, "end": 276, "text": "rash"}], "input_ids": [2, 1920, 5246, 5298, 8957, 2144, 4164, 1930, 2568, 1958, 1920, 28, 3297, 3951, 30, 14625, 12, 4378, 2007, 9087, 16, 18469, 1930, 25314, 13, 16, 26889, 18068, 1019, 16, 4324, 2909, 16, 19618, 16, 5746, 19323, 16, 14605, 16, 13954, 16, 10504, 15817, 2502, 16, 7143, 4407, 16, 18469, 16, 1930, 3890, 2106, 24327, 1019, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_78fbc8edc1", "text": "Rash was the only event of those listed that occurred in 2 or more subjects (N = 3).", "entities": [{"label": "ADR", "start": 0, "end": 4, "text": "Rash"}], "input_ids": [2, 18469, 1982, 1920, 2444, 4817, 1927, 2690, 7663, 1988, 4807, 1922, 22, 2014, 2253, 3297, 12, 56, 33, 23, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0fa0deb31f", "text": "KALETRA oral solution dosed at 300/75 mg/m 2 has been studied in 31 pediatric patients 14 days to 6 months of age.", "entities": [{"label": "DRUG", "start": 0, "end": 7, "text": "KALETRA"}], "input_ids": [2, 17338, 21193, 4726, 3331, 25922, 2019, 5255, 19, 4089, 2786, 19, 55, 22, 2258, 2252, 3942, 1922, 3470, 7460, 2132, 2607, 3000, 1942, 26, 3221, 1927, 2632, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_c65c0433f2", "text": "The adverse reaction profile in Study 1030 was similar to that observed in older children and adults.", "entities": [], "input_ids": [2, 1920, 5246, 3227, 5174, 1922, 2161, 9373, 1008, 1982, 2551, 1942, 1988, 2528, 1922, 4706, 3069, 1930, 4440, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_fe173f0893", "text": "No adverse reaction was reported in greater than 10% of subjects.", "entities": [], "input_ids": [2, 2239, 5246, 3227, 1982, 2568, 1922, 3430, 2254, 2119, 9, 1927, 3297, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_3e3c810393", "text": "Adverse drug reactions of moderate to severe intensity occurring in 2 or more subjects included decreased neutrophil count (N=3), anemia (N=2), high potassium (N=2), and low sodium (N=2).", "entities": [{"label": "ADR", "start": 130, "end": 136, "text": "anemia"}], "input_ids": [2, 5246, 2838, 5298, 1927, 5086, 1942, 4010, 4266, 6966, 1922, 22, 2014, 2253, 3297, 3063, 3261, 9460, 6500, 12, 56, 33, 23, 13, 16, 10679, 12, 56, 33, 22, 13, 16, 2149, 9057, 12, 56, 33, 22, 13, 16, 1930, 2330, 5227, 12, 56, 33, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a47ae9dd91", "text": "KALETRA oral solution and soft gelatin capsules dosed at higher than recommended doses including 400/100 mg/m 2 (without concomitant NNRTI) and 480/120 mg/m 2 (with concomitant NNRTI) have been studied in 26 pediatric patients 7 to 18 years of age in Study 1038.", "entities": [{"label": "DRUG", "start": 0, "end": 7, "text": "KALETRA"}], "input_ids": [2, 17338, 21193, 4726, 3331, 1930, 3793, 13200, 20206, 25922, 2019, 2580, 2254, 6198, 5312, 2710, 5805, 19, 2813, 2786, 19, 55, 22, 12, 2979, 8537, 27780, 1914, 13, 1930, 17628, 19, 6103, 2786, 19, 55, 22, 12, 1956, 8537, 27780, 1914, 13, 2162, 2252, 3942, 1922, 3179, 7460, 2132, 27, 1942, 2654, 2739, 1927, 2632, 1922, 2161, 26100, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a37b066fd8", "text": "Patients also had saquinavir mesylate added to their regimen at Week 4.", "entities": [], "input_ids": [2, 2132, 2222, 2430, 4611, 11072, 11046, 4438, 9075, 4057, 1942, 2310, 8607, 2019, 2982, 24, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_17dc4235f5", "text": "Rash (12%), blood cholesterol abnormal (12%) and blood triglycerides abnormal (12%) were the only adverse reactions reported in greater than 10% of subjects.", "entities": [{"label": "ADR", "start": 0, "end": 4, "text": "Rash"}], "input_ids": [2, 18469, 12, 2369, 9, 13, 16, 2877, 5463, 4552, 12, 2369, 9, 13, 1930, 2877, 13631, 4552, 12, 2369, 9, 13, 1985, 1920, 2444, 5246, 5298, 2568, 1922, 3430, 2254, 2119, 9, 1927, 3297, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2f95da7dc2", "text": "Adverse drug reactions of moderate to severe intensity occurring in 2 or more subjects included rash (N=3), blood triglycerides abnormal (N=3), and electrocardiogram QT prolonged (N=2).", "entities": [{"label": "ADR", "start": 96, "end": 100, "text": "rash"}], "input_ids": [2, 5246, 2838, 5298, 1927, 5086, 1942, 4010, 4266, 6966, 1922, 22, 2014, 2253, 3297, 3063, 18469, 12, 56, 33, 23, 13, 16, 2877, 13631, 4552, 12, 56, 33, 23, 13, 16, 1930, 22477, 8877, 7171, 12, 56, 33, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_de115f4df2", "text": "Both subjects with QT prolongation had additional predisposing conditions such as electrolyte abnormalities, concomitant medications, or pre-existing cardiac abnormalities.", "entities": [{"label": "ADR", "start": 19, "end": 34, "text": "QT prolongation"}, {"label": "DRUG", "start": 79, "end": 81, "text": "as"}], "input_ids": [2, 2321, 3297, 1956, 8877, 20334, 2430, 3281, 20908, 2961, 2427, 1966, 15428, 6754, 16, 8537, 7719, 16, 2014, 2097, 17, 6124, 4435, 6754, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6cc5382a8d", "text": "Laboratory Abnormalities in Pediatric Patients The percentages of pediatric patients treated with combination therapy including KALETRA with Grade 3-4 laboratory abnormalities are presented in Table 11.", "entities": [{"label": "DRUG", "start": 128, "end": 135, "text": "KALETRA"}], "input_ids": [2, 4542, 6754, 1922, 7460, 2132, 1920, 9655, 1927, 7460, 2132, 2868, 1956, 3921, 3181, 2710, 17338, 21193, 1956, 4927, 23, 17, 24, 4542, 6754, 2032, 3549, 1922, 2545, 2513, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1ddc0c895d", "text": "Grade 3-4 Laboratory Abnormalities Reported in ≥ 2% Pediatric Patients in Study 940 6.2 Postmarketing Experience", "entities": [], "input_ids": [2, 4927, 23, 17, 24, 4542, 6754, 2568, 1922, 374, 22, 9, 7460, 2132, 1922, 2161, 5650, 1008, 26, 18, 22, 11160, 2566, 6649, 4848, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cb26065d2a", "text": "The following adverse reactions have been reported during postmarketing use of KALETRA.", "entities": [{"label": "DRUG", "start": 79, "end": 86, "text": "KALETRA"}], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2568, 2409, 11160, 2566, 6649, 2485, 1927, 17338, 21193, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_20092cc9fd", "text": "Because these reactions are reported voluntarily from a population of unknown size, it is not possible to reliably estimate their frequency or establish a causal relationship to KALETRA exposure.", "entities": [{"label": "DRUG", "start": 178, "end": 185, "text": "KALETRA"}], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 5435, 3081, 16, 2176, 1977, 2084, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 17338, 21193, 3395, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7ef8e04c68", "text": "Body as a Whole Redistribution/accumulation of body fat has been reported", "entities": [{"label": "DRUG", "start": 5, "end": 7, "text": "as"}], "input_ids": [2, 3362, 1966, 43, 4292, 19265, 19, 4858, 1927, 3362, 3777, 2258, 2252, 2568, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_53b4df0a71", "text": "[see Warnings and Precautions ( 5.10 )] .", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 2119, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5d9b9f7786", "text": "First-degree AV block, second-degree AV block, third-degree AV block, QTc interval prolongation, torsades (torsade) de pointes [see Warnings and Precautions ( 5.5 , 5.6 )] .", "entities": [], "input_ids": [2, 2561, 17, 4647, 2781, 3367, 16, 2812, 17, 4647, 2781, 3367, 16, 4563, 17, 4647, 2781, 3367, 16, 23946, 4979, 20334, 16, 14823, 6363, 12, 14823, 2873, 13, 2028, 3575, 1918, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 16, 25, 18, 26, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0ff8b70b60", "text": "Renal and Urinary Disorders Nephrolithiasis Skin and Appendages Toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome and erythema multiforme.", "entities": [{"label": "ADR", "start": 64, "end": 90, "text": "Toxic epidermal necrolysis"}, {"label": "ADR", "start": 98, "end": 122, "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 4604, 1930, 7075, 4414, 7737, 2226, 29016, 4407, 1930, 7958, 2662, 6161, 9844, 10341, 27004, 12, 5656, 13, 16, 26913, 2099, 17, 13890, 4741, 1930, 23349, 15453, 2076, 1021, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_69bfdf728c", "text": "6 ADVERSE REACTIONS The following adverse reactions are discussed in greater detail in other sections of the labeling.", "entities": [], "input_ids": [2, 26, 5246, 5298, 1920, 2894, 5246, 5298, 2032, 5601, 1922, 3430, 3966, 1922, 2303, 4828, 1927, 1920, 7411, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d60470507d", "text": "Drug Interactions [see Warnings and Precautions (5.1) ]", "entities": [], "input_ids": [2, 2838, 3719, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f4e33fd3f5", "text": "Hepatotoxicity [see Warnings and Precautions (5.3) ]", "entities": [{"label": "ADR", "start": 0, "end": 14, "text": "Hepatotoxicity"}], "input_ids": [2, 24126, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_c47cd23c55", "text": "Pancreatitis [see Warnings and Precautions (5.4) ] Allergic Reactions/Hypersensitivity", "entities": [{"label": "ADR", "start": 70, "end": 86, "text": "Hypersensitivity"}], "input_ids": [2, 14605, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 10519, 5298, 19, 14625, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, -100], "source_type": "dailymed_insert"}
{"id": "silver_a0b1058465", "text": "[see Warnings and Precautions (5.5) ]", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f67b9a9d18", "text": "When co-administering ritonavir with other protease inhibitors, see the full prescribing information for that protease inhibitor including adverse reactions.", "entities": [{"label": "DRUG", "start": 22, "end": 31, "text": "ritonavir"}], "input_ids": [2, 2469, 2081, 17, 20921, 24019, 12502, 3026, 1956, 2303, 7154, 4472, 16, 3365, 1920, 4125, 15103, 2988, 1958, 1988, 7154, 4106, 2710, 5246, 5298, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8e190ce171", "text": "The most frequently reported adverse drug reactions among patients receiving ritonavir alone or in combination with other antiretroviral drugs were gastrointestinal (including diarrhea, nausea, vomiting, abdominal pain (upper and lower), neurological disturbances (including paresthesia and oral paresthesia), rash, and fatigue/asthenia (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "entities": [{"label": "ADR", "start": 204, "end": 218, "text": "abdominal pain"}, {"label": "ADR", "start": 194, "end": 202, "text": "vomiting"}, {"label": "ADR", "start": 320, "end": 327, "text": "fatigue"}, {"label": "ADR", "start": 186, "end": 192, "text": "nausea"}, {"label": "ADR", "start": 310, "end": 314, "text": "rash"}, {"label": "DRUG", "start": 77, "end": 86, "text": "ritonavir"}], "input_ids": [2, 1920, 2501, 5467, 2568, 5246, 2838, 5298, 2706, 2132, 5962, 24019, 12502, 3026, 4298, 2014, 1922, 3921, 1956, 2303, 14255, 4195, 1985, 8375, 12, 2710, 11904, 16, 13759, 16, 13954, 16, 6900, 3594, 12, 5199, 1930, 2826, 13, 16, 7605, 12654, 12, 2710, 2096, 29259, 1930, 4726, 2096, 29259, 13, 16, 18469, 16, 1930, 8656, 19, 6187, 8572, 12, 26, 18, 21, 13, 1942, 3809, 9407, 5246, 5298, 16, 5217, 11826, 17428, 10249, 1037, 24552, 3785, 16, 2043, 18, 2019, 21, 17, 5713, 1016, 17, 23196, 17, 22891, 1016, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f9de2250c7", "text": "6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.", "entities": [], "input_ids": [2, 26, 18, 21, 2535, 3046, 4848, 2882, 2535, 3848, 2032, 3609, 2441, 5673, 7155, 2961, 16, 5246, 5298, 3389, 2528, 1922, 1920, 2535, 3848, 1927, 43, 2838, 5156, 1998, 4103, 2452, 1942, 3389, 1922, 1920, 2535, 3848, 1927, 3741, 2838, 1930, 2278, 2084, 5840, 1920, 3389, 2528, 1922, 4695, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ec9ca51a33", "text": "Adverse Reactions in Adults The safety of ritonavir alone and in combination with other antiretroviral agents was studied in 1,755 adult patients.", "entities": [{"label": "DRUG", "start": 42, "end": 51, "text": "ritonavir"}], "input_ids": [2, 5246, 5298, 1922, 4440, 1920, 5407, 1927, 24019, 12502, 3026, 4298, 1930, 1922, 3921, 1956, 2303, 14255, 4820, 1982, 3942, 1922, 21, 16, 4089, 1015, 4160, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_cd57504a4c", "text": "Table 2 lists treatment-emergent Adverse Reactions (with possible or probable relationship to study drug) occurring in greater than or equal to 1% of adult patients receiving ritonavir in combined Phase II/IV studies.", "entities": [{"label": "DRUG", "start": 175, "end": 184, "text": "ritonavir"}], "input_ids": [2, 2545, 22, 11823, 2311, 17, 18252, 5246, 5298, 12, 1956, 3216, 2014, 12584, 3303, 1942, 2161, 2838, 13, 6966, 1922, 3430, 2254, 2014, 5557, 1942, 21, 9, 1927, 4160, 2132, 5962, 24019, 12502, 3026, 1922, 4252, 3193, 2890, 19, 4370, 2351, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b8bfeb935d", "text": "The most frequently reported adverse drug reactions among patients receiving ritonavir alone or in combination with other antiretroviral drugs were gastrointestinal (including diarrhea, nausea, vomiting, abdominal pain (upper and lower)), neurological disturbances (including paresthesia and oral paresthesia), rash, and fatigue/asthenia.", "entities": [{"label": "ADR", "start": 204, "end": 218, "text": "abdominal pain"}, {"label": "ADR", "start": 194, "end": 202, "text": "vomiting"}, {"label": "ADR", "start": 321, "end": 328, "text": "fatigue"}, {"label": "ADR", "start": 186, "end": 192, "text": "nausea"}, {"label": "ADR", "start": 311, "end": 315, "text": "rash"}, {"label": "DRUG", "start": 77, "end": 86, "text": "ritonavir"}], "input_ids": [2, 1920, 2501, 5467, 2568, 5246, 2838, 5298, 2706, 2132, 5962, 24019, 12502, 3026, 4298, 2014, 1922, 3921, 1956, 2303, 14255, 4195, 1985, 8375, 12, 2710, 11904, 16, 13759, 16, 13954, 16, 6900, 3594, 12, 5199, 1930, 2826, 13, 13, 16, 7605, 12654, 12, 2710, 2096, 29259, 1930, 4726, 2096, 29259, 13, 16, 18469, 16, 1930, 8656, 19, 6187, 8572, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_884d32d731", "text": "Laboratory Abnormalities in Adults Table 3 shows the percentage of adult patients who developed marked laboratory abnormalities.", "entities": [], "input_ids": [2, 4542, 6754, 1922, 4440, 2545, 23, 3661, 1920, 4466, 1927, 4160, 2132, 2746, 3530, 4961, 4542, 6754, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2a0e9711e2", "text": "Adverse Reactions in Pediatric Patients Ritonavir has been studied in 265 pediatric patients greater than 1 month to 21 years of age.", "entities": [{"label": "DRUG", "start": 40, "end": 49, "text": "Ritonavir"}], "input_ids": [2, 5246, 5298, 1922, 7460, 2132, 24019, 12502, 3026, 2258, 2252, 3942, 1922, 21473, 7460, 2132, 3430, 2254, 21, 2935, 1942, 2900, 2739, 1927, 2632, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_e373032a1c", "text": "The adverse event profile observed during pediatric clinical trials was similar to that for adult patients.", "entities": [], "input_ids": [2, 1920, 5246, 4817, 5174, 2528, 2409, 7460, 2535, 3848, 1982, 2551, 1942, 1988, 1958, 4160, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_809c3c76f9", "text": "Vomiting, diarrhea, and skin rash/allergy were the only drug-related clinical adverse events of moderate to severe intensity observed in greater than or equal to 2% of pediatric patients enrolled in ritonavir clinical trials.", "entities": [{"label": "ADR", "start": 0, "end": 8, "text": "Vomiting"}, {"label": "ADR", "start": 29, "end": 33, "text": "rash"}, {"label": "DRUG", "start": 199, "end": 208, "text": "ritonavir"}], "input_ids": [2, 13954, 16, 11904, 16, 1930, 4407, 18469, 19, 13255, 1985, 1920, 2444, 2838, 17, 2712, 2535, 5246, 3916, 1927, 5086, 1942, 4010, 4266, 2528, 1922, 3430, 2254, 2014, 5557, 1942, 22, 9, 1927, 7460, 2132, 7316, 1922, 24019, 12502, 3026, 2535, 3848, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_8e503aeaab", "text": "Laboratory Abnormalities in Pediatric Patients The following Grade 3 to 4 laboratory abnormalities occurred in greater than 3% of pediatric patients who received treatment with ritonavir either alone or in combination with reverse transcriptase inhibitors: neutropenia (9%), hyperamylasemia (7%), thrombocytopenia (5%), anemia (4%), and elevated AST (3%).", "entities": [{"label": "ADR", "start": 297, "end": 313, "text": "thrombocytopenia"}, {"label": "ADR", "start": 257, "end": 268, "text": "neutropenia"}, {"label": "ADR", "start": 320, "end": 326, "text": "anemia"}, {"label": "DRUG", "start": 177, "end": 186, "text": "ritonavir"}], "input_ids": [2, 4542, 6754, 1922, 7460, 2132, 1920, 2894, 4927, 23, 1942, 24, 4542, 6754, 4807, 1922, 3430, 2254, 23, 9, 1927, 7460, 2132, 2746, 4004, 2311, 1956, 24019, 12502, 3026, 3108, 4298, 2014, 1922, 3921, 1956, 5267, 13335, 4472, 30, 18005, 12, 29, 9, 13, 16, 4194, 27302, 2051, 6026, 12, 27, 9, 13, 16, 17100, 12, 25, 9, 13, 16, 10679, 12, 24, 9, 13, 16, 1930, 4664, 5988, 12, 23, 9, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bfc3aee39e", "text": "The following adverse events (not previously mentioned in the labeling) have been reported during post-marketing use of ritonavir.", "entities": [{"label": "DRUG", "start": 120, "end": 129, "text": "ritonavir"}], "input_ids": [2, 1920, 2894, 5246, 3916, 12, 2084, 3024, 6996, 1922, 1920, 7411, 13, 2162, 2252, 2568, 2409, 2753, 17, 19584, 2485, 1927, 24019, 12502, 3026, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_50d3a56bf3", "text": "Because these reactions are reported voluntarily from a population of unknown size, it is not possible to reliably estimate their frequency or establish a causal relationship to ritonavir exposure.", "entities": [{"label": "DRUG", "start": 178, "end": 187, "text": "ritonavir"}], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 5435, 3081, 16, 2176, 1977, 2084, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 24019, 12502, 3026, 3395, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_bcb9b20736", "text": "Body as a Whole Dehydration, usually associated with gastrointestinal symptoms, and sometimes resulting in hypotension, syncope, or renal insufficiency has been reported.", "entities": [{"label": "ADR", "start": 107, "end": 118, "text": "hypotension"}, {"label": "DRUG", "start": 5, "end": 7, "text": "as"}], "input_ids": [2, 3362, 1966, 43, 4292, 16585, 16, 5394, 2458, 1956, 8375, 3601, 16, 1930, 8929, 3864, 1922, 16453, 16, 26742, 16, 2014, 4604, 14566, 2258, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_b97953ab11", "text": "Syncope, orthostatic hypotension, and renal insufficiency have also been reported without known dehydration.", "entities": [{"label": "ADR", "start": 21, "end": 32, "text": "hypotension"}], "input_ids": [2, 26742, 16, 24343, 11494, 16453, 16, 1930, 4604, 14566, 2162, 2222, 2252, 2568, 2979, 3171, 16585, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_65f1c7c07c", "text": "Co-administration of ritonavir with ergotamine or dihydroergotamine has been associated with acute ergot toxicity characterized by vasospasm and ischemia of the extremities and other tissues including the central nervous system.", "entities": [{"label": "DRUG", "start": 21, "end": 30, "text": "ritonavir"}], "input_ids": [2, 2081, 17, 4183, 1927, 24019, 12502, 3026, 1956, 11949, 7336, 25157, 2014, 11842, 2693, 7336, 25157, 2258, 2252, 2458, 1956, 3939, 11949, 1991, 5532, 4378, 2007, 22866, 3508, 2691, 1930, 7716, 1927, 1920, 18884, 1930, 2303, 3878, 2710, 1920, 4101, 7580, 2433, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_d2c89e805a", "text": "Cardiovascular System First-degree AV block, second-degree AV block, third-degree AV block, right bundle branch block have been reported", "entities": [], "input_ids": [2, 5321, 2433, 2561, 17, 4647, 2781, 3367, 16, 2812, 17, 4647, 2781, 3367, 16, 4563, 17, 4647, 2781, 3367, 16, 3659, 14142, 6089, 3367, 2162, 2252, 2568, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7dcc9eeeb7", "text": "[see Warnings and Precautions (5.6) ] .", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 26, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7450de0c78", "text": "Cardiac and neurologic events have been reported when ritonavir has been co-administered with disopyramide, mexiletine, nefazodone, fluoxetine, and beta blockers.", "entities": [{"label": "DRUG", "start": 54, "end": 63, "text": "ritonavir"}], "input_ids": [2, 4435, 1930, 14314, 3916, 2162, 2252, 2568, 2469, 24019, 12502, 3026, 2258, 2252, 2081, 17, 5254, 1956, 2054, 13518, 5482, 16, 10114, 2383, 4425, 16, 18301, 19370, 28615, 1021, 16, 22176, 16, 1930, 4666, 13628, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4ef03a6a14", "text": "The possibility of drug interaction cannot be excluded.", "entities": [], "input_ids": [2, 1920, 5341, 1927, 2838, 2835, 5156, 1998, 5450, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_72f0b17794", "text": "Endocrine System Cushing’s syndrome and adrenal suppression have been reported when ritonavir has been co­-administered with fluticasone propionate or budesonide.", "entities": [{"label": "DRUG", "start": 84, "end": 93, "text": "ritonavir"}], "input_ids": [2, 10749, 2433, 27773, 1941, 234, 61, 4741, 1930, 10651, 6412, 2162, 2252, 2568, 2469, 24019, 12502, 3026, 2258, 2252, 2081, 17, 5254, 1956, 2848, 21788, 5810, 1021, 24682, 2014, 8344, 1918, 27966, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_922042f621", "text": "Nervous System There have been postmarketing reports of seizure.", "entities": [], "input_ids": [2, 7580, 2433, 2276, 2162, 2252, 11160, 2566, 6649, 4710, 1927, 11015, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_296894a27a", "text": "Renal and Urinary Disorders Nephrolithiasis Skin and subcutaneous tissue disorders Toxic epidermal necrolysis (TEN) has been reported.", "entities": [{"label": "ADR", "start": 83, "end": 109, "text": "Toxic epidermal necrolysis"}], "input_ids": [2, 4604, 1930, 7075, 4414, 7737, 2226, 29016, 4407, 1930, 8634, 2960, 4414, 6161, 9844, 10341, 27004, 12, 5656, 13, 2258, 2252, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5cd8cbba02", "text": "6 ADVERSE REACTIONS The following adverse reactions are discussed in other sections of the labeling: • Hematologic toxicity, including neutropenia and anemia", "entities": [{"label": "ADR", "start": 135, "end": 146, "text": "neutropenia"}, {"label": "ADR", "start": 151, "end": 157, "text": "anemia"}], "input_ids": [2, 26, 5246, 5298, 1920, 2894, 5246, 5298, 2032, 5601, 1922, 2303, 4828, 1927, 1920, 7411, 30, 241, 18251, 5532, 16, 2710, 18005, 1930, 10679, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, -100], "source_type": "dailymed_insert"}
{"id": "silver_5134a94aad", "text": "[see Boxed Warning, Warnings and Precautions ( 5.1 )].", "entities": [], "input_ids": [2, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 21, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6c9079f5de", "text": "• Symptomatic myopathy [see Boxed Warning, Warnings and Precautions ( 5.2 )].", "entities": [{"label": "ADR", "start": 14, "end": 22, "text": "myopathy"}], "input_ids": [2, 241, 9371, 25017, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 22, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0411db1b63", "text": "• Lactic acidosis and severe hepatomegaly with steatosis [see Boxed Warning, Warnings and Precautions ( 5.3 )].", "entities": [{"label": "ADR", "start": 2, "end": 17, "text": "Lactic acidosis"}], "input_ids": [2, 241, 16562, 19051, 1930, 4010, 5746, 19323, 1956, 16387, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_2b11beacd7", "text": "• Exacerbations of hepatitis B [see Boxed Warning, Warnings and Precautions ( 5.4 )].", "entities": [], "input_ids": [2, 241, 19152, 1927, 7977, 44, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 24, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5c763ef498", "text": "• Hepatic decompensation in patients co-infected with HIV-1 and hepatitis C [see Warnings and Precautions ( 5.5 )].", "entities": [], "input_ids": [2, 241, 6095, 24691, 1943, 1922, 2132, 2081, 17, 4014, 1956, 3525, 17, 21, 1930, 7977, 45, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_07354283cb", "text": "• Exacerbation of anemia in HIV-1/HCV co-infected patients receiving ribavirin and zidovudine [see Warnings and Precautions ( 5.5 )].", "entities": [{"label": "ADR", "start": 18, "end": 24, "text": "anemia"}, {"label": "DRUG", "start": 83, "end": 93, "text": "zidovudine"}], "input_ids": [2, 241, 17021, 1927, 10679, 1922, 3525, 17, 21, 19, 6749, 2081, 17, 4014, 2132, 5962, 23635, 1930, 28666, 22389, 1020, 20597, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 25, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_4735d46dba", "text": "Pancreatitis [see Warnings and Precautions ( 5.6 )].", "entities": [], "input_ids": [2, 14605, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 26, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7c8d4859a2", "text": "• Immune reconstitution syndrome [see Warnings and Precautions ( 5.7 )].", "entities": [], "input_ids": [2, 241, 3743, 17513, 4741, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 27, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_c1dcdfb128", "text": "[see Warnings and Precautions ( 5.8 )].", "entities": [], "input_ids": [2, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 28, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ee216ec523", "text": "• Most commonly reported adverse reactions (incidence greater than or equal to 15%) in clinical trials of combination lamivudine and zidovudine were headache, nausea, malaise and fatigue, nasal signs and symptoms, diarrhea, and cough.", "entities": [{"label": "ADR", "start": 149, "end": 157, "text": "headache"}, {"label": "ADR", "start": 179, "end": 186, "text": "fatigue"}, {"label": "ADR", "start": 159, "end": 165, "text": "nausea"}, {"label": "DRUG", "start": 133, "end": 143, "text": "zidovudine"}, {"label": "DRUG", "start": 118, "end": 128, "text": "lamivudine"}], "input_ids": [2, 241, 2501, 5384, 2568, 5246, 5298, 12, 4332, 3430, 2254, 2014, 5557, 1942, 2461, 9, 13, 1922, 2535, 3848, 1927, 3921, 30208, 1930, 28666, 22389, 1020, 20597, 1985, 12187, 16, 13759, 16, 3054, 5504, 4127, 1930, 8656, 16, 9305, 6879, 1930, 3601, 16, 11904, 16, 1930, 13588, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 2, 0, 3, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_59204bf068", "text": "To report SUSPECTED ADVERSE REACTIONS, contact Hetero Labs Limited at 1-866-495-1995 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .", "entities": [], "input_ids": [2, 1942, 3809, 9407, 5246, 5298, 16, 5217, 19732, 17919, 3892, 2019, 21, 17, 5713, 1016, 17, 27141, 17, 6719, 2014, 11394, 2019, 21, 17, 9658, 17, 11394, 17, 9123, 1025, 2014, 6425, 18, 11394, 18, 10127, 19, 2242, 13956, 8888, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_a4a45b5af7", "text": "6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.", "entities": [], "input_ids": [2, 26, 18, 21, 2535, 3848, 4848, 2882, 2535, 3848, 2032, 3609, 2441, 5673, 7155, 2961, 16, 5246, 3227, 3389, 2528, 1922, 1920, 2535, 3848, 1927, 43, 2838, 5156, 1998, 4103, 2452, 1956, 3389, 1922, 1920, 2535, 3848, 1927, 3741, 2838, 1930, 2278, 2084, 5840, 1920, 3389, 2528, 1922, 2535, 4695, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_792c2e1b4e", "text": "Lamivudine plus Zidovudine Administered as Separate Formulations In 4 randomized, controlled trials of EPIVIR 300 mg per day plus RETROVIR 600 mg per day, the following selected adverse reactions and laboratory abnormalities were observed (Tables 1 and 2).", "entities": [{"label": "DRUG", "start": 16, "end": 26, "text": "Zidovudine"}, {"label": "DRUG", "start": 0, "end": 10, "text": "Lamivudine"}, {"label": "DRUG", "start": 130, "end": 138, "text": "RETROVIR"}, {"label": "DRUG", "start": 103, "end": 109, "text": "EPIVIR"}, {"label": "DRUG", "start": 40, "end": 42, "text": "as"}], "input_ids": [2, 30208, 5390, 28666, 22389, 1020, 20597, 5254, 1966, 5850, 11950, 1922, 24, 5542, 16, 4642, 3848, 1927, 13872, 3026, 5255, 2786, 2079, 3007, 5390, 7332, 3026, 8333, 2786, 2079, 3007, 16, 1920, 2894, 3790, 5246, 5298, 1930, 4542, 6754, 1985, 2528, 12, 8208, 21, 1930, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 0, 1, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_46fb027474", "text": "Selected Clinical Adverse Reactions (Greater than or Equal to 5% Frequency) in 4 Controlled Clinical Trials with EPIVIR 300 mg per day and RETROVIR 600 mg per day Pancreatitis was observed in 9 of the 2,613 adult subjects (0.3%) who received EPIVIR in controlled clinical trials [see Warnings and Precautions ( 5.6 )].", "entities": [{"label": "DRUG", "start": 139, "end": 147, "text": "RETROVIR"}, {"label": "DRUG", "start": 113, "end": 119, "text": "EPIVIR"}, {"label": "DRUG", "start": 242, "end": 248, "text": "EPIVIR"}], "input_ids": [2, 3790, 2535, 5246, 5298, 12, 3430, 2254, 2014, 5557, 1942, 25, 9, 3528, 13, 1922, 24, 4642, 2535, 3848, 1956, 13872, 3026, 5255, 2786, 2079, 3007, 1930, 7332, 3026, 8333, 2786, 2079, 3007, 14605, 1982, 2528, 1922, 29, 1927, 1920, 22, 16, 5473, 1010, 4160, 3297, 12, 20, 18, 23, 9, 13, 2746, 4004, 13872, 3026, 1922, 4642, 2535, 3848, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 26, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_304ac5a97a", "text": "Selected laboratory abnormalities observed during therapy are listed in Table 2.", "entities": [], "input_ids": [2, 3790, 4542, 6754, 2528, 2409, 3181, 2032, 7663, 1922, 2545, 22, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_aadbde3594", "text": "Frequencies of Selected Laboratory Abnormalities among Adults in 4 Controlled Clinical Trials of EPIVIR 300 mg per day plus RETROVIR 600 mg per day a ULN = Upper limit of normal.", "entities": [{"label": "DRUG", "start": 124, "end": 132, "text": "RETROVIR"}, {"label": "DRUG", "start": 97, "end": 103, "text": "EPIVIR"}], "input_ids": [2, 6458, 1927, 3790, 4542, 6754, 2706, 4440, 1922, 24, 4642, 2535, 3848, 1927, 13872, 3026, 5255, 2786, 2079, 3007, 5390, 7332, 3026, 8333, 2786, 2079, 3007, 43, 3570, 1022, 33, 5199, 4411, 1927, 2791, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_439157bd4f", "text": "ANC = Absolute neutrophil count.", "entities": [], "input_ids": [2, 10315, 33, 6961, 9460, 6500, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_5897bf7f1f", "text": "= Number of subjects assessed.", "entities": [], "input_ids": [2, 33, 2529, 1927, 3297, 3683, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_284b8a3f4f", "text": "a Frequencies of these laboratory abnormalities were higher in subjects with mild laboratory abnormalities at baseline.", "entities": [], "input_ids": [2, 43, 6458, 1927, 2144, 4542, 6754, 1985, 2580, 1922, 3297, 1956, 5809, 4542, 6754, 2019, 3703, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_ddcfd04c20", "text": "The following adverse reactions have been identified during postmarketing use.", "entities": [], "input_ids": [2, 1920, 2894, 5246, 5298, 2162, 2252, 2899, 2409, 11160, 2566, 6649, 2485, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_74b37345fd", "text": "Because these reactions are reported voluntarily from a population of unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.", "entities": [], "input_ids": [2, 2882, 2144, 5298, 2032, 2568, 12200, 4697, 2037, 43, 2973, 1927, 5435, 3081, 16, 2176, 1977, 2084, 6789, 3216, 1942, 13445, 5383, 2310, 3528, 2014, 5389, 43, 9263, 3303, 1942, 2838, 3395, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_202252bde7", "text": "Body as a Whole Redistribution/accumulation of body fat [see Warnings and Precautions ( 5.8 )].", "entities": [{"label": "DRUG", "start": 5, "end": 7, "text": "as"}], "input_ids": [2, 3362, 1966, 43, 4292, 19265, 19, 4858, 1927, 3362, 3777, 37, 3365, 18149, 1036, 1930, 30363, 12, 25, 18, 28, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_7c43255a4c", "text": "Endocrine and Metabolic Gynecomastia, hyperglycemia.", "entities": [], "input_ids": [2, 10749, 1930, 4487, 14662, 4956, 11574, 16, 14022, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_fb45c660f2", "text": "Gastrointestinal Oral mucosal pigmentation, stomatitis.", "entities": [], "input_ids": [2, 8375, 4726, 9565, 20542, 16, 9347, 6219, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_6bce7d1d87", "text": "Hemic and Lymphatic Anemia, (including pure red cell aplasia and anemias progressing on therapy), lymphadenopathy, splenomegaly.", "entities": [{"label": "ADR", "start": 20, "end": 26, "text": "Anemia"}], "input_ids": [2, 25482, 1930, 13388, 10679, 16, 12, 2710, 7358, 2312, 2024, 18373, 6646, 1930, 10679, 1036, 23612, 1990, 3181, 13, 16, 25948, 16, 29707, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_469aac37aa", "text": "Hepatic and Pancreatic Lactic acidosis and hepatic steatosis, pancreatitis, posttreatment exacerbations of hepatitis B", "entities": [{"label": "ADR", "start": 23, "end": 38, "text": "Lactic acidosis"}], "input_ids": [2, 6095, 1930, 6356, 16562, 19051, 1930, 6095, 16387, 16, 14605, 16, 26562, 19152, 1927, 7977, 44, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f9eab44065", "text": "[see Boxed Warning, Warnings and Precautions ( 5.3 ), ( 5.4 ), ( 5.6 )].", "entities": [], "input_ids": [2, 37, 3365, 28206, 18149, 16, 18149, 1036, 1930, 30363, 12, 25, 18, 23, 13, 16, 12, 25, 18, 24, 13, 16, 12, 25, 18, 26, 13, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1a4b4c531d", "text": "Hypersensitivity Sensitization reactions (including anaphylaxis), urticaria.", "entities": [{"label": "ADR", "start": 0, "end": 16, "text": "Hypersensitivity"}, {"label": "ADR", "start": 52, "end": 63, "text": "anaphylaxis"}, {"label": "ADR", "start": 66, "end": 75, "text": "urticaria"}], "input_ids": [2, 14625, 12770, 5298, 12, 2710, 26726, 13, 16, 27986, 6148, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 0, 0, 0, 0, 3, 0, 0, 3, 4, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_1ea7f03f28", "text": "Musculoskeletal Muscle weakness, CPK elevation, rhabdomyolysis.", "entities": [{"label": "ADR", "start": 48, "end": 62, "text": "rhabdomyolysis"}], "input_ids": [2, 15322, 3760, 12175, 16, 4244, 1040, 8644, 16, 25369, 6892, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_f649a28b37", "text": "Nervous Paresthesia, peripheral neuropathy, seizures.", "entities": [{"label": "ADR", "start": 21, "end": 42, "text": "peripheral neuropathy"}], "input_ids": [2, 7580, 2096, 29259, 16, 5009, 13177, 16, 10060, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 0, 0, -100], "source_type": "dailymed_insert"}
{"id": "silver_0fc7d65630", "text": "Skin Alopecia, erythema multiforme, Stevens-Johnson syndrome.", "entities": [{"label": "ADR", "start": 36, "end": 60, "text": "Stevens-Johnson syndrome"}], "input_ids": [2, 4407, 29640, 16, 23349, 15453, 2076, 1021, 16, 26913, 2099, 17, 13890, 4741, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "dailymed_insert"}
{"id": "nl_608f58c22d", "text": "The Upper West and Upper East regions submitted the highest number of reports per 1,000,000 inhabitants in 2016; this is largely due to the Seasonal Malaria Chemoprevention (SMC) programme in these two regions. 0 20 40 60 80 100 120 140 160 Amoxicillin clavulanic Artemether/ Lumefantrine Iron Dextran Metformin Artesunate/ Amodiaquine Lisinopril/ Hydrochlorthiazide Lisinopril Ciprofloxacin Nifedipine Sulfadoxine/ Pyrimethamine Amlodipine Diclofenac Ivermectin Praziquantel Albendazole", "entities": [{"label": "DRUG", "start": 378, "end": 391, "text": "Ciprofloxacin"}, {"label": "DRUG", "start": 463, "end": 475, "text": "Praziquantel"}, {"label": "DRUG", "start": 324, "end": 335, "text": "Amodiaquine"}, {"label": "DRUG", "start": 241, "end": 252, "text": "Amoxicillin"}, {"label": "DRUG", "start": 476, "end": 487, "text": "Albendazole"}, {"label": "DRUG", "start": 312, "end": 322, "text": "Artesunate"}, {"label": "DRUG", "start": 441, "end": 451, "text": "Diclofenac"}, {"label": "DRUG", "start": 392, "end": 402, "text": "Nifedipine"}, {"label": "DRUG", "start": 430, "end": 440, "text": "Amlodipine"}, {"label": "DRUG", "start": 336, "end": 346, "text": "Lisinopril"}, {"label": "DRUG", "start": 367, "end": 377, "text": "Lisinopril"}, {"label": "DRUG", "start": 452, "end": 462, "text": "Ivermectin"}, {"label": "DRUG", "start": 302, "end": 311, "text": "Metformin"}], "input_ids": [2, 1920, 5199, 9195, 1930, 5199, 10319, 3451, 10568, 1920, 4554, 2529, 1927, 4710, 2079, 21, 16, 3240, 16, 3240, 22248, 1922, 4759, 31, 2052, 1977, 6318, 2810, 1942, 1920, 10995, 7505, 22896, 20126, 12, 16312, 13, 9481, 1922, 2144, 2288, 3451, 18, 20, 2036, 3040, 3276, 3729, 2813, 6103, 8949, 9608, 24987, 19887, 5617, 19730, 20897, 23568, 1915, 19, 5491, 7726, 2031, 5773, 5680, 15195, 11885, 20897, 20490, 5791, 1021, 19, 2150, 13968, 15520, 19620, 3522, 2047, 1970, 19, 14369, 22523, 29895, 19620, 3522, 2047, 1970, 18502, 25968, 5141, 12595, 25204, 19, 17015, 3184, 3812, 9508, 26584, 27304, 4370, 2166, 5922, 29041, 2850, 25453, 1024, 5311, 20997, 13642, 1952, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 2, 2, 2, 0, 1, 2, 2, 1, 2, 2, 2, 0, 0, 0, 0, 1, 2, 2, 2, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 1, 2, 2, 1, 2, 2, 2, 1, 2, 2, 2, -100], "source_type": "fda_newsletter"}
{"id": "nl_264736807e", "text": "No Indicator Example 1 Staff and Infrastructure Institutional Contact Person (ICP) available and trained 2 Tools for Pharmacovigilance Availability of Adverse Reaction and Adverse Event Following Immunization forms 3 Systems and Structures Drug and Therapeutics Committees exists and has the mandate to carry out pharmacovigilance activities 4 Training and skills Pharmacovigilance training for healthcare professionals within the past 12 months 5 Safety issues Knowledge of safety issues to report DRUGLENS ISSUE 5 Hyoscine butylbromide (Buscopan) injection and risk of serious adverse effects in patients with underlying cardiac disease 6 FDA Organized Continuous Professional Development Training Course for Pharmacists The FDA on 10th April, 2017 organized a one-day Continuous Professional Development (CPD) training workshop for ninety-nine Pharmacists on Drug Regulation and Life Cycle of Pharmaceutical Products at the FDA Offices in Accra.", "entities": [{"label": "DRUG", "start": 516, "end": 537, "text": "Hyoscine butylbromide"}, {"label": "DRUG", "start": 539, "end": 547, "text": "Buscopan"}], "input_ids": [2, 2239, 8413, 3534, 21, 6651, 1930, 15009, 6540, 5217, 5952, 12, 13215, 13, 3322, 1930, 7800, 22, 6257, 1958, 4602, 25210, 6121, 17576, 1972, 6855, 1927, 5246, 3227, 1930, 5246, 4817, 2894, 10139, 4952, 23, 3771, 1930, 4061, 2838, 1930, 12552, 19351, 8655, 1930, 2258, 1920, 8280, 2010, 1942, 9875, 2397, 4602, 25210, 6121, 17576, 1972, 4209, 24, 4096, 1930, 7474, 4602, 25210, 6121, 17576, 1972, 4096, 1958, 5841, 9229, 2651, 1920, 5375, 2369, 3221, 25, 5407, 6384, 4163, 1927, 5407, 6384, 1942, 3809, 2838, 15253, 1036, 6972, 25, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 12, 11730, 2972, 1928, 13, 4107, 1930, 2565, 1927, 7433, 5246, 2564, 1922, 2132, 1956, 5030, 4435, 2573, 26, 11394, 11275, 4798, 8578, 2740, 4096, 4914, 1958, 18019, 1920, 11394, 1990, 20005, 11071, 16, 5664, 11275, 43, 2340, 17, 3007, 4798, 8578, 2740, 12, 23698, 13, 4096, 18462, 1958, 18086, 17, 6360, 18019, 1990, 2838, 3640, 1930, 3308, 4048, 1927, 11106, 4461, 2019, 1920, 11394, 29756, 1922, 14467, 1019, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_d344195e03", "text": "The UK medicines regulation agency, Medicines and Healthcare products Regulatory Agency (MHRA) in their Drug Safety Update newsletter, volume 10 issue 7, published in February 2017, provided updates to guide the prescribing and administration on Hyoscine butylbromide injection.", "entities": [{"label": "DRUG", "start": 246, "end": 267, "text": "Hyoscine butylbromide"}], "input_ids": [2, 1920, 5999, 12864, 3640, 11920, 16, 12864, 1930, 5841, 4461, 4948, 11920, 12, 5146, 5524, 13, 1922, 2310, 2838, 5407, 15623, 19483, 28509, 1915, 16, 3776, 2119, 6972, 27, 16, 4586, 1922, 13331, 5664, 16, 3675, 26404, 1942, 7857, 1920, 15103, 1930, 4183, 1990, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_d8923680f2", "text": "7 DRUGLENS ISSUE 5 Hyoscine butylbromide (Buscopan) is indicated for acute muscular spasm including renal or biliary colic, in radiology for differential diagnosis of obstruction and to reduce spasm and pain in pyelography, and in other diagnostic procedures where spasm may be a problem.", "entities": [{"label": "DRUG", "start": 19, "end": 40, "text": "Hyoscine butylbromide"}, {"label": "DRUG", "start": 42, "end": 50, "text": "Buscopan"}], "input_ids": [2, 27, 2838, 15253, 1036, 6972, 25, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 12, 11730, 2972, 1928, 13, 1977, 3391, 1958, 3939, 12330, 24431, 2710, 4604, 2014, 13210, 5178, 1030, 16, 1922, 19528, 1958, 5611, 3574, 1927, 10849, 1930, 1942, 4412, 24431, 1930, 3594, 1922, 6085, 1938, 3796, 16, 1930, 1922, 2303, 4785, 4869, 2597, 24431, 2278, 1998, 43, 4915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_14f49b2889", "text": "Hyoscine butylbromide injection can cause adverse effects including tachycardia, hypotension, and anaphylaxis.", "entities": [{"label": "ADR", "start": 81, "end": 92, "text": "hypotension"}, {"label": "ADR", "start": 98, "end": 109, "text": "anaphylaxis"}, {"label": "ADR", "start": 68, "end": 79, "text": "tachycardia"}, {"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 2112, 3936, 5246, 2564, 2710, 17397, 16, 16453, 16, 1930, 26726, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_277f982a66", "text": "Hyoscine butylbromide injection is contraindicated in patients with tachycardia.", "entities": [{"label": "ADR", "start": 68, "end": 79, "text": "tachycardia"}, {"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 1977, 17825, 22171, 1922, 2132, 1956, 17397, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c8866c1ead", "text": "The MHRA recommended that patients with underlying cardiac conditions who are administered Hyoscine butylbromide injection should be monitored.", "entities": [{"label": "DRUG", "start": 91, "end": 112, "text": "Hyoscine butylbromide"}], "input_ids": [2, 1920, 5146, 5524, 6198, 1988, 2132, 1956, 5030, 4435, 2961, 2746, 2032, 5254, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 3066, 1998, 7027, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_2ac53b50fc", "text": "Cardiac symptoms reported include restlessness, sudden collapse with hypovolemic shock and sweating with cold peripheries.", "entities": [{"label": "ADR", "start": 69, "end": 86, "text": "hypovolemic shock"}, {"label": "ADR", "start": 105, "end": 121, "text": "cold peripheries"}, {"label": "ADR", "start": 48, "end": 63, "text": "sudden collapse"}, {"label": "ADR", "start": 34, "end": 46, "text": "restlessness"}, {"label": "ADR", "start": 91, "end": 99, "text": "sweating"}], "input_ids": [2, 4435, 3601, 2568, 3951, 6172, 26481, 16, 12446, 15687, 1956, 14395, 27602, 4197, 7418, 1930, 25386, 1941, 1956, 6685, 4709, 2062, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 3, 4, 0, 3, 4, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_2155d0c5be", "text": "Cardiovascular disease and anaphylaxis.", "entities": [{"label": "ADR", "start": 27, "end": 38, "text": "anaphylaxis"}], "input_ids": [2, 5321, 2573, 1930, 26726, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_ea43a3c83b", "text": "Testosterone replacement for men Sanofi Aventis Quinimax 125mg Tablets 18’s Quinine hydrochloride + Quinidine hydrochloride + Cinchonidine hydrochloride + Cinchonodine Hydrochloride Plasmodium Falciparum Malaria Quinimax 500mg Tablets 9’s Quinine hydrochloride + Quinidine hydrochloride + Cinchonidine hydrochloride + Cinchonodine Hydrochloride Plasmodium Falciparum Malaria Flagyl 500mg Pessaries Metronidazole Topical treatment of Trichomonas vaginitis and nonspecific vaginitis Nospa Forte Tablets (80mg) Drotavarine Smooth Muscle Spasms Connected with Diseases of Biliary Origin e.g. cholecystolithiasis Smooth Muscle Spasms of the Urinary Tract e.g. nephrolithiasis As an adjunct in treatment of: Smooth Muscle Spasms of Gastrointestinal Origin e.g. gastric and duodenal ulcer Headaches of Vascular Origin Gynecological Diseases e.g Dysmenorrhoea, Insuman Basal 100IU/ml suspension for injection in a vial 5ml Human insulin Diabetes mellitus where treatment with insulin is required Insuman Rapid 100 IU/ml suspension for injection in vial 5ml Human Insulin F Hoffman La Roche Limited Pegasys Vial 180 mcg/1ml Peginterferon alfa-2a Chronic Hepatitis B and C with compensated liver disease Glaxo- SmithKline Augmentin Infant Drops Amoxicillin+Clavulanic Acid 62.5mg/1ml Short-term treatment of susceptible bacteria infections Continued from page 6", "entities": [{"label": "DRUG", "start": 398, "end": 411, "text": "Metronidazole"}, {"label": "DRUG", "start": 1235, "end": 1246, "text": "Amoxicillin"}, {"label": "DRUG", "start": 1212, "end": 1221, "text": "Augmentin"}, {"label": "DRUG", "start": 375, "end": 381, "text": "Flagyl"}], "input_ids": [2, 10592, 7619, 1958, 3925, 6867, 29826, 16959, 3600, 9012, 12874, 1039, 7151, 9759, 16576, 2654, 234, 61, 9012, 2053, 16675, 15, 9012, 5802, 16675, 15, 10510, 28226, 8635, 27099, 16675, 15, 10510, 28226, 11873, 27099, 16675, 15663, 13098, 7505, 9012, 12874, 1039, 4599, 9759, 16576, 29, 234, 61, 9012, 2053, 16675, 15, 9012, 5802, 16675, 15, 10510, 28226, 8635, 27099, 16675, 15, 10510, 28226, 11873, 27099, 16675, 15663, 13098, 7505, 7030, 2199, 4599, 9759, 30300, 5816, 26402, 12259, 2311, 1927, 10477, 10480, 7715, 11566, 3600, 1930, 12720, 7715, 11566, 3600, 9291, 4302, 17133, 1021, 16576, 12, 3729, 9759, 13, 8442, 3857, 19313, 2053, 6689, 3760, 24431, 1036, 7951, 1956, 3902, 1927, 13210, 4853, 47, 18, 49, 18, 19348, 17895, 11550, 6689, 3760, 24431, 1036, 1927, 1920, 7075, 6482, 47, 18, 49, 18, 7737, 2226, 29016, 1966, 1925, 22481, 1922, 2311, 1927, 30, 6689, 3760, 24431, 1036, 1927, 8375, 4853, 47, 18, 49, 18, 6319, 1930, 17752, 10096, 24339, 1927, 4541, 4853, 30373, 3902, 47, 18, 49, 26906, 19824, 18858, 10647, 5376, 16, 7697, 3862, 5342, 2813, 1033, 1032, 19, 2646, 8971, 1958, 4107, 1922, 43, 20462, 25, 8772, 2616, 4122, 4032, 9695, 2597, 2311, 1956, 4122, 1977, 3414, 7697, 3862, 4052, 2813, 11176, 19, 2646, 8971, 1958, 4107, 1922, 20462, 25, 8772, 2616, 4122, 48, 22622, 3862, 5114, 9329, 3892, 7404, 12997, 1036, 20462, 8585, 18761, 19, 19166, 1024, 7404, 9185, 2070, 1916, 26131, 17, 5251, 3724, 7977, 44, 1930, 45, 1956, 17566, 3568, 2573, 29883, 1037, 17, 11742, 16244, 2053, 18680, 1921, 8125, 15867, 24987, 15, 19887, 5617, 19730, 2687, 5374, 18, 25, 9759, 19, 19166, 1024, 3662, 17, 2576, 2311, 1927, 7819, 4802, 5024, 7583, 2037, 7178, 26, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_04d2852c8c", "text": "Secondly, improved stakeholder collaboration has been found most effective, as the recent opioid epidemic - abuse of codeine, tramadol and other prescription medicines continues to be one of the major challenges facing the youth in our country.", "entities": [{"label": "DRUG", "start": 125, "end": 133, "text": "tramadol"}], "input_ids": [2, 14158, 16, 4305, 27185, 11670, 2258, 2252, 2435, 2501, 47, 1871, 2451, 16, 1966, 1920, 3505, 9384, 12107, 17, 7764, 1927, 7815, 2053, 16, 23179, 28280, 1930, 2303, 10524, 12864, 12455, 1942, 1998, 2340, 1927, 1920, 3044, 7321, 15424, 1920, 7925, 1922, 2342, 7722, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_df449f4753", "text": "I. 168 to prohibit the importation and sale of codeine–containing cough syrups and control the importation, manufacture and sale of tramadol respectively.", "entities": [{"label": "DRUG", "start": 132, "end": 140, "text": "tramadol"}], "input_ids": [2, 51, 18, 14004, 1942, 18519, 1932, 1920, 2582, 1943, 1930, 29523, 1927, 7815, 2053, 229, 3165, 13588, 11458, 25372, 1930, 2285, 1920, 2582, 1943, 16, 24021, 1930, 29523, 1927, 23179, 28280, 2763, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_0a45402278", "text": "Strategies put in place include increased public education and awareness creation on the dangers of these products, withdrawal of the marketing authorization and ban on the importation of codeine-containing cough syrups, reclassification of tramadol as a controlled narcotic medicine, intensification of market surveillance particularly at the ports of entry and collaboration with relevant stakeholders like Pharmacy Council, Mental Health Authority, the security agencies and the media to execute measures aimed at reducing the incidence of abuse.", "entities": [{"label": "DRUG", "start": 240, "end": 248, "text": "tramadol"}], "input_ids": [2, 4762, 5366, 1922, 4368, 3951, 2502, 4462, 4767, 1930, 8755, 13874, 1990, 1920, 15378, 1036, 1927, 2144, 4461, 16, 9594, 1927, 1920, 19584, 6799, 2466, 1930, 15114, 1990, 1920, 2582, 1943, 1927, 7815, 2053, 17, 3165, 13588, 11458, 25372, 16, 27681, 1033, 1787, 11281, 2001, 1927, 23179, 28280, 1966, 43, 4642, 22872, 3153, 5380, 16, 14449, 1033, 1787, 11281, 2001, 1927, 10878, 7889, 4443, 2019, 1920, 9260, 1036, 1927, 6904, 1930, 11670, 1956, 4494, 15087, 3189, 14429, 11198, 16, 5018, 2436, 18791, 16, 1920, 13269, 15202, 1930, 1920, 4996, 1942, 29583, 3975, 6822, 2019, 5526, 1920, 4332, 1927, 7764, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_f77212b9a1", "text": "Te remaining 1,132 were AEFI reports from stimulated spontaneous reporting during the nationwide yellow fever and measles rubella campaigns.", "entities": [{"label": "ADR", "start": 114, "end": 129, "text": "measles rubella"}, {"label": "ADR", "start": 97, "end": 109, "text": "yellow fever"}], "input_ids": [2, 3602, 5719, 21, 16, 11824, 1985, 10194, 19894, 4710, 2037, 5449, 6242, 6605, 2409, 1920, 19006, 7463, 9087, 1930, 19344, 10010, 5870, 20780, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 3, 4, 4, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_7a436f0534", "text": "Te highest number of adverse reactions was for Nifedipine tablets, with the most commonly reported reactions being sleepless nights, general body discomfort, cough, dizziness, headache and palpitation.", "entities": [{"label": "ADR", "start": 115, "end": 131, "text": "sleepless nights"}, {"label": "ADR", "start": 141, "end": 156, "text": "body discomfort"}, {"label": "ADR", "start": 189, "end": 200, "text": "palpitation"}, {"label": "ADR", "start": 165, "end": 174, "text": "dizziness"}, {"label": "ADR", "start": 176, "end": 184, "text": "headache"}, {"label": "DRUG", "start": 47, "end": 57, "text": "Nifedipine"}], "input_ids": [2, 3602, 4554, 2529, 1927, 5246, 5298, 1982, 1958, 25968, 16576, 16, 1956, 1920, 2501, 5384, 2568, 5298, 3301, 5006, 5427, 28386, 16, 3335, 3362, 15335, 16, 13588, 16, 24009, 16, 12187, 1930, 15771, 3644, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 3, 0, 3, 0, 3, 4, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_705441d317", "text": "Tese reactions were reported with a minimum frequency of three and all these reactions are listed for Nifedipine.", "entities": [{"label": "DRUG", "start": 102, "end": 112, "text": "Nifedipine"}], "input_ids": [2, 2672, 1021, 5298, 1985, 2568, 1956, 43, 6081, 3528, 1927, 2559, 1930, 2136, 2144, 5298, 2032, 7663, 1958, 25968, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_9393914fa6", "text": "Just submit a completed adverse reaction report and take a 5 minute online test at https://www.az-engage.com/login/ to obtain your 2 points Figure 7: A man ready to receive yellow fever (YF) vaccine in the Akatsi South District in the Volta Region Increasingly more patients through the Community Pharmacies are becoming active participants in the Patient Engagement in Medicine Safety initiative since it was launched in June 2016.", "entities": [{"label": "ADR", "start": 173, "end": 185, "text": "yellow fever"}], "input_ids": [2, 6244, 19608, 43, 5721, 5246, 3227, 3809, 1930, 6132, 43, 25, 8623, 6302, 2648, 2019, 11582, 30, 19, 19, 6425, 18, 6352, 17, 11580, 18, 2008, 19, 3968, 1921, 19, 1942, 5649, 10186, 22, 4273, 2292, 27, 30, 43, 2323, 16550, 1942, 7130, 7463, 9087, 12, 29962, 13, 5955, 1922, 1920, 4464, 5149, 1033, 6061, 11306, 1922, 1920, 6375, 1019, 3031, 8827, 2253, 2132, 2596, 1920, 4413, 25843, 2032, 11589, 3500, 3003, 1922, 1920, 2774, 9577, 1922, 5380, 5407, 13690, 3328, 2176, 1982, 24850, 1922, 10343, 4759, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_6aeb563e2f", "text": "Te Food and Drugs Authority in collaboration with the Expanded Programme on Immunization (EPI) also employed enhanced (stimulated) passive surveillance for adverse events following immunization (AEFI) during the 2018 sub-national yellow fever and nationwide measles-rubella vaccination campaigns.", "entities": [{"label": "ADR", "start": 230, "end": 242, "text": "yellow fever"}], "input_ids": [2, 3602, 3959, 1930, 4195, 18791, 1922, 11670, 1956, 1920, 8899, 9481, 1990, 10139, 12, 13872, 13, 2222, 5789, 4256, 12, 5449, 13, 9832, 7889, 1958, 5246, 3916, 2894, 10139, 12, 10194, 19894, 13, 2409, 1920, 7714, 2316, 17, 3852, 7463, 9087, 1930, 19006, 19344, 17, 10010, 5870, 7507, 20780, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_69a0dd5d50", "text": "GHANA Your Well-being, Our Priority. 7 Fever", "entities": [{"label": "ADR", "start": 39, "end": 44, "text": "Fever"}], "input_ids": [2, 20685, 10186, 2486, 17, 3301, 16, 2342, 12655, 18, 27, 9087, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, -100], "source_type": "fda_newsletter"}
{"id": "nl_175d0bf701", "text": "EPI Code FDA Code Causality 1 ASH-SEK-18-001 1218AEFIAR0013 Coincidental 2 ASH-SKC-18-001 1218AEFIAR0012 Coincidental 3 BAR-SUW-18-009 1218AEFIBA0047 Coincidental 4 BAR-TAS-18-002 1218AEFIBA0046 Coincidental 5 BAR-TAS-18-003 1218AEFIBA0045 Coincidental 6 CEN KEA-18-006 1218AEFICR0088 Coincidental 7 EAS-AKS-18-003 1218AEFIER0010 Unclassifiable 8 EAS-EAK-18-006 1218AEFIER0011 Coincidental 9 EAS-EAK-18-008 1218AEFIER0013 Coincidental 10 EAS-KAP-18-002 1218AEFIER0012 Coincidental 11 VOL-HOH-18-001 1218AEFIVR0020 Unclassifiable Te EPI also carried out a sub-national yellow fever (YF) preventive mass vaccination campaign from 28th November to 4th December 2018 in nine regions excluding the Upper West Region.", "entities": [{"label": "ADR", "start": 568, "end": 580, "text": "yellow fever"}], "input_ids": [2, 13872, 7815, 11394, 7815, 19140, 21, 13696, 17, 2058, 1040, 17, 2654, 17, 3472, 11844, 16269, 7726, 9475, 18201, 1010, 22829, 1923, 22, 13696, 17, 3097, 1030, 17, 2654, 17, 3472, 11844, 16269, 7726, 9475, 18201, 1028, 22829, 1923, 23, 3241, 17, 2020, 1018, 17, 2654, 17, 14838, 11844, 16269, 7726, 26073, 22077, 1027, 22829, 1923, 24, 3241, 17, 11017, 17, 2654, 17, 9299, 11844, 16269, 7726, 26073, 22077, 1016, 22829, 1923, 25, 3241, 17, 11017, 17, 2654, 17, 10438, 11844, 16269, 7726, 26073, 22077, 1015, 22829, 1923, 26, 14585, 3364, 1019, 17, 2654, 17, 12791, 11844, 16269, 7726, 1935, 1005, 23789, 1025, 22829, 1923, 27, 4843, 17, 4464, 1036, 17, 2654, 17, 10438, 11844, 16269, 7726, 3453, 18201, 1008, 29562, 18860, 28, 4843, 17, 11377, 1040, 17, 2654, 17, 12791, 11844, 16269, 7726, 3453, 18201, 1009, 22829, 1923, 29, 4843, 17, 11377, 1040, 17, 2654, 17, 13587, 11844, 16269, 7726, 3453, 18201, 1010, 22829, 1923, 2119, 4843, 17, 17367, 17, 2654, 17, 9299, 11844, 16269, 7726, 3453, 18201, 1028, 22829, 1923, 2513, 2984, 17, 6673, 1023, 17, 2654, 17, 3472, 11844, 16269, 7726, 2068, 1005, 22536, 1008, 29562, 18860, 3602, 13872, 2222, 4371, 2397, 43, 2316, 17, 3852, 7463, 9087, 12, 29962, 13, 10962, 3411, 7507, 13986, 2037, 3158, 1963, 12832, 1942, 18117, 9474, 7714, 1922, 6360, 3451, 10566, 1920, 5199, 9195, 3031, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_1281c8baa4", "text": "Study Suggests Risk of Birth Defects in Babies Born to Women on HIV Medicine Dolutegravir (Tivicay) Hyoscine Butylbromide Injection: Risk of Serious Adverse Effects in Patients with Underlying Cardiac Disease Tere are increased cases of lower limb amputation (mostly affecting the toes) observed in patients taking the Type 2 diabetes medicine Canagliflozin compared with those taking placebo in two clinical trials, CANVAS (Canagli- flozin Cardiovascular Assessment Study) and CANVAS-R (A Study of the Effects of Canagliflozin on Renal Endpoints in Adult Participants with Type 2 Diabetes Mellitus) studies.", "entities": [{"label": "ADR", "start": 236, "end": 257, "text": "lower limb amputation"}, {"label": "ADR", "start": 23, "end": 36, "text": "Birth Defects"}, {"label": "DRUG", "start": 100, "end": 121, "text": "Hyoscine Butylbromide"}], "input_ids": [2, 2161, 4015, 2565, 1927, 5043, 6007, 1922, 18203, 8813, 1942, 3089, 1990, 3525, 5380, 17837, 2696, 2299, 11046, 12, 8685, 9833, 2050, 13, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 30, 2565, 1927, 7433, 5246, 47, 1871, 2284, 1922, 2132, 1956, 5030, 4435, 2573, 6005, 1021, 2032, 2502, 2919, 1927, 2826, 7755, 19491, 12, 6969, 43, 1871, 3991, 1920, 22820, 1036, 13, 2528, 1922, 2132, 6303, 1920, 2601, 22, 4032, 5380, 2112, 15915, 1033, 1501, 25257, 2452, 1956, 2690, 6303, 5936, 1922, 2288, 2535, 3848, 16, 2112, 10916, 12, 2112, 15915, 1033, 17, 959, 25257, 5321, 4076, 2161, 13, 1930, 2112, 10916, 17, 60, 12, 43, 2161, 1927, 1920, 47, 1871, 2284, 1927, 2112, 15915, 1033, 1501, 25257, 1990, 4604, 13613, 1922, 4160, 3003, 1956, 2601, 22, 4032, 9695, 13, 2351, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_68c6c75eed", "text": "Tis publication sought to update healthcare professionals on a publication in the 2017 edition of the Druglens on the safety information relating to reports published by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) of acute myocardial infarction or cardiac arrest with fatal outcomes associated with the use of hyoscine butylbromide injection.", "entities": [{"label": "ADR", "start": 270, "end": 284, "text": "cardiac arrest"}, {"label": "DRUG", "start": 332, "end": 353, "text": "hyoscine butylbromide"}], "input_ids": [2, 30152, 7292, 8758, 1942, 15623, 5841, 9229, 1990, 43, 7292, 1922, 1920, 5664, 17407, 1927, 1920, 2838, 15253, 1036, 1990, 1920, 5407, 2988, 13056, 1942, 4710, 4586, 2007, 1920, 5999, 12864, 1930, 5841, 4461, 4948, 11920, 12, 5146, 5524, 13, 1927, 3939, 6497, 8358, 2014, 4435, 8048, 1956, 11990, 3685, 2458, 1956, 1920, 2485, 1927, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_508205a7fb", "text": "Hyoscine butylbromide given intravenously or intramuscularly is indicated in acute muscular spasm, as in renal or biliary colic; in radiology for differential diagnosis of obstruction and to reduce spasm and pain in pyelography; and in other diagnostic procedures where spasm may be a problem (eg, gastroduodenal endoscopy).Hyoscine butylbromide injection can cause adverse effects including tachycardia, hypotension, and anaphylaxis.", "entities": [{"label": "ADR", "start": 403, "end": 414, "text": "hypotension"}, {"label": "ADR", "start": 420, "end": 431, "text": "anaphylaxis"}, {"label": "ADR", "start": 390, "end": 401, "text": "tachycardia"}, {"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}, {"label": "DRUG", "start": 323, "end": 344, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 3258, 15132, 2014, 16774, 1954, 1977, 3391, 1922, 3939, 12330, 24431, 16, 1966, 1922, 4604, 2014, 13210, 5178, 1030, 31, 1922, 19528, 1958, 2137, 1871, 1959, 4905, 2086, 3574, 1927, 10849, 1930, 1942, 4412, 24431, 1930, 3594, 1922, 6085, 1938, 3796, 31, 1930, 1922, 2303, 4785, 4869, 2597, 24431, 2278, 1998, 43, 4915, 12, 7282, 16, 6858, 10015, 5215, 3163, 15228, 13, 18, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 2112, 3936, 5246, 47, 1871, 2284, 2710, 17397, 16, 16453, 16, 1930, 26726, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_25da95d0a2", "text": "Tese effects can be more serious in patients with underlying cardiac DrugLens Issue 7 GHANA Your Well-being, Our Priority. 2 10 4 5 6 disease (eg, heart failure, coronary heart disease, cardiac arrhythmia, or hypertension).", "entities": [{"label": "ADR", "start": 146, "end": 159, "text": "heart failure"}, {"label": "ADR", "start": 193, "end": 203, "text": "arrhythmia"}], "input_ids": [2, 2672, 1021, 47, 1871, 2284, 2112, 1998, 2253, 7433, 1922, 2132, 1956, 5030, 4435, 2838, 15253, 1036, 6972, 27, 20685, 10186, 2486, 17, 3301, 16, 2342, 12655, 18, 22, 2119, 24, 25, 26, 2573, 12, 7282, 16, 4003, 4574, 16, 5846, 4003, 2573, 16, 4435, 18346, 16, 2014, 5579, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_7a5504b68e", "text": "Studies have suggested that anaphylaxis is more likely to be fatal in patients with underlying coronary heart disease compared with those without.", "entities": [{"label": "ADR", "start": 28, "end": 39, "text": "anaphylaxis"}], "input_ids": [2, 2351, 2162, 3978, 1988, 26726, 1977, 2253, 3205, 1942, 1998, 11990, 1922, 2132, 1956, 5030, 5846, 4003, 2573, 2452, 1956, 2690, 2979, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_3734499fa0", "text": "Hyoscine butylbromide injection can cause serious adverse effects including tachycardia, hypotension, and anaphylaxis. 2.", "entities": [{"label": "ADR", "start": 88, "end": 99, "text": "hypotension"}, {"label": "ADR", "start": 105, "end": 116, "text": "anaphylaxis"}, {"label": "ADR", "start": 75, "end": 86, "text": "tachycardia"}, {"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 2112, 3936, 7433, 5246, 47, 1871, 2284, 2710, 17397, 16, 16453, 16, 1930, 26726, 18, 22, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_d4bda70982", "text": "Tese adverse effects can result in a fatal outcome in patients with underlying cardiac disease, such as those with heart failure, coronary heart disease, cardiac arrhythmia or hypertension. 3.", "entities": [{"label": "ADR", "start": 114, "end": 127, "text": "heart failure"}, {"label": "ADR", "start": 161, "end": 171, "text": "arrhythmia"}], "input_ids": [2, 2672, 1021, 5246, 47, 1871, 2284, 2112, 3211, 1922, 43, 11990, 3924, 1922, 2132, 1956, 5030, 4435, 2573, 16, 2427, 1966, 2690, 1956, 4003, 4574, 16, 5846, 4003, 2573, 16, 4435, 18346, 2014, 5579, 18, 23, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_f83edc520d", "text": "Hyoscine butylbromide injection should be used with caution in patients with cardiac disease. 4.", "entities": [{"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 3066, 1998, 2251, 1956, 12838, 1922, 2132, 1956, 4435, 2573, 18, 24, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_9cff99b658", "text": "Hyoscine butylbromide injection remains contraindi cated in patients with tachycardia.", "entities": [{"label": "ADR", "start": 74, "end": 85, "text": "tachycardia"}, {"label": "DRUG", "start": 0, "end": 21, "text": "Hyoscine butylbromide"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 4497, 17825, 1033, 3115, 1919, 1922, 2132, 1956, 17397, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_d480b16b7e", "text": "Advice to patients and healthcare professionals: Patients • Seek medical attention immediately if you experience any symptoms of tenderness, redness, or swellng of the genitals or the area from the genitals back to therectum, and have a fever above 38oC or a general feeling of being unwell.", "entities": [{"label": "ADR", "start": 259, "end": 290, "text": "general feeling of being unwell"}, {"label": "ADR", "start": 129, "end": 139, "text": "tenderness"}, {"label": "ADR", "start": 141, "end": 148, "text": "redness"}, {"label": "ADR", "start": 237, "end": 242, "text": "fever"}], "input_ids": [2, 12267, 1942, 2132, 1930, 5841, 9229, 30, 2132, 241, 7592, 3423, 4976, 6183, 2647, 6253, 4848, 2967, 3601, 1927, 25900, 16, 2312, 2971, 16, 2014, 9736, 11560, 2029, 1927, 1920, 13473, 1036, 2014, 1920, 3403, 2037, 1920, 13473, 1036, 3231, 1942, 2276, 2341, 1989, 16, 1930, 2162, 43, 9087, 3538, 3738, 1994, 2014, 43, 3335, 14452, 1927, 3301, 12620, 1992, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 4, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_fa018683be", "text": "SGLT2 containing-medicines registered for use in Ghana are Forxiga (Dapagliflozin) tablets, Invokana (Canagli flozin) tablets and Vokanamet (Canagliflozin and Metformin hydrochloride) tablets.", "entities": [{"label": "DRUG", "start": 156, "end": 179, "text": "Metformin hydrochloride"}], "input_ids": [2, 24482, 12904, 3165, 17, 12864, 10012, 1958, 2485, 1922, 20685, 2032, 1958, 18068, 4223, 12, 8243, 15915, 1033, 1501, 25257, 13, 16576, 16, 2269, 22526, 2175, 12, 2112, 15915, 1033, 959, 25257, 13, 16576, 1930, 9805, 7640, 12253, 1946, 12, 2112, 15915, 1033, 1501, 25257, 1930, 11885, 16675, 13, 16576, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_f26f27bbc5", "text": "Valsartan is also used in adults to treat heart failure, and to lower the risk of death after a heart attack.", "entities": [{"label": "ADR", "start": 42, "end": 55, "text": "heart failure"}], "input_ids": [2, 2326, 5735, 7446, 1928, 1977, 2222, 2251, 1922, 4440, 1942, 2297, 4003, 4574, 16, 1930, 1942, 2826, 1920, 2565, 1927, 3539, 2256, 43, 4003, 8926, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_daa0e45c13", "text": "Astra Zeneca 5 Astra Zeneca Losec Mumps 20mg tablets Nolvadex 20mg tablets Tamoxifen 20mg Omeprazole 20mg Treatment of symptoms of gastroesophageal reflux disease (GERD) and other conditions caused by excess stomach acid.", "entities": [{"label": "DRUG", "start": 90, "end": 100, "text": "Omeprazole"}, {"label": "DRUG", "start": 28, "end": 33, "text": "Losec"}], "input_ids": [2, 20329, 1019, 22339, 19384, 25, 20329, 1019, 22339, 19384, 15970, 1030, 16833, 2523, 2036, 9759, 16576, 2239, 14937, 26996, 2036, 9759, 16576, 13011, 2036, 9759, 12453, 26252, 2036, 9759, 2311, 1927, 3601, 1927, 28933, 13583, 2573, 12, 22273, 13, 1930, 2303, 2961, 4189, 2007, 5799, 11399, 2687, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_65f2e60553", "text": "Omeprazole may also be given together with antibiotics to treat gastric ulcer caused by infection with Helicobacter pylori (H. pylori) Treatment of some types of breast cancer in men and women.", "entities": [{"label": "DRUG", "start": 0, "end": 10, "text": "Omeprazole"}], "input_ids": [2, 12453, 26252, 2278, 2222, 1998, 3258, 4084, 1956, 7560, 1942, 2297, 6319, 10096, 4189, 2007, 2909, 1956, 22293, 10665, 12, 50, 18, 10665, 13, 2311, 1927, 2673, 3584, 1927, 3739, 2539, 1922, 3925, 1930, 3089, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_8bc02d754b", "text": "DrugLens Issue 7 NO MAH NAME OF DRUG ACTIVE INGREDIENT INDICATION 6 7 GSK GSK Nepine SR 20mg tablets Ventolin Rotacaps 200mcg Nifedipine SR 20mg Ventolin Rotacaps 200mcg Treatment of hypertension (high blood pressure) and angina (chest pain).", "entities": [{"label": "DRUG", "start": 126, "end": 136, "text": "Nifedipine"}], "input_ids": [2, 2838, 15253, 1036, 6972, 27, 2239, 18770, 9533, 1927, 2838, 3500, 24364, 10331, 26, 27, 9822, 9822, 26046, 2053, 4581, 2036, 9759, 16576, 14654, 8261, 30029, 9991, 1036, 2191, 7112, 1029, 25968, 4581, 2036, 9759, 14654, 8261, 30029, 9991, 1036, 2191, 7112, 1029, 2311, 1927, 5579, 12, 2149, 2877, 3772, 13, 1930, 16961, 12, 8475, 3594, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_f26f27bbc5", "text": "Valsartan is also used in adults to treat heart failure, and to lower the risk of death after a heart attack.", "entities": [{"label": "ADR", "start": 42, "end": 55, "text": "heart failure"}], "input_ids": [2, 2326, 5735, 7446, 1928, 1977, 2222, 2251, 1922, 4440, 1942, 2297, 4003, 4574, 16, 1930, 1942, 2826, 1920, 2565, 1927, 3539, 2256, 43, 4003, 8926, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_decc4ff450", "text": "GSK Augmentin ES 642.9mg/5ml suspension Amoxicillin trihydrate /potassium clavunate Used in adults and children to treat middle ear and sinus, respiratory tract, urinary tract, skin and soft tissue, including dental, bone and joint infections.", "entities": [{"label": "DRUG", "start": 40, "end": 62, "text": "Amoxicillin trihydrate"}, {"label": "DRUG", "start": 4, "end": 13, "text": "Augmentin"}], "input_ids": [2, 9822, 18680, 1921, 2376, 4723, 1028, 18, 29, 9759, 19, 25, 8772, 8971, 24987, 5083, 10806, 2010, 19, 9057, 19887, 27365, 2251, 1922, 4440, 1930, 3069, 1942, 2297, 5576, 4352, 1930, 9414, 16, 5481, 6482, 16, 7075, 6482, 16, 4407, 1930, 3793, 2960, 16, 2710, 7915, 16, 3622, 1930, 6047, 5024, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_af7b5608f7", "text": "GHANA Your Well-being, Our Priority. 2 14 NO MAH NAME OF DRUG ACTIVE INGREDIENT INDICATION 12 14 15 GSK GSK Bayer Clavulin 457mg/5ml suspension Flixonase Nasal Spray 0.05% w/w Magnevist Injection Fluticasone propionate/ Salmeterol Gadopentetic acid Amoxicillin trihydrate/ potassium clavunate Used in adults and children to treat middle ear and sinus, respiratory tract, urinary tract, skin and soft tissue, including dental, bone and joint infections.", "entities": [{"label": "DRUG", "start": 249, "end": 271, "text": "Amoxicillin trihydrate"}], "input_ids": [2, 20685, 10186, 2486, 17, 3301, 16, 2342, 12655, 18, 22, 2607, 2239, 18770, 9533, 1927, 2838, 3500, 24364, 10331, 2369, 2607, 2461, 9822, 9822, 26089, 19887, 3392, 30321, 9759, 19, 25, 8772, 8971, 2300, 2416, 9259, 1021, 9305, 14239, 20, 18, 2914, 9, 65, 19, 65, 3679, 9488, 2184, 4107, 2848, 21788, 5810, 1021, 24682, 19, 3370, 14578, 6506, 1024, 10279, 4907, 4905, 3023, 2687, 24987, 5083, 10806, 2010, 19, 9057, 19887, 27365, 2251, 1922, 4440, 1930, 3069, 1942, 2297, 5576, 4352, 1930, 9414, 16, 5481, 6482, 16, 7075, 6482, 16, 4407, 1930, 3793, 2960, 16, 2710, 7915, 16, 3622, 1930, 6047, 5024, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_cd82819967", "text": "Used with magnetic resonance imaging (MRI) in adults and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. 16 GSK Protedex 1000mg, 2000mg and 5000mg Injection Ceftriaxone Treatment of chest and sexually transmitted infections,Lyme disease, bacterial infection in patients with neutropenia and prevention of infections during surgery.", "entities": [{"label": "ADR", "start": 387, "end": 398, "text": "neutropenia"}, {"label": "DRUG", "start": 269, "end": 280, "text": "Ceftriaxone"}], "input_ids": [2, 2251, 1956, 5691, 6912, 3755, 12, 5371, 13, 1922, 4440, 1930, 7460, 2132, 12, 22, 2739, 1927, 2632, 1930, 4706, 13, 1942, 13159, 4518, 1956, 4552, 4541, 1999, 1922, 1920, 3068, 12, 12179, 4518, 13, 16, 8859, 1930, 2458, 3878, 18, 2641, 9822, 2174, 26754, 5672, 9759, 16, 4314, 9759, 1930, 13576, 9759, 4107, 28248, 2311, 1927, 8475, 1930, 14427, 11019, 5024, 16, 30131, 2573, 16, 4543, 2909, 1922, 2132, 1956, 18005, 1930, 5455, 1927, 5024, 2409, 3782, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_516c756228", "text": "DrugLens Issue 7 NO MAH NAME OF DRUG ACTIVE INGREDIENT INDICATION 18 GSK Seretide Evohaler 25/125mcg and 25/50mcg Inhaler Fluticasone propionate/ Salmeterol Treatment of asthma where use of a combination product (longacting β2 agonist and inhaled corticosteroid) is appropriate and for the symptomatic treatment of patients with COPD, with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy 19 GSK Xylal 5mg Tablets Levocetirizine Hydrochloride Symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and urticaria in adults and children aged 6 years and above GHANA Your Well-being, Our Priority. 15", "entities": [{"label": "ADR", "start": 642, "end": 651, "text": "urticaria"}], "input_ids": [2, 2838, 15253, 1036, 6972, 27, 2239, 18770, 9533, 1927, 2838, 3500, 24364, 10331, 2654, 9822, 2375, 4988, 3695, 2180, 2977, 2603, 1005, 2637, 19, 7151, 7112, 1029, 1930, 2637, 19, 2761, 7112, 1029, 9927, 1915, 2848, 21788, 5810, 1021, 24682, 19, 3370, 14578, 6506, 1024, 2311, 1927, 6678, 2597, 2485, 1927, 43, 3921, 4863, 12, 2815, 6480, 11157, 7829, 1930, 16438, 17980, 13, 1977, 4703, 1930, 1958, 1920, 9371, 2311, 1927, 2132, 1956, 8714, 16, 1956, 43, 14336, 32, 3276, 9, 4396, 2791, 12, 2097, 17, 26272, 3061, 13, 1930, 43, 4403, 1927, 5116, 19152, 16, 2746, 2162, 2228, 3601, 4281, 6314, 26272, 3061, 3181, 2282, 9822, 9639, 1923, 25, 9759, 16576, 30129, 1972, 14365, 2061, 2053, 16675, 9371, 2311, 1927, 10519, 21298, 12, 2710, 7733, 10519, 21298, 13, 1930, 27986, 6148, 1922, 4440, 1930, 3069, 5177, 26, 2739, 1930, 3538, 20685, 10186, 2486, 17, 3301, 16, 2342, 12655, 18, 2461, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c0ed60cfd0", "text": "The lower number of adverse reaction reports received in 2020 compared to the previous years’ is likely due to COVID-19 pandemic resulting in reduced hospital visits. 11 13 14 14 16 16 17 18 24 25 27 38 41 49 72 0 10 20 30 40 50 60 70 80 Methyldopa Chloroquine phospate Artemether Lumefantrine Pregabalin Meƞormin Sacubitril Valsartan Amoxicillin Diclofenac Hydroxychloroquine Hydroxycarbamide Ciprofloxacin Praziquantel Tenofovir/Lamivudine/Dolutegavir Lisinopril Nifedipine Fig. 5: Outcome of reported adverse reactions 1274 1687 1542 2236 1325 0 500 1000 1500 2000 2500 2016 2017 2018 2019 2020 33.7 61.6 4.7 Males Females Unknown", "entities": [{"label": "DRUG", "start": 358, "end": 376, "text": "Hydroxychloroquine"}, {"label": "DRUG", "start": 407, "end": 419, "text": "Praziquantel"}, {"label": "DRUG", "start": 249, "end": 260, "text": "Chloroquine"}, {"label": "DRUG", "start": 335, "end": 346, "text": "Amoxicillin"}, {"label": "DRUG", "start": 430, "end": 440, "text": "Lamivudine"}, {"label": "DRUG", "start": 347, "end": 357, "text": "Diclofenac"}, {"label": "DRUG", "start": 464, "end": 474, "text": "Nifedipine"}, {"label": "DRUG", "start": 453, "end": 463, "text": "Lisinopril"}, {"label": "DRUG", "start": 420, "end": 429, "text": "Tenofovir"}], "input_ids": [2, 1920, 2826, 2529, 1927, 5246, 3227, 4710, 4004, 1922, 22656, 2452, 1942, 1920, 2555, 2739, 234, 1977, 3205, 2810, 1942, 6083, 1960, 17, 2282, 16913, 3864, 1922, 3028, 3461, 7870, 18, 2513, 2590, 2607, 2607, 2641, 2641, 2752, 2654, 2686, 2637, 3225, 3738, 4353, 4343, 4395, 20, 2119, 2036, 2627, 3040, 2761, 3276, 3895, 3729, 4963, 22389, 4302, 20813, 20175, 3508, 2010, 20897, 23568, 1915, 5491, 7726, 2031, 5773, 26424, 20013, 7782, 2142, 1905, 2076, 1921, 10791, 2255, 4250, 1970, 2326, 5735, 7446, 1928, 24987, 27304, 8275, 11600, 1037, 15520, 8275, 15339, 7972, 16408, 1021, 12998, 1931, 1501, 12333, 29041, 2850, 25453, 1024, 29122, 19, 30208, 19, 17837, 2696, 4223, 3026, 19620, 3522, 2047, 1970, 25968, 2095, 18, 25, 30, 3924, 1927, 2568, 5246, 5298, 10899, 1006, 14004, 1027, 14396, 1028, 16975, 1016, 11824, 1015, 20, 4599, 5672, 15297, 4314, 19041, 4759, 5664, 7714, 14064, 22656, 3401, 18, 27, 5473, 18, 26, 24, 18, 27, 5129, 5027, 5435, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 1, 0, 1, 0, 0, 0, 0, 0, 1, 2, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c042de2659", "text": "Three hundred (300) AEFI reports were received from the passive (spontaneous) reporting system, 744 from the Phase 2B Yellow Fever Preventive Mass vaccination campaign and 997 from the Malaria Vaccine Implementation Program (MVIP).", "entities": [{"label": "ADR", "start": 118, "end": 130, "text": "Yellow Fever"}], "input_ids": [2, 2559, 8295, 12, 5255, 13, 10194, 19894, 4710, 1985, 4004, 2037, 1920, 9832, 12, 6242, 13, 6605, 2433, 16, 5446, 1006, 2037, 1920, 3193, 5751, 7463, 9087, 10962, 3411, 7507, 13986, 1930, 4922, 1027, 2037, 1920, 7505, 5955, 6499, 3688, 12, 5963, 2049, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_05c94ad017", "text": "5 Fig. 7: Regional distribution of AEFI reports received in 2020 Fig. 8: Causality assessment of serious AEFI cases per vaccine received from the passive reporting system Fig 9: Outcome of causality assessment for 12 serious cases received during the YF campaign Fig 10: Top 5 commonly reported events with their System Organ Class during the YF campaign Fig 11: Regional distribution of reports received per 100,000 vaccinated during the YF campaign The top 5 commonly reported events with their System Organ Classification are as shown below: The regional distribution of AEFI reports received through the Spontaneous Reporting System is as shown below: The Food and Drugs Authority in collaboration with the Expanded Programme on Immunisation employed enhanced passive surveillance system during the 2020 sub-national Phase 2B Yellow Fever Preventive Mass vaccination campaign.", "entities": [{"label": "ADR", "start": 830, "end": 842, "text": "Yellow Fever"}], "input_ids": [2, 25, 2095, 18, 27, 30, 6937, 3282, 1927, 10194, 19894, 4710, 4004, 1922, 22656, 2095, 18, 28, 30, 19140, 4076, 1927, 7433, 10194, 19894, 2919, 2079, 5955, 4004, 2037, 1920, 9832, 6605, 2433, 2095, 29, 30, 3924, 1927, 19140, 4076, 1958, 2369, 7433, 2919, 4004, 2409, 1920, 29962, 13986, 2095, 2119, 30, 3700, 25, 5384, 2568, 3916, 1956, 2310, 2433, 3090, 2921, 2409, 1920, 29962, 13986, 2095, 2513, 30, 6937, 3282, 1927, 4710, 4004, 2079, 2813, 16, 3240, 13122, 2409, 1920, 29962, 13986, 1920, 3700, 25, 5384, 2568, 3916, 1956, 2310, 2433, 3090, 5492, 2032, 1966, 2522, 4535, 30, 1920, 6937, 3282, 1927, 10194, 19894, 4710, 4004, 2596, 1920, 6242, 6605, 2433, 1977, 1966, 2522, 4535, 30, 1920, 3959, 1930, 4195, 18791, 1922, 11670, 1956, 1920, 8899, 9481, 1990, 2519, 6284, 5789, 4256, 9832, 7889, 2433, 2409, 1920, 22656, 2316, 17, 3852, 3193, 5751, 7463, 9087, 10962, 3411, 7507, 13986, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_eac67d39ef", "text": "The outcome of the causality assessment of the 12 serious cases by the TAC-VBP is shown below: AEFI reports from 2020 sub-national Phase 2B Yellow Fever Preventive Mass vaccination campaign Out of the 300 AEFI reports received from the passive reporting system, sixty (60) were classified as serious and the results of the Causality Assessment per antigen by the Technical Advisory Committee on Safety of Vaccines and Biological Products (TAC-VBP) using the process outlined in the WHO User Manual on Revised Classification of AEFI is shown in Figure 8. 1 1 5 6 7 10 11 13 14 14 16 1 1 1 1 2 1 1 1 1 4 2 2 3 1 4 5 0 5 10 15 20 25 30 HepaƟƟs B BCG YF Men A IPV Rota mOPV MR PCV OPV Penta No. of Cases per Causality AnƟgen Coincidental Ineligible for causality Vaccine product ImmunizaƟon error 7 4 1 0 1 2 3 4 5 6 7 8 Coincidental Vaccine product related ImmunizaƟon error related 23 50 57 60 79 0 10 20 30 40 50 60 70 80 90 Muscle pain (Musculoskeletal and connecƟve Ɵssue disorders) Fever (General disorders and administraƟon site condiƟons) Severe local reacƟon (General disorders and administraƟon site condiƟons) Malaise (General disorders and administraƟon site condiƟons) Headache (Nervous System Disorders) 18 16 14 13 12 11 10 9 7 6 3 3 2 0 2 4 6 8 10 12 14 16 18 20 Bono East Volta Savanna Ahafo Central Greater Accra Eastern Bono Upper West Upper East OƟ AshanƟ Northern 64 64 41 27 23 21 18 9 8 7 7 5 4 2 0 0 0 10 20 30 40 50 60 70 Bono East Bono Central Ahafo Eastern Northern Upper East Volta Upper West OƟ Region AshanƟ Greater Accra Western Savannah North East Western North No. of Cases Series1", "entities": [{"label": "ADR", "start": 140, "end": 152, "text": "Yellow Fever"}, {"label": "ADR", "start": 1178, "end": 1186, "text": "Headache"}, {"label": "ADR", "start": 984, "end": 989, "text": "Fever"}], "input_ids": [2, 1920, 3924, 1927, 1920, 19140, 4076, 1927, 1920, 2369, 7433, 2919, 2007, 1920, 9214, 17, 16535, 1034, 1977, 2522, 4535, 30, 10194, 19894, 4710, 2037, 22656, 2316, 17, 3852, 3193, 5751, 7463, 9087, 10962, 3411, 7507, 13986, 2397, 1927, 1920, 5255, 10194, 19894, 4710, 4004, 2037, 1920, 9832, 6605, 2433, 16, 14063, 12, 3276, 13, 1985, 5947, 1966, 7433, 1930, 1920, 2274, 1927, 1920, 19140, 4076, 2079, 4730, 2007, 1920, 7423, 18989, 6182, 1990, 5407, 1927, 9375, 1930, 3933, 4461, 12, 9214, 17, 16535, 1034, 13, 2193, 1920, 2585, 12312, 1922, 1920, 2746, 8124, 8507, 1990, 10041, 5492, 1927, 10194, 19894, 1977, 2522, 1922, 2292, 28, 18, 21, 21, 25, 26, 27, 2119, 2513, 2590, 2607, 2607, 2641, 21, 21, 21, 21, 22, 21, 21, 21, 21, 24, 22, 22, 23, 21, 24, 25, 20, 25, 2119, 2461, 2036, 2637, 2627, 3357, 1019, 1893, 1893, 1036, 44, 15708, 29962, 3925, 43, 17193, 30029, 25437, 1020, 2852, 19192, 2494, 1020, 9412, 1019, 2239, 18, 1927, 2919, 2079, 19140, 1925, 1893, 2432, 22829, 1923, 30168, 6976, 1958, 19140, 5955, 4863, 2519, 2061, 1019, 1893, 1916, 4622, 27, 24, 21, 20, 21, 22, 23, 24, 25, 26, 27, 28, 22829, 1923, 5955, 4863, 2712, 2519, 2061, 1019, 1893, 1916, 4622, 2712, 3020, 2761, 4786, 3276, 5637, 20, 2119, 2036, 2627, 3040, 2761, 3276, 3895, 3729, 3865, 3760, 3594, 12, 15322, 1930, 4045, 1940, 1893, 1961, 133, 5590, 2182, 4414, 13, 9087, 12, 3335, 4414, 1930, 10473, 1019, 1893, 1916, 3200, 8646, 1033, 1893, 2101, 13, 4010, 3076, 1964, 1948, 1893, 1916, 12, 3335, 4414, 1930, 10473, 1019, 1893, 1916, 3200, 8646, 1033, 1893, 2101, 13, 3054, 5504, 4127, 12, 3335, 4414, 1930, 10473, 1019, 1893, 1916, 3200, 8646, 1033, 1893, 2101, 13, 12187, 12, 7580, 2433, 4414, 13, 2654, 2641, 2607, 2590, 2369, 2513, 2119, 29, 27, 26, 23, 23, 22, 20, 22, 24, 26, 28, 2119, 2369, 2607, 2641, 2654, 2036, 7960, 1037, 10319, 6375, 1019, 13243, 27693, 22844, 15282, 4101, 3430, 14467, 1019, 11562, 7960, 1037, 5199, 9195, 5199, 10319, 57, 1893, 13696, 1928, 1893, 9250, 4723, 4723, 4353, 3225, 3020, 2900, 2654, 29, 28, 27, 27, 25, 24, 22, 20, 20, 20, 2119, 2036, 2627, 3040, 2761, 3276, 3895, 7960, 1037, 10319, 7960, 1037, 4101, 22844, 15282, 11562, 9250, 5199, 10319, 6375, 1019, 5199, 9195, 57, 1893, 3031, 13696, 1928, 1893, 3430, 14467, 1019, 4540, 13243, 27693, 1023, 6873, 10319, 4540, 6873, 2239, 18, 1927, 2919, 4696, 1009, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_58cc1fa536", "text": "From March to August 2021, three vaccines namely, Oxford/AstraZeneca (Covishield/Vaxzevria), Sputnik V and COVID-19 Vaccine Janssen (Johnson and Johnson vaccine) had been deployed in Ghana.", "entities": [{"label": "DRUG", "start": 57, "end": 68, "text": "AstraZeneca"}, {"label": "DRUG", "start": 70, "end": 80, "text": "Covishield"}, {"label": "DRUG", "start": 81, "end": 90, "text": "Vaxzevria"}, {"label": "DRUG", "start": 93, "end": 102, "text": "Sputnik V"}, {"label": "DRUG", "start": 124, "end": 131, "text": "Janssen"}], "input_ids": [2, 2037, 10225, 1942, 11907, 17401, 1009, 16, 2559, 9375, 8129, 16, 16616, 19, 20329, 27168, 19384, 12, 6083, 26458, 2884, 19, 9315, 1039, 6931, 23663, 2126, 13, 16, 13113, 23705, 64, 1930, 6083, 1960, 17, 2282, 5955, 29455, 12, 13890, 1930, 13890, 5955, 13, 2430, 2252, 20224, 1922, 20685, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 2, 2, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_6cdba1f89d", "text": "The total doses of the three vaccines administered is 1,404,463 consisting of 1,232,876 doses of Covishield, 107,766 doses of COVID-19 Vaccine Janssen and 63,821 doses of Sputnik V.", "entities": [{"label": "DRUG", "start": 97, "end": 107, "text": "Covishield"}, {"label": "DRUG", "start": 171, "end": 180, "text": "Sputnik V"}, {"label": "DRUG", "start": 143, "end": 150, "text": "Janssen"}], "input_ids": [2, 1920, 2698, 5312, 1927, 1920, 2559, 9375, 5254, 1977, 21, 16, 27397, 16, 4182, 1010, 7600, 1927, 21, 16, 20264, 16, 5783, 1016, 5312, 1927, 6083, 26458, 2884, 16, 9176, 16, 5439, 1016, 5312, 1927, 6083, 1960, 17, 2282, 5955, 29455, 1930, 4968, 16, 6175, 1009, 5312, 1927, 13113, 23705, 64, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_ace29dcdfc", "text": "There were 3,365 AEFI reports submitted for Oxford/AstraZeneca (Covishield/Vaxzevria), 1,993 for Sputnik V and 93 for COVID-19 Vaccine Janssen.", "entities": [{"label": "DRUG", "start": 51, "end": 62, "text": "AstraZeneca"}, {"label": "DRUG", "start": 64, "end": 74, "text": "Covishield"}, {"label": "DRUG", "start": 75, "end": 84, "text": "Vaxzevria"}, {"label": "DRUG", "start": 97, "end": 106, "text": "Sputnik V"}, {"label": "DRUG", "start": 135, "end": 142, "text": "Janssen"}], "input_ids": [2, 2276, 1985, 23, 16, 19526, 10194, 19894, 4710, 10568, 1958, 16616, 19, 20329, 27168, 19384, 12, 6083, 26458, 2884, 19, 9315, 1039, 6931, 23663, 2126, 13, 16, 21, 16, 4922, 1010, 1958, 13113, 23705, 64, 1930, 6156, 1958, 6083, 1960, 17, 2282, 5955, 29455, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_4f5908274f", "text": "The higher reporting rate for Sputnik V was because the AEFI reports were mainly through the active safety surveillance system.", "entities": [{"label": "DRUG", "start": 30, "end": 39, "text": "Sputnik V"}], "input_ids": [2, 1920, 2580, 6605, 2769, 1958, 13113, 23705, 64, 1982, 2882, 1920, 10194, 19894, 4710, 1985, 4994, 2596, 1920, 3500, 5407, 7889, 2433, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_21634f90a0", "text": "Manufacturer Sputnik V (Gam-COVID-Vac) 1. 2. 3. 4. 5. 6.", "entities": [{"label": "DRUG", "start": 24, "end": 37, "text": "Gam-COVID-Vac"}, {"label": "DRUG", "start": 13, "end": 22, "text": "Sputnik V"}], "input_ids": [2, 6075, 13113, 23705, 64, 12, 9011, 17, 6083, 1960, 17, 7017, 13, 21, 18, 22, 18, 23, 18, 24, 18, 25, 18, 26, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 1, 2, 2, 0, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_2d0b366bc4", "text": "Gameleya National Centre of Epidemiology and Microbiology, Russia 9th February, 2021 12th February, 2021 3rd June, 2021 30th June, 2021 30th June, 2021 29th July, 2021 -18°C Covishield (ChAdOX1Ncov-19 Corona Virus Vaccine (Recombinant) Serum Institute of India Pvt.", "entities": [{"label": "DRUG", "start": 174, "end": 184, "text": "Covishield"}], "input_ids": [2, 13685, 6659, 1019, 3852, 8141, 1927, 11683, 1930, 21230, 16, 24120, 29, 1963, 13331, 16, 17401, 1009, 29358, 13331, 16, 17401, 1009, 15349, 10343, 16, 17401, 1009, 2627, 1963, 10343, 16, 17401, 1009, 2627, 1963, 10343, 16, 17401, 1009, 3230, 1963, 10966, 16, 17401, 1009, 17, 2654, 3325, 6083, 26458, 2884, 12, 13297, 22389, 7653, 15895, 2579, 17, 2282, 5548, 1019, 3413, 5955, 12, 5752, 13, 3256, 5381, 1927, 9288, 5774, 1031, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_a1869ef38a", "text": "Limited, India 2°C - 8°C COVID-19 Vaccine Janssen Suspension for Injection (Ad26.COV2-S [recombinant]) Janssen Vaccines & Prevention B.", "entities": [{"label": "DRUG", "start": 42, "end": 49, "text": "Janssen"}, {"label": "DRUG", "start": 103, "end": 110, "text": "Janssen"}], "input_ids": [2, 3892, 16, 9288, 27670, 1030, 17, 28, 3325, 6083, 1960, 17, 2282, 5955, 29455, 8971, 1958, 4107, 12, 2041, 4684, 18, 6083, 1028, 17, 61, 37, 5752, 39, 13, 29455, 9375, 10, 5455, 44, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c68529e231", "text": "V, 2333 CN Leiden, The Netherlands 2°C - 8°C Moderna’s Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] Moderna Biotech Spain, S.L. -25°C - 15°C Comirnaty Concentrate for Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] BioNTech Manufacturing GmbH, Germany -80°C - 60°C (6months) and 2°C to 8°C up to 5days COVID-19 Vaccine AstraZeneca Suspension for Injection (ChAdOx1 S [recombinant]) AstraZeneca, United Kingdom 2°C - 8°C The FDA has granted Emergency Use Authorization (EUA) to six COVID-19 vaccines on the dates indicated below at the time of publication of this newsletter.", "entities": [{"label": "DRUG", "start": 368, "end": 379, "text": "AstraZeneca"}, {"label": "DRUG", "start": 431, "end": 442, "text": "AstraZeneca"}, {"label": "DRUG", "start": 167, "end": 176, "text": "Comirnaty"}], "input_ids": [2, 64, 16, 19598, 1010, 5940, 20014, 5233, 16, 1920, 11449, 27670, 1030, 17, 28, 3325, 10174, 1019, 234, 61, 11834, 1958, 4107, 37, 6083, 1960, 17, 2282, 3616, 5955, 12, 18015, 4795, 13, 39, 10174, 1019, 16388, 13325, 16, 61, 18, 54, 18, 17, 15026, 17, 2461, 3325, 2008, 1996, 5791, 1012, 18410, 1958, 11834, 1958, 4107, 37, 6083, 1960, 17, 2282, 3616, 5955, 12, 18015, 4795, 13, 39, 3718, 4905, 2305, 16140, 15281, 16, 6205, 17, 20486, 17, 18200, 12, 23235, 4202, 8092, 13, 1930, 27670, 1030, 1942, 28, 3325, 2353, 1942, 10048, 2390, 6083, 1960, 17, 2282, 5955, 20329, 27168, 19384, 8971, 1958, 4107, 12, 13297, 22389, 7653, 61, 37, 5752, 39, 13, 20329, 27168, 19384, 16, 6128, 13543, 27670, 1030, 17, 28, 3325, 1920, 11394, 2258, 21660, 7877, 2485, 6799, 2466, 12, 4791, 1019, 13, 1942, 3798, 6083, 1960, 17, 2282, 9375, 1990, 1920, 17483, 3391, 4535, 2019, 1920, 2367, 1927, 7292, 1927, 2052, 19483, 28509, 1915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_1ff67b357d", "text": "The most commonly reported AEFIs for the three vaccines were headache, fever, chills, pain at injection site and body pains which resolved within a day or two.", "entities": [{"label": "ADR", "start": 61, "end": 69, "text": "headache"}, {"label": "ADR", "start": 71, "end": 76, "text": "fever"}], "input_ids": [2, 1920, 2501, 5384, 2568, 10194, 19894, 1036, 1958, 1920, 2559, 9375, 1985, 12187, 16, 9087, 16, 7368, 11560, 1036, 16, 3594, 2019, 4107, 3200, 1930, 3362, 3594, 1036, 2154, 8397, 2651, 43, 3007, 2014, 2288, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c7924dec86", "text": "Strengthening Haemovigilance in Ghana New safety information or signals identified by FDA through the adverse reaction reporting system in 2020 Product Name: Brand (Active Ingredient) Bupivacaine Hydrochloride Injection Paraconica (Paracetamol 10mg/ml) Solution Crystallization and Discoloration of Paracetamol 1000mg IV Healthcare professionals were advised about the proper storage condition of the product.", "entities": [{"label": "DRUG", "start": 232, "end": 243, "text": "Paracetamol"}, {"label": "DRUG", "start": 299, "end": 310, "text": "Paracetamol"}], "input_ids": [2, 17805, 7105, 25210, 6121, 17576, 1972, 1922, 20685, 2814, 5407, 2988, 2014, 4771, 2899, 2007, 11394, 2596, 1920, 5246, 3227, 6605, 2433, 1922, 22656, 4863, 9533, 30, 17154, 12, 3500, 24364, 13, 25473, 16675, 4107, 13344, 3490, 1019, 12, 27021, 2119, 9759, 19, 2646, 13, 3331, 15416, 1930, 2863, 18778, 1943, 1927, 27021, 5672, 9759, 4370, 5841, 9229, 1985, 19625, 3001, 1920, 3405, 7451, 2625, 1927, 1920, 4863, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_6353fba141", "text": "This publication was targeted towards healthcare professionals to provide information on the safety signal of rare events of thrombosis and thrombocytopenia following vaccination with COVID-19 Vaccine AstraZeneca (Covishield) in Ghana.", "entities": [{"label": "ADR", "start": 140, "end": 156, "text": "thrombocytopenia"}, {"label": "DRUG", "start": 201, "end": 212, "text": "AstraZeneca"}, {"label": "DRUG", "start": 214, "end": 224, "text": "Covishield"}], "input_ids": [2, 2052, 7292, 1982, 5154, 5681, 5841, 9229, 1942, 3394, 2988, 1990, 1920, 5407, 2733, 1927, 5844, 3916, 1927, 11354, 1930, 17100, 2894, 7507, 1956, 6083, 1960, 17, 2282, 5955, 20329, 27168, 19384, 12, 6083, 26458, 2884, 13, 1922, 20685, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_188fe155ed", "text": "These rare reports consisted of blood clots associated with thrombocytopenia, with or without bleeding, including rare cases of cerebral venous sinus thrombosis (CVST) i.e. clots in the vessels draining blood from the brain.", "entities": [{"label": "ADR", "start": 60, "end": 76, "text": "thrombocytopenia"}], "input_ids": [2, 2144, 5844, 4710, 6994, 1927, 2877, 15053, 1036, 2458, 1956, 17100, 16, 1956, 2014, 2979, 7633, 16, 2710, 5844, 2919, 1927, 6329, 8562, 9414, 11354, 12, 24112, 1031, 13, 51, 18, 47, 18, 15053, 1036, 1922, 1920, 7208, 21072, 2877, 2037, 1920, 3068, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_c5876dc6e1", "text": "Whilst no causal link has been found between the reported thrombotic events and the AstraZeneca Covid-19 vaccine, the FDA advised healthcare professionals to closely monitor persons vaccinated and ask them to seek immediate medical attention if they develop any of the underlisted after vaccination: Shortness of breath, chest pain, leg swelling, persistent abdominal pain Neurological symptoms including severe or persistent headaches or blurred vision, headache for more than 4 days after vaccination, or experiences skin bruising (petechia) beyond the site of vaccination after a few days.", "entities": [{"label": "ADR", "start": 358, "end": 372, "text": "abdominal pain"}, {"label": "ADR", "start": 455, "end": 463, "text": "headache"}, {"label": "DRUG", "start": 84, "end": 112, "text": "AstraZeneca Covid-19 vaccine"}], "input_ids": [2, 12126, 2239, 9263, 3300, 2258, 2252, 2435, 2192, 1920, 2568, 21039, 3916, 1930, 1920, 20329, 27168, 19384, 6083, 1960, 17, 2282, 5955, 16, 1920, 11394, 19625, 5841, 9229, 1942, 6538, 8434, 7618, 13122, 1930, 5839, 3581, 1942, 7592, 8426, 3423, 4976, 2647, 2611, 2392, 2967, 1927, 1920, 9886, 4316, 2256, 7507, 30, 3662, 2971, 1927, 8735, 16, 8475, 3594, 16, 6703, 11438, 16, 7733, 6900, 3594, 7605, 3601, 2710, 4010, 2014, 7733, 24339, 2014, 2266, 19294, 9266, 16, 12187, 1958, 2253, 2254, 24, 3000, 2256, 7507, 16, 2014, 7651, 4407, 28171, 4007, 12, 5889, 2305, 2126, 13, 6844, 1920, 3200, 1927, 7507, 2256, 43, 3855, 3000, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_de72b9e56f", "text": "Rare Events of Thrombosis and Thrombocytopenia Following Vaccination with Covid-19 Vaccine AstraZeneca", "entities": [{"label": "ADR", "start": 30, "end": 46, "text": "Thrombocytopenia"}, {"label": "DRUG", "start": 91, "end": 102, "text": "AstraZeneca"}], "input_ids": [2, 5844, 3916, 1927, 11354, 1930, 17100, 2894, 7507, 1956, 6083, 1960, 17, 2282, 5955, 20329, 27168, 19384, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, -100], "source_type": "fda_newsletter"}
{"id": "nl_b543c933dd", "text": "11 Crystallization and Discoloration of Paracetamol 100mg IV Public Statement on the Withdrawal of Johnson and Johnson Brand of Baby Talcum Powder from North American Market Rigorous Quality Control Laboratory analysis to verify that indeed the talc-containing powders submitted do not contain asbestos.", "entities": [{"label": "DRUG", "start": 40, "end": 51, "text": "Paracetamol"}], "input_ids": [2, 2513, 15416, 1930, 2863, 18778, 1943, 1927, 27021, 2813, 9759, 4370, 4462, 12977, 1990, 1920, 9594, 1927, 13890, 1930, 13890, 17154, 1927, 16099, 11571, 18021, 1035, 10201, 2037, 6873, 5339, 10878, 16372, 3455, 2285, 4542, 2333, 1942, 10491, 1988, 5087, 1920, 11571, 1030, 17, 3165, 25019, 10568, 2608, 2084, 5531, 24453, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_0106efb5cf", "text": "The FDA has since informed the manufacturer of Paraconica IV Solution and other Paracetamol IV Solutions containing mannitol as an inactive ingredient to revise the storage conditions on the product labels to include the instruction “Do not refrigerate or freeze” and also list all excipients on the product labels.", "entities": [{"label": "DRUG", "start": 80, "end": 91, "text": "Paracetamol"}], "input_ids": [2, 1920, 11394, 2258, 3328, 6210, 1920, 6075, 1927, 13344, 3490, 1019, 4370, 3331, 1930, 2303, 27021, 4370, 6551, 3165, 20915, 1966, 1925, 9078, 24364, 1942, 26084, 1021, 1920, 7451, 2961, 1990, 1920, 4863, 13282, 1942, 3951, 1920, 6401, 236, 2608, 2084, 27484, 2010, 2014, 14672, 237, 1930, 2222, 6069, 2136, 3619, 2049, 6746, 1990, 1920, 4863, 13282, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_943fb86393", "text": "This publication was to alert healthcare professionals on reports of pharmaceutical defects presenting in the form of crystallization and discoloration with Paraconica (Paracetamol 10mg/ml) Solution for Infusion when stored under refrigerated conditions (2°C-8°C).", "entities": [{"label": "DRUG", "start": 169, "end": 180, "text": "Paracetamol"}], "input_ids": [2, 2052, 7292, 1982, 1942, 18635, 5841, 9229, 1990, 4710, 1927, 11106, 6007, 8326, 1922, 1920, 2386, 1927, 15416, 1930, 2863, 18778, 1943, 1956, 13344, 3490, 1019, 12, 27021, 2119, 9759, 19, 2646, 13, 3331, 1958, 7386, 2469, 6574, 2441, 27484, 1981, 2961, 12, 27670, 1030, 17, 28, 3325, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_ad6fdbbf10", "text": "Healthcare professionals are therefore advised not to refrigerate or freeze Paracetamol IV Solution containing mannitol Storage of the product under refrigerated condition because of ambiguous storage conditions on the primary package which indicated “Do not store above 30°C” Advice to Healthcare Professionals:", "entities": [{"label": "DRUG", "start": 76, "end": 87, "text": "Paracetamol"}], "input_ids": [2, 5841, 9229, 2032, 2955, 19625, 2084, 1942, 27484, 2010, 2014, 14672, 27021, 4370, 3331, 3165, 20915, 7451, 1927, 1920, 4863, 2441, 27484, 1981, 2625, 2882, 1927, 17307, 7451, 2961, 1990, 1920, 3065, 8511, 2154, 3391, 236, 2608, 2084, 14582, 3538, 15017, 237, 12267, 1942, 5841, 9229, 30, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_293bd71d2d", "text": "Newly reported ADRs of interest were one report each of tremor for doxycycline; scrotal pain, dyspnoea, gait disturbances and dysgeusia for chloroquine; and dry throat, hyperhidrosis, restlessness and micturition frequency increased for hydroxychloroquine.", "entities": [{"label": "ADR", "start": 80, "end": 92, "text": "scrotal pain"}, {"label": "ADR", "start": 184, "end": 196, "text": "restlessness"}, {"label": "ADR", "start": 157, "end": 167, "text": "dry throat"}, {"label": "ADR", "start": 94, "end": 102, "text": "dyspnoea"}, {"label": "DRUG", "start": 237, "end": 255, "text": "hydroxychloroquine"}, {"label": "DRUG", "start": 140, "end": 151, "text": "chloroquine"}, {"label": "DRUG", "start": 67, "end": 78, "text": "doxycycline"}], "input_ids": [2, 7471, 2568, 28863, 1927, 4501, 1985, 2340, 3809, 2362, 1927, 18388, 1958, 16647, 31, 7572, 10868, 3594, 16, 14633, 26447, 16, 11031, 12654, 1930, 3890, 2106, 24327, 1019, 1958, 20813, 31, 1930, 7143, 23555, 16, 4194, 7969, 3883, 2475, 16, 6172, 26481, 1930, 2206, 1031, 25682, 3528, 2502, 1958, 8275, 11600, 1037, 15520, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 3, 4, 4, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_5f0ac99557", "text": "In 2021, the FDA granted Emergency Use Authorization (EUA) to six COVID-19 to vaccines listed below: • Sputnik V (Gam-COVID-Vac) • Covishield (ChAdOX1Ncov-19 Corona Virus Vaccine (Recombinant) • COVID-19 Vaccine Janssen Suspension for Injection (Ad26.COV2-S [recombinant]) • Moderna’s Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] • Comirnaty Concentrate for Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] • COVID-19 Vaccine AstraZeneca Suspension for Injection (ChAdOx1 S [recombinant]) The FDA employed a robust safety monitoring strategy including spontaneous and active monitoring during the deployment of these vaccines.", "entities": [{"label": "DRUG", "start": 114, "end": 127, "text": "Gam-COVID-Vac"}, {"label": "DRUG", "start": 474, "end": 485, "text": "AstraZeneca"}, {"label": "DRUG", "start": 131, "end": 141, "text": "Covishield"}, {"label": "DRUG", "start": 358, "end": 367, "text": "Comirnaty"}, {"label": "DRUG", "start": 103, "end": 112, "text": "Sputnik V"}, {"label": "DRUG", "start": 212, "end": 219, "text": "Janssen"}], "input_ids": [2, 1922, 17401, 1009, 16, 1920, 11394, 21660, 7877, 2485, 6799, 2466, 12, 4791, 1019, 13, 1942, 3798, 6083, 1960, 17, 2282, 1942, 9375, 7663, 4535, 30, 241, 13113, 23705, 64, 12, 9011, 17, 6083, 1960, 17, 7017, 13, 241, 6083, 26458, 2884, 12, 13297, 22389, 7653, 15895, 2579, 17, 2282, 5548, 1019, 3413, 5955, 12, 5752, 13, 241, 6083, 1960, 17, 2282, 5955, 29455, 8971, 1958, 4107, 12, 2041, 4684, 18, 6083, 1028, 17, 61, 37, 5752, 39, 13, 241, 10174, 1019, 234, 61, 11834, 1958, 4107, 37, 6083, 1960, 17, 2282, 3616, 5955, 12, 18015, 4795, 13, 39, 241, 2008, 1996, 5791, 1012, 18410, 1958, 11834, 1958, 4107, 37, 6083, 1960, 17, 2282, 3616, 5955, 12, 18015, 4795, 13, 39, 241, 6083, 1960, 17, 2282, 5955, 20329, 27168, 19384, 8971, 1958, 4107, 12, 13297, 22389, 7653, 61, 37, 5752, 39, 13, 1920, 11394, 5789, 43, 5786, 5407, 5378, 4884, 2710, 6242, 1930, 3500, 5378, 2409, 1920, 18898, 1927, 2144, 9375, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 2, 2, 2, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_be668b9f3e", "text": "DrugLens Newsletter 11 Figure 10: Outcome of causality assessment of RTS,S serious AEFI reports, Ghana, 1st May 2019 – 31st May 2022 Ghana has been deploying COVID-19 vaccines since March 2021 and as of 31st May 2022, approximately 15,496,852 doses of the five vaccine types (AstraZeneca COVID-19 Vaccine, COVID-19 vaccine Janssen, Moderna COVID-19 vaccine, Pfizer BioNTech COVID-19 vaccine and Sputnik V) have been administered to various segments of the target population.", "entities": [{"label": "DRUG", "start": 276, "end": 304, "text": "AstraZeneca COVID-19 Vaccine"}, {"label": "DRUG", "start": 395, "end": 404, "text": "Sputnik V"}, {"label": "DRUG", "start": 323, "end": 330, "text": "Janssen"}], "input_ids": [2, 2838, 15253, 1036, 19483, 28509, 1915, 2513, 2292, 2119, 30, 3924, 1927, 19140, 4076, 1927, 17842, 16, 61, 7433, 10194, 19894, 4710, 16, 20685, 16, 13646, 2278, 14064, 229, 3470, 2156, 2278, 17401, 1028, 20685, 2258, 2252, 12759, 1941, 6083, 1960, 17, 2282, 9375, 3328, 10225, 17401, 1009, 1930, 1966, 1927, 3470, 2156, 2278, 17401, 1028, 16, 3993, 2461, 16, 4343, 1016, 16, 5140, 1028, 5312, 1927, 1920, 3628, 5955, 3584, 12, 20329, 27168, 19384, 6083, 1960, 17, 2282, 5955, 16, 6083, 1960, 17, 2282, 5955, 29455, 16, 10174, 1019, 6083, 1960, 17, 2282, 5955, 16, 21932, 3718, 4905, 2305, 6083, 1960, 17, 2282, 5955, 1930, 13113, 23705, 64, 13, 2162, 2252, 5254, 1942, 3425, 7492, 1927, 1920, 2758, 2973, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_6f9abd3b7e", "text": "12 DrugLens Newsletter Table 3: AEFI reporting per vaccine Name of Vaccine Cumulative Dose Administered Method of Detection No. of AEFIs AstraZeneca COVID-19 Vaccine 9,471,006 Active Spontaneous 4,093 Sputnik V 17,982 Active 2458 COVID-19 Vaccine Janssen 1,755,751 Active Spontaneous 1668 Moderna COVID-19 Vaccine 1,065,357 Active Passive 826 Pfizer-BioNTech COVID-19 Vaccine 3,186,756 Active Passive 379 The JCVSRC has performed causality assessment for 49 serious AEFIs as at its 16th Meeting held on 22nd June 2022 as shown in figure 10 below Figure 11: Causality assessment for COVID-19 vaccines Following the extension of vaccination to persons 15 years and above and pregnant women, in addition to booster doses, the FDA has been monitoring the safety of the vaccines in these categories of persons.", "entities": [{"label": "DRUG", "start": 343, "end": 375, "text": "Pfizer-BioNTech COVID-19 Vaccine"}, {"label": "DRUG", "start": 137, "end": 165, "text": "AstraZeneca COVID-19 Vaccine"}, {"label": "DRUG", "start": 201, "end": 210, "text": "Sputnik V"}, {"label": "DRUG", "start": 247, "end": 254, "text": "Janssen"}], "input_ids": [2, 2369, 2838, 15253, 1036, 19483, 28509, 1915, 2545, 23, 30, 10194, 19894, 6605, 2079, 5955, 9533, 1927, 5955, 8274, 3253, 5254, 2417, 1927, 3805, 2239, 18, 1927, 10194, 19894, 1036, 20329, 27168, 19384, 6083, 1960, 17, 2282, 5955, 29, 16, 4261, 1009, 16, 12791, 3500, 6242, 24, 16, 7102, 1010, 13113, 23705, 64, 2752, 16, 5613, 1028, 3500, 20020, 1025, 6083, 1960, 17, 2282, 5955, 29455, 21, 16, 4089, 1015, 16, 4089, 1009, 3500, 6242, 15255, 1025, 10174, 1019, 6083, 1960, 17, 2282, 5955, 21, 16, 6604, 1015, 16, 26099, 3500, 9832, 6175, 1016, 21932, 17, 3718, 4905, 2305, 6083, 1960, 17, 2282, 5955, 23, 16, 16524, 16, 4089, 1016, 3500, 9832, 28066, 1920, 14904, 7147, 15618, 2258, 2593, 19140, 4076, 1958, 4343, 7433, 10194, 19894, 1036, 1966, 2019, 2496, 2641, 1963, 8957, 9865, 1990, 2950, 10249, 10343, 17401, 1028, 1966, 2522, 1922, 2292, 2119, 4535, 2292, 2513, 30, 19140, 4076, 1958, 6083, 1960, 17, 2282, 9375, 2894, 1920, 7140, 1927, 7507, 1942, 7618, 2461, 2739, 1930, 3538, 1930, 7808, 3089, 16, 1922, 2459, 1942, 26419, 5312, 16, 1920, 11394, 2258, 2252, 5378, 1920, 5407, 1927, 1920, 9375, 1922, 2144, 6118, 1927, 7618, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_f583fc73fa", "text": "The AEFIs were similar to those reported by non-pregnant vaccinees including headache, chills and dizziness.", "entities": [{"label": "ADR", "start": 98, "end": 107, "text": "dizziness"}, {"label": "ADR", "start": 77, "end": 85, "text": "headache"}], "input_ids": [2, 1920, 10194, 19894, 1036, 1985, 2551, 1942, 2690, 2568, 2007, 2447, 17, 7808, 5955, 1918, 2710, 12187, 16, 7368, 11560, 1036, 1930, 24009, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_e5efd85cee", "text": "Table 4: Products with additional Risk Minimization Measures Product Name Indication Safety Concern Additional Risk Minimization Measure Etanercept (Enbrel) • Rheumatoid arthritis • Psoriatic arthritis • Ankylosing spondylitis • Non-radiographic axial spondylarthritis • Plaque psoriasis • Juvenile idiopathic arthritis Congestive heart failure in adult subjects is an identified important risk Patient card to be distributed to patient by etanercept prescribing physicians aimed at reducing the risk of serious infections and congestive heart failure and ensuring the traceability of Enbrel drug product.", "entities": [{"label": "ADR", "start": 331, "end": 344, "text": "heart failure"}, {"label": "ADR", "start": 538, "end": 551, "text": "heart failure"}], "input_ids": [2, 2545, 24, 30, 4461, 1956, 3281, 2565, 20940, 3975, 4863, 9533, 10331, 5407, 8353, 3281, 2565, 20940, 2931, 29692, 12, 2066, 6371, 1024, 13, 241, 13053, 8884, 241, 26611, 8884, 241, 29154, 11934, 20213, 3678, 241, 2447, 17, 12859, 9438, 20213, 18956, 16900, 241, 9148, 14109, 241, 13010, 13513, 8884, 20180, 4003, 4574, 1922, 4160, 3297, 1977, 1925, 2899, 2715, 2565, 2774, 9429, 1942, 1998, 6533, 1942, 2774, 2007, 29692, 15103, 6967, 6822, 2019, 5526, 1920, 2565, 1927, 7433, 5024, 1930, 20180, 4003, 4574, 1930, 14435, 1920, 9950, 2550, 1927, 2066, 6371, 1024, 2838, 4863, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_de1e51b08f", "text": "The card will provide the following important safety information to the patients: • Etanercept treatment may increase the risk of infection and congestive heart failure in adults. • Signs or symptoms of infection and congestive heart failure and when to seek attention from a healthcare professional Instructions to record the brand name and batch number of the medication to ensure traceability.", "entities": [{"label": "ADR", "start": 155, "end": 168, "text": "heart failure"}, {"label": "ADR", "start": 228, "end": 241, "text": "heart failure"}], "input_ids": [2, 1920, 9429, 2832, 3394, 1920, 2894, 2715, 5407, 2988, 1942, 1920, 2132, 30, 241, 29692, 2311, 2278, 2760, 1920, 2565, 1927, 2909, 1930, 20180, 4003, 4574, 1922, 4440, 18, 241, 6879, 2014, 3601, 1927, 2909, 1930, 20180, 4003, 4574, 1930, 2469, 1942, 7592, 4976, 2037, 43, 5841, 8578, 7186, 1942, 3727, 1920, 17154, 9533, 1930, 10778, 2529, 1927, 1920, 6093, 1942, 6486, 9950, 2550, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_775b21dbe9", "text": "14 DrugLens Newsletter Product Name Indication Safety Concern Additional Risk Minimization Measure Xarelto (Rivarobaxan) Adults Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack.", "entities": [{"label": "ADR", "start": 276, "end": 289, "text": "heart failure"}], "input_ids": [2, 2607, 2838, 15253, 1036, 19483, 28509, 1915, 4863, 9533, 10331, 5407, 8353, 3281, 2565, 20940, 2931, 23447, 5703, 4575, 12, 30146, 15129, 3013, 1928, 13, 4440, 5455, 1927, 5235, 1930, 5510, 19287, 1922, 4160, 2132, 1956, 2447, 4701, 21791, 9224, 13671, 1956, 2340, 2014, 2253, 2565, 2790, 16, 2427, 1966, 20180, 4003, 4574, 16, 5579, 16, 2632, 374, 4089, 2739, 16, 4032, 9695, 16, 3432, 5235, 2014, 6809, 19855, 8926, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_63a570633c", "text": "The National Pharmacovigilance Centre reviewed the SafetyWatch System (FDA’s national safety database) as part of its routine signal management processes and identified 8 adverse reaction reports of cord infection (including laceration and haemorrhage) associated with the use of chlorhexidine gel between July 2019 to December 2021.", "entities": [{"label": "ADR", "start": 199, "end": 213, "text": "cord infection"}, {"label": "ADR", "start": 240, "end": 251, "text": "haemorrhage"}, {"label": "ADR", "start": 225, "end": 235, "text": "laceration"}], "input_ids": [2, 1920, 3852, 4602, 25210, 6121, 17576, 1972, 8141, 5487, 1920, 5407, 13956, 8888, 2433, 12, 11394, 234, 61, 3852, 5407, 5039, 13, 1966, 3131, 1927, 2496, 7341, 2733, 4280, 4028, 1930, 2899, 28, 5246, 3227, 4710, 1927, 6670, 2909, 12, 2710, 7511, 5026, 1930, 23352, 13, 2458, 1956, 1920, 2485, 1927, 4891, 17797, 5802, 4669, 2192, 10966, 14064, 1942, 9474, 17401, 1009, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 3, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_591c15c234", "text": "Cord infection has not been stated as an adverse reaction in the product information of chlorhexidine digluconate gel, however, review of literature showed that cord infection could occur whilst using the product.", "entities": [{"label": "ADR", "start": 0, "end": 14, "text": "Cord infection"}, {"label": "ADR", "start": 161, "end": 175, "text": "cord infection"}], "input_ids": [2, 6670, 2909, 2258, 2084, 2252, 9662, 1966, 1925, 5246, 3227, 1922, 1920, 4863, 2988, 1927, 4891, 17797, 5802, 4325, 18369, 8870, 4669, 16, 2406, 16, 3043, 1927, 4431, 2594, 1988, 6670, 2909, 2578, 4704, 12126, 2193, 1920, 4863, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_697407a62c", "text": "Safety Advisory - Constipation: a Potentially Serious Side Effect Product Information (PI) and Consumer Medicine Information (CMI) for clozapine have been updated to strengthen warnings about potential severe gastrointestinal side effects, including constipation.", "entities": [{"label": "ADR", "start": 209, "end": 238, "text": "gastrointestinal side effects"}, {"label": "ADR", "start": 18, "end": 30, "text": "Constipation"}, {"label": "ADR", "start": 250, "end": 262, "text": "constipation"}], "input_ids": [2, 5407, 18989, 17, 19618, 30, 43, 5063, 7433, 4159, 2495, 4863, 2988, 12, 4269, 13, 1930, 15863, 5380, 2988, 12, 3195, 1033, 13, 1958, 24424, 2162, 2252, 13236, 1942, 17976, 18149, 1036, 3001, 2889, 4010, 8375, 4159, 2564, 16, 2710, 19618, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "nl_113cdf094c", "text": "Clozapine may also affect the bowels by slowing them down and can cause severe constipation.", "entities": [{"label": "ADR", "start": 79, "end": 91, "text": "constipation"}], "input_ids": [2, 24424, 2278, 2222, 4081, 1920, 9472, 1036, 2007, 20025, 3581, 3292, 1930, 2112, 3936, 4010, 19618, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
{"id": "f1bce2d9160c_aug_severe", "text": "Consequently, research studies that evaluated the performance of the new anti-malarials reported widespread serious side effects such as serious headache, body weakness, dizziness and vomiting [4, 5].", "entities": [{"start": 108, "end": 115, "label": "SEVERITY", "text": "serious"}, {"start": 145, "end": 153, "label": "ADR", "text": "headache"}, {"start": 155, "end": 168, "label": "ADR", "text": "body weakness"}, {"start": 170, "end": 179, "label": "ADR", "text": "dizziness"}, {"start": 184, "end": 192, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 7099, 16, 2659, 2351, 1988, 3747, 1920, 3604, 1927, 1920, 2814, 2246, 17, 29535, 1036, 2568, 9360, 7433, 4159, 2564, 2427, 1966, 7433, 12187, 16, 3362, 12175, 16, 24009, 1930, 13954, 37, 24, 16, 25, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 3, 0, 3, 4, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "9e21d54664cc_aug_severe", "text": "Patients with mild side effects were able to contain them at home and serious cases reported to health facilities.", "entities": [{"start": 14, "end": 18, "label": "SEVERITY", "text": "mild"}, {"start": 70, "end": 77, "label": "SEVERITY", "text": "serious"}], "input_ids": [2, 2132, 1956, 5809, 4159, 2564, 1985, 4236, 1942, 5531, 3581, 2019, 4502, 1930, 7433, 2919, 2568, 1942, 2436, 8774, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-32 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 163, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 164, "end": 180, "label": "ADR", "text": "Loss of appetite"}, {"start": 187, "end": 195, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 205, "end": 227, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 236, "end": 240, "label": "ADR", "text": "weak"}, {"start": 245, "end": 268, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "5673dd503067_aug_serious", "text": "Some of the commonly reported adverse drug reactions include injection site pain, redness, tiredness, or body ache [5, 6, 15, 16].Although most of the AEFIs reported to be associated with the COVID-19 vaccines are generally mild to moderate, there have been reports of some very rare and severe reactions including deaths associated with the use of the vaccines.", "entities": [{"start": 61, "end": 80, "label": "ADR", "text": "injection site pain"}, {"start": 82, "end": 89, "label": "ADR", "text": "redness"}, {"start": 91, "end": 100, "label": "ADR", "text": "tiredness"}, {"start": 105, "end": 114, "label": "ADR", "text": "body ache"}, {"start": 288, "end": 294, "label": "SEVERITY", "text": "severe"}, {"start": 315, "end": 321, "label": "ADR", "text": "deaths"}], "input_ids": [2, 2673, 1927, 1920, 5384, 2568, 5246, 2838, 5298, 3951, 4107, 3200, 3594, 16, 2312, 2971, 16, 16661, 1919, 2971, 16, 2014, 3362, 18564, 37, 25, 16, 26, 16, 2461, 16, 2641, 39, 18, 2876, 2501, 1927, 1920, 10194, 19894, 1036, 2568, 1942, 1998, 2458, 1956, 1920, 6083, 1960, 17, 2282, 9375, 2032, 4933, 5809, 1942, 5086, 16, 2276, 2162, 2252, 4710, 1927, 2673, 3345, 5844, 1930, 4010, 5298, 2710, 7601, 2458, 1956, 1920, 2485, 1927, 1920, 9375, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 3, 4, 0, 3, 4, 4, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "c4eb4d48561e_aug_severe", "text": "Both cases were also associated with serious diarrhoea and vomiting and the subjects were rehydrated, stabilized and discharged, with appropriate counselling to continue and complete the course of 28 days since their risk assessment were rated high.", "entities": [{"start": 37, "end": 44, "label": "SEVERITY", "text": "serious"}, {"start": 45, "end": 54, "label": "ADR", "text": "diarrhoea"}, {"start": 59, "end": 67, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 2321, 2919, 1985, 2222, 2458, 1956, 7433, 20998, 1930, 13954, 1930, 1920, 3297, 1985, 26583, 16, 12017, 1930, 14062, 16, 1956, 4703, 19765, 1942, 9085, 1930, 4080, 1920, 4914, 1927, 3158, 3000, 3328, 2310, 2565, 4076, 1985, 10036, 2149, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 5, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "d5e037d75f74_aug_serious", "text": "The recommendations for vaccinating these special populations against COVID‐19 will continue to evolve as research advances [51].From the Adjusted Logistic Regression model of factors associated with the severeness of AEFIs among people who reported COVID-19 vaccine-related AEFIs, relative to those 50 years and above, the odds of severe AEFI was 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019).It is, however, worth noting that of the 57 severe AEFIs, the causality assessment by the FDA’s Joint COVID-19 Vaccine Safety Review Committee indicated that only 8 (14%) were vaccine product-related reactions providing further assurance of the safety of the vaccines in Ghana.The eight severe AEFIs which resulted in hospitalization were assessed by the FDA’s Joint COVID-19 Vaccine Safety Review Committee using the WHO Guidelines on Causality Assessment of AEFIs as having a Consistent causal association to immunization (A1: Vaccine product-related) [33].", "entities": [{"start": 300, "end": 318, "label": "PATIENT_DEMO", "text": "50 years and above"}, {"start": 369, "end": 383, "label": "PATIENT_DEMO", "text": "aged <30 years"}, {"start": 470, "end": 482, "label": "SEVERITY", "text": "severe AEFIs"}], "input_ids": [2, 1920, 7578, 1958, 4117, 9691, 2144, 5180, 4098, 3316, 6083, 1960, 226, 2282, 2832, 9085, 1942, 17175, 1966, 2659, 9382, 37, 4892, 39, 18, 2037, 1920, 4967, 6933, 4165, 2322, 1927, 2790, 2458, 1956, 1920, 4010, 2971, 1927, 10194, 19894, 1036, 2706, 4329, 2746, 2568, 6083, 1960, 17, 2282, 5955, 17, 2712, 10194, 19894, 1036, 16, 3338, 1942, 2690, 2761, 2739, 1930, 3538, 16, 1920, 6408, 1927, 4010, 10194, 19894, 1982, 3276, 9, 2941, 2706, 2690, 5177, 32, 2627, 2739, 12, 14973, 33, 20, 18, 3040, 16, 3371, 30, 37, 20, 18, 2282, 16, 20, 18, 5713, 39, 16, 58, 33, 20, 18, 19074, 13, 18, 2176, 1977, 16, 2406, 16, 10267, 16415, 1988, 1927, 1920, 4786, 4010, 10194, 19894, 1036, 16, 1920, 19140, 4076, 2007, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 3391, 1988, 2444, 28, 12, 2607, 9, 13, 1985, 5955, 4863, 17, 2712, 5298, 5453, 2520, 21625, 1927, 1920, 5407, 1927, 1920, 9375, 1922, 20685, 18, 1920, 5066, 4010, 10194, 19894, 1036, 2154, 4306, 1922, 9679, 1985, 3683, 2007, 1920, 11394, 234, 61, 6047, 6083, 1960, 17, 2282, 5955, 5407, 3043, 6182, 2193, 1920, 2746, 5522, 1990, 19140, 4076, 1927, 10194, 19894, 1036, 1966, 4537, 43, 3499, 9263, 3279, 1942, 10139, 12, 8080, 30, 5955, 4863, 17, 2712, 13, 37, 3401, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 6, 6, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "adba0e72bdf9_aug_serious", "text": "The third case of severe adverse event of fatigue, headache and weakness involving an exposed female HCW of 42 years was also stabilized and discharged (after three days hospitalisation) with appropriate counselling to continue and complete the course of 28 days.This study could not establish any association between the report of at least one adverse events and factors such as gender, age, profession, outcome of risk assessment and type of exposure in the multivariate analysis although other studies have associated adverse events with gender [17].", "entities": [{"start": 18, "end": 24, "label": "SEVERITY", "text": "severe"}, {"start": 42, "end": 49, "label": "ADR", "text": "fatigue"}, {"start": 51, "end": 59, "label": "ADR", "text": "headache"}, {"start": 64, "end": 72, "label": "ADR", "text": "weakness"}, {"start": 94, "end": 116, "label": "PATIENT_DEMO", "text": "female HCW of 42 years"}], "input_ids": [2, 1920, 4563, 3087, 1927, 4010, 5246, 4817, 1927, 8656, 16, 12187, 1930, 12175, 5884, 1925, 4616, 4232, 4387, 1018, 1927, 3858, 2739, 1982, 2222, 12017, 1930, 14062, 12, 2256, 2559, 3000, 26185, 13, 1956, 4703, 19765, 1942, 9085, 1930, 4080, 1920, 4914, 1927, 3158, 3000, 18, 2052, 2161, 2578, 2084, 5389, 2967, 3279, 2192, 1920, 3809, 1927, 2019, 3464, 2340, 5246, 3916, 1930, 2790, 2427, 1966, 5125, 16, 2632, 16, 6112, 16, 3924, 1927, 2565, 4076, 1930, 2601, 1927, 3395, 1922, 1920, 6884, 2333, 2876, 2303, 2351, 2162, 2458, 5246, 3916, 1956, 5125, 37, 2752, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 5, 0, 0, 0, 3, 0, 3, 0, 3, 0, 0, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "cohort_study"}
{"id": "7dcfb568b4eb_demoaug_27_year__aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-27 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 163, "label": "PATIENT_DEMO", "text": "27 year old female patient"}, {"start": 164, "end": 180, "label": "ADR", "text": "Loss of appetite"}, {"start": 187, "end": 195, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 205, "end": 227, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 236, "end": 240, "label": "ADR", "text": "weak"}, {"start": 245, "end": 268, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 3225, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_44_year__aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-44 year old female patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 163, "label": "PATIENT_DEMO", "text": "44 year old female patient"}, {"start": 164, "end": 180, "label": "ADR", "text": "Loss of appetite"}, {"start": 187, "end": 195, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 205, "end": 227, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 236, "end": 240, "label": "ADR", "text": "weak"}, {"start": 245, "end": 268, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 4044, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_32_year__aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-32 year old male patient)Loss of appetite “When my child took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 161, "label": "PATIENT_DEMO", "text": "32 year old male patient"}, {"start": 162, "end": 178, "label": "ADR", "text": "Loss of appetite"}, {"start": 185, "end": 193, "label": "PATIENT_DEMO", "text": "my child"}, {"start": 203, "end": 225, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 234, "end": 238, "label": "ADR", "text": "weak"}, {"start": 243, "end": 266, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 3323, 2476, 4156, 4005, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 2748, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_my_son_aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-32 year old female patient)Loss of appetite “When my son took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 163, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 164, "end": 180, "label": "ADR", "text": "Loss of appetite"}, {"start": 187, "end": 193, "label": "PATIENT_DEMO", "text": "my son"}, {"start": 203, "end": 225, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 234, "end": 238, "label": "ADR", "text": "weak"}, {"start": 243, "end": 266, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 9337, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}
{"id": "7dcfb568b4eb_demoaug_my_daugh_aug_serious", "text": "When it starts unless he takes akpetashie (type of wine prepared locally) (type of wine prepared locally) it will always be severe” (IDI-32 year old female patient)Loss of appetite “When my daughter took the artesunate-amodiaquine, he was weak and could not open his eyes.", "entities": [{"start": 124, "end": 130, "label": "SEVERITY", "text": "severe"}, {"start": 137, "end": 163, "label": "PATIENT_DEMO", "text": "32 year old female patient"}, {"start": 164, "end": 180, "label": "ADR", "text": "Loss of appetite"}, {"start": 187, "end": 198, "label": "PATIENT_DEMO", "text": "my daughter"}, {"start": 208, "end": 230, "label": "DRUG", "text": "artesunate-amodiaquine"}, {"start": 239, "end": 243, "label": "ADR", "text": "weak"}, {"start": 248, "end": 271, "label": "ADR", "text": "could not open his eyes"}], "input_ids": [2, 2469, 2176, 15447, 10292, 2234, 9620, 4464, 9626, 3857, 6150, 2621, 12, 2601, 1927, 19201, 4649, 10753, 13, 12, 2601, 1927, 19201, 4649, 10753, 13, 2176, 2832, 6789, 1998, 4010, 237, 12, 11407, 17, 3323, 2476, 4156, 4232, 2774, 13, 3257, 1927, 17990, 236, 2469, 3057, 16229, 8659, 1920, 20897, 20490, 5791, 1021, 17, 2150, 13968, 15520, 16, 2234, 1982, 5015, 1930, 2578, 2084, 4437, 4167, 7127, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 7, 8, 8, 8, 8, 0, 3, 4, 4, 0, 0, 7, 8, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 3, 4, 4, 4, 4, 0, -100], "source_type": "qualitative_interview"}